diff --git a/exercicios/para-casa/exercicioCrisPereira/connectingHealthIndicators.py b/exercicios/para-casa/exercicioCrisPereira/connectingHealthIndicators.py new file mode 100644 index 0000000..822634b --- /dev/null +++ b/exercicios/para-casa/exercicioCrisPereira/connectingHealthIndicators.py @@ -0,0 +1,35 @@ +import sqlite3 +import csv +connection = sqlite3.connect('health_indicators.db') +cursor = connection.cursor() + +# VAR,"Variable","UNIT","Measure","COU","Country","YEA","Year","Value","Flag Codes","Flags" + +cursor.execute('''CREATE TABLE IF NOT EXISTS pharmaceuticals ( + id INTEGER PRIMARY KEY AUTOINCREMENT, + VAR TEXT, + Variable TEXT, + UNIT TEXT, + Measure TEXT, + COU TEXT, + Country TEXT, + YEA TEXT, + Year TEXT, + Value FLOAT, + Flag_Codes TEXT, + Flags TEXT + );''') + +file = open("health_indicators_ocde.csv") + +content = csv.reader(file) + +insert_content = "INSERT INTO pharmaceuticals (VAR,Variable,UNIT,Measure,COU,Country,YEA,Year,Value,Flag_Codes,Flags) VALUES(?, ?, ?, ?, ?, ?, ?, ?, ?, ?, ?)" + +cursor.executemany(insert_content, content) + +select_all = "SELECT * FROM pharmaceuticals" +entry = cursor.execute(select_all).fetchall() + +connection.commit() +connection.close() \ No newline at end of file diff --git a/exercicios/para-casa/exercicioCrisPereira/connectingMaternalMortality.py b/exercicios/para-casa/exercicioCrisPereira/connectingMaternalMortality.py new file mode 100644 index 0000000..cefed47 --- /dev/null +++ b/exercicios/para-casa/exercicioCrisPereira/connectingMaternalMortality.py @@ -0,0 +1,28 @@ +import sqlite3 +import csv +connection = sqlite3.connect('maternal_mortality.db') +cursor = connection.cursor() + +# Entity,Code,Year,Indicator:Maternal mortality ratio (per 100 000 live births) + +cursor.execute('''CREATE TABLE IF NOT EXISTS maternal_mortality ( + id INTEGER PRIMARY KEY AUTOINCREMENT, + Entity TEXT, + Code TEXT, + Year TEXT, + Maternal_mortality_ratio FLOAT + );''') + +file = open("maternal-mortality-who.csv") + +content = csv.reader(file) + +insert_content = "INSERT INTO maternal_mortality (Entity,Code,Year,Maternal_mortality_ratio) VALUES(?, ?, ?, ?)" + +cursor.executemany(insert_content, content) + +select_all = "SELECT * FROM maternal_mortality" +entry = cursor.execute(select_all).fetchall() + +connection.commit() +connection.close() \ No newline at end of file diff --git a/exercicios/para-casa/exercicioCrisPereira/extra_functions.py b/exercicios/para-casa/exercicioCrisPereira/extra_functions.py new file mode 100644 index 0000000..d1d8d4d --- /dev/null +++ b/exercicios/para-casa/exercicioCrisPereira/extra_functions.py @@ -0,0 +1,31 @@ +import sqlite3 +import csv + +# Abaixo as funções extras +# edição +def data_update(banco, tabela, id_registro, novo_valor, campo): + connection = sqlite3.connect(f'{banco}.db') + cursor = connection.cursor() + atualizar_conteudo = f"UPDATE {tabela} SET {campo} = ? WHERE id = ?" + cursor.execute(atualizar_conteudo, (novo_valor, id_registro)) + connection.commit() + connection.close() + +# deleção +def delete_register(banco, tabela, id_registro): + connection = sqlite3.connect(f'{banco}.db') + cursor = connection.cursor() + excluir_conteudo = f"DELETE FROM {tabela} WHERE id = ?" + cursor.execute(excluir_conteudo, (id_registro,)) + connection.commit() + connection.close() + + +# chamando as funções para atualizar os dados. +data_update("health_indicators", "pharmaceuticals",4,"newAustralia","Country") +data_update("maternal_mortality", "maternal_mortality",2,"newAfeghanistan","Entity") + +delete_register("health_indicators", "pharmaceuticals",3) +delete_register("maternal_mortality", "maternal_mortality",4) + + diff --git a/exercicios/para-casa/exercicioCrisPereira/health_indicators.db b/exercicios/para-casa/exercicioCrisPereira/health_indicators.db new file mode 100644 index 0000000..759e988 Binary files /dev/null and b/exercicios/para-casa/exercicioCrisPereira/health_indicators.db differ diff --git a/exercicios/para-casa/exercicioCrisPereira/health_indicators_ocde.csv b/exercicios/para-casa/exercicioCrisPereira/health_indicators_ocde.csv new file mode 100644 index 0000000..aeffb0c --- /dev/null +++ b/exercicios/para-casa/exercicioCrisPereira/health_indicators_ocde.csv @@ -0,0 +1,62545 @@ +"VAR","Variable","UNIT","Measure","COU","Country","YEA","Year","Value","Flag Codes","Flags" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",9795,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",10261,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",10355,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",11820,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",11888,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",12284,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",15305,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",14774,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",14905,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",15559,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",16614,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",17556,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",8984.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",10584.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",10721.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",11411,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",10716.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",9228.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",11377.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",11323.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",11136.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",10816.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",11433.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",13187.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",6514.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",6790.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",6723.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",8167.9,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",8184.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",8335.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",10554,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",9999,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",10136.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",10513.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",11426.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",12127.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",407.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",473.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",471.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",493.4,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",456.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",387.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",470.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",460.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",446,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",426.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",445.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",513.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",295.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",304,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",295.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",353.2,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",348.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",350,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",436.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",406.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",406,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",414.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",445.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",472.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",2493,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",2549.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",2613,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",2635.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",2787.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",2928.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",3006.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",3127.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",3213.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",3312.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",3475.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",3711.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",3305,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",3548.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",3357.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",3499.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",3703.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",3249.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",3327.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",3532.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",3795.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",3708.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",3970.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",4390,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",2959.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",3066.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",3211.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",3306,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",3489.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",3666.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",3869.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",4035.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",4198.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",4421.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",4657.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",4907.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",395.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",422.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",398.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",412.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",433.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",376,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",380.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",401.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",429.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",417.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",445.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",490.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",353.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",365.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",381,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",389.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",408.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",424.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",442.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",458.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",474.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",498,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",522.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",548,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",5881.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",5993.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",5939.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",5947.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",5947.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",6191.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",6242.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",6543.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",6681.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",7355.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",7662,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",8051.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",9006.9,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",7797.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",8342.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",7630.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",7899.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",7901.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",6869.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",6910,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",7391.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",7890,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",8234.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",8751.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",9523,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",9484.8,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",7030.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",7204.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",7224.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",7378,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",7432.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",7739.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",7993,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",8435.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",8717.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",9851.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",10491.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",10929.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",12615.9,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",715.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",755.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",687,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",707.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",704.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",609.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",609.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",649.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",690.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",716.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",758.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",821.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",816.4,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",645.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",652.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",650.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",661.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",663.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",686.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",705.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",741.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",762.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",857.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",909.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",943.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",1085.9,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",24297.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",24579.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",25517,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",27126.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",28334.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",29776.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",30603.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",31829.5,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",34260.5,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",36839.6,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",39943.9,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",24313.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",23860.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",23097.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",21212.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",21374.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",22941.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",23617.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",23989.8,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",25545.5,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",29380.5,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",30689.3,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",19522.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",20081,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",20739.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",21735.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",23474.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",24561.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",25365.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",25778.8,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",27830,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",29753.6,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",31857.3,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",700.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",680.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",651.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",594.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",591.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",627.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",637.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",638,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",671.6,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",768.2,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",789.3,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",562.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",572.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",585.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",608.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",650.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",672.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",684.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",685.6,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",731.7,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",778,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",819.3,"E; D","Estimated value; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",81467.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",80927.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",83749.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",79711.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",81080.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",84444.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",87267.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",92013.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",97984.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",103398.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",87781.9,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",93006.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",4265.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",4573.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",4277.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",4073,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",3906.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",3432.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",3570.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",3936.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",4509.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",4508.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",3782,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",4290.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",5958.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",6064.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",6298,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",6234.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",6382.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",6526.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",6939,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",7405.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",7920.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",8423.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",7044.5,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",7298.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",407.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",435.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",407,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",387.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",371.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",325.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",337.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",371.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",424.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",422.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",353.5,"B","Break" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",408.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",568.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",577.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",599.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",593,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",606.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",618.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",656.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",699,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",745.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",789.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",658.5,"B","Break" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",694.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",21171.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",20540.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",20459.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",20422.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",21418.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",21897.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",22110,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",22941.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",23831.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",24553.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",25270.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",25516.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",3764.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",3825.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",3532.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",3636.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",3816.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",3254.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",3284.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",3474.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",3774,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",3681.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",3862.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",4058.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",2788.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",2751,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",2704.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",2776.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",2922.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",2997.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",3122.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",3338.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",3522.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",3701.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",3857.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",3872.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",678.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",686.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",631.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",647.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",676.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",572.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",573.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",602.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",651.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",633.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",662.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",693,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",502.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",493.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",483.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",494.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",517.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",527.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",545.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",579.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",608,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",636.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",661.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",661.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",1880.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",1927.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",1964.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",2012.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",2093.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",2200.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",2288.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",2313.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",2502.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",2658.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",2693.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",2852.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",2492.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",2683.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",2524.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",2673.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",2781.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",2441,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",2533.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",2613.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",2955.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",2976.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",3077,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",3373.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",2087.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",2146.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",2162.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",2223.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",2307.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",2423.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",2598.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",2679,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",2931,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",3171.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",3273.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",3450.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",464.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",498,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",466.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",491.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",509.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",445.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",461,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",474.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",535.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",539,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",556.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",608.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",389.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",398.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",399.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",408.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",422.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",442.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",472.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",486.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",531.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",574.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",591.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",622.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FRA","France","2010","2010",27539,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",27600,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FRA","France","2012","2012",27200,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","FRA","France","2013","2013",26800,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FRA","France","2010","2010",36508.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",38418,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FRA","France","2012","2012",34946.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","FRA","France","2013","2013",35593.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2010","2010",32221.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",32804,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2012","2012",32216,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2013","2013",33019.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FRA","France","2010","2010",563.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",589.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FRA","France","2012","2012",534,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","FRA","France","2013","2013",541.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2010","2010",497.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",503.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2012","2012",492.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2013","2013",502,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",29724.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",29716.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",30442,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",31524.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",33564.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",35349.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",36118.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",37188.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",44230.1,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",46853.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",49155.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",53299.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",39406.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",41363.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",39111.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",41867.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",44590.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",39221,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",39979.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",42011.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",52233.7,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",52451.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",56145.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",63040,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",36921.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",37675.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",38669,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",40687.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",43650.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",45429.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",47991.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",49932.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",60140.3,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",64337.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",67800.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",72391.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",481.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",515.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",486.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",519.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",550.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",480.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",485.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",508.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",630,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",631.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",675.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",757.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",451.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",469.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",480.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",504.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",539,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",556.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",582.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",604.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",725.4,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",774.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",815.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",870.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",498140.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",515299.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",444548.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",430163.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",442945.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",466411.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",498866.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",493022.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",500762.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",527613.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",557449.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",568039.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",597360.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",2395.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",2563,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",1974.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",1923,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",1904.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",1669.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",1772,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",1796.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",1853.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",1815.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",1809.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",1873.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",1603.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",3940.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",4146.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",3538.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",3441.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",3422.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",3518.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",3778.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",3624.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",3600.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",3746.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",3835.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",3670.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",3704.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",239.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",257,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",199.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",194.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",193,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",169.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",180.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",183.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",189.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",185.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",185.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",193,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",165.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",394,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",415.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",356.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",347.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",346.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",357.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",385,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",370.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",368.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",383.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",393.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",378,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",382.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",25011.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",26083.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",24278,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",26023.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",23689.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",24403.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",25384.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",26522.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",30184.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",33635,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",39846.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",45105.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",204.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",224.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",194.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",213,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",202.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",185,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",210.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",248.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",278.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",274.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",294.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",355.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",188.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",193,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",177.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",189.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",171,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",171.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",181.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",191.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",214.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",239.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",271.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",301.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",643.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",705.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",605.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",657.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",619.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",559.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",626.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",722.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",790.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",760.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",802.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",953.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",591.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",605,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",552.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",586.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",522.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",519.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",540.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",558.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",607,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",663,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",741.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",808.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",2050,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",1956.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",2044.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",1959.6,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",1913.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",1985.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",2076,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",2124.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",2264.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",2406.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",2458.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",2621.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",2717.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",2723.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",2627.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",2602.6,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",2542.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",2202.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",2298,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",2399.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",2674.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",2693.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",2808.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",3100.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",2413,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",2353.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",2484.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",2415.6,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",2336.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",2451.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",2613.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",2674.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",2858.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",2986.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",3088.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",3298.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",596,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",594.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",571.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",562.9,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",545.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",468.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",483.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",499.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",549.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",545.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",563.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",616,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",529.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",513.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",540.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",522.4,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",501.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",521.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",549.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",556.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",587.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",605.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",619.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",655.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",19514,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",19077.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",19445,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",19887.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",22615.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",22780.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",22618.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",22361.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",22859.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",23151.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",23842.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",24798.5,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",27162.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",24511,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",25825.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",26420.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",25092,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",25215.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",25552,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",26408,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",25591.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",26444,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",28199.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",26114,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",25720.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",25514.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",26373.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",26888,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",30615.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",32518.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",32785.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",32825.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",34806.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",35744.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",36819.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",40164.8,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",457.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",411.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",428.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",434.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",413.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",415.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",422.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",437.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",428.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",444.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",476.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",442.4,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",433.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",428.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",437.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",442.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",504.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",536.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",541.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",543.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",582.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",601.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",622.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",680.4,"E","Estimated value" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",6779099,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",6987367,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",6976712,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",6894014,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",6589762,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",6748121,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",6623860,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",6721317,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",6907722,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",9489305,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",9264066,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",9180180,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",77228.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",87553.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",87437.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",70638.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",62200,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",55749.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",60885,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",59922.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",62556.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",87050.1,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",86762.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",83643,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",60685,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",65026.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",66907.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",68053.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",63945.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",65218.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",62773.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",63950.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",66319.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",91045.5,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",90444.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",89957.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",603.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",684.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",685.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",554.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",488.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",438.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",479.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",472.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",494.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",690,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",687.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",666.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",473.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",508.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",524.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",534.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",502.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",513.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",494.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",504.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",524.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",721.6,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",717,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",716.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",20322863,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",22054640,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",21735937.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",22556709.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",23669148,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",24607410,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",25393661.2,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",26957165.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",28893231.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",31031450.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",32522204.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",34704585,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",17573.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",19900.7,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",19289.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",20600.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",22481.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",21758.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",21876.6,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",23834.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",26262.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",26628.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",27555,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",30337.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",24165.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",25807.4,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",25425.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",25954.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",27147.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",28697.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",29568.4,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",30892,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",33798.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",36233.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",38824.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",40633.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",354.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",398.5,"B","Break" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",384.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",408.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",443,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",426.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",427.1,"B","Break" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",464.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",509.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",514.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",531.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",586.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",487.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",516.8,"B","Break" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",506.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",514.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",535,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",562.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",577.3,"B","Break" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",601.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",655.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",700,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",749,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",785.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",189.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",190.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",195.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",194.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",191.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",192.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",194.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",194.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",198.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",204.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",209.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",239.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",257.3,"D; P","Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",251.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",265,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",251.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",258.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",254.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",213.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",215.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",219.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",234.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",228.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",238.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",283.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",270.9,"D; P","Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",204.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",210.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",215.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",217.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",216.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",218.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",228.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",228.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",234,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",242.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",244.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",279.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",309.4,"D; P","Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",530.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",549.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",510.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",515.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",497.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",412.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",409.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",409,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",429.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",411.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",421.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",492.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",461.9,"D; P","Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",432.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",436.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",438.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",433.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",423.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",421.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",434.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",426.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",428.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",436.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",430.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",485.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",527.5,"D; P","Difference in methodology; Provisional value" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","MEX","Mexico","2013","2013",141748.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","MEX","Mexico","2018","2018",228114.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2013","2013",11098.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2018","2018",11853.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2013","2013",17978.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2018","2018",24591,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2013","2013",93.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2018","2018",94.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2013","2013",151.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2018","2018",196.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",5213.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",5210,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",4608.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",4301.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",4328.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2015","2015",4463.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2016","2016",4532.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2017","2017",4561.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2018","2018",4624,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2019","2019",4846.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2020","2020",4971.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NLD","Netherlands","2021","2021",4860.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",6911.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",7252.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",5920.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",5712.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",5750.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2015","2015",4952.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2016","2016",5016.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2017","2017",5152.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2018","2018",5460.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2019","2019",5425.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2020","2020",5678.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2021","2021",5749.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",6103.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",6231.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",5589.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",5388.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",5351.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2015","2015",5510.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2016","2016",5697.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2017","2017",5831.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2018","2018",5953,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2019","2019",6225,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2020","2020",6512.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2021","2021",6313,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",415.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",434.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",353.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",339.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",341,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2015","2015",292.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2016","2016",294.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2017","2017",300.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2018","2018",316.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2019","2019",312.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2020","2020",325.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2021","2021",327.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",367.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",373.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",333.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",320.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",317.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2015","2015",325.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2016","2016",334.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2017","2017",340.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2018","2018",345.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2019","2019",358.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2020","2020",373.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2021","2021",360.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",748.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",817,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",924.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",922.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",959.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",987.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",1072.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",1262.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",1321.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",1492,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",1652,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",1777,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",1903,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",539.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",645.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",748.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",756.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",796,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",688.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",746.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",896.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",914.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",983,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",1071.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",1256.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",1206.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",500.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",549.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",617.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",638.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",666,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",668.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",744,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",882.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",898.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",1053.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",1168.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",1217.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",1319.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",124,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",147.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",169.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",170.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",176.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",149.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",158.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",186.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",186.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",197.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",210.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",245.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",235.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",115,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",125.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",140.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",143.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",147.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",145,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",157.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",183.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",183.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",211.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",229.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",238.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",257.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",17890,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",18200,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",18800,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",19300,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",21077,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",22769,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",24769,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",26650,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",27494,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",28400,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",29708,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",33559,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",36008,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",2959.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",3247.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",3231.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",3285.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",3344.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",2823.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",2948.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",3221.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",3380.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",3227.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",3155.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",3906.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",3745.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",1954.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",2003.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",2080.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",2137.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",2271.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",2292.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",2466.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",2733.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",2868.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",2952.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",3006.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",3528,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",3352.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",605.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",655.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",643.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",646.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",651.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",544.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",563.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",610.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",636.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",603.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",586.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",722.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",690.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",399.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",404.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",414.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",420.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",442.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",441.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",471.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",518,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",540.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",552,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",559,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",652.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",618,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",3237.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",2942.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",2614,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",2409.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",2397.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",2491.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",2530.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",2555.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",2627.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",2789.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",2809.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",2923,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",3187.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",4292.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",4096,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",3358.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",3200.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",3185.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",2764.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",2800.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",2886.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",3103.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",3123.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",3208.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",3457.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",3357,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",5195.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",4722.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",4317.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",4128.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",4141.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",4259,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",4428.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",4438.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",4600.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",4993,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",5042.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",5149.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",5796.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",406,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",388,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",319.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",306,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",306.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",266.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",271.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",280.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",301.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",303.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",311.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",333.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",324.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",491.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",447.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",410.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",394.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",398.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",411.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",428.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",430.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",447.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",485.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",489.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",496.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",559.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",1115.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",1128.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",1104.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",1229.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",1317.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",1384.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",1573.3,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",1563,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",1629.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",1730.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",1661.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",1789.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",1479.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",1570.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",1418.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",1632.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",1749.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",1536.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",1741.5,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",1765.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",1924.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",1936.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",1898,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",2116.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",2222,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",2228.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",2188.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",2502.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",2713.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",2816.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",3126.6,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",3026.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",3097.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",3343.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",3195.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",3354.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",274.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",291,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",262.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",301.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",322.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",283.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",320.7,"B","Break" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",324.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",353.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",355.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",347.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",388.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",412.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",412.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",404.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",462.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",500.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",519.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",575.7,"B","Break" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",556.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",568.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",613,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",585.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",615.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",13238.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",12356.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",11072,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",10669.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",11302.6,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",11403.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",11833,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",12064.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",18994,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",20007.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",20802.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",22020.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",22932.1,"P","Provisional value" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",17550.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",17199.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",14225.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",14170.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",15015.6,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",12652.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",13098,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",13629.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",22431.1,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",22397.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",23760.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",26044.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",24148.6,"P","Provisional value" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",18211.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",17302.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",15931.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",15811.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",17064.2,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",17155,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",18412.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",19125.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",30063.4,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",32640.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",33479.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",35179.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",38462.8,"P","Provisional value" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",376.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",368,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",304.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",304,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",323,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",272.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",281.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",292.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",479.3,"B","Break" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",475.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",501.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",549.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",509.1,"P","Provisional value" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",391,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",370.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",340.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",339.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",367.1,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",369.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",396.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",410.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",642.4,"B","Break" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",692.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",706.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",741.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",810.9,"P","Provisional value" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",36059.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",36781.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",36116.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",36337.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",37808.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",40557.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",42346.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",43703.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",47840.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",50523.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",52438.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",53870.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",57795.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",5003,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",5664.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",5330.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",5578.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",5510.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",4808.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",4945.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",5112.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",5503.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",5341.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",5693.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",6281.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",5714.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",3995.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",4158.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",4173,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",4226.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",4332.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",4580.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",4799.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",4937,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",5396,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",5800.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",6049.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",6176.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",6669,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",533.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",599.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",560,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",581.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",568.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",490.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",498.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",508.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",540.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",519.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",549.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",603,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",546.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",426,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",440.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",438.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",440.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",446.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",467.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",483.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",490.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",530.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",564.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",584.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",593,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",638,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",5744.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",5776,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",5937,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",5931,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",5931,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",6184,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",6380,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",6520,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",6605,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",6696,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",6836,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",7116,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",7596,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",5507.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",6504.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",6331.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",6398.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",6473.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",6425.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",6474.6,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",6621.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",6754.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",6738.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",7280.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",7786.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",7955.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",3917.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",4133.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",4384.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",4518.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",4627.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",5004.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",5308,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",5489.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",5602.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",5820.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",6019.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",6431.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",7126.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",703.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",822,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",791.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",791,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",790.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",775.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",773.2,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",783.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",793.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",785.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",842.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",894.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",910.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",500.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",522.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",548.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",558.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",565.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",604.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",633.9,"B; D","Break; Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",649.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",658,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",678.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",696.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",738.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",815.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",15588.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",14167,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",13519.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",14335.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",15698.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",18303.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",21893.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",25447.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",32038,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",42070.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",49965.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",64807.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",10372.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",8458.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",7527.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",7530.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",7173.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",6729.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",7249.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",6975.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",6635.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",7414.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",7129.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",7322.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",16937.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",14663,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",13256.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",13394,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",14213.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",15745.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",17641,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",18387.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",19623.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",22569.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",23087.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",23080.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",141.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",114,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",100.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",98.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",92.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",86,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",91.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",86.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",81.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",89.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",85.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",87,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",231.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",197.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",176.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",175.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",184.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",201.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",222.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",228.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",241.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",273.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",276.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",274.3,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2010","2010",13156.1,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2011","2011",12983.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",13772.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",14602.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",15995.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",17686.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",18554.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",19525.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",20446.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2010","2010",20328.4,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2011","2011",20802.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",21755.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",22827.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",26319.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",27021.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",25051.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",25129.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",27279,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2010","2010",18733.4,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2011","2011",18389,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",19629.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",21002.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",22901.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",25538.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",26944.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",28520.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",29731.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2010","2010",323.9,"B","Break" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2011","2011",328.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",341.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",356.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",407.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",415,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",381.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",380.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",410.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2010","2010",298.5,"B","Break" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2011","2011",290.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",308.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",327.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",354.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",392.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",410.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",431.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",447.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",826115.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",1179279,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",1248234.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",1446986.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",1546451.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",1823693.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",2023878.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",2067820.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",2296898.5,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",2522481.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",2689451.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",2813418,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",2817224.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",1619,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",2438.2,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",2565.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",2921.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",2711.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",2788,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",2989.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",3187,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",3581.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",3588.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",3392.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",3707,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",3225.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",2295.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",3388.6,"B","Break" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",3594.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",4138,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",4211.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",4662,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",5094.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",5199.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",5796.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",6280.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",6427.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",6465.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",6438.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",94.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",141.3,"B","Break" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",147.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",165.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",152.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",155.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",164.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",173,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",191,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",187.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",174.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",188.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",162.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",134.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",196.4,"B","Break" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",206.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",235,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",236.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",259.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",280.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",282.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",309.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",328.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",330.3,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",328.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",324.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",194.1,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",204.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",221.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",231,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",249.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",265.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",289.9,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",301,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",325.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",344.4,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",358.6,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",408.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",431.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",257.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",284.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",284.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",306.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",331.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",294.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",320.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",340,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",384.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",385.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",409.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",483.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",454.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",379,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",399.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",425.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",442.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",473.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",493.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",549.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",562.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",604,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",641.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",684.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",752.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",757.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",193.2,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",214.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",215.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",232.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",252.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",223.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",243.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",258.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",290.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",290.5,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",308.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",363.3,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",341,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",284.6,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",301,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",321.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",335.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",360.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",375,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",417.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",427.1,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",456.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",483.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",515,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",565.2,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",568.8,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",474.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",470,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",454.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",451.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",432.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",446,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",466.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",484.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",516.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",542.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",568.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",613.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",679.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",628.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",654.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",583.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",599.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",574.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",494.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",516.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",547,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",610.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",606.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",649,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",725.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",715.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",743.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",753.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",748.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",764,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",731.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",749.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",808.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",849.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",910.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",981.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",1038.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",1088.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",1231.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",307,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",318.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",283.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",290.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",278.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",239.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",250.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",264.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",294.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",290.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",308.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",344.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",339.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",363,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",367,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",364,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",370.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",354.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",363.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",391.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",411,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",439,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",470.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",493.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",516.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",584.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",1227,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",1218,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",1214,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",1399,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",1351,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",1353,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",1383,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",1424,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",1410,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",1415,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",1493,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",1634,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",1125.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",1256.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",1257,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",1350.6,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",1217.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",1016.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",1028.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",1091.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",1053.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",983.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",1027.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",1227.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",816,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",806.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",788.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",966.7,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",930.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",918.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",953.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",963.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",958.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",956.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",1026.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",1128.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",51.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",56.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",55.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",58.4,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",51.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",42.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",42.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",44.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",42.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",38.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",40,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",47.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",37,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",36.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",34.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",41.8,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",39.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",38.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",39.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",39.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",38.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",37.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",40,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",43.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",12.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",11.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",11.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",11.8,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",11.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",11,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",9.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",9.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",9.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",9.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",274.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",272.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",273,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",275.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",287.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",297.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",296.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",304.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",316.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",343,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",368.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",391.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",363.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",379.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",350.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",365.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",381.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",329.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",328.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",343.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",373.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",384,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",420.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",462.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",325.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",327.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",335.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",345.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",359.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",372,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",382.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",392.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",413.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",457.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",493.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",517.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",43.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",45.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",41.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",43.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",44.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",38.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",37.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",39.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",42.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",43.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",47.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",51.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",39,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",39,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",39.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",40.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",42,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",43,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",43.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",44.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",46.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",51.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",55.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",57.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",11,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",10.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",10.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",10.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",10.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",10.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",9.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",9.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",9.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",10.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",10.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",10.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",627,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",647.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",647.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",649.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",633.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",651.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",677.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",697.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",699.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",750.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",772.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",802.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",876.6,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",831.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",901.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",831.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",862.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",841.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",722.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",750.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",788,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",825.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",840.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",882,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",949,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",923.1,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",749.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",778.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",787.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",805.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",791.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",814.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",867.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",899.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",912.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",1005.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",1057.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",1089.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",1227.8,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",76.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",81.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",74.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",77.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",75.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",64.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",66.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",69.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",72.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",73.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",76.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",81.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",79.5,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",68.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",70.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",70.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",72.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",70.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",72.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",76.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",79.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",79.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",87.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",91.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",94,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",105.7,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",10.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",10.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",10.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",10.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",10.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",10.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",10.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",10.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",10.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",10.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",10.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",10,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",9.7,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",3199.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",3245.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",3377.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",3825,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",3822.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",4045.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",4288.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",4648.8,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",5292.6,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",5971.9,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",6932.4,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",3201.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",3150.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",3057.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",2991.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",2883.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",3117.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",3309.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",3503.8,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",3946.3,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",4762.7,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",5326.3,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",2570.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",2651.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",2745.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",3064.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",3166.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",3337.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",3554.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",3765.1,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",4299.2,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",4823.2,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",5529,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",92.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",89.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",86.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",83.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",79.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",85.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",89.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",93.2,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",103.7,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",124.5,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",137,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",74.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",75.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",77.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",85.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",87.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",91.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",95.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",100.1,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",113,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",126.1,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",142.2,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",13.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",13.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",13.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",14.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",13.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",13.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",14,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",14.6,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",15.4,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",16.2,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",17.4,"E; D","Estimated value; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",8968.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",9060.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",9641.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",9350.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",9917.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",10350,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",11002.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",11476.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",12131.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",12817.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",11067.1,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",11646.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",469.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",512,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",492.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",477.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",477.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",420.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",450.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",490.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",558.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",558.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",476.8,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",537.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",656,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",678.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",725.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",731.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",780.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",800,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",874.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",923.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",980.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",1044.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",888.1,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",914,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",44.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",48.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",46.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",45.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",45.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",39.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",42.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",46.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",52.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",52.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",44.6,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",51.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",62.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",64.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",69,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",69.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",74.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",75.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",82.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",87.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",92.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",97.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",83,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",87,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",11,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",11.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",11.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",11.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",12.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",12.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",12.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",12.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",12.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",12.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",12.6,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",12.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",1740,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",1682.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",1777,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",1825.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",1954.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",2086.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",2214.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",2320.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",2492.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",2721,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",2800.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",3036,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",309.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",313.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",306.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",325,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",348.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",310.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",328.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",351.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",394.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",408,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",428.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",482.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",229.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",225.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",234.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",248.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",266.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",285.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",312.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",337.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",368.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",410.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",427.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",460.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",55.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",56.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",54.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",57.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",61.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",54.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",57.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",61,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",68.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",70.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",73.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",82.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",41.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",40.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",42,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",44.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",47.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",50.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",54.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",58.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",63.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",70.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",73.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",78.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",8.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",8.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",8.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",8.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",9.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",9.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",10,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",10.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",10.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",11.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",11.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",11.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",227.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",241.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",254.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",265,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",279.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",293,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",302.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",295.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",300.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",309.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",321.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",334.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",301.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",336.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",327.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",352,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",371.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",325.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",334.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",333.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",354.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",346.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",367.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",395.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",252.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",269.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",280.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",292.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",307.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",322.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",343.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",341.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",351.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",369.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",390.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",404.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",56.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",62.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",60.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",64.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",67.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",59.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",60.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",60.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",64.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",62.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",66.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",71.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",47.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",50,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",51.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",53.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",56.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",58.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",62.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",62,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",63.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",66.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",70.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",73,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",12.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",12.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",13,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",13.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",13.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",13.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",13.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",12.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",12,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",11.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",11.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",11.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",2952.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",4109.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",3509,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",63.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",53.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","FRA","France","2011","2011",10.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",3714.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",3704,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",3894.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",4031.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",4132.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",4253.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",4404.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",4483.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",4775.5,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",5025.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",5246,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",5597.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",4924.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",5155.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",5003.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",5354.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",5489.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",4719,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",4875.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",5064.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",5639.6,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",5625.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",5992,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",6619.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",4614.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",4696.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",4946.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",5203.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",5374,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",5466,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",5852.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",6019.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",6493.3,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",6900.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",7235.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",7601.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",60.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",64.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",62.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",66.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",67.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",57.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",59.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",61.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",68,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",67.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",72.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",79.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",56.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",58.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",61.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",64.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",66.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",66.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",71.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",72.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",78.3,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",83,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",87,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",91.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",12.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",12.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",12.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",12.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",12.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",12,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",12.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",12.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",10.8,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",10.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",10.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",10.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",856,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",743.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",678.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",630.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",634.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",594.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",749.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",760.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",805,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",833.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",874.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",944.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",813,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",1134.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",1035.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",871.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",836.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",843.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",659.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",829.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",859.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",950.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",933.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",998.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",1116.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",856.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",1185.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",1043.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",990.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",998.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",1038.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",976.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",1272.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",1323.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",1425.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",1519.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",1607.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",1730.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",1538.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",102,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",93.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",78.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",76.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",77.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",61,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",77,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",79.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",88.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",87.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",93.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",105.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",81.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",106.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",93.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",89.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",91,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",95.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",90.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",118.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",123,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",132.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",141.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",150.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",163.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",147.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",64095.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",68963.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",64446.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",60613.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",64320.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",67533,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",73066.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",78667.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",85394.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",94664.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",107184.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",109798.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",117157,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",308.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",343,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",286.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",271,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",276.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",241.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",259.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",286.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",316,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",325.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",348,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",362.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",314.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",507,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",554.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",513,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",485,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",497,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",509.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",553.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",578.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",613.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",672.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",737.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",709.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",726.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",30.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",34.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",28.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",27.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",28,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",24.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",26.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",29.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",32.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",33.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",35.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",37.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",32.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",50.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",55.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",51.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",49,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",50.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",51.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",56.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",59.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",62.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",68.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",75.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",73.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",75,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",12.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",13.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",14.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",14.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",14.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",14.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",14.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",16,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",17.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",17.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",19.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",19.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",19.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",2071.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",1894.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",1700.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",2134,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",1897.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",2003.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",2188.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",2159.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",2463.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",2929.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",3578.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",4281.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",16.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",16.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",13.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",17.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",16.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",15.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",18.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",20.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",22.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",23.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",26.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",33.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",15.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",14,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",12.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",15.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",13.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",14.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",15.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",15.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",17.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",20.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",24.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",28.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",53.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",51.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",42.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",53.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",49.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",45.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",54,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",58.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",64.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",66.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",72.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",90.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",49,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",43.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",38.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",48.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",41.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",42.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",46.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",45.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",49.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",57.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",66.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",76.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",8.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",7.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",8.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",8.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",8.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",8.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",8.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",8.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",9.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",263.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",239,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",248.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",233.4,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",207.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",206,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",210.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",215.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",227,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",242,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",260.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",282,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",349.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",332.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",319.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",310,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",275.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",228.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",232.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",243.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",268,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",270.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",297.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",333.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",310,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",287.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",302.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",287.7,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",253.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",254.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",264.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",271.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",286.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",300.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",327.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",354.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",76.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",72.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",69.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",67,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",59.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",48.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",49,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",50.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",55.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",54.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",59.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",66.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",68,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",62.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",65.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",62.2,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",54.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",54.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",55.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",56.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",58.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",60.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",65.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",70.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",12.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",12.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",12.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",11.9,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",10.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",10.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",10.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",10.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",10,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",10.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",10.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",10.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",2281.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",2363.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",2478.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",2584.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",2654.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",2695.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",2754,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",2837.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",2901.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",2878.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",3064.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",3258.6,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",3176.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",3036.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",3292,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",3433.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",2945.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",2983.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",3111.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",3350.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",3247.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",3287.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",3624.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",3431.5,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",3007.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",3160.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",3361.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",3494.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",3594,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",3847.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",3992,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",4165.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",4417.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",4444.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",4732.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",5277.8,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",53.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",51,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",54.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",56.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",48.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",49.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",51.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",55.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",54.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",55.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",61.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",58.1,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",50.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",53.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",55.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",57.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",59.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",63.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",65.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",68.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",74,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",74.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",80,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",89.4,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",11.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",12.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",12.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",13,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",11.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",11.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",12.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",12.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",12.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",12.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",12.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",13.1,"E","Estimated value" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",581966,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",570135,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",572354,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",532593,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",484331,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",464073,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",400328,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",403493,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",375517,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",561901,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",560631,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",540915,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",6629.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",7143.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",7173.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",5457.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",4571.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",3833.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",3679.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",3597.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",3400.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",5154.6,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",5250.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",4928.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",5209.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",5305.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",5488.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",5257.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",4699.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",4485.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",3793.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",3839.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",3605.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",5391.2,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",5473.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",5300.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",51.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",55.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",56.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",42.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",35.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",30.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",29,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",28.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",26.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",40.9,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",41.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",39.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",40.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",41.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",43,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",41.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",36.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",35.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",29.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",30.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",28.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",42.7,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",43.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",42.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",8.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",8.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",8.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",7.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",7.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",6.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",5.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",5.9,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",6.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",5.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",3258189,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",3370253.9,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",3197570.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",3351225.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",3508305.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",3705647.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",3857818.7,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",4137071.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",4431342.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",4752462.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",5102463.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",5476282.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",2817.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",3041.1,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",2837.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",3060.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",3332.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",3276.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",3323.5,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",3657.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",4027.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",4078.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",4323.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",4787.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",3874.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",3943.7,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",3740.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",3856.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",4023.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",4321.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",4492.1,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",4741,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",5183.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",5549.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",6091.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",6411.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",56.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",60.9,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",56.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",60.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",65.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",64.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",64.9,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",71.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",78.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",78.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",83.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",92.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",78.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",79,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",74.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",76.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",79.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",84.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",87.7,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",92.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",100.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",107.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",117.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",123.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",16,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",15.3,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",14.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",14.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",14.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",15.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",15.2,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",15.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",15.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",15.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",15.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",15.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",28.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",28.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",29.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",31.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",32.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",33.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",34.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",35.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",36.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",38.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",39.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",42.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",42.7,"D; P","Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",37.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",39.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",38.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",42,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",43.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",36.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",38,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",39.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",43.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",42.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",44.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",50,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",45,"D; P","Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",30.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",31.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",33,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",35.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",37.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",37.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",40.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",41.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",43.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",45.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",45.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",49.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",51.3,"D; P","Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",79.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",82,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",78,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",83.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",85.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",71.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",72.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",74.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",79.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",76.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",79,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",87,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",76.6,"D; P","Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",65.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",65.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",66.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",70.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",72.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",72.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",76.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",77.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",78.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",81.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",80.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",85.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",87.5,"D; P","Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",15.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",14.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",15.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",16.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",17.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",17.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",17.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",18.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",18.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",18.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",18.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",17.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",16.6,"D; P","Difference in methodology; Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",668,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",684.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",646.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",651.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",651.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",885.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",952.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",830.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",865.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",865.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",782.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",818.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",784.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",816.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",805.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",53.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",57.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",49.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",51.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",51.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",47.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",49,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",46.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",48.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",47.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",12.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",13.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",14,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",15.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",15.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",68.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",71.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",71.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",75.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",79.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",90.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",91.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",88.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",97.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",98.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",116.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",132.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",174,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",49.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",56.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",58.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",61.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",65.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",62.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",63.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",63,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",67.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",64.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",75.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",93.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",110.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",45.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",48.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",48,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",52,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",55,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",61,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",63.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",62,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",66.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",69.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",82.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",90.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",120.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",11.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",12.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",13.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",13.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",14.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",13.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",13.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",13.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",13.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",13,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",14.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",18.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",21.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",10.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",11,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",10.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",11.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",12.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",13.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",13.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",12.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",13.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",13.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",16.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",17.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",23.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",9.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",8.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",7.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",8.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",8.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",9.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",8.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",7.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",6.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",7.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",9.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",1829,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",1886,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",1910,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",1915,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",2061,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",2224,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",2559,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",2775,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",2944,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",3134,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",3470,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",4141,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",5090,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",302.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",336.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",328.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",326,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",327.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",275.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",304.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",335.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",362,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",356.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",368.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",482.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",529.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",199.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",207.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",211.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",212.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",222.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",223.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",254.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",284.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",307.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",325.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",351.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",435.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",473.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",61.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",67.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",65.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",64.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",63.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",53.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",58.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",63.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",68.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",66.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",68.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",89.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",97.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",40.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",41.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",42.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",41.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",43.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",43.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",48.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",53.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",57.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",60.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",65.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",80.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",87.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",10.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",10.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",10.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",9.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",9.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",9.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",10.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",10.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",10.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",11,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",11.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",12.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",14.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",511.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",455.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",400.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",396.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",404.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",440,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",460.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",478,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",513,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",561.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",596.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",658.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",747.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",677.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",634.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",515,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",526,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",537.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",488.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",509.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",540,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",605.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",629,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",681,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",779.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",787.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",820.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",731.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",662.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",678.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",699.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",752.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",806,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",830.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",898.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",1005.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",1070.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",1160.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",1359.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",64.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",60.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",49,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",50.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",51.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",47.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",49.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",52.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",58.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",61.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",66.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",75.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",76.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",77.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",69.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",63,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",64.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",67.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",72.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",78.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",80.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",87.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",97.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",103.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",112,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",131.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",15.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",15.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",15.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",16.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",16.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",17.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",18.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",18.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",19.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",20.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",21.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",22.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",23.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",116.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",120.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",112.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",127.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",136.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",152.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",186,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",186.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",196.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",211.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",216,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",238.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",154.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",167.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",144.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",168.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",181.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",169.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",205.8,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",210.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",232.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",236.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",246.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",282.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",231.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",237.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",223.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",258.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",281.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",310.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",369.6,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",361.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",374.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",408.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",415.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",447.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",28.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",31,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",26.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",31.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",33.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",31.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",37.9,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",38.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",42.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",43.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",45.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",51.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",43,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",44,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",41.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",47.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",52,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",57.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",68,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",66.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",68.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",74.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",76.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",82.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",10.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",10.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",10.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",10.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",10.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",11,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",11.8,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",11.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",12.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",12.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",13,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",13.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",1778.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",1777.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",1678.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",1685.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",1852.4,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",1958,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",2104.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",2215.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",2612.3,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",2797,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",2955,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",3246.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",3474.2,"P","Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",2358,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",2474.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",2156.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",2238.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",2460.9,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",2172.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",2329.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",2502.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",3085,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",3131.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",3375.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",3839.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",3658.5,"P","Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",2446.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",2489,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",2415.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",2497.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",2796.7,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",2945.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",3274.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",3512,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",4134.7,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",4563,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",4755.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",5186,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",5827.1,"P","Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",50.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",52.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",46.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",48,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",52.9,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",46.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",50.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",53.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",65.9,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",66.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",71.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",81,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",77.1,"P","Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",52.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",53.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",51.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",53.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",60.2,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",63.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",70.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",75.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",88.4,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",96.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",100.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",109.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",122.8,"P","Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",13.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",14.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",15.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",15.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",16.4,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",17.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",17.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",18.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",13.8,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",14,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",14.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",14.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",15.2,"P","Provisional value" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",3736.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",3675.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",3732,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",3749.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",3841.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",4115.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",4397.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",4618.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",4954,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",5382.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",5723.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",6118.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",6826,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",518.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",566.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",550.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",575.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",560,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",487.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",513.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",540.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",569.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",569.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",621.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",713.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",674.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",414,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",415.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",431.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",436.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",440.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",464.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",498.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",521.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",558.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",618,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",660.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",701.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",787.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",55.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",59.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",57.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",60,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",57.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",49.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",51.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",53.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",56,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",55.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",60,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",68.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",64.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",44.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",44,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",45.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",45.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",45.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",47.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",50.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",51.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",54.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",60.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",63.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",67.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",75.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",10.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",10,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",10.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",10.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",10.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",10.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",10.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",10.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",10.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",10.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",10.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",11.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",11.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",875.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",847,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",851,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",858,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",863,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",890,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",923,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",934,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",925,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",943,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",987,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",1037,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",1112,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",839.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",953.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",907.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",925.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",942,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",924.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",936.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",948.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",945.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",949,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",1051.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",1134.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",1164.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",597.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",606.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",628.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",653.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",673.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",720.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",767.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",786.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",784.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",819.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",869.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",937.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",1043.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",107.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",120.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",113.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",114.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",115,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",111.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",111.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",112.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",111.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",110.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",121.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",130.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",133.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",76.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",76.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",78.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",80.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",82.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",87,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",91.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",93,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",92.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",95.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",100.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",107.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",119.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",15.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",14.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",14.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",14.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",14.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",14.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",14.5,"B; D","Break; Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",14.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",14,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",14.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",14.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",14.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",14.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",2158.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",1965.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",1947.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",2115.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",2328.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",2779.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",3349.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",4164.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",5223.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",6893.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",9117.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",12158.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",1436.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",1173.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",1084.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",1111.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",1064,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",1021.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",1109.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",1141.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",1081.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",1215,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",1300.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",1373.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",2345.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",2034.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",1909.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",1976.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",2108.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",2390.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",2699.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",3008.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",3199.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",3698.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",4213,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",4330.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",19.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",15.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",14.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",14.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",13.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",13.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",14,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",14.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",13.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",14.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",15.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",16.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",32.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",27.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",25.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",26,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",27.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",30.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",34,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",37.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",39.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",44.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",50.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",51.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",13.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",13.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",14.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",14.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",14.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",15.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",15.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",16.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",16.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",16.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",18.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",18.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",1384.3,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",1410.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",1537.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",1710.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",1773.2,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",1854.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",1981.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",2186.7,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",2204.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",2529.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",2613.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",2394.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",2387.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",2643.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",1973,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",2028.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",2200.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",2470.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",2575.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",2709.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",2880.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",34.3,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",34.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",39.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",40.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",36.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",36.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",39.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",31,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",31.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",34.1,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",37.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",39.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",41,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",43.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",10.1,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",9.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",9.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",9.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",9.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",9.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",9.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",151311.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",184612.6,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",203569.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",220594,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",260015,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",317777.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",361148.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",385291.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",397573.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",479315.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",508617,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",542926.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",498922,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",296.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",381.7,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",418.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",445.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",455.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",485.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",533.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",593.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",620,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",681.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",641.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",715.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",571.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",420.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",530.5,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",586.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",630.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",708.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",812.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",909.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",968.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",1003.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",1193.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",1215.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",1247.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",1140.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",17.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",22.1,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",24,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",25.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",25.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",27,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",29.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",32.2,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",33.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",35.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",33,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",36.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",28.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",24.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",30.7,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",33.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",35.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",39.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",45.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",50,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",52.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",53.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",62.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",62.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",63.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",57.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",18.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",15.7,"B","Break" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",16.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",15.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",16.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",17.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",17.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",18.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",17.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",19,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",18.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",19.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",17.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",23.5,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",24.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",26.9,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",28.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",30.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",32.7,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",34.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",35.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",38.1,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",39.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",41.3,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",43.4,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",50,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",31.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",33.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",34.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",38.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",40.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",36.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",38,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",40.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",45,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",44.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",47.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",51.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",52.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",46,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",47.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",51.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",54.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",58.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",60.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",65.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",66.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",70.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",73.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",78.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",79.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",87.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",23.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",25.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",26.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",28.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",31.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",27.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",28.9,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",30.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",34.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",33.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",35.5,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",38.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",39.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",34.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",35.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",39,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",41.7,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",44.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",46.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",49.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",50.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",53.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",55.6,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",59.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",60,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",66,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",12.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",11.9,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",12.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",12.4,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",12.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",12.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",11.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",11.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",11.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",11.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",11.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",10.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",11.6,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",55.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",55.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",51.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",49.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",50.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",52.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",56.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",57.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",62.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",67.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",72.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",76.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",87.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",73.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",76.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",66.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",66.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",66.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",58.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",62.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",65.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",73.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",75.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",82.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",90.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",92.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",86.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",88.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",85.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",84.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",84.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",88.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",97.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",101.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",109.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",121.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",132,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",136.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",158.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",35.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",37.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",32.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",32.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",32.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",28.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",30.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",31.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",35.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",36,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",39.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",43.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",43.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",42.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",43.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",41.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",41,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",41.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",43,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",47.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",49,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",52.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",58.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",62.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",64.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",75.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",11.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",11.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",11.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",11.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",11.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",11.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",12,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",11.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",12,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",12.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",12.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",12.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",12.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",2,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",1.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",2.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",2.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",1.9,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",1.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",1.4,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",1.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",0.1,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",0.1,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",0,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",1.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",1.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",1.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",1.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",1.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",1.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",1.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",1.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",10.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",11.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",11.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",11.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",10.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",10,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",9.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",9.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",9.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",9.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",10.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",10,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",9.8,"E","Estimated value" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",14.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",16,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",14.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",14.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",13.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",11.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",10.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",10.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",11.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",11.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",11.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",11.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",10.3,"E","Estimated value" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",12.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",13.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",14.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",13.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",13.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",12.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",12.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",12.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",12.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",13.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",14.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",13.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",13.7,"E","Estimated value" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",1.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",1.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",1.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",1.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",1.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",0.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",0.9,"E","Estimated value" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",1.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",1.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",1.2,"E","Estimated value" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0.1,"E","Estimated value" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",1.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",103.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",101.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",102.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",110.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",100.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",97.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",101,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",100.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",100.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",98.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",0,"B","Break" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",5.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",5.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",5.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",5.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",4.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",4.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",4.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",4.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",4.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",0,"B","Break" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",7.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",7.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",7.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",8.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",7.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",7.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",8.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",8.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",0,"B","Break" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",0,"B","Break" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",0,"B","Break" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0,"B","Break" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",2.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",2.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",3.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",3.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",3.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",3.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",3.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",3.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",3.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",3.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",3.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",3.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",3.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",4.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",3.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",3.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",3.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",4.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",4.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",3.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",3.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",3.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",3.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",3.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",3.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",3.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",4.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",4.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",4.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",0.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",0.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",0.9,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",14.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",14.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",14.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",15.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",17.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",17.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",19.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",19.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",21,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",23.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",25.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",27.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",19.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",20.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",19.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",20.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",22.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",19.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",21.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",21.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",24.8,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",26.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",28.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",32.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",18,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",18.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",18.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",19.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",22.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",22.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",25.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",25.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",28.6,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",32.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",34.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",37.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",0.3,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",0.3,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",0,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",5.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",5.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",5.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",5.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",5.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",4.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",4.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",4.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",5.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",5.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",5.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",5.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",7.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",8.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",6.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",7.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",7.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",5.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",4.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",5.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",5.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",6.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",6.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",5.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",8.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",7.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",8.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",8.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",8.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",7.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",7.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",8.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",9.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",10.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",9.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",10.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",0.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",0.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",0.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",53.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",0.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",0.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",1.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",1.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",0.1,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",0.1,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",0.1,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",0,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",0,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",0,"B; D","Break; Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",21.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",21.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",22.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",24.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",24.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",25.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",25.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",26,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",23.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",24.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",25,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",32.8,"E","Estimated value" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",30.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",27.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",29.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",32.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",27.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",28,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",28.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",30.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",26.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",28.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",29.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",34.6,"E","Estimated value" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",28.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",29.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",30,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",32.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",33.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",36.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",36.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",38.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",36.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",38.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",38.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",53.2,"E","Estimated value" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",0.6,"E","Estimated value" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",0.9,"E","Estimated value" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0.1,"E","Estimated value" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",107888,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",94392,"B","Break" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",83934.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",79360.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",78601.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",75437.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",68368.6,"B","Break" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",68847,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",70990.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",73827.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",80978.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",79702.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",93.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",85.2,"B","Break" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",74.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",72.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",74.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",66.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",58.9,"B","Break" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",60.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",64.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",63.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",68.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",69.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",128.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",110.5,"B","Break" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",98.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",91.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",90.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",88,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",79.6,"B","Break" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",78.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",83,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",86.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",96.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",93.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",1.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",1.7,"B","Break" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",1.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",1.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",1.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",1.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",1.1,"B","Break" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",1.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",1.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",1.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",1.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",1.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",2.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",2.2,"B","Break" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",1.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",1.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",1.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",1.6,"B","Break" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",1.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",1.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",1.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",1.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",1.8,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0.5,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.4,"B","Break" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.4,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0.4,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0.3,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.3,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.3,"B","Break" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.3,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",0.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",0.3,"D; P","Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",0.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",0.3,"D; P","Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",0.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",0.4,"D; P","Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",0.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",0.6,"D; P","Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",0.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",0.7,"D; P","Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",0.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",0.1,"D; P","Difference in methodology; Provisional value" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",28,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",28,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",28,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",29,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",28,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",28,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",30,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",29,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",28,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",29,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",33,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",36,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",35,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",4.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",4.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",4.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",4.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",3.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",3.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",3.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",3.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",3.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",3.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",4.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",3.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",3.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",3.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",3.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",3.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",2.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",2.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",3.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",3.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",3.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",0.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",0.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",0.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",0.6,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",6.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",6.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",5.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",4.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",5.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",5.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",5.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",5.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",5.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",5.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",5.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",8.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",8.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",7.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",6.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",6.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",6.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",5.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",6.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",6.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",6.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",6.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",6.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",5.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",10.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",9.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",10,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",8.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",8.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",9.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",9.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",10.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",10.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",10.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",10.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",9.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",9.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",0.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",0.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",0.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",0.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",0.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",0.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",0.9,"B","Break" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",0,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",0.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",0.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",0.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",0.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",1.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",0.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",0.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",1,"B","Break" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",0,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",0.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",1.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",1.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",1.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",1.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",1.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",1.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",1.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",1.8,"B","Break" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",0,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",1.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",1.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",1.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",1.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",0.2,"B","Break" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",0.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",0.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",0.3,"B","Break" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",0,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",0.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",0.3,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",0.1,"B","Break" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",0,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",0.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",19.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",17.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",11.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",25.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",24.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",15,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",26.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",25,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",16.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",62.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",70.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",70.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",75.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",81.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",92.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",95.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",98.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",99,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",104.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",104.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",108,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",107.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",8.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",10.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",10.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",11.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",11.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",11,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",11.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",11.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",11.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",11,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",11.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",12.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",10.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",6.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",8.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",8.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",9.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",10.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",10.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",11.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",11.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",11.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",12,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",12.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",12.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",0.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",1.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",1.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",1.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",1.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",0.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",0.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",1.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",94.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",102.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",101.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",93.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",99,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",125.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",161.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",198.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",221.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",265.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",333.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",424,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",62.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",61,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",56.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",49.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",45.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",46.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",53.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",54.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",45.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",46.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",47.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",47.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",102.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",105.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",99.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",87.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",89.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",108,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",130.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",143.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",135.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",142.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",154,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",151,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",0.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",0.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",0.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",1.4,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",1.4,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",1.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",1.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",1.4,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",1.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",1.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",1.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",1.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",1.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",1.8,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",0.6,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",0.8,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0.6,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0.8,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0.6,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",0.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",8337.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",9337.8,"B","Break" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",9204.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",9763.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",10396.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",11322.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",11264.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",11617,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",12658.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",11513.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",11755.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",9854.6,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",10301.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",16.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",19.3,"B","Break" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",18.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",19.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",18.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",17.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",16.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",17.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",19.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",16.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",14.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",13,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",11.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",23.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",26.8,"B","Break" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",26.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",27.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",28.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",28.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",28.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",29.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",31.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",28.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",28.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",22.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",23.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",1.1,"B","Break" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",0.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",1.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",0.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",0.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",0.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",1.4,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",1.6,"B","Break" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",1.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",1.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",1.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",1.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",1.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",1.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",1.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",1.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",1.4,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",1.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",1.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0.8,"B","Break" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",0.7,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0.6,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0.6,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0.6,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0.6,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0.5,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",0.4,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",0.4,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",0.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",0.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",0.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",0.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",0.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",0.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",0.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",0.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",0.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",0.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",0.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",0.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",0.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",0.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",0.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",0.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",0.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",0.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",0.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",0.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",0.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",0.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",0.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",0.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",0.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",0.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",0.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",0.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",0.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",0.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",0.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",0.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",0.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",0.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",0.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",0.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",0.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",1.2,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",0.4,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",0.4,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",0.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",0.7,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",0.9,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",0.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",1.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",1.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",1.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",1.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",1.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",1.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",628,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",567,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",502,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",589,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",532,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",492,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",486,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",452,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",406,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",378,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",376,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",394,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",576.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",584.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",519.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",568.6,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",479.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",369.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",361.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",346.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",303.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",262.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",258.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",296,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",417.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",375.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",325.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",407,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",366.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",333.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",335.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",305.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",276.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",255.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",258.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",272.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",26.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",26.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",22.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",24.6,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",20.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",15.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",14.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",14.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",12.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",10.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",10.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",11.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",19,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",16.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",14.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",17.6,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",15.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",14,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",13.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",12.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",11.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",10.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",10.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",10.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",6.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",5.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",4.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",5,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",4.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",3.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",3.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",2.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",2.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",2.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",2.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",107.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",96.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",88.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",83,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",79.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",76.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",51.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",38.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",35.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",33.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",31,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",30.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",142.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",134,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",113.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",110.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",105.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",84.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",57.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",43.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",41.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",37.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",35.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",35.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",127.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",115.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",108.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",104.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",99.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",95.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",66.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",49.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",45.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",44.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",41.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",40,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",17.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",16,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",13.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",13,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",12.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",9.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",6.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",4.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",4.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",15.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",13.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",12.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",12.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",11.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",11.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",7.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",5.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",5.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",4.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",4.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",4.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",3.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",3.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",3.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",2.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",2.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",1.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",1.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",1.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",177.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",176.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",158.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",142.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",144.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",154.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",163.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",155.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",157.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",166.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",163.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",159.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",155.3,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",235.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",246,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",203.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",189.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",191.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",171.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",180.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",175.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",185.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",186.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",186.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",188.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",163.6,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",212,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",212.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",192.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",177.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",180,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",193.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",209,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",200.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",205.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",222.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",224.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",216,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",217.6,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",21.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",22.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",18.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",17,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",17.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",15.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",15.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",15.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",16.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",16.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",16.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",16.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",14.1,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",19.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",19.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",17.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",15.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",16.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",17.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",18.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",17.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",18,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",19.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",19.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",18.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",18.7,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",2.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",2.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",2.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",2.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",1.7,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1298.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1195.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1134.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1146.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1037.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",994,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",854.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",835.9,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",889.5,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",892.8,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",890.1,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1299,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1160.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1027.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",896.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",782.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",765.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",659.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",630,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",663.2,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",712.1,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",683.9,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1043.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",976.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",922.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",919,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",859.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",819.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",708.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",677,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",722.6,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",721.1,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",709.9,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",37.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",33.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",29,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",25.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",21.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",21,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",17.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",16.8,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",17.4,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",18.6,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",17.6,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",30,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",27.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",26,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",25.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",23.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",22.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",19.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",18,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",19,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",18.9,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",18.3,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",5.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",4.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",4.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",3.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",3.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",2.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",2.6,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",2.6,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",2.4,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",2.2,"E; D","Estimated value; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",1324,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",1357.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",1465.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",1250.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",1081.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",915.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",955.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",823.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",775.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",808.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",739.4,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",747.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",69.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",76.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",74.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",63.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",52.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",37.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",39.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",35.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",35.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",35.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",31.9,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",34.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",96.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",101.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",110.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",97.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",85.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",70.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",76,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",66.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",62.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",65.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",59.3,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",58.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",6.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",7.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",7.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",6.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",4.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",3.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",3.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",3.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",3,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",3.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",9.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",9.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",10.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",9.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",8.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",6.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",7.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",6.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",5.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",6.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",5.5,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",1.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",1.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0.8,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",33.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",29.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",30.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",32,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",33,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",35.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",35.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",34.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",31.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",29.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",27.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",26.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",44,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",40.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",39.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",42.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",43.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",39.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",39.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",38.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",37.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",32.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",31.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",31.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",36.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",32.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",33.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",35.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",36.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",39,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",40.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",39.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",37.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",34.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",33,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",31.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",8.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",7.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",7.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",7.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",7.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",7.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",6.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",5.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",6.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",6.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",6.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",6.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",6.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",7.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",7.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",7.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",6.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",6.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",5.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",912,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",796.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",805.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",778.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",795.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",796.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",772.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",695.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",687,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",670.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",620,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",595.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",1209.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",1109,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",1034.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",1034.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",1056.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",883.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",855,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",785.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",811.3,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",750.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",708.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",704.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",1132.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",1010.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",1023.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",1005.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",1034.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",1023.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",1026.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",934.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",934.1,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",921,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",855.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",809.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",14.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",13.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",12.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",12.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",13.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",10.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",10.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",9.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",9.8,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",8.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",8.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",13.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",12.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",12.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",12.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",12.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",12.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",12.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",11.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",11.3,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",11.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",10.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",9.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",3.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",2.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",2.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",2.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",2.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",2.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",2.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",1.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",1.6,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",1.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",1.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",1.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",321.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",264.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",222.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",180,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",161.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",155.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",166.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",152.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",150.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",146.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",144.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",154.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",118.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",425.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",368.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",286.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",239,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",214.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",172,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",184.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",172.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",177.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",164.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",164.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",182.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",124.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",444.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",371.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",325.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",285.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",264.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",254.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",283.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",265.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",266.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",267.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",264.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",283.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",223.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",38.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",33.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",25.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",21.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",19.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",15.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",17.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",16,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",16.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",15.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",15.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",17.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",11.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",40,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",33.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",29.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",26,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",24.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",23.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",26.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",24.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",24.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",24.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",24.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",26.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",21.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",18687.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",18507.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",12740.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",9057.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",8814.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",8905.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",8548.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",8825.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",9239.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",11030.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",13882.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",13825.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",14075.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",89.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",92.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",56.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",40.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",37.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",31.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",30.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",32.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",34.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",38,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",45.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",45.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",37.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",147.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",148.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",101.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",72.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",68.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",67.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",64.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",64.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",66.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",78.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",95.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",89.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",87.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",9.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",5.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",4.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",3.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",3.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",3.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",3.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",3.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",3.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",4.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",4.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",3.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",14.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",14.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",10.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",7.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",6.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",6.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",6.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",6.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",6.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",9.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",9.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",3.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",3.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",2.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",2.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",1.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",1.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",1.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",1.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",2.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",2.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",2.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",2.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",853.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",808.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",581,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",621,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",569.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",561.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",596.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",626.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",666.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",700.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",778.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",838.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",4.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",5.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",4.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",4.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",4.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",5.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",6.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",5.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",5.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",6.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",6.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",4.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",4.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",4.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",4.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",4.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",4.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",5.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",22,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",21.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",14.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",15.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",14.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",12.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",14.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",17.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",17.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",15.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",15.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",17.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",20.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",18.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",13.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",14,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",12.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",11.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",12.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",13.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",13.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",13.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",14.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",15,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",3.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",2.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",2.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",1.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",135,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",107.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",108.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",95,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",66.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",55.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",52.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",51.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",52,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",53,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",54.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",56.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",178.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",150,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",139.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",126.2,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",88.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",61.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",58,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",58.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",61.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",59.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",61.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",66.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",158.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",129.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",131.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",117.2,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",81,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",68.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",66,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",65.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",65.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",65.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",68.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",70.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",39.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",32.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",30.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",27.3,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",18.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",13.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",12.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",12.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",12.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",12,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",12.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",13.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",34.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",28.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",28.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",25.3,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",17.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",14.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",13.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",13.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",13.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",13.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",13.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",14,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",6.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",5.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",5.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",4.8,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",3.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",2.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",2.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",2.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",2.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",2.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",2.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",2.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",987.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",979.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",997.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",1037,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",981.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",907.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",889.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",843.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",791.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",753.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",753,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",720,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",1374.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",1259,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",1324.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",1377.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",1089.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",1004.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",1005.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",995.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",886,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",860.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",890.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",758.2,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",1301.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",1310.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",1352.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",1402,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",1328.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",1294.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",1289.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",1237.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",1205,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",1163.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",1162.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",1166.2,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",23.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",21.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",22,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",22.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",17.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",16.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",16.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",16.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",14.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",14.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",15.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",12.8,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",21.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",22,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",22.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",23.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",21.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",21.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",21.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",20.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",20.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",19.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",19.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",19.8,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",5.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",5.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",5.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",5.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",4.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",3.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",3.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",3.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",3.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",2.9,"E","Estimated value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",727243,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",785646.1,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",750318.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",779352.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",824285.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",872847.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",900276.8,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",961820.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",1039828.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",1070467.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",1093712,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",1225994.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",628.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",708.9,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",665.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",711.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",782.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",771.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",775.6,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",850.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",945.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",918.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",926.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",1071.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",864.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",919.3,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",877.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",896.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",945.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",1017.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",1048.3,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",1102.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",1216.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",1249.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",1305.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",1435.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",12.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",14.2,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",13.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",14.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",15.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",15.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",15.1,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",16.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",18.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",17.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",17.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",20.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",17.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",18.4,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",17.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",17.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",18.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",20,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",20.5,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",21.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",23.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",24.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",25.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",27.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",3.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",3.6,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",3.5,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",3.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",3.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",10.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",8.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",8.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",8.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",8.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",7.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",7.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",6.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",6.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",6.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",6.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",5.8,"D; P","Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",14,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",12,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",11.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",11.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",11.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",8.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",7.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",8.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",7.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",7.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",7.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",6.1,"D; P","Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",11.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",9.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",9.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",10,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",9.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",8.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",8.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",8.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",8.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",8.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",7.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",7.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",6.9,"D; P","Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",29.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",25,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",22.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",23.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",21.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",15.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",15.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",14.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",15,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",13.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",13,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",12.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",10.4,"D; P","Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",24.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",19.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",19.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",19.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",18.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",15.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",16.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",15.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",15,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",14.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",13.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",12.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",11.8,"D; P","Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",5.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",4.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",4.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",4.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",4.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",3.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",3.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",3.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",3.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",3.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",3.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",2.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",2.2,"D; P","Difference in methodology; Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",202.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",185.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",125.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",118.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",117.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",268,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",257.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",161.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",157.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",155.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",236.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",221.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",152.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",148.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",144.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",16.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",15.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",9.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",9.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",9.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",14.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",13.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",9.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",8.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",8.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",3.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",3.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",2.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",2.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",2.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",12.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",11.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",7.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",6.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",6.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",5.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",5.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",4.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",4.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",5.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",5.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",9.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",6.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",5.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",5.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",4.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",3.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",3.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",2.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",3.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",3.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",8.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",5.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",4.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",4.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",4.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",4.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",3.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",3.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",3.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",3.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",3.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",2.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",2.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",1.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",1.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",1.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",1.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",1.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",1.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",1.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",1.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",0.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",1.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",1.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",459,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",447,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",414,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",387,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",373,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",320,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",329,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",330,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",329,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",327,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",368,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",383,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",405,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",75.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",79.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",71.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",65.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",59.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",39.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",39.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",39.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",40.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",37.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",39.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",44.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",42.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",50.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",49.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",45.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",42.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",40.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",32.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",32.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",33.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",34.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",34,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",37.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",40.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",37.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",15.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",16.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",14.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",13,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",11.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",7.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",7.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",7.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",7.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",6.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",7.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",8.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",7.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",10.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",9.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",9.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",8.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",7.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",6.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",6.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",6.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",6.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",6.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",6.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",7.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",2.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",2.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",1.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",186.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",124.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",66.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",62.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",62.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",62.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",64.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",61.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",63.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",70,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",70.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",75.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",78.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",247.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",173.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",86,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",83.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",83.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",69.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",71.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",69.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",75,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",78.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",80.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",88.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",82.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",299.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",199.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",110.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",107.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",108.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",107.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",113.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",107,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",111.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",125.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",126.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",132.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",142.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",23.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",16.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",8.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",7.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",6.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",6.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",6.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",7.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",7.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",7.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",8.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",28.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",18.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",10.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",10.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",10.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",10.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",11,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",10.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",10.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",12.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",12.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",12.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",13.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",5.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",2.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",2.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",2.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",2.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",2.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",2.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",2.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",2.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",2.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",2.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",2.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",9.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",8.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",7.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",8.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",8.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",9.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",10.4,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",10,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",10.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",11.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",11.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",12.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",12.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",12,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",9.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",11.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",11.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",10.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",11.5,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",11.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",12.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",12.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",13.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",14.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",19.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",17,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",15.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",17.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",18.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",18.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",20.7,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",19.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",20.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",21.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",22.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",22.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",2.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",2.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",2.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",1.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",2.1,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",2.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",2.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",3.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",2.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",3.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",3.8,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",3.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",3.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",3.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",4.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",4.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",0.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",0.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",0.7,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",0.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",0.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",0.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",655.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",562.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",449.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",419.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",420.8,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",414.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",422.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",423.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",449.5,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",463.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",472,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",505.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",526.7,"P","Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",868.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",783.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",577.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",556.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",559.1,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",459.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",468,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",478.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",530.9,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",518.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",539.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",597.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",554.6,"P","Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",901.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",788.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",646.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",621.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",635.4,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",623.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",657.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",671.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",711.5,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",755.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",759.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",807,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",883.4,"P","Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",18.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",16.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",12.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",11.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",12,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",9.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",10.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",10.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",11.3,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",11,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",11.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",12.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",11.7,"P","Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",19.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",16.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",13.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",13.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",13.7,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",13.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",14.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",14.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",15.2,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",16,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",16,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",17,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",18.6,"P","Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",4.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",4.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",3.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",3.7,"B; D","Break; Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",3.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",3.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",3.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",2.4,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",2.3,"P","Provisional value" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",727.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",560.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",536.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",500.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",474.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",493.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",493.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",482.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",492.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",528.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",523.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",500.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",534.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",101,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",86.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",79.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",76.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",69.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",58.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",57.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",56.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",56.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",55.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",56.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",58.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",52.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",80.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",63.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",62,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",58.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",54.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",55.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",56,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",54.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",55.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",60.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",60.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",57.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",61.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",10.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",9.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",8.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",7.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",5.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",5.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",5.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",5.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",8.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",6.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",6.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",6.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",5.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",5.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",5.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",5.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",5.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",5.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",5.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",1.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",633.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",429.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",424.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",416,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",423.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",517.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",595.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",671.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",739.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",824.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",854.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",1162.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",421.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",256.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",236.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",218.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",193.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",190.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",197.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",184,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",153.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",145.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",121.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",131.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",688.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",444.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",416.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",388.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",383,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",445.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",479.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",485.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",453,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",442.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",394.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",414.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",5.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",3.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",2.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",2.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",2.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",1.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",9.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",5.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",5.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",5.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",5.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",5.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",4.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",4.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",4.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",3.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",2.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",2.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",2.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",2.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",2.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",1.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",16183.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",21124.4,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",22320.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",24042.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",26581.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",30504,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",27671.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",31943,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",28521.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",32593.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",31750.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",44395.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",45021.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",31.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",43.7,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",45.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",48.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",46.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",46.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",40.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",49.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",44.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",46.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",40.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",58.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",51.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",45,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",60.7,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",64.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",68.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",72.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",78,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",69.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",80.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",72,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",81.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",75.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",102,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",102.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",1.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",2.5,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",2.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",2.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",2.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",2.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",3.5,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",3.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",3.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",4.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",4.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",3.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",4.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",3.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",4.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",3.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",5.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",5.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",1.8,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",1.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",1.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",1.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",1.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",3.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",3.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",3.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",3.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",3.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",4.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",4.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",4.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",4.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",4.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",4.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",4.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",4.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",4.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",3.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",4.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",4.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",4.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",4.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",5.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",5.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",5.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",7.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",6.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",6.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",6.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",6.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",6.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",7.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",8.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",8.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",8.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",8.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",3.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",3.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",3.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",3.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",2.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",3.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",3.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",3.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",3.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",3.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",4.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",3.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",5.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",4.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",5.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",4.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",4.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",5.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",5.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",5.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",6.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",6.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",6.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",6.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",1.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",1.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",1.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",1.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",19.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",17.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",13.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",11.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",10.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",10.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",10.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",9.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",9.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",9.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",9.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",9.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",10.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",26.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",24.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",17.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",15.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",14.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",11.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",11.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",10.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",11.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",11.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",10.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",11.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",10.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",31.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",28.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",22.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",19.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",18.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",18,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",18.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",16.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",17.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",18,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",17.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",17.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",18.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",12.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",12.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",8.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",7.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",5.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",5.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",5.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",5.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",5.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",5.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",5.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",5.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",15.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",14,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",10.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",9.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",8.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",8.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",8.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",8.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",8.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",8.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",8.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",8.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",8.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",3.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",2.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",2.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",2.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",2.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",1.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",1.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",1.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",1.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",1.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",424,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",470,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",519,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",594,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",589,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",617,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",648,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",718,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",747,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",784,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",868,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",977,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",388.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",484.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",537.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",573.4,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",530.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",463.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",481.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",550.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",558.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",545,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",597.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",733.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",282,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",311,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",337,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",410.5,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",405.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",418.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",446.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",485.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",508,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",529.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",597,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",674.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",17.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",21.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",23.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",24.8,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",22.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",19.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",19.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",22.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",22.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",21.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",23.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",28.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",12.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",13.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",14.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",17.7,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",17.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",17.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",18.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",19.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",20.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",20.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",23.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",26.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",4.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",4.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",5,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",4.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",4.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",5.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",5.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",96.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",104.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",110.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",115.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",123.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",134,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",149.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",165.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",179.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",195.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",214.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",228.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",128.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",144.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",142,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",152.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",164.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",148.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",165.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",187.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",211.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",219.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",245.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",270.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",114.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",125.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",135.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",144.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",155,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",167.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",192.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",213.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",234,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",261.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",287.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",302.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",15.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",17.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",16.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",18,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",19.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",17.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",19,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",21.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",23.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",24.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",27.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",30.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",13.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",14.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",16.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",17,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",18.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",19.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",22.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",24.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",26.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",29.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",32.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",33.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",3.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",4.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",4.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",4.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",4.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",4.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",5.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",5.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",5.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",6.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",6.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",139.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",150.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",155.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",163.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",171.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",178.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",191.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",201.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",210.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",237.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",258.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",287.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",330.6,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",184.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",209.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",199.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",216.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",227.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",198.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",212.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",227.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",249.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",266.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",295,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",339.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",348.2,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",166.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",180.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",188.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",202.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",214.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",223.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",245.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",259.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",275.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",318.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",353.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",389.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",463.1,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",17,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",19,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",18,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",19.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",20.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",17.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",18.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",20,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",21.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",23.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",25.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",29.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",30,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",15.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",16.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",17,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",18.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",19.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",19.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",21.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",22.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",24.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",27.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",30.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",33.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",39.9,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",2.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",2.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",2.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",2.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",2.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",2.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",3.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",3.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",3.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",3.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",3.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",3.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",3.7,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1233.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1369,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1514.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1702.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1947.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",2175.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",2402.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",2673.1,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",3086.4,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",3536.2,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",4299.2,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1234.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1328.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1370.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",1331,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",1468.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",1676.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",1854.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",2014.7,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",2301.3,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",2820.2,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",3303.1,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",991.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",1118.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",1230.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",1363.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1613.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1794.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",1991.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",2164.9,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",2507.1,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",2856,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",3428.9,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",35.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",37.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",38.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",37.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",40.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",45.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",50,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",53.6,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",60.5,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",73.7,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",85,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",28.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",31.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",34.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",38.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",44.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",49.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",53.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",57.6,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",65.9,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",74.7,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",88.2,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",5.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",5.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",5.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",6.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",6.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",7.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",7.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",8.4,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",9,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",9.6,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",10.8,"E; D","Estimated value; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",3639.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",3775,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",4194.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",4098.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",4614,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",5120.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",5517.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",5999.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",6345,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",6768.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",7133.6,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",7499.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",190.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",213.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",214.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",209.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",222.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",208.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",225.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",256.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",292,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",295.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",307.3,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",346,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",266.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",282.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",315.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",320.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",363.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",395.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",438.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",482.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",512.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",551.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",572.5,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",588.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",18.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",20.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",20.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",19.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",21.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",19.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",21.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",24.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",27.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",27.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",28.7,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",32.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",25.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",26.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",30,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",30.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",34.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",37.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",41.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",45.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",48.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",51.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",53.5,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",56,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",4.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",4.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",5.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",5.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",6.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",6.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",6.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",6.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",6.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",8.1,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",8.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",104.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",117.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",127.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",131,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",140,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",148.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",153.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",148,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",154.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",161.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",170.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",180.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",138.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",163,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",163.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",174,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",186,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",164.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",169.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",167.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",182.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",180.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",195.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",213.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",116.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",130.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",140,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",144.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",154.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",163.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",174.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",171.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",181.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",192.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",207.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",218.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",25.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",30.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",30.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",32,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",34.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",30,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",30.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",30.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",33.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",32.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",35.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",38.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",21.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",24.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",25.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",26.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",28.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",29.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",31.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",31.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",32.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",34.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",37.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",39.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",5.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",6.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",6.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",6.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",6.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",6.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",6.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",6.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",6.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",6.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",6.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",6.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",1888.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",1947.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",2068.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",2203,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",2229.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",2303.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",2416.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",2502,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",2635.8,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",2791.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",2972,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",3234.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",2504.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",2710.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",2658,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",2925.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",2962,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",2555.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",2675.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",2826.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",3112.8,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",3125.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",3394.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",3825.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",2346.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",2468.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",2627.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",2843.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",2899.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",2960.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",3211.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",3359.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",3583.9,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",3833.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",4099.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",4392.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",30.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",33.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",33,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",36.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",36.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",31.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",32.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",34.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",37.5,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",37.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",40.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",46,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",28.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",30.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",32.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",35.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",35.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",36.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",39,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",40.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",43.2,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",46.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",49.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",52.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",6.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",6.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",6.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",6.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",6.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",6.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",6,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",6.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",303.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",277.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",281.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",286.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",306.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",283.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",398.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",408.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",418,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",442.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",426.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",513.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",472.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",401.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",386.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",361.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",380.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",406.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",314.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",440.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",461.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",493.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",495.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",487.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",607.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",497.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",419.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",388.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",410.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",453.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",500.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",465.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",676.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",710.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",740.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",805.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",784.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",941.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",893.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",36.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",34.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",32.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",34.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",37.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",29.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",40.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",42.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",46,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",46.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",45.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",57.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",47.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",37.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",35,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",37.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",41.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",46,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",43.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",62.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",66.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",69,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",75.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",73.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",89.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",85.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",30573.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",33416.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",34389.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",35559.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",38486.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",40546,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",45267.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",50037.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",55484.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",61900.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",69245.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",71161.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",78318.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",147,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",166.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",152.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",159,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",165.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",145.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",160.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",182.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",205.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",213,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",224.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",234.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",210.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",241.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",268.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",273.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",284.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",297.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",305.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",342.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",367.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",398.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",439.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",476.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",459.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",485.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",14.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",16.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",15.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",16.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",16.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",14.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",16.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",18.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",21,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",21.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",23.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",24.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",21.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",24.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",27,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",27.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",28.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",30.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",31.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",34.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",37.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",40.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",45,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",48.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",47.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",50.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",6.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",7.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",8.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",8.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",8.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",9.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",10.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",11.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",11.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",12.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",12.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",13.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",612.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",645.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",673.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",738,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",726.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",731.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",838.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",845.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",1057.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",1327.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",1834.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",2435.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",5.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",5.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",6.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",5.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",6.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",7.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",9.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",10.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",13.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",19.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",4.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",4.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",5.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",5.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",5.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",6.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",7.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",9.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",12.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",16.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",15.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",17.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",16.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",18.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",19,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",16.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",20.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",23.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",27.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",30,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",37,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",51.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",14.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",15,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",15.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",16.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",16,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",15.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",17.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",17.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",21.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",26.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",34.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",43.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",2.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",2.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",2.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",2.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",3.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",3.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",3.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",3.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",3.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",4.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",5.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",68,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",73.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",81.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",82,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",83.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",89.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",94,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",97.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",104.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",114.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",124.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",134.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",90.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",102.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",104.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",108.9,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",111.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",99.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",104,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",110.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",123.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",128.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",142,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",159.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",80,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",88.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",98.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",101,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",102.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",110.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",118.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",123.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",132.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",142,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",156.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",169.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",19.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",22.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",22.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",23.5,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",23.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",21.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",21.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",23,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",25.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",26,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",28.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",31.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",17.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",19.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",21.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",21.9,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",21.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",23.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",24.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",25.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",27.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",28.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",31.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",33.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",3.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",3.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",4.2,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",4.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",4.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",4.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",4.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",4.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",4.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",5.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",5.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",742.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",779.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",812,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",809.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",869.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",898.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",904.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",945.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",1010,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",1095,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",1178.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",1346.6,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",1033.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",1001.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",1078.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",1075.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",965.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",994.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",1021.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",1116.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",1130.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",1250.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",1393.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",1418,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",978.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",1042.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",1101.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",1094.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",1177.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",1282.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",1310.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",1387.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",1537.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",1690.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",1819.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",2180.9,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",17.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",16.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",17.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",17.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",15.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",16.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",16.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",18.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",18.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",21,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",23.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",24,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",16.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",17.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",18.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",18,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",19.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",21.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",21.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",23,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",25.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",28.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",30.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",36.9,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",3.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",4.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",4.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",4.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",3.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",3.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",4.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",4.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",4.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",5.4,"E","Estimated value" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",554852,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",585107.5,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",573474.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",634317.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",690951.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",772617.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",845488.9,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",954874.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",1087093.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",1193608.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",1310982.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",1419692.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",479.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",528,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",508.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",579.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",656.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",683.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",728.4,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",844.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",988.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",1024.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",1110.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",1241,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",659.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",684.7,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",670.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",729.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",792.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",901,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",984.5,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",1094.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",1271.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",1393.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",1565,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",1662.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",9.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",10.6,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",10.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",11.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",12.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",13.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",14.2,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",16.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",19.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",19.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",21.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",24,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",13.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",13.7,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",13.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",14.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",15.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",17.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",19.2,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",21.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",24.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",26.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",30.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",32.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",2.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",2.7,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",2.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",2.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",2.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",3.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",3.3,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",3.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",3.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",3.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",4.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",9.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",10.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",11,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",12.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",13.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",15.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",15.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",17.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",18.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",19.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",21,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",22.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",22.6,"D; P","Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",12.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",14.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",14.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",16.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",18.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",16.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",17.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",19.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",21.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",21.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",24,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",26.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",23.8,"D; P","Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",9.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",11.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",12.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",13.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",15.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",17.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",18.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",20.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",21.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",23.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",24.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",26,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",27.1,"D; P","Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",25.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",29.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",28.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",32,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",36,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",32.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",33.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",36,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",39.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",39.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",42.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",46,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",40.5,"D; P","Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",20.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",23.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",24.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",26.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",30.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",33.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",35.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",37.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",39,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",41.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",43.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",45.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",46.3,"D; P","Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",4.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",5.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",5.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",6.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",7.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",7.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",8.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",8.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",9.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",9.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",10,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",9.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",8.8,"D; P","Difference in methodology; Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",242.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",252,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",260.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",269.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",268.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",321.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",350.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",334.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",358.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",356.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",283.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",301.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",315.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",338,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",331.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",19.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",21,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",19.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",21.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",21.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",17.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",18.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",18.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",20.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",19.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",4.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",4.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",5.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",6.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",6.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",29.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",32.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",35.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",39.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",42.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",46.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",50,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",53.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",57.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",60.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",75.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",86.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",123,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",21.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",25.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",28.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",32.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",35.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",32.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",34.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",37.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",39.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",40,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",48.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",61,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",78,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",19.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",21.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",23.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",27,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",29.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",31.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",34.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",37.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",39.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",42.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",53.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",59.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",85.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",4.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",5.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",7.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",7.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",7.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",7.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",8.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",9.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",11.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",15.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",4.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",5.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",6.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",6.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",7.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",7.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",8.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",10.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",11.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",16.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",3.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",4.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",4.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",4.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",4.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",4.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",4.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",4.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",4.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",4.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",517,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",556,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",596,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",601,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",683,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",786,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",913,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",1001,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",1099,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",1218,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",1405,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",1907,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",2663,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",85.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",99.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",102.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",102.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",108.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",97.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",108.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",121,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",135.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",138.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",149.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",222,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",277,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",56.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",61.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",66,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",66.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",73.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",79.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",90.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",102.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",114.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",126.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",142.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",200.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",248,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",17.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",20,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",20.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",20.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",21.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",18.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",20.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",22.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",25.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",25.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",27.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",41,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",51.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",11.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",12.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",13.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",13.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",14.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",15.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",17.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",19.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",21.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",23.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",26.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",37.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",45.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",2.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",3.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",3.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",3.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",3.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",3.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",3.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",3.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",4.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",4.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",5.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",7.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",208.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",222.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",224.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",228.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",238.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",265,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",279.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",291.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",322,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",359.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",395.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",440.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",515.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",276.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",309.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",288.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",303.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",317.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",294,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",309.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",329.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",380.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",402.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",452.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",521,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",543.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",334.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",356.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",370.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",391.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",412.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",453,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",488.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",506.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",563.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",644,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",710.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",775.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",937.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",26.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",29.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",27.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",29,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",30.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",28.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",29.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",32,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",37,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",39.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",43.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",50.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",52.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",31.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",33.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",35.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",37.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",39.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",43.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",47.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",49.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",54.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",62.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",69,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",74.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",90.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",6.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",7.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",8.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",9.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",10,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",10.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",11,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",11.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",12.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",12.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",14.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",15.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",16.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",39.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",43,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",39.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",45.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",52.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",62.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",67.6,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",67.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",69.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",74.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",80.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",84.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",52.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",59.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",51,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",60.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",69.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",69.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",74.8,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",76,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",82.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",83.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",92.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",99.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",78.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",84.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",78.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",92.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",107.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",127.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",134.4,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",130.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",132.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",144.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",155.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",158.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",9.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",11.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",9.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",11.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",12.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",12.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",13.8,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",14,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",15.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",15.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",16.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",18.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",14.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",15.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",14.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",17.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",19.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",23.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",24.7,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",23.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",24.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",26.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",28.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",29,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",3.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",3.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",3.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",3.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",4.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",4.3,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",4.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",4.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",4.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",4.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",802.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",890.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",941.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",1024.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",1167.2,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",1269.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",1383.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",1467.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",1594.8,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",1711.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",1834.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",2012.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",2175.3,"P","Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",1063.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",1239.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",1210.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",1361,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",1550.7,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",1408.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",1531.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",1657.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",1883.4,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",1915.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",2094.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",2380.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",2290.7,"P","Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",1103.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",1247.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",1355.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",1518.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",1762.2,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",1910,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",2153.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",2325.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",2524.2,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",2792.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",2951.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",3215.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",3648.6,"P","Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",22.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",26.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",25.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",29.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",33.4,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",30.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",33,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",35.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",40.2,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",40.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",44.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",50.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",48.3,"P","Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",23.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",26.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",29,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",32.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",37.9,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",41.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",46.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",49.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",53.9,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",59.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",62.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",67.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",76.9,"P","Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",6.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",7.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",8.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",9.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",10.3,"B; D","Break; Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",11.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",11.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",12.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",8.4,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",8.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",8.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",9.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",9.5,"P","Provisional value" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",1293.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",1322.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",1384,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",1366.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",1410.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",1535.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",1687.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",1855,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",2100,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",2372.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",2640.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",2951.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",3474.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",179.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",203.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",204.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",209.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",205.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",182.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",197.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",217,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",241.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",250.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",286.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",344.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",343.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",143.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",149.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",159.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",159,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",161.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",173.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",191.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",209.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",236.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",272.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",304.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",338.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",400.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",19.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",21.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",21.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",21.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",21.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",18.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",19.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",21.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",23.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",24.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",27.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",33,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",32.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",15.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",15.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",16.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",16.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",16.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",17.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",19.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",20.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",23.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",26.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",29.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",32.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",38.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",3.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",3.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",3.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",3.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",3.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",3.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",4.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",4.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",4.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",5.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",699.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",658,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",658.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",798,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",913.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",1051.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",1234.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",1534.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",1933.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",2630.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",3713.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",4640.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",465.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",392.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",366.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",419.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",417.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",386.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",408.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",420.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",400.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",463.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",529.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",524.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",759.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",681,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",645.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",745.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",827.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",904.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",994.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",1108.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",1184.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",1411.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",1715.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",1652.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",6.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",5.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",5.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",5.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",5.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",5.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",5.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",6.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",6.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",10.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",9.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",8.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",9.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",10.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",11.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",12.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",13.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",14.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",17.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",20.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",19.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",4.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",4.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",5.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",5.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",5.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",5.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",6.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",7.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",7.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",21597.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",34618.4,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",41736.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",50330.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",66175.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",87238.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",96716.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",111563.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",105573.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",138703.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",180033.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",219396.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",249712.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",42.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",71.6,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",85.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",101.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",116,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",133.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",142.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",171.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",164.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",197.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",227.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",289.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",285.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",60,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",99.5,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",120.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",143.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",180.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",223,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",243.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",280.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",266.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",345.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",430.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",504.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",570.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",2.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",4.1,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",5.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",6.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",7.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",7.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",9.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",8.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",10.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",11.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",14.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",14.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",3.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",5.8,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",6.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",8.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",10.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",12.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",13.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",15.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",14.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",18.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",22.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",25.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",28.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",2.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",2.9,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",3.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",3.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",4.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",4.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",4.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",5.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",4.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",5.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",6.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",7.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",8.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",11.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",11.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",13.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",14.1,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",15.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",16.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",17.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",18,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",19.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",20.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",22.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",24.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",29.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",15.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",16.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",17.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",18.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",20.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",18.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",19.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",20.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",23.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",23.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",25.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",28.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",30.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",22.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",23.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",25.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",27.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",29.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",30.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",32.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",33.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",36.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",38.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",42.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",44.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",51.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",11.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",12.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",13,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",14.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",15.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",13.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",14.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",15.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",17.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",17.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",19.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",21.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",23.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",16.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",17.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",19.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",20.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",22.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",23.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",24.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",25.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",27.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",29.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",32.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",33.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",38.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",5.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",5.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",6.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",6.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",6.2,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",6.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",6.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",6.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",5.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",6.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",25.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",26.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",28.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",28,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",28.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",28.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",30.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",31.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",34,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",36.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",39.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",43.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",52.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",34,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",37.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",36.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",37.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",37.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",32,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",33.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",35.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",40.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",41,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",45,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",51.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",55.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",40.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",43.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",46.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",47.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",47.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",48.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",52.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",55.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",59.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",66.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",72,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",77.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",95.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",16.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",18.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",17.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",18,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",18.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",15.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",16.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",17.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",19.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",19.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",21.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",24.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",26.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",19.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",21,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",22.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",23,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",23.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",23.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",25.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",26.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",28.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",31.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",34.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",36.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",45.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",5.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",5.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",6.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",6.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",6.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",6.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",6.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",6.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",7.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",7.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",406,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",417,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",405,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",481,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",545,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",617,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",667,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",748,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",816,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",880,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",947,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",1022,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",372.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",430.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",419.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",464.4,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",491.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",463.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",495.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",573.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",609.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",611.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",651.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",767.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",270,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",276,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",263,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",332.4,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",375.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",418.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",460,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",506.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",554.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",594.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",651.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",706,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",16.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",19.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",18.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",20.1,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",20.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",19.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",20.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",23.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",24.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",24.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",25.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",29.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",12.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",12.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",11.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",14.4,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",16,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",17.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",19,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",20.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",22.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",23.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",25.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",27.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",4.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",4.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",3.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",4.1,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",4.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",4.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",5.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",5.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",5.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",5.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",5.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",151.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",145.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",164.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",191.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",220.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",246.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",280.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",309.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",335,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",355.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",381.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",406.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",200.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",203,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",211.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",254.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",292.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",273.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",310.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",350,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",395.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",398.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",435.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",481.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",179.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",175.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",202.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",240.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",275.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",308.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",360.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",399.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",437.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",475.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",511.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",538,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",24,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",24.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",25.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",30,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",34.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",31.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",35.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",39.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",44.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",44.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",48.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",53.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",21.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",20.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",24,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",28.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",32.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",35.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",41.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",45.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",49.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",53.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",57.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",60.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",6.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",5.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",6.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",7.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",7.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",8.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",9.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",9.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",10.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",10.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",11,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",11,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",448.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",444.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",450.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",491.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",501.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",522.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",559.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",595,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",611.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",683,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",745.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",816.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",891.1,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",595.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",618.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",578.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",652.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",666.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",580,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",619.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",672.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",722.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",764.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",851.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",966,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",938.4,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",536.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",533.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",548,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",609.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",626.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",653.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",716.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",767.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",797.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",914.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",1020.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",1108.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",1248.2,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",54.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",56,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",52.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",58.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",59.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",51.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",54.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",59.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",63.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",66.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",73.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",83.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",80.8,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",49.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",48.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",49.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",54.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",55.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",58,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",63.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",67.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",69.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",79.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",88.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",95.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",107.4,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",7.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",7.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",7.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",8.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",8.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",8.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",9.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",9.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",9.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",9.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",10.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",9.9,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",742.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",774.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",870.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",954.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1064.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1161.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",1246.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",1345.5,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",1476.1,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",1572.2,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",1611.6,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",743.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",751.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",787.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",746.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",802.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",895.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",961.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",1014.1,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",1100.6,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",1253.9,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",1238.2,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",596.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",632.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",707.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",765,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",881.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",958.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",1032.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",1089.7,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",1199.1,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",1269.8,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",1285.4,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",21.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",21.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",22.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",20.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",22.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",24.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",25.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",27,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",28.9,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",32.8,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",31.8,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",17.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",18,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",20,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",21.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",24.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",26.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",27.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",29,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",31.5,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",33.2,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",33.1,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",3.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",3.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",3.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",3.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",3.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",3.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",4.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",4.2,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",4.3,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",4.3,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",4,"E; D","Estimated value; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",5259.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",5429,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",6184.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",6193.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",6890.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",7422.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",7961.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",8615.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",9450.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",9824.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",9517.8,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",10694.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",275.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",306.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",315.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",316.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",332,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",301.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",325.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",368.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",434.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",428.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",410.1,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",493.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",384.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",406.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",465.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",484.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",542.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",573.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",633.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",693.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",763.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",800.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",763.8,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",839.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",26.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",29.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",30.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",30.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",31.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",28.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",30.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",34.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",40.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",40.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",38.3,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",47,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",36.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",38.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",44.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",46.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",51.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",54.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",59.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",65.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",71.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",75,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",71.4,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",79.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",6.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",6.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",7.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",7.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",8.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",8.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",9.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",9.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",9.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",9.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",10.8,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",11.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",1243.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",1206,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",1344.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",1405.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",1593.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",1721.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",1851.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",1993.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",2168.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",2239,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",2370.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",2521,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",221.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",224.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",232,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",250.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",284,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",255.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",275.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",302,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",343.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",335.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",362.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",401,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",163.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",161.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",177.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",191.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",217.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",235.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",261.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",290.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",320.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",337.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",361.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",382.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",39.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",40.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",41.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",44.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",50.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",45,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",48,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",52.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",59.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",57.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",62.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",68.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",29.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",29,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",31.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",34,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",38.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",41.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",45.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",50.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",55.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",58,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",62,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",65.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",5.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",5.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",6.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",6.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",7.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",7.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",8.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",8.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",9.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",9.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",9.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",9.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",131.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",138.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",152.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",156.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",162.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",177.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",195.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",217.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",237.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",268.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",284.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",296.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",174.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",192.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",195.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",207.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",215.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",196.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",216.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",245.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",280.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",300.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",325.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",350.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",145.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",154.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",167.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",172.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",178.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",195.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",222.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",251.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",278.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",320,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",345.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",358.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",32.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",35.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",36.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",38.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",39.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",35.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",39.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",44.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",50.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",54.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",58.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",63.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",27.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",28.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",31,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",31.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",32.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",35.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",40.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",45.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",50.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",58,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",62.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",64.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",7.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",7.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",7.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",7.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",8.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",8.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",9.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",9.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",10.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",10.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",10.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",2128.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",2963.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",2530.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",45.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",38.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","FRA","France","2011","2011",7.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",1650.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",1592.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",1758.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",2013.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",2317.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",2564.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",2837.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",3168.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",3675,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",4064.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",4566.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",5290.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",2188.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",2217,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",2258.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",2674.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",3079.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",2845,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",3140.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",3579.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",4340,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",4550.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",5216,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",6257.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",2050.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",2019.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",2233.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",2598.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",3014.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",3295.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",3770,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",4254.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",4997,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",5581.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",6298.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",7185.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",26.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",27.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",28.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",33.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",38,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",34.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",38.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",43.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",52.3,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",54.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",62.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",75.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",25.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",25.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",27.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",32.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",37.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",40.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",45.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",51.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",60.3,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",67.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",75.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",86.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",5.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",5.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",5.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",6.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",6.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",7.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",7.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",8.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",8.3,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",8.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",9.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",9.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",643.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",579.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",509.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",463.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",492,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",449.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",1701.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",1024.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",1090.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",809.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",765,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",819.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",810.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",853.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",806.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",655.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",615.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",653.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",498.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",1883.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",1157.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",1288.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",906.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",873.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",969,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",853.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",891.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",812.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",744.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",734.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",805.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",737.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",2891.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",1781.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",1931,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",1475.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",1406.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",1501.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",1534.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",76.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",72.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",59.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",56.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",60,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",46.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",174.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",107.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",120,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",84.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",81.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",91.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",81.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",80.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",73.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",67.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",67,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",73.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",68.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",268.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",165.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",179.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",137.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",131.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",142.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",146.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",39342.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",40274.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",39070,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",38973.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",43658.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",48375.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",53187.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",50338.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",46539.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",53924.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",61036.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",67066,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",72200.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",189.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",200.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",173.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",174.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",187.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",173.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",188.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",183.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",172.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",185.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",198.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",221.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",193.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",311.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",324.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",311,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",311.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",337.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",364.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",402.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",370,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",334.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",382.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",419.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",433.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",447.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",18.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",20.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",17.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",17.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",19,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",17.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",19.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",18.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",17.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",19,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",20.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",22.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",20,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",31.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",32.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",31.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",31.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",34.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",37.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",41,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",37.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",34.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",39.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",43.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",44.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",46.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",7.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",7.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",8.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",9.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",9.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",10.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",10.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",10.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",9.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",10.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",10.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",11.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",12.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",1316,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",1283.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",1325.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",1557,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",1526.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",1575.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",1922.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",1768.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",1992.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",2454,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",2952.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",3356.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",10.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",11.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",10.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",12.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",13.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",11.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",15.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",16.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",18.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",20,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",21.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",26.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",9.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",9.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",9.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",11.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",11,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",11.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",13.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",12.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",14.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",17.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",20.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",22.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",33.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",34.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",33,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",39.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",39.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",36.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",47.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",48.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",52.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",55.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",59.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",70.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",31.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",29.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",30.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",35.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",33.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",33.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",40.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",37.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",40.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",48.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",54.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",60.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",5.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",4.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",5.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",6.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",6.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",7.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",6.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",6.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",7.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",7.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",7.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",93.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",89.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",91.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",89.7,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",90.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",95.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",104.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",113.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",123.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",132.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",141.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",148.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",124.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",124.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",117.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",119.2,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",120.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",105.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",116.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",127.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",146.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",147.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",161.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",175.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",110.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",107.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",111.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",110.6,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",110.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",117.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",132.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",142.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",156.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",164,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",177.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",186.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",27.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",27.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",25.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",25.8,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",25.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",22.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",24.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",26.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",30,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",30,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",32.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",34.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",24.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",23.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",24.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",23.9,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",23.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",25,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",27.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",29.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",32.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",33.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",35.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",37.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",4.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",4.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",4.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",4.6,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",4.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",4.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",5.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",5.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",5.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",5.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",5.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",5.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",1775.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",1764.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",1717.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",1853.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",1981.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",2027,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",2088.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",2082.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",2178.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",2304.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",2349.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",2406.8,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",2471.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",2267.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",2280.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",2462.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",2198.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",2243.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",2359.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",2459.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",2439.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",2632.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",2778.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",2534.4,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",2340.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",2360.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",2329.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",2506.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",2683,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",2893.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",3027,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",3057.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",3317.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",3558.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",3628.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",3898.1,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",41.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",38.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",37.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",40.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",36.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",37,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",39,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",40.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",40.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",44.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",47,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",42.9,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",39.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",39.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",38.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",41.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",44.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",47.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",50,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",50.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",55.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",59.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",61.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",66,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",9.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",9.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",8.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",9.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",8.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",8.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",9.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",9.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",9.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",10,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",9.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",9.7,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",446699,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",463919,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",510891,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",497196,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",448987,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",461825,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",425618,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",420896,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",469262,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",683211,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",641276,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",616820,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",5088.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",5813,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",6402.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",5094.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",4237.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",3815.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",3912.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",3752.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",4249.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",6267.4,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",6005.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",5620,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",3998.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",4317.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",4899.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",4908,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",4356.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",4463.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",4033.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",4004.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",4505.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",6555.1,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",6260.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",6044.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",39.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",45.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",50.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",40,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",33.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",30,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",30.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",29.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",33.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",49.7,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",47.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",44.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",31.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",33.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",38.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",38.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",34.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",35.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",31.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",31.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",35.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",52,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",49.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",48.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",6.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",6.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",7.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",7.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",6.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",6.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",6.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",6.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",6.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",7.2,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",6.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",6.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",1647148,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",1767579.5,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",1782148.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",1852464.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",1967406.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",2093006.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",2000397.8,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",2107041.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",2300183.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",2470833.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",2608157,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",2786025.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",1424.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",1595,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",1581.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",1691.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",1868.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",1850.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",1723.3,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",1863,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",2090.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",2120.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",2209.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",2435.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",1958.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",2068.3,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",2084.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",2131.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",2256.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",2440.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",2329.3,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",2414.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",2690.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",2885.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",3113.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",3262,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",28.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",31.9,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",31.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",33.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",36.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",36.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",33.6,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",36.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",40.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",41,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",42.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",47.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",39.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",41.4,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",41.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",42.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",44.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",47.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",45.5,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",47,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",52.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",55.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",60.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",63,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",8.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",8,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",8.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",8.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",8.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",8.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",7.9,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",7.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",9.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",9.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",10.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",10.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",11.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",13,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",14.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",15.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",16.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",18.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",19.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",22.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",22.6,"D; P","Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",12.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",12.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",12.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",14.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",15.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",14.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",15.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",17.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",19.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",20.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",22.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",26.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",23.8,"D; P","Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",10.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",10.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",11.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",12.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",13.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",14.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",16.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",18.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",19.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",21.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",23.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",26.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",27.2,"D; P","Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",26.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",26.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",26.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",28.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",30.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",27.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",30.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",32.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",36.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",37,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",40.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",46.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",40.6,"D; P","Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",21.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",21,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",22.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",24.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",26.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",28.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",32.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",34.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",36.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",39.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",41,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",45.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",46.4,"D; P","Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",5.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",4.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",5.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",5.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",6.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",6.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",7.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",8.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",9.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",9.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",8.8,"D; P","Difference in methodology; Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2010","2010",3930,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2011","2011",2231,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2012","2012",4172,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2013","2013",2218,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2014","2014",2176,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2015","2015",2320,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2016","2016",1766,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2017","2017",1640,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2018","2018",1401,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2019","2019",1889,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2020","2020",2109,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2021","2021",2435.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","MEX","Mexico","2022","2022",2290.7,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2010","2010",311,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2011","2011",179.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2012","2012",316.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2013","2013",173.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2014","2014",163.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2015","2015",146.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2016","2016",94.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2017","2017",86.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2018","2018",72.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2019","2019",98.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2020","2020",98.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2021","2021",120.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2022","2022",113.8,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2010","2010",511.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2011","2011",290.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2012","2012",530.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2013","2013",281.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2014","2014",270.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2015","2015",278.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2016","2016",209.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2017","2017",184,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2018","2018",151,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2019","2019",195.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2020","2020",210.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2021","2021",234.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2022","2022",216.6,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2010","2010",2.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2011","2011",1.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2012","2012",2.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2013","2013",1.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2014","2014",1.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2015","2015",1.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2016","2016",0.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2017","2017",0.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2018","2018",0.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2019","2019",0.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2020","2020",0.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2021","2021",0.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2022","2022",0.9,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2010","2010",4.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2011","2011",2.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2012","2012",4.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2013","2013",2.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2014","2014",2.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2015","2015",2.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2016","2016",1.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2017","2017",1.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2018","2018",1.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2019","2019",1.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2020","2020",1.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2021","2021",1.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2022","2022",1.7,"E","Estimated value" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","MEX","Mexico","2013","2013",1.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","MEX","Mexico","2018","2018",0.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",245.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",242.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",244.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",258.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",267.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",325.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",337.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",313.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",342.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",355.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",287.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",290.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",296.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",323.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",330.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",19.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",20.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",18.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",20.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",21.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",17.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",17.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",17.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",19.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",19.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",4.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",4.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",5.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",6.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",26.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",26.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",42.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",48.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",87.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",99,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",84.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",68.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",80,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",81,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",99.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",113.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",126,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",18.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",20.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",34.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",39.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",72.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",69.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",59,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",48.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",55.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",53.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",64.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",80.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",79.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",17.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",17.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",28.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",33.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",60.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",67,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",58.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",47.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",54.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",57.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",70.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",77.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",87.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",4.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",4.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",7.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",8.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",16,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",15,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",12.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",10.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",11.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",10.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",12.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",15.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",15.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",6.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",7.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",13.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",14.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",12.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",9.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",11.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",11.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",13.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",15.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",17,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",3.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",3.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",4.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",5.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",9.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",10,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",7.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",5.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",6.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",5.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",6.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",6.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",1188,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",1203,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",1274,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",1498,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",1654,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",1846,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",2127,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",2330,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",2510,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",2679,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",2762,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",2931,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",3082,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",196.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",214.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",219,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",255,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",262.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",228.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",253.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",281.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",308.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",304.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",293.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",341.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",320.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",129.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",132.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",141,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",165.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",178.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",185.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",211.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",239,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",261.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",278.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",279.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",308.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",287,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",40.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",43.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",43.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",50.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",51.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",44.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",48.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",53.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",58.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",56.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",54.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",63.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",59.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",26.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",26.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",28.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",32.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",34.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",35.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",40.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",45.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",49.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",52.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",52,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",57,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",52.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",6.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",6.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",6.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",7.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",7.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",8.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",8.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",8.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",9.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",9.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",9.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",8.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",8.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",120.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",105.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",87.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",91.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",110.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",140.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",175.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",192.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",225.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",258.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",262.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",283.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",303,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",159.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",147.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",112.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",121.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",147.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",155.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",194.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",217,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",266.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",289.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",299.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",335.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",319.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",193.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",169.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",144.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",157.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",191.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",240.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",307.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",333.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",394.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",463.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",470.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",499.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",551,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",15.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",13.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",10.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",11.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",14.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",15.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",18.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",21.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",25.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",28.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",29.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",32.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",30.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",18.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",16.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",13.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",15,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",18.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",23.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",29.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",32.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",38.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",45,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",45.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",48.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",53.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",3.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",3.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",3.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",3.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",4.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",5.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",6.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",7.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",8.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",9.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",9.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",9.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",9.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",102.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",97.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",106.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",118.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",134.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",146.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",180.7,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",191.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",213.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",217.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",203.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",176,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",135.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",136,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",137.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",157.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",178.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",162.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",200,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",215.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",252.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",243,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",232.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",208.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",203.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",193,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",211.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",241.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",276.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",298.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",359.1,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",370,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",406.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",419.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",392,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",329.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",25.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",25.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",25.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",29.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",32.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",30,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",36.8,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",39.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",46.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",44.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",42.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",38.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",37.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",35.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",39.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",44.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",51,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",55.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",66.1,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",68,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",74.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",76.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",71.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",60.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",9.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",8.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",9.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",9.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",10.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",10.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",11.5,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",12.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",13.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",12.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",12.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",9.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",612.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",529.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",501.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",526.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",593.7,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",652.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",729,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",806.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",1638.6,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",1746.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",1847.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",2023.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",2090.9,"P","Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",812.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",737.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",644.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",699.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",788.8,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",724.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",806.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",910.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",1935.2,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",1954.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",2109.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",2393,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",2201.8,"P","Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",842.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",741.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",722,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",780.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",896.4,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",982,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",1134.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",1277.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",2593.6,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",2848.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",2973,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",3232.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",3507,"P","Provisional value" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",17.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",15.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",13.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",15,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",17,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",15.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",17.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",19.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",41.4,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",41.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",44.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",50.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",46.4,"P","Provisional value" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",18.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",15.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",15.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",16.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",19.3,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",21.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",24.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",27.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",55.4,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",60.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",62.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",68.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",73.9,"P","Provisional value" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",4.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",4.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",4.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",4.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",5.3,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",5.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",6.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",6.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",8.6,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",8.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",8.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",9.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",9.1,"P","Provisional value" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",3079.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",3169.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",3172.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",3148.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",3223,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",3520.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",3887.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",4294.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",4641.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",5018.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",5405,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",5630.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",5980.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",427.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",488.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",468.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",483.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",469.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",417.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",454,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",502.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",534,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",530.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",586.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",656.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",591.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",341.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",358.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",366.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",366.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",369.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",397.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",440.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",485.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",523.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",576.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",623.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",645.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",690.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",45.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",51.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",49.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",50.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",48.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",42.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",45.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",49.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",52.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",51.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",56.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",63,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",56.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",36.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",37.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",38.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",38.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",38.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",40.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",44.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",48.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",51.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",56.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",60.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",62,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",66,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",8.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",8.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",8.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",8.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",8.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",8.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",9.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",9.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",9.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",9.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",10.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",10.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",10.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",215.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",208,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",222,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",245,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",263,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",285,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",320,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",354,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",387,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",397,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",422,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",453,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",455,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",206.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",234.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",236.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",264.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",287.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",296.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",324.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",359.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",395.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",399.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",449.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",495.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",476.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",147,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",148.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",163.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",186.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",205.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",230.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",266.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",298,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",328.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",345.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",371.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",409.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",426.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",26.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",29.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",29.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",32.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",35.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",35.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",38.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",42.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",46.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",46.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",52,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",56.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",54.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",18.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",18.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",20.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",23.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",25.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",27.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",31.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",35.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",38.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",40.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",43,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",47,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",48.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",3.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",3.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",3.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",4.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",4.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",4.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",5,"B; D","Break; Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",5.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",5.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",5.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",6.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",6.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",716.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",739,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",744.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",824.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",959.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",1179,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",1410.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",1774.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",2309.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",3114.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",3935,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",5042,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",476.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",441.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",414.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",433.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",438.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",433.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",467.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",486.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",478.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",549,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",561.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",569.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",778.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",764.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",729.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",770.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",869.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",1014.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",1136.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",1282.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",1414.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",1671,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",1818.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",1795.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",6.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",5.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",5.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",5.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",5.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",5.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",5.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",6.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",5.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",6.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",6.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",6.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",10.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",10.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",9.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",10.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",11.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",13,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",14.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",16,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",17.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",20.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",21.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",21.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",4.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",5.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",5.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",5.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",6.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",6.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",6.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",7.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",7.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",7.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",7.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",580,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",649.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",761.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",900.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",1029.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",1182.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",1335,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",916.2,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",1015.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",1252.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",1376.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",1390.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",1522.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",1781.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",826.6,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",934.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",1090.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",1300.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",1495.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",1727.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",1941.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",14.4,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",15.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",19.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",21.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",21.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",23.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",26.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",13,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",14.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",16.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",20,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",22.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",26.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",29.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",4.2,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",4.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",4.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",5.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",5.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",6.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",6.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",19663.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",55202.5,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",66082.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",75138.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",68583.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",92673.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",99840,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",93218.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",117343.5,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",137320.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",139350.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",199401.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",178790.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",38.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",114.1,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",135.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",151.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",120.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",141.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",147.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",143.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",183,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",195.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",175.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",262.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",204.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",54.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",158.6,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",190.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",214.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",186.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",236.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",251.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",234.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",296.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",341.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",333,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",458.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",408.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",2.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",6.6,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",7.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",8.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",6.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",7.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",8.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",7.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",9.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",10.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",13.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",10.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",3.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",9.2,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",10.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",12.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",10.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",13.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",13.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",12.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",15.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",17.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",17.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",23.3,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",20.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",2.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",4.7,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",5.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",5.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",4.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",5.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",4.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",4.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",5.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",5.4,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",5.2,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",7.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",6.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",10.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",11.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",13.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",14.1,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",17.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",21.3,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",25.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",29.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",35.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",37.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",40.4,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",42.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",46,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",13.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",15.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",16.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",18.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",23.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",23.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",28.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",33.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",42,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",42.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",46.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",50.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",48.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",20.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",22.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",25.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",27,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",33,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",39.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",48,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",54.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",66,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",70.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",77.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",78.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",80.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",10.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",11.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",12.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",14.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",17.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",17.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",21.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",25.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",31.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",31.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",34.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",38,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",36.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",15.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",16.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",19.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",20.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",25.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",30.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",36.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",41.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",50,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",53.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",58,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",59.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",60.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",5.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",5.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",5.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",6.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",8.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",9.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",10.9,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",11,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",11.3,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",10.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",10.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",25.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",25.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",25.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",28.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",31.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",35,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",40,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",46.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",54.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",60.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",67.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",74.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",79.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",33.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",35,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",32.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",38.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",41.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",38.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",44.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",52.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",64.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",68.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",77.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",88.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",83.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",39.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",40.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",41.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",48.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",52.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",58.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",69.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",81.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",95.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",110.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",123.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",132.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",143.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",16.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",17.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",15.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",18.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",20.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",18.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",21.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",25.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",31,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",32.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",36.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",41.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",39.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",19.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",19.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",20.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",23.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",25.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",28.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",33.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",39.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",46.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",52.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",58.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",62.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",68.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",5.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",5.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",5.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",6.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",7.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",7.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",8.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",9.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",10.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",11.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",11.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",12.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",11.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",2744,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",2825,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",2538,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",2516,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",2200,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",1992,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",1860,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",1798,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",1822,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",1862,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",1962,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",2061,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",2517.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",2914,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",2627.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",2428.9,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",1983.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",1496.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",1382.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",1378,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",1361.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",1294.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",1350.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",1548.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",1824.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",1869.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",1647.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",1738.6,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",1514.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",1351.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",1282.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",1216.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",1239.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",1258.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",1349.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",1423.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",114.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",130.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",115.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",105,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",84.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",62.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",57.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",56,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",54.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",51.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",52.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",60.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",82.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",83.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",72.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",75.2,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",64.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",56.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",53,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",49.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",49.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",49.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",52.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",55.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",28,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",27.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",24.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",21.3,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",18.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",16.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",12.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",12.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",12.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",12,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",11.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",11.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",498,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",495.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",483.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",437.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",432.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",426.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",427.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",434.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",415.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",394.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",388.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",380.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",660.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",690.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",620.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",581.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",574.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",473.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",473.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",491,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",491.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",441.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",443.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",450.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",591.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",596.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",593.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",549.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",541.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",534.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",550.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",560.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",543.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",526.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",520.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",503.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",78.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",82.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",73.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",68.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",67.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",54.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",54.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",55.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",55.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",49.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",49.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",50.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",70.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",71.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",70.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",64.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",63.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",61.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",63,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",63.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",61.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",59.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",58.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",56.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",20,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",19.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",18.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",16.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",15.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",14.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",14.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",13.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",12.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",11.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",11.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",10.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",893.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",889.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",840.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",782.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",724.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",701.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",686.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",655.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",586.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",596.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",581.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",569.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",595.3,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",1184.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",1238.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",1079.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",1039.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",962.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",778.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",760.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",740.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",692.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",667.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",664,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",674,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",626.9,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",1068.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",1069.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",1021.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",971.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",905,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",877.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",879.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",845.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",765.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",798.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",796.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",773.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",833.9,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",108.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",112.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",97.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",93.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",85.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",69.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",67.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",65.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",60.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",58.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",57.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",58.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",54,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",98.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",96.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",92,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",87,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",80.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",77.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",77.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",74.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",67,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",69.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",69,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",66.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",71.8,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",15.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",14.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",14.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",13.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",12.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",11.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",11,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",10,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",8.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",8.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",7.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",7.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",6.6,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",4627.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",4082.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",3973.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",3888.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",3942.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",3999.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",3386.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",3162.5,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",3318.3,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",3394.2,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",3557.2,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",4630.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",3963.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",3596.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",3040.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",2974,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",3081.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",2613.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",2383.6,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",2474.2,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",2707,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",2733,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",3717.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",3335.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",3229.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",3115.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",3266.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",3298.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",2807,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",2561.3,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",2695.4,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",2741.4,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",2837,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",133.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",113,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",101.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",85.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",82.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",84.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",70.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",63.4,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",65,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",70.8,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",70.3,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",107.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",95.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",91.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",87.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",90.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",90.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",75.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",68.1,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",70.9,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",71.7,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",73,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",19,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",16.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",15.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",14.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",13.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",13.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",11.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",9.9,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",9.7,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",9.2,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",8.9,"E; D","Estimated value; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",12949.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",12647.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",12682.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",11618.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",10632.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",10160.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",10153,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",10372.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",10425.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",10754.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",9837.8,"B","Break" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",9928.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",678.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",714.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",647.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",593.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",512.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",413.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",415.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",443.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",479.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",469,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",423.9,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",458,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",947.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",947.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",953.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",908.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",837,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",785.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",807.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",834.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",842.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",876.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",789.5,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",779.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",64.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",68.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",61.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",56.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",48.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",39.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",39.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",41.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",45.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",43.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",39.6,"B","Break" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",43.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",90.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",90.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",90.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",86.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",79.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",74.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",76.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",78.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",79.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",82.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",73.8,"B","Break" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",74.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",15.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",15.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",15.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",14.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",13.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",12,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",11.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",11.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",10.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",10.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",11.2,"B","Break" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",10.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",1722,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",1418.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",1273.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",1128.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",1153.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",1152.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",1084.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",1079.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",978.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",1192.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",1217.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",1051,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",306.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",264.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",219.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",200.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",205.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",171.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",161.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",163.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",155,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",178.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",186.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",167.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",226.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",190,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",168.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",153.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",157.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",157.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",153.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",157.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",144.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",179.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",185.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",159.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",55.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",47.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",39.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",35.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",36.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",30.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",28.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",28.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",26.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",30.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",31.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",28.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",40.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",34.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",30.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",27.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",27.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",27.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",26.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",27.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",25,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",30.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",31.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",27.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",8.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",6.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",6.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",5.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",5.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",5.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",4.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",4.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",4.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",4.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",4.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",4.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",195,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",178.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",176.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",181.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",190.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",203.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",210.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",197.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",172.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",150.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",138.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",130.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",258.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",248,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",226.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",241.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",253.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",225.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",232.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",223.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",203.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",168.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",158,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",154.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",216.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",198.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",193.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",200.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",210.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",223.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",238.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",228.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",201.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",179.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",168,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",158.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",48.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",46,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",41.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",44.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",46.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",41.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",42.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",40.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",36.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",30.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",28.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",27.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",40.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",36.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",35.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",36.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",38.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",40.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",43.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",41.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",36.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",32.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",30.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",28.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",10.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",9.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",9.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",9.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",9.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",8.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",6.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",5.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",5.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",4.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",3937,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",5480.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",4679.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",84.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",71.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","FRA","France","2011","2011",14.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",4869.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",4794.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",4529.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",4455.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",4399.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",4273.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",4366.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",4431.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",4541.9,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",4692.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",4771.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",4907.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",6455.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",6673.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",5819.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",5918,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",5845,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",4741.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",4833.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",5006.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",5363.8,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",5253.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",5449.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",5804.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",6048.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",6078.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",5753.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",5751.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",5721.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",5492.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",5802,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",5949.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",6175.7,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",6443.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",6580.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",6665.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",78.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",83.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",72.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",73.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",72.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",58,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",58.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",60.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",64.7,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",63.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",65.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",69.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",74,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",75.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",71.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",71.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",70.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",67.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",70.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",72,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",74.5,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",77.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",79.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",80.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",16.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",16.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",14.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",14.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",13.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",12.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",12.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",11.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",10.3,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",10,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",9.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",9.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",1425.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",1314.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",1196.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",1018,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",953.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",885.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",939.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",873.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",853,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",850.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",810.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",829,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",650.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",1889.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",1829.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",1537.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",1352,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",1267.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",982.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",1039.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",987,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",1007.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",952.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",925.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",980.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",685,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",1974.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",1843.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",1748.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",1612.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",1560.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",1454.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",1596.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",1519.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",1510.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",1550.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",1489.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",1519.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",1230.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",169.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",164.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",139.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",123.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",116.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",90.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",96.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",91.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",93.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",88.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",86.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",92.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",65.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",177.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",166,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",158.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",147.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",143.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",134.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",148.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",141.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",140.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",144.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",139.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",143.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",117.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",129978.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",127453,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",105895,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",95396.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",90647.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",90577.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",92167.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",92973.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",93271.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",94477.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",99352.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",96764.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",100396.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",625.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",633.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",470.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",426.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",389.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",324.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",327.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",338.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",345.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",325,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",322.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",319.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",269.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",1028.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",1025.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",843,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",763.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",700.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",683.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",698.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",683.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",670.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",670.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",683.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",625.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",622.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",62.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",63.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",47.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",43.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",39.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",32.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",33.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",34.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",35.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",33.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",33.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",32.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",27.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",102.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",102.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",85,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",77.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",71,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",69.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",71.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",69.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",68.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",68.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",70.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",64.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",64.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",26.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",24.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",23.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",22.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",20.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",19.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",18.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",18.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",18.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",17.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",17.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",17,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",16.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",1906.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",1946.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",1866.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",1814,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",1783.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",1713.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",1734.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",1827.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",1998.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",2169.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",2440.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",2639.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",15.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",16.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",14.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",14.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",15.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",13,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",14.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",17.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",18.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",17.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",18,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",20.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",14.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",14.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",13.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",13.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",12.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",12.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",12.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",13.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",14.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",15.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",16.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",17.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",49,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",52.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",46.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",45.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",46.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",39.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",42.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",49.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",52.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",49.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",49.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",55.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",45.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",45.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",42.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",40.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",39.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",36.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",36.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",38.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",40.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",42.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",45.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",47.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",7.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",7.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",7.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",7.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",6.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",6.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",6.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",6.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",6.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",5.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",398.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",339.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",337.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",288.4,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",233.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",217.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",218.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",211.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",209.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",203.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",207.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",214.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",528.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",473.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",433.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",383,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",310.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",241.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",241.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",238.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",247.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",227.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",237.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",253.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",469,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",408.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",410,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",355.5,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",285.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",269,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",274.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",266,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",264.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",252.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",260.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",270,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",115.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",103.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",94.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",82.8,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",66.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",51.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",50.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",49.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",50.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",46.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",47.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",50.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",102.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",89.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",89.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",76.9,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",61.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",57.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",57.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",55.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",54.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",51.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",52.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",53.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",19.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",17.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",16.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",14.7,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",12.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",11,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",10.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",9.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",9.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",8.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",8.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",8.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",4542.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",3968.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",3769.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",3624,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",3617.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",3629.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",3549.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",3241.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",3182.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",3276.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",3318.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",3393.8,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",6323.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",5098.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",5006.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",4814.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",4013.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",4017.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",4010,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",3827.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",3562.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",3742.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",3924.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",3573.9,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",5987.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",5307.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",5112.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",4899.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",4897.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",5181,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",5145.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",4758,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",4845.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",5058.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",5124.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",5496.8,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",106.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",85.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",83.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",79.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",66.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",66.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",66.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",63.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",59.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",63,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",66.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",60.5,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",100.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",89.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",84.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",80.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",80.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",85.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",85,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",78.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",81.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",85.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",86.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",93.1,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",23.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",20.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",19.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",18.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",16,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",15.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",15.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",14.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",13.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",14.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",13.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",13.7,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",1401736,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",1347996,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",1297037,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",1255017,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",1157221,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",1088475,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",1007745,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",934437,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",802634,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",996769,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",939361,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",898665,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",15968.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",16890.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",16255.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",12859.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",10922.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",8992.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",9263,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",8330.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",7268.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",9143.9,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",8797.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",8188,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",12548,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",12544.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",12438.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",12388.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",11229.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",10519.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",9550.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",8890.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",7705.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",9563.5,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",9171,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",8806.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",124.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",132.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",127.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",100.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",85.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",70.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",73,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",65.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",57.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",72.5,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",69.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",65.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",98,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",98.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",97.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",97.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",88.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",82.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",75.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",70.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",60.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",75.8,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",72.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",70.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",20.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",19.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",18.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",18.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",17.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",16.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",15.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",13.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",11.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",10.5,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",10.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",9.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",2801238,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",2980199.5,"B","Break" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",2861087.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",2909973.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",2959711.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",3047770.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",3208747.7,"B","Break" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",3475580.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",3753638.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",3981146.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",4466464.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",4922786,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",2422.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",2689.1,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",2539.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",2657.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",2811.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",2694.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",2764.3,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",3073,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",3411.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",3416.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",3784.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",4303.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",3330.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",3487.3,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",3346.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",3348.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",3394.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",3554.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",3736.3,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",3982.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",4390.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",4648.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",5332,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",5763.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",48.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",53.9,"B","Break" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",50.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",52.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",55.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",52.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",54,"B","Break" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",59.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",66.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",66,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",73,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",83.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",67.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",69.8,"B","Break" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",66.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",66.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",66.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",69.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",72.9,"B","Break" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",77.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",85.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",89.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",102.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",111.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",13.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",13.5,"B","Break" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",13.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",12.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",12.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",12.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",12.6,"B","Break" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",12.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",13,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",12.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",13.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",14.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",41.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",42,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",41.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",38.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",34.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",33,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",32.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",30.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",26.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",26.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",26.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",26.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",27.3,"D; P","Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",54.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",58.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",53.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",51.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",45.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",36.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",36,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",34.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",31.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",29.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",30.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",31.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",28.7,"D; P","Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",44.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",46.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",46,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",43.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",38.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",37.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",38.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",35.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",31.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",31.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",30.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",31.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",32.8,"D; P","Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",115.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",121.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",108.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",102.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",88.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",70.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",68.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",63.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",57.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",52.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",53.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",55.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",49,"D; P","Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",93.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",96.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",93.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",86.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",75.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",72.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",72.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",66.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",57.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",55.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",54.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",54.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",55.9,"D; P","Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",21.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",22,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",21.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",19.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",17.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",17.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",16.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",15.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",13.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",12.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",12.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",11.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",10.6,"D; P","Difference in methodology; Provisional value" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2010","2010",10123,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2011","2011",10277,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2012","2012",9747,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2013","2013",9926,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2014","2014",8388,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2015","2015",9583,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2016","2016",11846,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2017","2017",10490,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2018","2018",10015,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2019","2019",9183.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2020","2020",9090,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2021","2021",7824.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","MEX","Mexico","2022","2022",7963.2,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2010","2010",801.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2011","2011",827.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2012","2012",740.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2013","2013",777.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2014","2014",631,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2015","2015",604.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2016","2016",634.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2017","2017",554.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2018","2018",520.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2019","2019",476.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2020","2020",423.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2021","2021",386,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2022","2022",395.6,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2010","2010",1318.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2011","2011",1339.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2012","2012",1240.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2013","2013",1258.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2014","2014",1042.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2015","2015",1150.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2016","2016",1402.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2017","2017",1176.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2018","2018",1079.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2019","2019",950.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2020","2020",905.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2021","2021",752.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2022","2022",752.9,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2010","2010",7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2011","2011",7.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2012","2012",6.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2013","2013",6.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2014","2014",5.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2015","2015",5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2016","2016",5.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2017","2017",4.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2018","2018",4.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2019","2019",3.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2020","2020",3.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2021","2021",3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2022","2022",3,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2010","2010",11.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2011","2011",11.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2012","2012",10.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2013","2013",10.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2014","2014",8.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2015","2015",9.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2016","2016",11.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2017","2017",9.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2018","2018",8.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2019","2019",7.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2020","2020",7.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2021","2021",5.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2022","2022",5.8,"E","Estimated value" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","MEX","Mexico","2013","2013",7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","MEX","Mexico","2018","2018",4.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",906.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",896.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",776.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",714.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",682.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",1201.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",1247.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",997.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",948.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",906.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",1061.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",1071.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",942,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",894.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",843.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",72.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",74.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",59.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",56.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",53.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",63.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",64.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",56.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",53.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",50,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",17.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",17.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",16.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",16.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",15.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",122.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",134.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",153.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",86.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",69.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",66.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",51,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",51.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",46.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",45.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",47.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",59.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",71.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",88.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",106.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",124.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",70.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",58,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",46.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",35.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",36.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",32.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",30.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",31.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",41.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",45.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",81.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",90.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",102.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",59.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",48.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",45.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",35.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",36.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",31.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",32.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",33.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",40.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",49.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",20.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",24.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",28.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",16,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",12.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",10.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",7.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",7.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",6.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",6.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",6.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",8.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",8.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",18.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",20.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",23.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",13.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",10.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",9.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",7.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",7.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",6.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",6.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",6.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",9.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",16.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",16.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",16.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",9.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",7.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",6.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",4.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",4.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",3.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",3.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",2.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",3.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",3.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",1869,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",1797,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",1631,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",1481,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",1477,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",1508,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",1632,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",1708,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",1732,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",1793,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",1825,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",1873,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",1974,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",309.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",320.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",280.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",252.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",234.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",187,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",194.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",206.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",213,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",203.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",193.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",218,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",205.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",204.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",197.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",180.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",164,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",159.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",151.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",162.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",175.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",180.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",186.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",184.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",196.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",183.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",63.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",64.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",55.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",49.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",45.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",36,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",37.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",39.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",40.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",38.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",36,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",40.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",37.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",41.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",39.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",36,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",32.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",31,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",29.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",31,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",33.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",34,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",34.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",34.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",36.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",33.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",10.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",9.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",8.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",7.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",6.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",6.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",6.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",6.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",6.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",6.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",5.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",5.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",892.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",781.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",668.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",591.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",568.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",554.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",539.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",519.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",493.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",507.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",532.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",556.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",590.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",1182.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",1088,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",859.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",785.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",755.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",615.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",597.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",587,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",582.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",568.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",608.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",658.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",621.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",1431.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",1254.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",1104.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",1013,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",981.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",947.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",944.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",902.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",863.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",908.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",956.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",980.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",1072.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",111.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",103.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",81.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",75.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",72.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",59.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",57.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",57,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",56.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",55.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",59.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",63.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",60,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",135.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",118.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",105.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",96.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",94.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",91.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",91.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",87.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",84,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",88.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",92.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",94.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",103.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",27.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",26.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",25.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",24.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",23.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",22.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",21.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",20.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",18.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",18.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",19,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",19.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",18.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",183.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",189.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",165,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",159.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",155.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",154.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",194.1,"B","Break" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",188.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",187.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",191.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",199.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",207.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",242.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",263.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",212,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",211.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",207.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",171.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",214.9,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",213.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",221.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",214.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",228,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",245.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",365,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",373.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",327,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",324,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",321.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",314.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",385.8,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",365.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",357,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",369.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",384,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",389.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",45.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",48.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",39.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",39,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",38.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",31.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",39.6,"B","Break" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",39.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",40.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",39.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",41.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",45.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",67.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",69.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",60.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",59.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",59.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",58.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",71,"B","Break" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",67.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",65.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",67.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",70.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",71.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",16.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",16.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",14.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",12.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",11.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",11.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",12.3,"B","Break" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",12.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",11.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",11.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",12,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",11.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",3077.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",2591,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",2209.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",2078.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",2140.8,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",2151.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",2235.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",2202.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",2299.8,"B","Break" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",2363.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",2438.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",2443.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",2540,"P","Provisional value" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",4080.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",3606.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",2838.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",2760.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",2844.1,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",2387.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",2474.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",2488.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",2716,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",2645.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",2785.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",2890.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",2674.8,"P","Provisional value" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",4233.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",3628.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",3179.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",3080.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",3232.1,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",3237.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",3478.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",3491.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",3640.1,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",3855.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",3924.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",3904.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",4260.3,"P","Provisional value" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",87.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",77.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",60.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",59.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",61.2,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",51.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",53.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",53.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",58,"B","Break" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",56.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",58.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",61,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",56.4,"P","Provisional value" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",90.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",77.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",68,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",66.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",69.5,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",69.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",74.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",74.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",77.8,"B","Break" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",81.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",82.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",82.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",89.8,"P","Provisional value" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",23.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",21,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",20,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",19.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",18.9,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",18.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",18.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",18.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",12.1,"B","Break" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",11.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",11.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",11.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",11.1,"P","Provisional value" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",3118.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",3035.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",2543.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",2295.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",2338.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",2404.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",2398.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",2515.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",2545.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",2802.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",3029.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",2993.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",3235.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",432.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",467.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",375.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",352.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",340.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",285,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",280.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",294.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",292.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",296.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",328.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",349,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",319.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",345.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",343.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",293.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",267,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",267.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",271.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",271.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",284.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",287.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",321.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",349.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",343.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",373.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",46.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",49.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",39.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",36.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",35.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",29.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",28.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",29.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",28.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",28.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",31.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",33.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",30.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",36.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",36.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",30.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",27.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",27.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",27.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",27.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",28.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",28.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",31.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",33.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",32.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",35.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",8.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",8.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",6.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",6.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",5.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",5.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",5.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",5.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",5.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",5.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",5.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",5.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",946.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",929,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",876,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",791,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",770,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",777,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",799,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",792,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",774,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",797,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",797,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",865,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",900,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",907.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",1046.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",934.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",853.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",840.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",807.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",810.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",804.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",791.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",802,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",848.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",946.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",942.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",645.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",664.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",646.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",602.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",600.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",628.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",664.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",666.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",656.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",692.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",701.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",781.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",844.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",115.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",132.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",116.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",105.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",102.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",97.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",96.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",95.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",93,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",93.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",98.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",108.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",107.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",82.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",84,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",80.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",74.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",73.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",75.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",79.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",78.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",77.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",80.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",81.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",89.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",96.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",16.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",16.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",14.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",13.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",13,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",12.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",12.5,"B; D","Break; Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",12.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",11.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",11.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",11.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",12.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",11.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",1834.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",1624.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",1396.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",1389.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",1434.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",1541.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",1743.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",2133.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",2609,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",3441.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",4375.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",5358,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",1220.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",969.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",777.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",729.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",655.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",566.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",577.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",584.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",540.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",606.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",624.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",605.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",1993.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",1681.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",1369.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",1298.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",1298.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",1326.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",1405.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",1541.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",1598.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",1846.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",2021.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",1908.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",16.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",13.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",10.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",9.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",8.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",7.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",7.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",7.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",6.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",7.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",7.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",7.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",27.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",22.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",18.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",17,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",16.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",17,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",17.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",19.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",19.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",22.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",24.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",22.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",11.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",11.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",10.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",9.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",9.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",8.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",8.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",8.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",8.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",8.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",8.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",1332.3,"B","Break" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",1156.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",1186.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",1267.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",1280.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",1301,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",1287.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",2104.6,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",1807.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",1952.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",1936.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",1728.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",1674.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",1717.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",1898.9,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",1663.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",1699.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",1830.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",1859.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",1900.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",1871.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",33,"B","Break" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",28.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",30.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",29.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",26.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",25.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",25.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",29.8,"B","Break" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",25.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",26.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",28.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",28.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",28.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",28.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",9.7,"B","Break" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",7.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",7.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",7.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",6.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",6.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",6.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",74875.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",91532.1,"B","Break" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",100837.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",105559,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",124399.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",138496.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",152031.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",146723.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",154799.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",184317.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",193006.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",179534.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",213450.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",146.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",189.2,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",207.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",213.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",218.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",211.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",224.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",226.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",241.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",262.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",243.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",236.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",244.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",208.1,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",263,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",290.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",301.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",338.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",354,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",382.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",368.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",390.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",458.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",461.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",412.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",487.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",8.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",11,"B","Break" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",11.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",12.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",12.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",11.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",12.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",12.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",12.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",13.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",12.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",12,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",12.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",12.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",15.2,"B","Break" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",16.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",17.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",19,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",19.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",21.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",20,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",20.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",24,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",23.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",21,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",24.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",9.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",7.8,"B","Break" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",8.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",7.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",7.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",7.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",7.1,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",6.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",7.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",7.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",6.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",7.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",35,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",31.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",32.6,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",31.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",32,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",31.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",30.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",29.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",30.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",31.8,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",34.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",34.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",36.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",46.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",43.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",41.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",42.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",42.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",34.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",34.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",33.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",36.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",35.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",39.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",40.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",38.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",68.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",60.9,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",62.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",60.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",60.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",58.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",58.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",56,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",57.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",59.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",65.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",63.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",63.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",34.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",32.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",31.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",31.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",32.4,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",26.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",25.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",25.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",27.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",26.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",29.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",30.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",28.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",51.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",45.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",47.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",46,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",46.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",44.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",44.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",42.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",43.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",44.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",49.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",47.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",47.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",18,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",15.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",14.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",13.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",12.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",11.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",10.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",9.9,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",9.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",9.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",9.6,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",8.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",8.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",122.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",113.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",105.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",100.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",81.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",77,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",75.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",75.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",76,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",78.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",83.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",85.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",90.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",162.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",158.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",135.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",133.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",107.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",85.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",83.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",85.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",89.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",88,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",95.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",100.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",94.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",192,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",182.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",173.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",170.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",137.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",129.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",130.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",133.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",133.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",142.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",152.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",151.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",163.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",79.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",77.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",65.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",64.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",52.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",41.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",40.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",41.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",43.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",42.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",45.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",47.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",45,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",93.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",88.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",84.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",82.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",66.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",62.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",63.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",64.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",64.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",68.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",72.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",71.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",77.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",25.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",24.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",23.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",22.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",18.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",17.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",16.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",15.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",14.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",14.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",14.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",13.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",13.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",4,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",3.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",4.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",4.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",3.9,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",3.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",3.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",3.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",3.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",3.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",3.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",3.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",3.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",2.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",2.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",2.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",2.8,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",2.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",3.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",3.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",3.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",3.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",3.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",3.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",3.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",0.2,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",0.1,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",0,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",0.6,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",1.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",1.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",0.6,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",1.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",1.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",0.8,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",0.1,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",0.1,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",22.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",21.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",20.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",19,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",17.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",16.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",16.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",16,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",16.8,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",15.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",14.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",22.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",21.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",18.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",14.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",13.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",12.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",12.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",12.1,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",12.5,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",12.2,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",11,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",17.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",17.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",16.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",15.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",14.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",13.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",13.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",13,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",13.6,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",12.4,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",11.4,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",0.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",0.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",0.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",0.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",0.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",0.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",0.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",0.4,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",0.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",0.3,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",0.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",0.1,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",0,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",0,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",0,"E; D","Estimated value; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",22.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",21.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",23.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",22.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",20.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",19,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",18.8,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",20.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",19.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",21.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",19.5,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",18.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",0.8,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",1.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",1.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",1.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",1.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",1.6,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",0.1,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",0.1,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",39.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",35.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",33.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",30.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",28.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",26.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",23.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",21.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",20.8,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",19.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",18.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",18.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",52.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",49.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",43.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",40.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",38.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",29.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",26.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",24.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",24.6,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",22.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",21.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",21.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",48.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",45.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",42.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",39.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",37.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",33.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",31.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",29.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",28.3,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",27.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",26.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",24.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",0.3,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",0.3,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",0,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",1.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",1.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",279.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",260.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",234.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",219.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",204,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",188.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",174.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",162.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",149.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",134.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",132.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",115.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",101.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",1.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",1.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",2.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",2.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",1.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",1.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",1.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",1.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",1.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",1.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",1.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",9.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",10,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",10.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",11.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",11.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",11.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",11.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",11.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",10.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",10.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",9.8,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",9.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",1.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",1.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",1.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",1.5,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",1.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",1.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",1.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",1.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",2.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",2.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",2,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",1.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",1.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",1.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",1.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",1.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",1.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",1.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",1.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",1.9,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",1.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",1.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",1.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",1.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",1.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",1.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",0.4,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",0.4,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",0.1,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",10.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",9.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",8.8,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",8.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",7.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",6.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",5.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",5.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",4.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",4.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",4.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",3.9,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",14.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",12.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",11.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",10.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",7.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",6.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",6.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",5.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",5.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",4.1,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",14,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",13,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",11.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",10.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",9.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",9.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",8.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",7.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",7.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",6.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",6.3,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",0.1,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",0.1,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0,"E","Estimated value" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",781,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",788.4,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",770.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",952.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",883.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",864,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",740.8,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",704.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",667.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",625.8,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",679.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",620,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",0.7,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",0.6,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",0.9,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",0.9,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",0,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",0,"D; P","Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",0,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",0,"D; P","Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",0,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",0,"D; P","Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",0.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",0.1,"D; P","Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",0.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",0.1,"D; P","Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",0,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",0,"D; P","Difference in methodology; Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",6.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",6.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",6.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",6.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",8.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",8.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",8.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",7.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",7.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",7.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",7.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",8.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",7.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",1.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",1.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",1.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",1.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",1.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",0.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",0.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",1.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",1.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",1.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",1.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",1.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",1.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",1.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",1.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",1.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",1.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",1.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",0.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",0.3,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",0.4,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",0.6,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",0.1,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",0.1,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",3.7,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",3.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",3.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",3.2,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",2.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",2.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",2.3,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",2.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",1.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",1.8,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",1.6,"P","Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",5.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",5.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",4.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",4.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",4.2,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",3.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",3.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",2.9,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",2.7,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",2.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",2.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",2.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",1.7,"P","Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",5.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",5.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",4.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",4.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",4.8,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",4.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",4.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",3.6,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",3.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",3.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",2.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",2.7,"P","Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",0.1,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",0.1,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",0,"P","Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",0.1,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",0.1,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",0.1,"P","Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",0,"B; D","Break; Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0,"P","Provisional value" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",14.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",13.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",13.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",14.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",15.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",13.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",12.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",12.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",12.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",11.8,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",11.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",10.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",13.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",2.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",2.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",1.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",1.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",1.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",2.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",4.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",4.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",5.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",2.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",2.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",2.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",49,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",91.5,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",185.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",136,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",247.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",173.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",335.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",198.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",337.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",304.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",361.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",438.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",691.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",0.2,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",0.3,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",0.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",0.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",0.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",0,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",0.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",0.6,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",0.5,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",0.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",17,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",17,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",17,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",18,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",19,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",19,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",20,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",20,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",21,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",22,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",24,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",26,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",15.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",17.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",17.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",17.4,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",17.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",14.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",14.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",15.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",15.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",15.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",16.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",19.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",11.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",11.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",11,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",12.4,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",13.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",12.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",13.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",13.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",14.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",14.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",16.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",18,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",0.8,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",0.5,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",0.2,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",6.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",7.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",7.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",7.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",7.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",6.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",6.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",6.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",5.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",4.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",4.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",10.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",9.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",9.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",9.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",7.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",7.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",7.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",7.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",6.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",5.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",8.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",9.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",9.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",8.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",8.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",8.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",8.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",7.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",6.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",5.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",16,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",15.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",15.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",15.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",15.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",15.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",14.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",14.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",14.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",14.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",14,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",13.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",13.4,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",21.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",21,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",19.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",20.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",20.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",16.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",16.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",16.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",17.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",16.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",15.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",16.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",14.1,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",19.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",18.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",18.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",19.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",19.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",19.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",19,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",19.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",19.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",20,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",19.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",18.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",18.7,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",1.2,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",1.6,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0.1,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",30.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",28.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",28.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",28.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",29,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",29.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",25.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",23.7,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",25.2,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",22.8,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",23.4,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",30.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",27.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",26.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",22.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",21.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",22.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",19.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",17.8,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",18.8,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",18.2,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",18,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",24.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",23.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",23.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",22.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",24,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",24.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",21,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",19.2,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",20.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",18.4,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",18.6,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",0.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",0.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",0.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",0.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",0.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",0.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",0.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",0.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",0.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",0.5,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",0.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",0.1,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",0.1,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",0.1,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",0.1,"E; D","Estimated value; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",176.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",222.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",233.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",206.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",198.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",195.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",194.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",197.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",200.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",208.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",209.1,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",212.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",9.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",12.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",11.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",10.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",9.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",7.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",8.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",9.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",9.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",9,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",9.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",12.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",16.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",17.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",16.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",15.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",15.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",15.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",15.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",16.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",17,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",16.8,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",16.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",0.8,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",1.6,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",3.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",3.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",3.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",3.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",4.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",3.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",2.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",2.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",5.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",4.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",4.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",4.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",4.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",4.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",4.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",4.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",4.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",3.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",3.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",4.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",4.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",4.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",4.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",4.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",4.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",4.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",3.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",76.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",87.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",79.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",79.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",80.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",77.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",75.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",71.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",68.3,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",68.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",61.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",59.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",100.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",122.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",101.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",105.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",106.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",86.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",83.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",80.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",80.7,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",76.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",70.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",70,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",94.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",111.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",100.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",102.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",104.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",100.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",100.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",95.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",92.9,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",93.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",84.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",80.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",1.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",1,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",1.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",1.1,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",0.2,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",5.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",6.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",5.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",6.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",6.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",6.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",7.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",7.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",8.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",8.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",8.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",8.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",6.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",7.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",8.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",7.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",8.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",8.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",7.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",8.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",8.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",9.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",9.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",9.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",10.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",6.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",7.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",8.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",8.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",10.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",10.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",10.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",12.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",13.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",14.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",15.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",15.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",15.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",11.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",1.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",1511.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",1522.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",1427.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",1406.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",1405,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",1391.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",1384.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",1380.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",1362.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",1378.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",1571.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",1469.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",1451.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",7.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",7.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",6.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",6.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",4.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",4.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",5.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",4.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",3.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",12,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",12.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",11.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",11.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",10.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",10.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",10.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",10.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",9.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",9.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",10.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",9.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",61.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",69.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",77.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",79.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",73,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",69.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",77.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",83.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",92.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",104.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",126.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",121.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",2.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",2.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",2.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",2.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",2.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",2.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",2.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",2.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",2.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",3.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",3,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",2.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",3.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",3.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",4.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",3.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",3.9,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",3.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",3.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",3.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",3.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",3.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",3.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",3.6,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",2.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",3.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",3.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",3.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",3.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",3.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",0.8,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",0.8,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",0.2,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",75.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",73.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",74.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",75.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",77.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",77.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",79,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",80.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",81.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",83.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",82.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",82,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",104.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",94.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",99.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",100.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",85.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",86,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",89.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",95,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",91.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",95.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",97.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",86.4,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",99.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",98.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",101.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",102.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",104.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",110.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",114.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",118.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",124.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",128.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",127.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",132.9,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",1.5,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",2.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",2.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",2.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",2.3,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0.3,"E","Estimated value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",8636,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",11558.9,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",11018.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",11041.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",11754,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",12980.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",14174.3,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",16183.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",18654.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",21623.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",25886.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",28729.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",7.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",10.4,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",9.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",10.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",11.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",11.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",12.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",14.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",17,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",18.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",21.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",25.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",10.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",13.5,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",12.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",12.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",13.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",15.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",16.5,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",18.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",21.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",25.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",30.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",33.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",0.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",0.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",0.3,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",0.3,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.1,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.1,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",0.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",0.4,"D; P","Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",0.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",0.4,"D; P","Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",0.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",0.5,"D; P","Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",1.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",1.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",1.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",1.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",1.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",0.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",0.7,"D; P","Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",0.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",0.8,"D; P","Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",0.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",0.2,"D; P","Difference in methodology; Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",10.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",10.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",9.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",9.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",9.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",14.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",14.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",12.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",12.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",12.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",12.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",12.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",11.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",12.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",11.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",4.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",4.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",4.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",5.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",4.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",4.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",4.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",4.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",4.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",2.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",1.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",1.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",3.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",3.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",3.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",4.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",4.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",3.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",3.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",2.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",2.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",2.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",1.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",3.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",3.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",3.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",3.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",3.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",3.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",2.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",2.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",1.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",25,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",29,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",29,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",31,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",33,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",36,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",38,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",41,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",44,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",47,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",43,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",36,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",35,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",4.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",5.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",5.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",5.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",4.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",4.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",5.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",5.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",4.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",3.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",2.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",3.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",3.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",3.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",3.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",3.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",3.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",4.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",4.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",4.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",3.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",3.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",4.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",4.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",4.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",3.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",3.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",3.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",3.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",6.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",5.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",5.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",5.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",4.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",4.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",4.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",4.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",4.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",4.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",4.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",7.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",6.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",6.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",6.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",6.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",6.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",6.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",6.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",6.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",6.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",6.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",6.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",6.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",3.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",4.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",4.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",5.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",5.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",5.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",6.1,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",5.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",5.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",5.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",5.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",5.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",4.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",6.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",5.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",6.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",6.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",6.7,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",6.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",6.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",6.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",6.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",6.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",6.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",8.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",8.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",10.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",10.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",11.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",12.1,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",11.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",10.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",11.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",11.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",11,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",1.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",1.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",1.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",1.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",1.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",2.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",2.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",2.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",0.4,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",22.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",33.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",31.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",31.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",35.5,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",36.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",35.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",29.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",29.6,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",27.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",23,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",22.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",22.6,"P","Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",30.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",46.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",40.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",42.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",47.1,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",40.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",39.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",33.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",35,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",30.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",26.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",26.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",23.8,"P","Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",31.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",47.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",44.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",47,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",53.5,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",55.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",55.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",47,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",46.9,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",44.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",36.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",36.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",37.9,"P","Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",1,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",0.7,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",0.5,"P","Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",1.2,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",1,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",0.8,"P","Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",0.3,"B; D","Break; Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0.1,"P","Provisional value" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",36.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",49.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",50.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",54.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",60.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",66.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",74.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",80.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",88.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",97.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",88.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",88.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",55.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",7.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",7.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",8.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",8.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",7.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",8.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",9.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",10.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",10.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",9.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",10.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",5.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",5.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",5.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",6.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",6.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",7.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",8.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",9.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",10,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",11.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",10.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",10.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",6.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",6.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",7.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",9.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",10.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",13.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",17.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",23.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",31.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",37.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",53.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",3.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",4.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",4.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",4.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",5.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",5.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",6.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",6.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",7.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",7.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",8.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",8.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",11.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",12.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",14.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",17.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",17.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",19.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",1169.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",1341.3,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",1457.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",1625.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",1688.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",1679.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",2214.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",2149.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",2166.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",3246.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",3705.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",4299.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",4747.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",2.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",2.8,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",3.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",2.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",3.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",3.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",3.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",4.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",4.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",5.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",5.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",3.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",3.9,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",4.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",4.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",4.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",5.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",5.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",5.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",8.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",8.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",9.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",10.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",0.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",0.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0.1,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",1.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",1.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",1.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",1.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",1.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",0.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",0.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",1.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",1.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",1.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",1.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",1.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",0.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",0.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",0.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",1.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",1.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",1.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",1.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",1.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",1.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",1.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",1.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",1.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",64,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",72,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",78,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",88,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",83,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",91,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",98,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",107,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",116,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",134,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",150,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",169,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",58.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",74.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",80.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",85,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",74.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",68.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",72.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",82,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",86.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",93.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",103.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",127,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",42.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",47.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",50.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",60.8,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",57.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",61.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",67.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",72.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",78.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",90.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",103.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",116.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",3.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",3.7,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",3.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",3.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",4.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",2.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",2.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",2.6,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",2.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",2.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",4.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",0.7,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",39.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",39.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",41.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",42.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",42.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",45.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",48.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",49.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",45.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",47.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",49.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",50.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",52.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",55.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",53.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",55.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",56.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",50.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",53.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",56,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",53.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",52.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",56.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",59.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",46.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",47.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",50.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",52.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",53.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",57.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",62.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",64,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",59.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",63,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",66.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",66.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",6.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",6.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",6.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",6.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",6.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",5.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",6.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",6.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",6.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",5.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",6.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",6.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",5.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",5.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",6.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",6.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",6.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",7.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",7.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",6.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",7.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",7.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",7.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",1.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",1.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",1.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",1.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",17.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",20.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",19.6,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",19.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",20.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",24.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",25.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",26.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",26.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",30.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",33,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",32.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",36.2,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",23.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",28.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",25.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",25.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",26.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",27,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",28.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",29.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",30.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",33.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",37.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",38.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",38.1,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",21.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",24.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",23.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",24,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",25.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",30.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",33.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",33.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",34.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",40.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",45.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",43.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",50.7,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",2.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",2.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",2.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",2.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",2.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",2.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",2.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",3.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",3.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",3.3,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",1.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",2.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",2.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",2.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",2.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",2.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",2.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",3.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",3.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",3.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",4.4,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0.4,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",73.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",76.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",92,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",104.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",119.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",129.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",107.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",116.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",125.2,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",127.2,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",113.2,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",73.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",74.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",83.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",81.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",89.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",99.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",82.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",87.8,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",93.3,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",101.4,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",87,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",59,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",62.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",74.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",83.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",98.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",106.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",88.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",94.3,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",101.7,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",102.7,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",90.3,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",2.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",2.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",2.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",2.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",2.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",2.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",2.3,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",2.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",2.7,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",2.2,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",1.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",2.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",2.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",2.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",2.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",2.7,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",2.7,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",2.3,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",0.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",0.4,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",0.4,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",0.3,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",0.3,"E; D","Estimated value; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",879.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",800.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",796,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",752.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",734.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",689.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",690.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",725.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",733.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",731.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",682.8,"B","Break" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",625.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",46.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",45.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",40.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",38.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",35.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",28,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",28.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",31,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",33.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",31.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",29.4,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",28.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",64.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",60,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",59.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",58.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",57.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",53.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",54.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",58.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",59.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",59.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",54.8,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",49.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",4.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",4.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",3.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",3.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",3.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",2.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",2.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",2.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",3.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",2.7,"B","Break" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",2.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",6.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",5.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",5.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",5.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",5.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",5.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",5.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",5.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",5.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",5.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",5.1,"B","Break" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",4.7,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",1.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",0.9,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",0.9,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0.7,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0.7,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0.8,"B","Break" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",4.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",5.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",5.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",5.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",6.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",7.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",7.6,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",6.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",7.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",9.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",9.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",6.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",7.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",6.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",7.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",8.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",7.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",8.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",7.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",8.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",8.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",10.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",10.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",5.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",5.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",5.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",6.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",6.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",7.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",8.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",7.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",8.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",9.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",11.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",11.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",1.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",1.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",1.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",1.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",1.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",1.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",1.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",1.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",1.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",1.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",1.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",1.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",1.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",1.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",1.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",1.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",1.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",1.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",306.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",299.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",310.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",326,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",356.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",371.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",390.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",391.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",316,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",323.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",305.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",301.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",406.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",416.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",399.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",433,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",473.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",412.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",431.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",442,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",373.2,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",362.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",348.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",356.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",381,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",379.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",394.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",420.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",463.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",477.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",518.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",525.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",429.7,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",444.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",421.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",409.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",5.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",5.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",5.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",5.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",5.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",4.5,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",4.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",4.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",4.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",4.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",4.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",5.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",5.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",5.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",6.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",6.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",5.2,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",5.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",5.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",4.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",0.7,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",41.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",39.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",32.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",27,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",25.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",25.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",26,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",24.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",24.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",25.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",33.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",30.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",23,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",55.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",54.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",41.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",35.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",33.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",27.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",28.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",28.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",29.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",28.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",38.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",35.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",24.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",57.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",55.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",47.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",42.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",41.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",41.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",44.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",43.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",44,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",47,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",61.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",55.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",43.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",4.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",3.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",3.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",3.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",2.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",2.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",2.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",2.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",2.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",3.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",3.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",2.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",5.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",4.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",3.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",3.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",3.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",4.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",4.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",4.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",5.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",5.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",4.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",7338.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",7703.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",7380.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",7583.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",8102.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",8633.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",9311.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",9804.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",9734.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",10135.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",10964.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",10709.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",11191.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",35.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",38.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",32.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",33.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",34.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",30.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",33.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",35.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",36,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",34.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",35.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",35.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",30,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",58,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",62,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",58.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",60.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",62.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",65.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",70.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",72.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",70,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",72,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",75.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",69.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",69.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",3.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",3.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",3.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",3.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",3.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",3.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",3.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",3.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",3.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",5.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",6.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",5.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",6.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",6.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",6.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",7.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",7.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",7.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",7.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",7.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",7.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",7.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",1.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",1.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",1.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",1.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",37.6,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",48.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",57.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",50.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",45.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",50.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",49,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",51,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",59.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",76,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",83.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",103.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",0.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",0.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",0.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",0.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",0.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",0.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",0.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",0.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",0.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",0.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",0.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",0.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",0.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",0.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",1.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",1.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",1.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",1.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",1.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",1.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",1.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",1.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",1.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",1.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",2.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",0.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",1.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",1.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",1.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",1.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",1.9,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",0.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",21.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",21.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",21.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",16.9,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",16.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",17.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",18.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",17.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",17.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",17.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",17.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",17.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",28,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",29.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",27.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",22.4,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",22,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",19.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",20.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",20.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",20.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",19.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",20.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",21.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",24.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",25.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",25.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",20.8,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",20.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",21.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",23.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",22.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",21.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",21.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",22.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",22.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",6.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",6.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",5.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",4.8,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",4.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",4.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",4.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",3.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",4.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",5.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",5.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",5.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",4.5,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",4.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",4.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",4.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",4.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",4.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",4.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",4.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",4.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",0.9,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",197.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",194.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",189.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",197.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",224.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",227.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",221.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",177.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",175,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",177.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",165,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",166.7,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",274.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",249.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",251.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",262.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",248.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",251.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",250.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",209.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",195.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",202.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",195.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",175.6,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",260.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",260.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",256.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",267.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",303.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",324.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",321.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",260.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",266.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",273.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",254.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",270.1,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",4.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",4.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",4.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",4.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",4.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",4.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",4.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",3.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",3.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",3.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",3.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",3,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",4.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",4.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",4.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",4.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",5.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",5.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",4.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",4.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",4.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",4.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",4.6,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0.7,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0.7,"E","Estimated value" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",35631,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",36901.8,"B","Break" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",33694.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",33695.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",31250.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",29043.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",29877.4,"B","Break" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",32908.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",35023.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",36730,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",39405.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",44689.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",30.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",33.3,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",29.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",30.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",29.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",25.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",25.7,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",29.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",31.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",31.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",33.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",39.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",42.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",43.2,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",39.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",38.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",35.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",33.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",34.8,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",37.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",41,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",42.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",47,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",52.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",0.7,"B","Break" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",0.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",0.5,"B","Break" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",0.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",0.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",0.9,"B","Break" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",0.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",0.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",0.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",0.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",0.7,"B","Break" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",0.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",0.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",0.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",0.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.2,"B","Break" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.1,"B","Break" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",0.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",0.7,"D; P","Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",0.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",0.7,"D; P","Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",0.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",0.8,"D; P","Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",1.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",1.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",1.2,"D; P","Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",1.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",1.3,"D; P","Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",0.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",0.3,"D; P","Difference in methodology; Provisional value" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",35.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",34.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",34.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",34.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",35,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",47.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",48.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",44.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",45.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",46.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",41.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",41.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",42.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",42.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",43.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",2.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",2.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",2.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",2.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",2.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",3.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",3.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",2.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",2.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",2.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",3.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",2.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",2.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",3.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",2.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",1.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",2.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",2.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",2.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",2.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",2.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",1.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",2.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",2.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",2.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",2.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",54,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",56,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",61,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",69,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",74,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",91,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",103,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",110,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",104,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",99,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",106,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",105,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",121,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",8.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",10,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",10.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",11.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",11.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",11.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",12.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",13.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",12.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",11.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",11.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",12.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",12.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",5.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",6.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",6.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",7.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",9.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",10.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",11.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",10.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",10.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",10.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",11,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",11.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",1.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",2.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",2.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",2.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",2.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",2.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",2.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",2.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",1.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",1.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",1.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",1.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",1.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",1.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",2.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",1.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",2.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",4.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",4.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",3.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",3.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",3.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",5.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",4.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",4.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",3.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",3.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",7.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",6.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",6.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",6.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",6.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",6.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",5.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",5.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",5.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",5.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",5.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",4.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",5.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",0.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",0.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",0.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",13.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",14.6,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",15,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",16.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",17.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",17.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",22.9,"B","Break" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",20.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",18.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",18.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",18.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",17.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",17.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",20.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",19.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",22.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",23,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",19.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",25.3,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",22.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",22.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",20.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",20.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",20.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",26.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",28.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",29.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",34.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",35.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",36.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",45.5,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",39.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",35.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",35.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",35.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",32.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",3.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",3.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",3.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",4.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",4.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",3.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",4.7,"B","Break" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",4.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",4.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",3.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",3.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",3.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",4.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",5.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",5.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",6.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",6.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",6.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",8.4,"B","Break" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",7.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",6.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",6.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",6.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",6,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",1.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",1.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",1.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",1.5,"B","Break" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",1.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",1.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",1.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",1.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",59.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",45,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",40.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",40.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",41.3,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",40.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",41.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",45.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",116.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",128.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",128,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",100.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",103.5,"P","Provisional value" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",78.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",62.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",52.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",53.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",54.9,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",45.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",45.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",51.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",137.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",143.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",146.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",119.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",108.9,"P","Provisional value" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",81.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",63.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",58.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",59.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",62.4,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",61.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",64,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",71.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",184.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",209.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",206,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",161.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",173.5,"P","Provisional value" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",1.2,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",1.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",2.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",3.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",2.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",2.3,"P","Provisional value" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",1.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",1.3,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",1.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",1.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",1.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",4.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",4.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",3.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",3.7,"P","Provisional value" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",0.4,"B; D","Break; Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0.6,"B","Break" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0.6,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0.6,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0.5,"P","Provisional value" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",137.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",145.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",147.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",154.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",181.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",214.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",211.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",226.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",221.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",251.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",307.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",299.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",305.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",19.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",22.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",21.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",23.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",26.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",25.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",24.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",26.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",25.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",26.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",33.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",34.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",30.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",15.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",16.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",17,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",17.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",20.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",24.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",24,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",25.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",25,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",28.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",35.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",34.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",35.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",2.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",2.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",2.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",2.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",2.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",2.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",2.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",2.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",3.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",3.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",2.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",1.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",1.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",1.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",1.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",2.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",2.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",2.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",2.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",2.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",2.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",3.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",3.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",3.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",0.6,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0.6,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",26.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",26.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",26.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",27.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",28.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",28.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",27.6,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",45,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",52.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",70.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",88.6,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",117.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",17.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",15.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",14.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",14.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",13,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",10.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",9.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",12.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",10.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",12.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",12.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",13.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",28.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",27.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",26,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",25.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",25.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",24.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",22.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",32.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",31.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",37.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",40.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",41.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",0.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",0.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",0.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",0.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",0.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",0.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",0.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",0.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",0.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",0.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",0.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0.1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",0.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",1699.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",2317.9,"B","Break" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",2551.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",2861.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",3129,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",3557.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",4456.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",4932.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",6971.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",8295.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",7817.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",6964.7,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",7014.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",3.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",4.8,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",5.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",5.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",5.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",5.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",6.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",7.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",10.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",11.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",9.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",9.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",4.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",6.7,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",7.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",8.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",8.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",9.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",11.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",12.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",17.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",20.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",18.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",16,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",16,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",0.3,"B","Break" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",0.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",0.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",0.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",0.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",0.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",0.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",0.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",0.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",0.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",0.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",0.4,"B","Break" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",0.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",0.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",0.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",0.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",0.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",0.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",0.9,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",0.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0.2,"B","Break" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",0.2,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",0.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",0.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",0.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",0.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",0.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",0.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",0.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",0.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",0.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",1.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",1.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",1.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",1.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",1.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",1.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",1.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",1.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",1.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",0.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",0.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",1.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",1.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",1.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",1.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",1.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",1.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",1.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",1.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",1.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",1.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",1.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",1.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",1.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",1.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",2.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",2.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",2.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",0.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",0.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",0.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",0.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",0.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",0.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",0.6,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",0.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",0.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",1.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",1.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",1.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",1.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",1.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",1.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",1.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",1.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",1.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",1.7,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",1.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",1.7,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",0.5,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",0.4,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",0.3,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",0.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",4.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",4.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",4.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",4.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",3.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",3.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",4.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",4.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",4.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",5.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",6.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",5.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",5.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",5.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",3.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",4.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",4.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",5.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",5.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",5.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",6.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",7.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",7.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",7.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",6.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",5.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",5.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",5.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",6.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",7.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",8.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",8.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",8.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",2.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",1.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",2.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",2.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",2.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",3.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",3.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",2.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",3.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",3.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",4.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",31,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",30,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",30,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",37,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",38,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",43,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",46,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",48,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",49,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",54,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",62,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",65,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",28.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",30.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",31.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",35.7,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",34.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",32.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",34.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",36.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",36.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",37.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",42.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",48.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",20.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",19.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",19.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",25.6,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",26.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",29.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",31.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",32.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",33.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",36.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",42.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",44.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",1.5,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",1.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",1.1,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",1.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",1.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",0.3,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",15.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",15.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",15.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",15.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",16.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",16.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",16.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",18.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",20,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",21.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",24,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",24.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",21,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",21.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",20.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",20.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",21.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",18.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",18.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",20.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",23.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",24.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",27.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",29.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",18.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",18.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",19.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",19.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",20.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",20.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",21.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",23.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",26.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",29,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",32.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",32.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",2.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",2.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",2.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",2.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",2.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",2.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",2.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",3.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",38.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",36.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",35.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",35.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",34.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",33.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",33,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",32.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",31.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",29,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",28.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",27.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",28.2,"E","Estimated value" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",50.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",51.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",45.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",46.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",46.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",37.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",36.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",37.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",37.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",32.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",32.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",32.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",29.7,"E","Estimated value" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",45.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",44.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",43.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",43.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",43.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",41.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",42.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",42.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",41.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",38.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",39.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",37.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",39.6,"E","Estimated value" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",4.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",4.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",4.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",4.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",4.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",3.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",3.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",3.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",3.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",2.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",2.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",2.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",2.6,"E","Estimated value" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",4.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",3.9,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",3.9,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",3.9,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",3.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",3.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",3.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",3.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",3.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",3.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",3.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",3.4,"E","Estimated value" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0.3,"E","Estimated value" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",198.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",200.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",201.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",207,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",214.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",226.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",258.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",265.8,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",298.5,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",342.8,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",365.6,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",198.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",194.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",182.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",161.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",161.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",174.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",199.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",200.3,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",222.6,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",273.4,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",280.9,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",159.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",163.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",164.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",165.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",177.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",187,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",214.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",215.3,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",242.5,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",276.9,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",291.6,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",5.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",5.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",5.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",4.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",4.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",4.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",5.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",5.3,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",5.9,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",7.1,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",7.2,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",4.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",4.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",4.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",4.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",4.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",5.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",5.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",5.7,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",6.4,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",7.2,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",7.5,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",0.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",0.8,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",0.9,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",0.9,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",0.9,"E; D","Estimated value; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",433.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",420.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",476.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",493.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",534.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",524.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",530.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",525.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",535.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",542.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",531.2,"B","Break" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",547.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",22.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",23.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",24.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",25.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",25.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",21.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",21.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",22.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",24.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",23.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",22.9,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",25.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",31.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",31.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",35.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",38.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",42.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",40.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",42.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",42.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",43.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",44.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",42.6,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",43,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",2.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",2.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",2.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",2.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",2.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",2.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",2.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",2.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",2.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",2.1,"B","Break" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",3.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",3.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",3.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",4.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",4.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",4,"B","Break" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",4.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0.6,"B","Break" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",8.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",8.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",8.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",8.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",8.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",7.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",8.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",8.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",9.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",9.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",11.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",12.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",10.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",11,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",11.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",9.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",8.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",8.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",9.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",9.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",10.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",10.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",10,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",9.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",9.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",9.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",9.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",9.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",9.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",9.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",10.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",11.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",11.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",2.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",2.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",1.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",2.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",1.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",1.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",1.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",1.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",1.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",1.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",1.9,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",1.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",1.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",1.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",1.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",1.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",1.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",1.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",1.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",1.9,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",2,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",392.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",389.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",401.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",418.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",440.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",443.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",449.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",448.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",490.3,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",531,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",559.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",586.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",520.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",541.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",515.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",556.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",585.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",491.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",498,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",506.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",579,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",594.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",638.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",693.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",487.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",493.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",509.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",540.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",572.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",569.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",597.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",602.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",666.7,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",729.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",771.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",796.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",6.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",6.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",6.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",6.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",7.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",6.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",7,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",7.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",7.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",8.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",6.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",6.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",6.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",7.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",7.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",7.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",8,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",8.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",9.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",9.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",1.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",1.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",1.1,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",1.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",1.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",1.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",36.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",35.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",36.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",38.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",36.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",30.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",34.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",34.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",33.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",32,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",29.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",30,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",23.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",48.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",49.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",47.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",50.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",48.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",34.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",38.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",39.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",39.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",35.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",34.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",35.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",24.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",50.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",50.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",53.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",60.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",59.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",50.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",58.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",60.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",59.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",58.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",54.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",55.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",43.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",4.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",4.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",4.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",4.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",4.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",3.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",3.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",3.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",3.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",3.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",3.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",3.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",2.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",4.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",4.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",4.9,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",5.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",5.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",4.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",5.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",5.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",5.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",5.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",5.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",5.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",4.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",4641.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",4864.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",4833,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",4641.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",4504.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",4496.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",4527.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",4545.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",4568.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",4743.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",4975.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",4916.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",5138.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",22.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",24.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",21.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",20.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",19.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",16.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",16.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",16.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",16.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",16.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",16.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",16.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",13.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",36.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",39.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",38.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",37.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",34.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",33.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",34.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",33.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",32.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",33.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",34.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",31.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",31.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",3.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",3.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",3.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",1.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",1.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",204.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",219.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",221.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",225,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",206.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",186.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",205.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",216.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",202.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",212.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",232.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",234.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",1.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",1.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",1.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",1.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",1.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",1.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",1.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",1.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",1.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",1.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",1.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",1.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",1.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",1.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",1.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",1.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",1.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",1.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",1.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",1.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",1.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",1.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",1.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",5.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",5.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",5.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",5.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",5.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",4.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",5.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",5.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",5.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",4.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",4.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",4.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",5.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",5.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",4.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",4.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",4.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",4.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",4.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",4.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",4.2,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",0.9,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",0.9,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",0.9,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",0.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",15.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",15.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",16.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",16.4,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",15.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",15.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",14.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",14.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",14,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",13.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",13.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",14,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",20.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",22,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",21.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",21.8,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",21.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",17.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",16.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",16.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",16.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",15.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",15.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",16.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",18.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",19,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",20,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",20.2,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",19.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",19,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",18.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",18,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",17.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",17.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",17.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",17.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",4.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",4.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",4.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",4.7,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",4.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",3.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",3.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",4.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",4.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",4.4,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",4.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",3.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",3.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",0.8,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",108.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",108.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",110.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",115.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",114.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",109.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",113,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",115.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",121.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",122.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",120.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",117,"E","Estimated value" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",151.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",139.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",146.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",153.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",127,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",121.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",127.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",136.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",136.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",140.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",142.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",123.2,"E","Estimated value" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",143.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",145,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",149.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",156.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",155,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",156.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",163.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",169.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",185.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",189.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",186.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",189.5,"E","Estimated value" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",2.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",2.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",2.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",2.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",2.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",2.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",2.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",2.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",2.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",2.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",2.1,"E","Estimated value" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",2.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",2.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",2.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",2.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",2.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",2.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",3.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",3.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",3.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",3.2,"E","Estimated value" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0.5,"E","Estimated value" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",25582,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",25540.4,"B","Break" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",22108.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",22273.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",22818.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",22838.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",21289,"B","Break" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",21832.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",22899.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",24483.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",29067.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",32086.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",22.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",23,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",19.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",20.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",21.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",20.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",18.3,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",19.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",20.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",21,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",24.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",28,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",30.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",29.9,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",25.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",25.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",26.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",26.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",24.8,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",25,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",26.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",28.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",34.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",37.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",0.5,"B","Break" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",0.4,"B","Break" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",0.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",0.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",0.6,"B","Break" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",0.5,"B","Break" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",0.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",0.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.1,"B","Break" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.1,"B","Break" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",1.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",1.3,"D; P","Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",1.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",1.3,"D; P","Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",1.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",1.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",1.5,"D; P","Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",4.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",4.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",4.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",4.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",4.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",2.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",2.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",2.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",2.3,"D; P","Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",3.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",3.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",2.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",2.6,"D; P","Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",0.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",0.5,"D; P","Difference in methodology; Provisional value" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",74.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",78,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",79,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",81.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",80.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",98.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",108.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",101.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",108.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",106.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",87.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",93.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",95.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",102.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",99.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",5.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",6.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",6.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",6.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",6.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",5.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",5.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",5.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",6.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",5.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",1.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",1.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",2.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",2.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",3.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",4.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",1.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",2.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",2.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",2.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",0.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",99,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",102,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",99,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",98,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",105,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",110,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",112,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",122,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",131,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",141,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",148,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",143,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",144,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",16.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",18.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",17,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",16.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",16.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",13.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",13.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",14.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",16.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",16,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",15.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",16.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",15,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",10.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",11.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",11,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",10.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",11.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",11.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",11.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",12.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",13.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",14.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",15,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",15,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",13.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",3.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",3.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",3.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",3.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",3.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",2.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",2.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",2.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",2.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",3.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",2.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",2.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",2.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",2.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",2.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",2.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",2.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",2.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",2.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",2.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",2.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",2.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",2.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",28.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",24.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",23.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",22.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",22.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",22.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",21.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",21.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",21.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",21.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",22.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",21.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",21,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",38.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",34.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",30.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",30,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",29.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",24.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",24.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",24.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",25.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",24.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",25.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",25.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",22.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",46.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",39.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",39.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",38.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",38.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",38,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",38.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",37.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",37.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",39.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",39.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",38,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",38.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",3.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",2.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",2.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",4.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",3.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",3.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",3.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",5.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",5.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",6.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",6.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",6.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",9,"B","Break" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",8.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",9.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",9.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",9.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",6.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",7.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",7.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",8.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",9.9,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",9.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",10.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",10.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",10.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",10.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",9.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",10.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",11.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",12.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",14,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",12.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",17.8,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",16.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",17.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",17.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",17.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",16.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",1.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",1.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",1.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",1.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",1.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",1.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",1.8,"B","Break" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",1.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",1.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",1.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",1.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",2.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",2.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",3.3,"B","Break" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",3.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",3.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",3.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",3.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",3.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",0.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",0.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",0.6,"B","Break" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",0.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",124.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",120.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",111.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",101.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",102.8,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",92.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",94.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",96,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",111.6,"B","Break" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",119.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",125.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",126.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",120.3,"P","Provisional value" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",165.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",167.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",143.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",135,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",136.6,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",102.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",104.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",108.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",131.8,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",133.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",143.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",149.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",126.7,"P","Provisional value" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",171.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",168.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",160.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",150.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",155.2,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",139.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",147.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",152.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",176.6,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",194.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",201.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",202.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",201.8,"P","Provisional value" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",3.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",2.9,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",2.8,"B","Break" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",2.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",3.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",2.7,"P","Provisional value" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",3.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",3.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",3.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",3.3,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",3.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",3.8,"B","Break" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",4.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",4.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",4.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",4.3,"P","Provisional value" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",0.9,"B; D","Break; Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0.6,"B","Break" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0.5,"P","Provisional value" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",269.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",265.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",259,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",257,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",255.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",241.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",223,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",221.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",221,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",218.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",237.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",227.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",248.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",37.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",40.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",38.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",39.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",37.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",28.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",26,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",25.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",25.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",23.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",25.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",26.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",24.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",29.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",30,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",29.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",29.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",29.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",27.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",25.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",25,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",24.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",25,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",27.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",26,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",28.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",4.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",4.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",3.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",2.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",2.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",2.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",2.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",2.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",2.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",2.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",3.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",3.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",3.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",3.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",2.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",2.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",2.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",2.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",2.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",2.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",2.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",38.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",39.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",37.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",40.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",47.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",53.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",64.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",79.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",97.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",158.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",246.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",339,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",25.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",23.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",21.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",21.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",21.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",19.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",21.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",21.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",20.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",28,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",35.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",38.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",41.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",41.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",37.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",37.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",42.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",45.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",52.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",57.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",59.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",85.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",113.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",120.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",0.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",0.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",0.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",0.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",0.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",0.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",0.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",1.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",1.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",0.2,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",0.5,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",0.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",1770.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",2756,"B","Break" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",3547.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",3467.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",4497.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",6793.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",6034.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",5534.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",6312.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",7955.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",6086,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",8160.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",9498.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",3.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",5.7,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",7.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",7.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",10.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",8.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",8.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",9.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",11.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",7.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",10.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",10.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",4.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",7.9,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",10.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",9.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",12.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",17.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",15.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",13.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",15.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",19.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",14.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",18.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",21.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",0.3,"B","Break" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",0.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",0.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",0.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",0.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",0.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",0.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",0.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",0.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",0.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",0.5,"B","Break" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",0.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",0.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",0.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",0.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",0.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",0.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",0.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",1.1,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",0.2,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0.2,"B","Break" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0.2,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",0.2,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",0.3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",0.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",1.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",1.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",1.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",1.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",1.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",1.8,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",1.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",1.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",2.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",2.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",2.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",2.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",2.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",2.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",2.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",2.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",2.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",2.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",2.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",2.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",2.5,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",2.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",2.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",2.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",2.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",3.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",3.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",3.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",3.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",3.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",3.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",3.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",3.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",3.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",3.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",4.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",4.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",1.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",1.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",1.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",1.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",1.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",1.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",1.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",1.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",1.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",1.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",1.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",2.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",2.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",2.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",2.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",2.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",2.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",2.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",2.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",2.9,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",2.9,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",3.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",3.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",3,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",0.6,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",0.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",6.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",6.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",6.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",6.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",6.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",6.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",6.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",6.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",6.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",6.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",6.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",6.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",8.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",8.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",7.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",8.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",8.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",7.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",7.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",7.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",7.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",6.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",9.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",9.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",10,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",10.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",10.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",10.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",11,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",11,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",10.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",11.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",11.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",11.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",11.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",4.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",4.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",3.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",3.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",3.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",3.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",4.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",4.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",4.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",5.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",5.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",5.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",5.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",5.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",5.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",5.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",5.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",5.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",1.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",1.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",1.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",142,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",141,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",137,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",151,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",142,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",144,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",153,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",153,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",158,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",163,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",176,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",187,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",130.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",145.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",141.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",145.8,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",128,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",108.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",113.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",117.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",118.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",113.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",121.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",140.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",94.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",93.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",89,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",104.3,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",97.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",97.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",105.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",103.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",107.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",110.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",121,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",129.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",5.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",6.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",6.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",6.3,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",5.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",4.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",4.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",4.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",4.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",4.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",4.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",5.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",3.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",4.5,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",4.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",4.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",1.3,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",63.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",57.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",51.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",46.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",46.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",44.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",43.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",41.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",35.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",34.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",33.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",31.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",84.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",79.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",65.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",61.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",61.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",49.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",48.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",46.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",42.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",38.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",38.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",37.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",75.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",69,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",63,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",58.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",57.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",55.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",56.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",53,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",46.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",46.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",45.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",41.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",10.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",9.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",7.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",7.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",7.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",5.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",5.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",5.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",4.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",4.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",8.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",7.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",6.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",6.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",6.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",6.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",5.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",5.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",5.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",4.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",2.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",2.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",1.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",1.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",1.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",108.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",99.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",97.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",97.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",91.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",87.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",86.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",82.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",78.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",76.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",69.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",62.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",60.4,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",143.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",138.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",125.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",128.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",122.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",96.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",95.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",93.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",92.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",85.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",79.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",73.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",63.6,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",129.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",119.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",119,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",120.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",114.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",109.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",110.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",106.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",102.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",102.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",95.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",84.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",84.6,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",13.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",12.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",11.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",11.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",10.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",8.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",8.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",8.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",8.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",7.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",6.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",6.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",5.5,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",11.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",10.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",10.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",10.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",10.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",9.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",9.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",9.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",8.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",8.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",8.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",7.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",7.3,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",1.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",1.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",1.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0.7,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",321.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",308.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",311.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",316.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",320.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",326.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",299.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",288.8,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",291.7,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",281.6,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",258.9,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",321.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",299.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",282.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",247.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",241.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",251.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",231.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",217.7,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",217.5,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",224.6,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",198.9,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",258.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",252,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",253.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",253.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",265.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",269.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",248.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",233.9,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",237,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",227.4,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",206.4,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",9.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",8.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",6.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",6.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",6.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",6.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",5.8,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",5.7,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",5.9,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",5.1,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",7.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",7.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",7.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",7.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",7.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",7.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",6.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",6.2,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",6.2,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",5.9,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",5.3,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",0.9,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",0.9,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",0.8,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",0.6,"E; D","Estimated value; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",1182.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",1140,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",1148.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",1118.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",1122.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",1089.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",1079.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",1125.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",1096.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",1088.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",1085.8,"B","Break" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",1100.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",61.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",64.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",58.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",57.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",54.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",44.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",44.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",48.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",50.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",47.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",46.8,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",50.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",86.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",85.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",86.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",87.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",88.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",84.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",85.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",90.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",88.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",88.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",87.1,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",86.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",5.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",6.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",5.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",5.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",5.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",4.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",4.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",4.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",4.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",4.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",4.4,"B","Break" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",4.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",8.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",8.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",8.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",8.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",8.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",8.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",8.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",8.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",8.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",8.1,"B","Break" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",8.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",1.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",1.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",1.2,"B","Break" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",1.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",29.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",25,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",26.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",27.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",27.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",27.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",26.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",23.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",21.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",20.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",19.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",18.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",39.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",34.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",33.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",36,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",36.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",30.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",29.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",26.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",25.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",22.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",22,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",21.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",33.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",27.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",28.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",29.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",30.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",30.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",30.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",27.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",25.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",24.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",23.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",22.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",7.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",6.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",6.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",6.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",6.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",5.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",5.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",4.8,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",4.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",4.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",3.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",6.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",5.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",5.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",5.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",5.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",5.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",5.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",4.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",4.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",4.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",4.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",1.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",666,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",647.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",654.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",661.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",669.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",668.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",659.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",654.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",662.8,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",677.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",681.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",683,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",882.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",900.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",840.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",878.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",889.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",742.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",730.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",739.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",782.7,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",758.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",778.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",807.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",827.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",820.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",831.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",853.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",871.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",859.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",876.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",879.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",901.2,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",930.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",939.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",927.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",10.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",11.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",10.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",10.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",11,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",9.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",8.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",9.4,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",9.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",9.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",9.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",10.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",10.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",10.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",10.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",10.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",10.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",10.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",10.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",10.9,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",11.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",11.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",11.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",1.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",1.5,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",81.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",81.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",79.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",64.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",58.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",57.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",59.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",57.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",58.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",60.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",67.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",78,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",60.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",107.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",113.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",102.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",85.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",78,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",63.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",66.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",65,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",69,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",68.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",77.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",92.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",63.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",112.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",114.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",116.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",101.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",96,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",94.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",101.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",100.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",103.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",110.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",124.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",143,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",114.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",9.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",10.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",9.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",7.8,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",7.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",5.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",6.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",6.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",6.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",7.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",8.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",6.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",10.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",10.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",10.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",9.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",8.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",8.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",9.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",9.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",9.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",10.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",11.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",13.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",10.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",12071.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",12185.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",10376.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",9953.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",9722.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",9746,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",9800,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",9854.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",9925.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",9790.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",10122.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",9312.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",9446.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",58.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",60.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",46.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",44.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",41.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",34.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",34.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",35.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",36.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",33.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",32.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",30.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",25.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",95.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",98.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",82.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",79.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",75.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",73.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",74.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",72.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",71.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",69.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",69.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",60.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",58.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",5.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",6.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",4.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",4.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",3.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",3.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",3.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",3.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",3.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",3.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",3.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",2.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",9.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",9.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",8.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",8.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",7.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",7.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",7.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",7.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",7.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",7.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",7.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",6.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",2.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",2.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",2.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",2.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",1.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",1.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",1.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",327.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",346.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",345.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",353.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",342.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",339.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",340.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",349.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",368.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",380.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",441.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",482.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",2.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",2.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",2.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",2.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",2.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",2.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",3.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",3.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",3.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",3.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",3.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",2.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",2.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",2.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",2.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",2.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",2.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",2.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",2.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",2.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",2.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",3.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",8.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",9.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",8.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",8.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",8.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",7.8,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",8.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",9.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",9.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",8.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",8.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",10.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",7.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",7.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",7.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",7.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",7.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",7.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",7.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",7.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",8.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",8.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",1.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",1.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",27.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",23.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",23.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",23.6,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",23.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",22.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",22.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",22.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",21.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",21.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",21.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",21.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",36.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",32.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",30.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",31.3,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",31,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",25.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",25.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",25.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",25.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",24,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",24.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",25.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",32.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",28,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",28.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",29,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",28.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",28,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",28.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",28.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",27.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",26.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",26.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",27.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",7.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",6.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",6.8,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",6.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",5.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",5.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",5.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",5.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",4.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",4.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",5.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",7.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",6.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",6.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",6.3,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",6.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",6.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",5.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",5.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",5.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",5.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",5.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",1.2,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",284.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",289.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",302.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",323.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",333.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",343.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",347.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",352.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",359.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",369.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",373.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",375.1,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",396,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",372.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",402.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",429.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",369.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",379.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",392.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",416,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",402.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",421.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",441.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",395,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",375,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",387.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",410.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",437.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",451.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",489.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",504,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",517,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",547.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",570,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",576.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",607.5,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",6.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",6.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",6.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",7.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",6.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",6.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",6.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",6.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",6.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",7.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",7.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",6.7,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",6.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",6.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",6.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",7.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",7.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",8.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",8.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",8.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",9.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",9.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",9.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",10.3,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",1.5,"E","Estimated value" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",200847,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",194869,"B","Break" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",152919.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",133036.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",127839.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",127385.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",123930.9,"B","Break" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",126933.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",132278.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",134990.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",145065.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",151300.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",173.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",175.8,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",135.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",121.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",121.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",112.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",106.8,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",112.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",120.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",115.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",122.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",132.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",238.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",228,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",178.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",153.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",146.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",148.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",144.3,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",145.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",154.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",157.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",173.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",177.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",3.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",3.5,"B","Break" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",2.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",2.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",2.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",2.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",2.1,"B","Break" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",2.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",2.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",2.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",2.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",2.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",4.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",4.6,"B","Break" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",3.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",2.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",2.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",2.8,"B","Break" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",2.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",3.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",3.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.9,"B","Break" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.5,"B","Break" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",3.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",3.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",3.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",3.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",3.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",3.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",3,"D; P","Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",4.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",4.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",4.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",4.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",4.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",3.2,"D; P","Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",3.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",3.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",3.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",3.6,"D; P","Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",9.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",9.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",9.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",9.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",9.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",7.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",7.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",7.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",7.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",7.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",7.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",5.4,"D; P","Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",7.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",7.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",7.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",8.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",7.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",8.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",7.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",7.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",7.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",7.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",6.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",6.2,"D; P","Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",1.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",1.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",1.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",1.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",1.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",1.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",1.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",1.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",1.2,"D; P","Difference in methodology; Provisional value" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",110.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",96.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",93.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",93.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",93.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",146.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",134.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",120.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",124.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",123.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",129.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",115.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",113.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",117.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",115.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",8.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",8.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",7.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",7.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",7.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",7.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",6.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",6.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",6.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",1.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",23.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",18.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",18.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",14.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",14.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",14.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",7.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",12.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",7.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",7.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",6.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",8.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",7.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",16.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",14.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",15,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",11.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",12.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",9.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",5.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",8.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",5.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",4.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",4.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",5.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",15.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",12.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",12.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",10,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",10.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",9.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",5.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",8.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",5.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",5.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",4.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",5.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",5.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",3.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",3.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",3.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",2.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",2.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",2.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",2.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",2.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",3.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",1.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",1.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",168,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",166,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",165,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",167,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",172,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",174,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",180,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",183,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",186,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",202,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",206,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",208,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",225,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",27.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",29.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",28.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",28.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",27.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",21.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",21.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",22.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",22.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",23,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",21.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",24.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",23.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",18.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",18.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",18.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",18.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",18.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",17.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",17.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",18.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",19.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",21,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",20.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",21.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",21,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",5.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",5.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",5.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",5.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",4.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",4.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",4.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",4.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",4.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",4.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",4.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",4.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",3.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",3.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",3.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",3.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",3.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",3.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",3.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",3.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",3.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",3.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",3.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",3.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",0.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",0.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",0.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",0.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",0.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",0.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",0.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",34.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",31.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",29.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",30.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",30.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",31.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",32.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",32.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",34.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",36,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",37.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",38.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",39,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",45.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",43.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",37.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",40,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",40.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",35,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",36,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",37,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",40.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",40.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",43.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",45.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",41.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",55.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",50.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",48.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",51.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",52.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",53.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",57,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",56.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",59.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",64.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",67.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",67.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",70.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",3.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",3.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",3.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",3.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",3.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",3.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",3.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",4.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",5.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",4.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",4.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",4.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",5.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",5.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",5.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",5.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",5.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",6.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",6.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",6.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",6.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",15.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",15.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",14,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",15.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",15,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",15,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",21.9,"B","Break" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",22,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",22.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",23,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",24.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",24.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",20.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",21.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",18,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",20.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",19.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",16.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",24.2,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",24.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",26.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",25.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",27.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",28.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",30.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",30.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",27.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",30.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",30.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",30.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",43.5,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",42.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",42.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",44.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",46.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",45.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",3.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",3.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",3.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",3.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",3.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",4.5,"B","Break" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",4.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",4.8,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",4.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",5.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",5.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",5.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",5.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",5.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",5.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",5.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",5.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",8,"B","Break" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",7.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",7.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",8.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",8.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",8.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",1.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",1.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",1.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",1.4,"B","Break" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",1.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",99,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",84.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",79.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",80.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",84.4,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",82.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",85.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",88.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",92.7,"B","Break" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",96.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",100.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",103.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",104.9,"P","Provisional value" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",131.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",118.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",101.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",107.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",112.1,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",91.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",95.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",100,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",109.4,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",108.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",114.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",122.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",110.5,"P","Provisional value" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",136.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",118.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",113.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",119.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",127.4,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",124.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",133.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",140.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",146.7,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",158.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",161.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",165.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",175.9,"P","Provisional value" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",2.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",2.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",2.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",2.4,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",2.3,"B","Break" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",2.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",2.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",2.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",2.3,"P","Provisional value" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",2.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",2.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",2.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",2.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",2.7,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",2.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",2.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",3.1,"B","Break" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",3.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",3.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",3.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",3.7,"P","Provisional value" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",0.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",0.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",0.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",0.7,"B; D","Break; Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0.5,"B","Break" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0.5,"P","Provisional value" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",430,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",403,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",393,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",411,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",419.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",429.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",394.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",397.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",419.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",437.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",475.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",443.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",454.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",59.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",62.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",58,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",63.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",61.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",50.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",46,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",46.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",48.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",46.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",51.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",51.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",44.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",47.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",45.6,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",45.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",47.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",48,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",48.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",44.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",44.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",47.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",50.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",54.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",50.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",52.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",6.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",6.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",6.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",6.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",6.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",5.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",4.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",4.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",4.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",4.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",4.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",5.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",4.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",4.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",4.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",4.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",4.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",4.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",4.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",5.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",4.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",1.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",161.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",167.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",176.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",196.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",223.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",246.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",293.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",347,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",409.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",545,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",682.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",827.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",107.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",99.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",98.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",103,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",102.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",90.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",97.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",95.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",84.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",96.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",97.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",93.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",175.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",173.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",172.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",183.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",202.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",212.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",236.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",250.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",250.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",292.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",315.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",294.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",1.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",1.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",1.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",1.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",1.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",1.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",1.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",1.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",1.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",1.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",1.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",2.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",2.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",2.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",2.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",2.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",2.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",3.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",3.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",3.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",3.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",3.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",1.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",1.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",1.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",8640.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",10586.3,"B","Break" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",11971.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",12752.7,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",15358.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",16311,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",19105.1,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",18779.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",18941.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",21320.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",25554,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",22481.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",25660.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",16.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",21.9,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",24.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",25.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",26.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",24.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",28.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",28.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",29.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",30.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",32.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",29.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",29.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",24,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",30.4,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",34.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",36.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",41.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",41.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",48.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",47.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",47.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",53.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",61.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",51.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",58.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",1.3,"B","Break" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",1.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",1.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",1.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",1.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",1.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",1.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",1.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",1.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",1.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",1.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",1.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",1.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",1.8,"B","Break" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",2.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",2.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",2.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",2.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",2.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",2.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",2.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",3.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",2.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0.9,"B","Break" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",0.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",0.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",5.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",4.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",5.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",5.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",5.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",5.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",5.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",5.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",5.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",5.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",5.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",5.9,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",7.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",6.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",6.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",7.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",7.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",6.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",6.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",6.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",6.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",6.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",6.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",6.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",10.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",9.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",10.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",10.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",10.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",10.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",10.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",10.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",10.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",10.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",11.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",10.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",10.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",5.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",5.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",5.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",5.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",4.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",4.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",4.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",4.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",4.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",5.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",4.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",7.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",7.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",7.9,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",7.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",7.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",7.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",7.8,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",8.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",8.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",7.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",2.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",2.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",2.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",2.3,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",2.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",2.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",1.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",1.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",1.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",1.6,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",1.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",8.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",7.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",8.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",8.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",8.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",9.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",10.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",10.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",10.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",10.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",11.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",11,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",11.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",11.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",10.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",10.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",11.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",11.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",10.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",11.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",11.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",12.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",12.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",12.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",13,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",11.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",13.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",12.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",13.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",14.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",15.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",15.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",17.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",17.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",18.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",19.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",20.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",19.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",20.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",5.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",5.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",5.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",5.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",5.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",5.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",5.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",5.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",5.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",6.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",6.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",5.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",6.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",6.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",6.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",7.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",7.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",7.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",8.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",8.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",9.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",9.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",9.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",9.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",1.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",1.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",2.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",1.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",159,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",142,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",118,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",131,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",119,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",124,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",133,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",130,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",132,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",134,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",142,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",148,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",145.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",146.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",122.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",126.5,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",107.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",93.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",98.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",99.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",98.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",93.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",97.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",111.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",105.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",94,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",76.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",90.5,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",81.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",84.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",91.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",88,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",89.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",90.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",97.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",102.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",6.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",6.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",5.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",5.5,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",3.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",3.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",3.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",4.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",4.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",3.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",3.9,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",3.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",3.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",3.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",3.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",1.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",1.1,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",34.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",30.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",29.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",28.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",27.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",20.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",10.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",10.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",9.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",9.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",8.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",8.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",45.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",42.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",37.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",37.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",36.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",22.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",12,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",11.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",11.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",10.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",10.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",10.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",40.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",36.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",36.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",35.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",34.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",25.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",14,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",13,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",12.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",12.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",11.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",11.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",5.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",4.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",4.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",4.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",4.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",4.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",1.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",0.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",0.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",0.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",0.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",72.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",67.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",63.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",57.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",57.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",48.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",45.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",43.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",35.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",35.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",33.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",31.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",30.3,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",95.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",94.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",82,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",76.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",75.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",53.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",50.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",48.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",41.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",39.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",38.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",37.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",31.9,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",86.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",81.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",77.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",71.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",71.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",60.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",58.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",55.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",46.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",47.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",46.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",43,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",42.4,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",8.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",8.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",7.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",6.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",6.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",4.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",4.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",4.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",3.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",3.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",3.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",3.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",2.7,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",7.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",7.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",6.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",6.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",5.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",5.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",4.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",4.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",4.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",3.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",3.7,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",1.2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",1.1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",1.1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0.3,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",613.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",562.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",547.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",545.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",546.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",531.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",472,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",427.3,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",422.5,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",414.4,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",417.4,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",613.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",545.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",495.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",426.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",412.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",409.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",364.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",322,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",315.1,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",330.5,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",320.7,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",492.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",459.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",445,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",437.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",453.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",438.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",391.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",346.1,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",343.2,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",334.7,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",332.9,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",17.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",15.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",14,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",12,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",11.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",11.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",9.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",8.6,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",8.3,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",8.6,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",8.2,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",14.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",13.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",12.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",12.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",12.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",12,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",10.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",9.2,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",9,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",8.8,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",8.6,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",2.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",2.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",2.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",1.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",1.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",1.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",1.3,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",1.2,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",1.1,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",1,"E; D","Estimated value; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",1005.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",817.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",765.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",730.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",710,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",590.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",515.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",501.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",445.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",436.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",395,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",373.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",52.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",46.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",39.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",37.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",34.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",24,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",21.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",21.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",20.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",19,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",17,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",17.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",73.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",61.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",57.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",57.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",55.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",45.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",41,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",40.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",36,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",35.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",31.7,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",29.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",4.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",3.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",3.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",3.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",2.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",1.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",1.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",1.6,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",1.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",5.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",5.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",5.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",5.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",4.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",3.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",3.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",3.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",3.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",3,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",2.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",1.2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0.4,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",17,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",15.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",15.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",16.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",18.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",19,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",19.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",18.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",16.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",12.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",11.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",11.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",22.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",21.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",19.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",22.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",24,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",21.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",21.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",20.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",19.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",14.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",13,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",13.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",18.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",16.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",16.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",18.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",20,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",20.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",22,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",21.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",19.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",15.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",13.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",13.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",4.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",3.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",3.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",4.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",4.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",3.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",3.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",3.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",3.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",2.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",2.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",2.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",3.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",3.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",3.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",3.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",3.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",3.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",3.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",3.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",2.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",2.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",2.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",308,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",292,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",289.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",283.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",284.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",284.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",285,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",287.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",297.5,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",318.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",330.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",341.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",408.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",406.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",372.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",376.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",378.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",316.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",315.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",324.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",351.3,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",356.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",377.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",404.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",382.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",370.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",367.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",365.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",370.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",366.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",378.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",385.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",404.5,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",436.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",456.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",464.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",5.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",3.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",3.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",3.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",4.2,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",4.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",4.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",4.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",4.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",4.9,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",5.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",5.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",0.7,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",94.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",77.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",68.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",61,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",56,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",50.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",50.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",49.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",45.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",44.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",40.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",39.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",28.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",125,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",108.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",88.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",81,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",74.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",55.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",55.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",55.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",54.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",49.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",46.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",46.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",30.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",130.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",108.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",100.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",96.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",91.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",82.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",85.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",85.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",81.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",81,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",75.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",71.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",54.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",11.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",9.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",7.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",6.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",5.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",5.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",5.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",4.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",4.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",4.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",2.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",11.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",9.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",9.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",8.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",8.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",7.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",7.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",7.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",7.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",7.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",6.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",5.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",6967.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",6798.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",5530.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",3769.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",3109.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",2946.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",2787.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",2649.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",2558.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",2496.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",2522.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",2313.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",2220.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",33.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",33.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",24.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",16.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",13.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",10.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",9.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",9.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",9.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",8.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",8.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",7.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",55.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",54.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",44,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",30.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",24,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",22.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",21.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",19.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",18.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",17.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",17.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",15,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",13.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",3.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",3.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",2.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",1.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",4.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",2.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",2.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",2.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",1.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",1.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",1.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",0.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",0.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",0.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",223.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",229.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",211.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",198.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",185.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",156.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",165.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",164.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",180.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",199.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",236.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",289.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",1.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",1.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",1.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",1.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",1.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",1.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",1.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",1.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",1.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",1.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",2.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",1.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",1.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",1.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",1.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",1.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",1.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",1.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",1.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",1.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",1.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",1.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",1.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",5.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",6.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",5.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",4.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",3.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",4.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",4.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",4.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",4.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",4.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",6.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",5.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",5.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",4.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",4.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",4.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",3.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",3.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",3.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",3.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",3.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",4.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",5.2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",0.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",26.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",24.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",25.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",24,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",22.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",18,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",18.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",17.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",17.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",17.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",18.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",18.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",35.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",34.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",32.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",31.8,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",29.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",20,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",20,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",19.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",20.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",19.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",20.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",22.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",31.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",29.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",30.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",29.6,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",27.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",22.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",22.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",22.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",22.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",21.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",22.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",23.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",7.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",7.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",6.9,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",6.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",4.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",4.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",4.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",4.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",6.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",6.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",6.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",6.4,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",5.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",4.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",4.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",1.2,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",389,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",332.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",323.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",318.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",301.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",296.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",286.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",281,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",274.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",271.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",264.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",256.5,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",541.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",427.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",429.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",422.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",335,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",328.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",323.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",331.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",307.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",310.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",312.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",270.1,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",512.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",444.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",438.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",430.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",408.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",423.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",415.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",412.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",418.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",419.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",408.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",415.4,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",9.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",7.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",7.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",5.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",5.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",5.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",5.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",5.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",5.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",5.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",4.6,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",8.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",7.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",7.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",7.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",6.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",6.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",6.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",7.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",6.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",7,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",1.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",1.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",1.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",1.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",1.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",1.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",1.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",1.2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",1.2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",1.1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",1,"E","Estimated value" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",514083,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",493836.7,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",439045.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",412627,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",380517.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",364513.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",345301,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",337442.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",334169.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",326138.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",344643.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",345302.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",444.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",445.6,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",389.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",376.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",361.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",322.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",297.5,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",298.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",303.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",279.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",292,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",301.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",611.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",577.9,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",513.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",474.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",436.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",425.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",402.1,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",386.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",390.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",380.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",411.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",404.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",8.9,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",7.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",7.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",7.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",6.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",5.8,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",5.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",5.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",5.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",5.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",5.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",12.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",11.6,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",10.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",9.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",8.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",8.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",7.9,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",7.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",7.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",7.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",7.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",7.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",2.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",2.2,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",1.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",1.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",1.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",1.4,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",1.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",1.2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",1.1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",1.1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",2.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",2.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",2.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",2.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",1.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",1.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",1.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",1.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",1,"D; P","Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",3.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",2.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",2.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",1.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",1.1,"D; P","Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",2.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",2.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",2.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",2.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",2.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",1.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",1.2,"D; P","Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",7.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",7.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",6.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",3.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",2.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",2.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",2.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",2.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",1.8,"D; P","Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",6.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",5.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",5.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",4.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",3.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",2.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",2.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",2.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",2.1,"D; P","Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",0.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",0.4,"D; P","Difference in methodology; Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",62.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",60.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",60.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",64.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",65.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",82.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",84.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",78.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",86.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",87.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",72.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",72.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",73.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",81.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",81.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",5.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",5.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",5.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",4.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",4.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",4.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",4.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",4.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",13.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",14.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",13.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",9.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",8.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",8.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",5.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",5.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",5.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",5.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",6.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",7.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",9.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",11.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",10.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",7.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",6.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",5.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",3.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",3.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",3.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",4.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",8.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",10,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",6.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",5.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",3.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",5.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",2.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",2.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",2.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",1.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",2.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",1.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",1.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",159,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",141,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",132,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",128,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",130,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",121,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",126,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",128,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",111,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",108,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",111,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",109,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",114,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",26.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",25.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",22.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",21.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",20.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",15,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",15,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",15.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",13.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",12.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",11.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",12.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",11.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",17.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",15.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",14.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",14.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",14,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",12.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",12.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",13.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",11.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",11.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",11.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",11.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",10.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",5.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",5.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",4.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",4.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",2.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",2.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",2.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",2.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",2.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",2.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",2.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",2.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",3.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",3.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",2.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",2.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",2.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",2.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",2.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",2.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",2.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",2.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",2.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",2.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",54.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",44.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",35.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",29.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",27,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",26,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",25.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",24.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",23.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",23.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",23.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",23,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",23.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",72.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",61.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",45.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",38.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",35.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",28.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",27.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",27.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",28.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",26.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",26.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",27.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",24.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",87.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",71.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",58,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",50.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",46.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",44.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",43.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",42.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",41.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",42,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",41.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",40.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",42.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",6.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",5.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",3.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",3.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",2.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",2.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",2.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",2.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",2.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",8.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",6.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",4.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",4.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",3.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",1.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",17.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",16.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",10.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",10,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",8.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",11.3,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",10.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",9.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",9.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",9.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",8.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",22.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",22.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",12.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",13.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",12,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",9.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",12.6,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",11.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",11.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",10.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",10.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",10.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",34.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",31.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",19.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",20.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",18.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",16.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",22.5,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",20.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",18.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",17.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",17.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",15.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",4.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",4.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",2.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",2.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",2.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",1.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",2.3,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",2.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",2.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",1.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",1.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",1.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",6.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",5.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",3.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",3.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",3.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",3.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",4.1,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",3.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",3.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",3.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",3.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",2.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",0.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",0.7,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",0.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",238.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",187,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",126.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",110.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",112.6,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",108.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",108.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",107.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",109.5,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",110.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",109.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",110,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",109.5,"P","Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",316,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",260.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",162.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",147.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",149.5,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",120.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",120.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",121.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",129.3,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",123.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",125.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",130.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",115.3,"P","Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",327.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",261.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",182.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",164.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",169.9,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",162.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",168.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",170.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",173.3,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",179.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",176.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",175.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",183.7,"P","Provisional value" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",6.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",5.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",3.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",3.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",3.2,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",2.8,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",2.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",2.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",2.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",2.4,"P","Provisional value" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",5.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",3.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",3.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",3.7,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",3.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",3.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",3.7,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",3.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",3.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",3.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",3.9,"P","Provisional value" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",1.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",1,"B; D","Break; Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0.6,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0.5,"P","Provisional value" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",206.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",195.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",193,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",198.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",202,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",203.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",200.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",202.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",209.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",239.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",275.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",249.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",254.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",28.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",30.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",28.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",30.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",29.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",24.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",23.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",23.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",24.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",25.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",29.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",29.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",25.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",22.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",22.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",22.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",23.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",23.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",23,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",22.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",22.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",23.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",27.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",31.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",28.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",29.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",3.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",3.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",3.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",2.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",2.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",2.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",2.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",2.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",2.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",2.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",2.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",2.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",2.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",2.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",2.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",2.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",2.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",2.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",2.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",2.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",2.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",3.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",2.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",2.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",131.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",121.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",112.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",126.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",127.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",140.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",158.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",197.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",240.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",286.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",368.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",424.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",87.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",72.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",62.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",66.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",58.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",51.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",52.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",54.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",49.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",50.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",52.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",48,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",143,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",125.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",110.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",118.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",115.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",121,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",128,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",142.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",147,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",153.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",170.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",151.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",1.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",0.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",0.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",1.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",1.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",1.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",1.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",1.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",1.6,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",1.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",1.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",1.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",1.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",0.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",4975.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",5881.7,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",5913.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",5672.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",6613,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",6710.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",6996.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",8473.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",6690.4,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",7243.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",8829.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",7415.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",7600.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",9.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",12.2,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",12.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",11.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",11.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",10.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",10.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",13.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",10.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",10.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",11.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",9.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",8.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",13.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",16.9,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",17,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",16.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",18,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",17.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",17.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",21.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",16.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",18,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",21.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",17,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",17.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",0.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",0.7,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",0.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",0.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",0.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",0.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",0.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",0.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",0.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",0.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",0.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",0.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",0.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",0.8,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",1,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",0.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",1.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",0.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",0.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",1.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",0.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0.5,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",0.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",0.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",0.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",4.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",3.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",3.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",2.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",2.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",2.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",2.1,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",1.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",1.8,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",1.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",1.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",1.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",1.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",6.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",5.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",4.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",3.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",3.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",2.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",2.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",2.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",2.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",1.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",1.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",1.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",1.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",9.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",7.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",6.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",5.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",4.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",4.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",3.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",3.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",3.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",3.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",2.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",2.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",4.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",3.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",3.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",2.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",1.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",1.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",1.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",1.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",1.5,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",1.4,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",1.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",7.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",5.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",5.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",4.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",3.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",3.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",2.7,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",2.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",2.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",2.4,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",2.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",2.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",1.8,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",1.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",1.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",1,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",0.6,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",0.5,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",0.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",0.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",10,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",8.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",6.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",6.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",6.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",6.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",5.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",5.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",5.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",5.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",13.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",11.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",8.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",8.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",8.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",6.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",6.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",6.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",6.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",6.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",6.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",6.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",5.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",15.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",13.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",11,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",11.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",10.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",10.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",10.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",10.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",9.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",10,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",10.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",9.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",9.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",6.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",4.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",4.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",3.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",3.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",3.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",3.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",3.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",3.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",2.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",7.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",6.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",5.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",5.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",5.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",4.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",4.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",4.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",4.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",2.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",1.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",592,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",609,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",562,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",740,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",706,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",679,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",636,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",598,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",624,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",654,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",705,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",757,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",543,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",628.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",581.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",714.4,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",636.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",510.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",472.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",458.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",466.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",454.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",485.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",568.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",393.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",403,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",364.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",511.4,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",486.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",460.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",438.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",404.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",424.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",441.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",484.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",522.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",24.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",28.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",25.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",30.9,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",27.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",21.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",19.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",18.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",18.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",17.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",18.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",22.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",17.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",18,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",16.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",22.1,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",20.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",19.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",18.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",16.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",17,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",17.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",18.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",20.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",5.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",5.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",6.3,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",5.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",5.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",4.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",4.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",4.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",4.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",4.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",195.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",197,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",194.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",167.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",160.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",157.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",159.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",160.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",155.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",142.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",138.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",127.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",259.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",274.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",250,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",221.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",213.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",174.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",176.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",181.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",183.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",159.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",157.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",151,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",232,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",237,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",239.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",209.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",201.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",197.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",204.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",207,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",202.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",189.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",185.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",168.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",31,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",32.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",29.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",26.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",25,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",20.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",20.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",20.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",20.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",17.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",17.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",16.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",27.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",28.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",28.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",24.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",23.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",22.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",23.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",23.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",22.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",21.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",20.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",18.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",7.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",7.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",7.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",6.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",5.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",5.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",5.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",5.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",4.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",4.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",3.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",234.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",233,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",226.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",218.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",199.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",196.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",190.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",175.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",169.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",188.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",189.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",190,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",190.7,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",311.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",324.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",290.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",289.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",264.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",218,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",210.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",198.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",200.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",211.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",216.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",224.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",200.8,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",280.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",280,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",275.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",270.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",249.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",245.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",243.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",226.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",221.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",252.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",259.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",257.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",267.1,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",28.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",29.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",26.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",26,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",23.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",19.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",18.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",17.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",17.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",18.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",18.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",19.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",17.3,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",25.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",25.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",24.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",24.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",22.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",21.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",21.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",19.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",19.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",22,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",22.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",22.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",23,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",3.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",3.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",3.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",3.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",3.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",2.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",2.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",2.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",2.1,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1362.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1207.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1208.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1229,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1272.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1310,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",1051.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",946.4,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",994,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",971.5,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",1013.8,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1363.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1172.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1094.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",961.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",959.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",1009.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",811.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",713.3,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",741.2,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",774.8,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",778.9,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1094.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",986.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",982.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",984.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1053.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1080.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",871.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",766.5,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",807.5,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",784.6,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",808.5,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",39.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",33.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",30.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",26.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",26.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",27.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",21.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",19,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",19.5,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",20.3,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",20,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",31.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",28.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",27.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",27.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",29.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",29.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",23.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",20.4,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",21.2,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",20.5,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",20.8,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",5.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",4.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",4.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",4.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",4.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",4.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",3.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",3,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",2.9,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",2.6,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",2.5,"E; D","Estimated value; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",3919.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",3853.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",3699.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",3409.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",3058.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",2834,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",2861.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",2895.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",2896.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",3060.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",3164.7,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",3292.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",205.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",217.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",188.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",174.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",147.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",115.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",117.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",123.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",133.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",133.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",136.3,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",151.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",286.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",288.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",278.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",266.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",240.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",219,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",227.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",233,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",234.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",249.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",254,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",258.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",19.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",20.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",18,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",16.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",14,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",10.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",11.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",11.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",12.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",12.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",12.7,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",14.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",27.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",27.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",26.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",25.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",22.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",20.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",21.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",22,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",22,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",23.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",23.7,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",24.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",4.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",4.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",4.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",4.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",3.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",3.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",3.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",3.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",3.6,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",3.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",77.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",71.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",63,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",57.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",54.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",55,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",54.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",50.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",46.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",43.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",38.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",34.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",103.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",99.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",80.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",75.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",72.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",61,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",60,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",57,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",54.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",48.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",44,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",40.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",86.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",79.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",69.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",63.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",60.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",60.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",61.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",58.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",54.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",51.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",46.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",41.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",19.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",18.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",15,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",13.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",13.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",11.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",10.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",10.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",10,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",8.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",7.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",16.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",14.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",12.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",11.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",11,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",11.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",11.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",10.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",9.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",9.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",8.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",7.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",4.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",3.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",3.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",2.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",2.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",2.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",2.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",1.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",1.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",1.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",1.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",2144.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",2149.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",1919.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",1860.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",1739.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",1590,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",1604.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",1609.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",1680,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",1770.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",1838,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",1921.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",2842.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",2992.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",2465.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",2470.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",2311.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",1764.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",1775.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",1818.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",1984,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",1981.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",2099.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",2272.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",2663.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",2725.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",2437.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",2401.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",2262.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",2043.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",2131.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",2161,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",2284.3,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",2430.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",2535.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",2610,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",34.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",37.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",30.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",30.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",28.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",21.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",21.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",22,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",23.9,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",23.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",25.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",27.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",32.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",34,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",30.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",29.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",27.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",25,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",25.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",26.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",27.6,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",29.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",30.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",31.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",7.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",7.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",6.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",5.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",5.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",4.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",4.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",4.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",3.8,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",3.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",3.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",3.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",539.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",523.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",473.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",400.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",364.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",331.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",362.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",334.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",304.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",299.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",273.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",258.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",201.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",715.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",728.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",608,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",531.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",484.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",367.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",401.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",377.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",359.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",335.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",312.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",305.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",212,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",747.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",733.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",691.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",633.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",596.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",543.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",616.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",581.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",538.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",545.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",502.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",474,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",380.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",64.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",65.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",55.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",48.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",44.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",34,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",37.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",35.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",33.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",31.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",29.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",28.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",20.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",67.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",66.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",62.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",57.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",54.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",50.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",57.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",54.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",50.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",50.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",47,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",44.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",36.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",48076.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",45712.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",37976.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",35227.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",34341.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",35167.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",36400.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",37305.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",38914.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",40873.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",43416.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",43066.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",44307.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",231.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",227.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",168.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",157.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",147.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",125.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",129.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",135.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",144,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",140.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",141,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",142.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",118.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",380.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",367.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",302.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",281.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",265.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",265.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",275.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",274.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",279.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",290.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",298.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",278.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",274.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",23.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",22.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",17,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",15.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",15,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",12.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",13.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",13.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",14.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",14.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",14.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",14.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",12.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",38,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",36.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",30.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",28.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",26.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",27,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",28.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",28,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",28.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",29.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",30.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",28.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",28.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",9.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",8.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",8.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",8.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",7.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",7.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",7.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",7.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",7.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",7.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",7.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",7.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",7.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",543.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",520.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",435.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",417.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",439.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",438,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",448,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",454.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",522.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",597.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",663.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",711.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",4.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",4.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",3.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",3.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",3.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",3.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",3.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",4.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",4.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",4.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",4.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",5.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",4.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",3.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",3.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",3.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",3.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",3.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",3.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",3.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",4.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",4.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",4.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",14,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",14.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",10.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",10.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",11.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",10,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",11.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",12.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",13.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",13.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",13.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",15,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",12.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",12.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",9.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",9.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",9.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",9.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",9.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",9.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",10.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",11.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",12.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",12.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",2.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",1.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",1.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",1.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",1.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",1.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",1.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",1.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",1.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",1.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",1.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",95.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",85.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",85.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",76.8,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",67.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",59.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",59.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",53.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",54.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",55,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",57.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",60,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",127,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",118.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",110.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",102,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",89.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",66,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",65.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",60,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",64.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",61.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",65.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",70.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",112.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",102.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",104.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",94.7,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",82,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",73.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",74.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",66.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",68.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",68.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",72.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",75.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",27.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",25.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",23.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",22.1,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",19.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",14,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",13.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",12.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",13.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",12.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",13.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",14.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",24.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",22.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",22.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",20.5,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",17.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",15.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",15.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",13.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",14.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",13.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",14.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",15,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",4.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",4.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",4.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",3.9,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",3.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",2.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",2.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",2.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",2.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",2.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",2.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",1932.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",1645.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",1551.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",1398.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",1378.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",1342.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",1212.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",1186.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",1177.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",1198.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",1202.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",1211.6,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",2689.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",2114.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",2061.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",1857.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",1529.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",1486.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",1370,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",1400.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",1318.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",1369.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",1421.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",1275.8,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",2546.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",2201.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",2104.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",1890.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",1865.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",1916.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",1757.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",1741.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",1793.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",1850.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",1856.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",1962.3,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",45.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",35.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",34.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",30.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",25.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",24.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",22.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",23.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",22.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",23,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",24,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",21.6,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",42.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",37,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",34.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",31.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",30.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",31.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",29,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",28.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",30,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",31.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",31.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",33.2,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",9.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",8.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",6.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",5.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",5.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",5.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",5.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",5.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",4.9,"E","Estimated value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",961836,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",1069530.1,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",1064218.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",1080388,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",1087636.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",1101576.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",1155427.7,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",1216111.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",1305044.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",1358778.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",1501478.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",1601805.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",831.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",965.1,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",944.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",986.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",1033.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",974,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",995.4,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",1075.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",1186.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",1166,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",1272.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",1400.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",1143.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",1251.5,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",1244.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",1243.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",1247.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",1284.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",1345.4,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",1393.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",1526.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",1586.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",1792.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",1875.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",16.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",19.3,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",18.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",19.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",20.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",19.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",19.4,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",20.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",23,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",22.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",24.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",27.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",23.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",25.1,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",24.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",24.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",24.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",25.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",26.3,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",27.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",29.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",30.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",34.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",36.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",4.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",4.8,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",4.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",4.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",4.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",4.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",4.6,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",4.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",4.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",4.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",4.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",4.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",14.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",14.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",14.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",13.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",11.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",11,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",10.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",9.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",9.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",10,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",10.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",10,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",10,"D; P","Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",19.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",20.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",18.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",17.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",15.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",12.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",11.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",11,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",10.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",11.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",11.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",11.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",10.6,"D; P","Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",16.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",16.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",15.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",14.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",12.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",12.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",12.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",11.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",10.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",11.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",11.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",11.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",12.1,"D; P","Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",41.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",42.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",37.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",35.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",29.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",23.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",22.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",20.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",20,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",20,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",20.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",20.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",18,"D; P","Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",34,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",33.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",32.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",29.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",25.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",24.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",23.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",21.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",19.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",21.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",21,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",20.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",20.6,"D; P","Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",7.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",7.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",7.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",6.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",5.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",5.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",4.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",4.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",4.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",4.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",3.9,"D; P","Difference in methodology; Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",265.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",256.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",206.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",167.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",141.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",352,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",356.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",265.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",222.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",187.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",310.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",306.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",250.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",210,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",174.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",21.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",21.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",15.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",13.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",11.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",18.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",18.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",15,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",12.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",10.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",5.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",4.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",4.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",3.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",3.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",34.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",34.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",31.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",17.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",14.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",13.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",12.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",11.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",12.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",11.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",15.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",22.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",31.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",24.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",27.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",25.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",14.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",12.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",9.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",8.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",8.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",8.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",7.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",10.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",15.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",20.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",23,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",23.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",21.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",12.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",10.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",9.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",8.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",8.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",8.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",8.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",11,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",15.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",22,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",5.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",6.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",5.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",3.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",2.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",1.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",1.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",1.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",1.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",3.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",3.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",5.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",5.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",4.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",2.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",2.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",1.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",1.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",1.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",1.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",2.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",4.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",4.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",4.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",3.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",1.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",1.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",1.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",1.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",1.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",1.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",808,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",782,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",647,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",471,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",443,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",420,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",440,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",451,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",472,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",520,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",546,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",570,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",566,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",133.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",139.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",111.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",80.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",70.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",52.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",52.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",54.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",58,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",59.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",58,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",66.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",58.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",88.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",86.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",71.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",52.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",47.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",42.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",43.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",46.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",49.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",54.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",55.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",59.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",52.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",27.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",28.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",22.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",15.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",13.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",10,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",10,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",10.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",10.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",11,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",10.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",12.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",10.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",18.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",17.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",14.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",10.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",9.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",8.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",8.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",8.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",9.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",10.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",10.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",11.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",9.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",4.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",4.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",3.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",2.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",2.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",1.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",1.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",1.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",1.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",1.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",1.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",1.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",1.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",397.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",374.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",320.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",268.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",250,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",233.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",217,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",202.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",196.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",204.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",214.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",223.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",237.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",527.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",521.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",411.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",356.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",332.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",258.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",240.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",228.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",231.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",228.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",244.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",264.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",250.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",638.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",600.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",529,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",459.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",431.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",398.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",379.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",352,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",343.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",365.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",384.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",394.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",432.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",49.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",49.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",39.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",34.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",31.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",25,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",23.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",22.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",22.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",22.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",23.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",25.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",24.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",60.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",56.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",50.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",44,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",41.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",38.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",36.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",34.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",33.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",35.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",37.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",38,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",41.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",12.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",12.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",12.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",11.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",10.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",9.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",8.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",7.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",7.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",7.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",7.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",7.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",7.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",58.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",60.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",54.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",49.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",46.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",43.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",58.4,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",58.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",60.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",63.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",67.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",68.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",78,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",84.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",69.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",65.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",61.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",48.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",64.6,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",66.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",71.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",71.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",77.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",80.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",117.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",120.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",107.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",100.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",95.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",89.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",116,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",113.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",114.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",123.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",130.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",127.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",14.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",15.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",12.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",12.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",11.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",11.9,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",12.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",13.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",13.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",14.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",14.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",21.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",22.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",19.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",18.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",17.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",16.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",21.4,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",20.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",21.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",22.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",23.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",23.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",5.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",5.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",4.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",3.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",3.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",3.7,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",3.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",3.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",3.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",4.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",3.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",1246.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",1137.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",963,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",923,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",894.6,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",870.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",884,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",837.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",836.7,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",852.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",878.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",905.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",935.1,"P","Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",1652.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",1583.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",1237.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",1225.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",1188.4,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",965.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",978.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",946.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",988.1,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",954.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",1003.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",1071.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",984.7,"P","Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",1714.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",1592.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",1385.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",1367.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",1350.6,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",1308.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",1375.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",1328,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",1324.3,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",1391.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",1413.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",1447.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",1568.4,"P","Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",35.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",33.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",26.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",26.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",25.6,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",20.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",21.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",20.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",21.1,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",20.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",21.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",22.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",20.8,"P","Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",36.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",34.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",29.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",29.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",29.1,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",28.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",29.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",28.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",28.3,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",29.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",29.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",30.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",33.1,"P","Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",9.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",9.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",8.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",8.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",7.9,"B; D","Break; Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",7.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",7.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",6.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",4.4,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",4.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",4.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",4.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",4.1,"P","Provisional value" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",998.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",885.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",627.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",457.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",413.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",422,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",414,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",440.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",561.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",707.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",756.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",716.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",800.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",138.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",136.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",92.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",70.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",60.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",50,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",48.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",51.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",64.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",74.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",82.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",83.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",79.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",110.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",100.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",72.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",53.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",47.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",47.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",46.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",49.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",63.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",81.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",87.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",82.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",92.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",14.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",14.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",9.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",7.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",6.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",5.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",4.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",5.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",6.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",7.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",7.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",7.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",11.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",10.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",7.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",5.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",4.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",4.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",4.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",4.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",6.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",7.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",8.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",7.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",8.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",2.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",2.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",1.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",1.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",1.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",1.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",1.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",1.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",1.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",1.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",827.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",707.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",597.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",586.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",564.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",590.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",648.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",760.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",900.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",1189.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",1480.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",1722.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",550.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",422.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",332.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",307.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",258.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",217.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",214.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",208.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",186.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",209.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",211.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",194.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",899,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",732,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",585.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",547.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",511.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",507.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",522.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",549.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",551.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",638.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",684.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",613.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",7.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",5.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",4.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",3.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",2.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",2.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",2.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",2.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",2.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",12.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",9.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",7.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",7.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",6.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",6.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",6.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",6.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",6.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",7.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",8.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",7.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",5.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",4.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",4.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",3.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",3.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",2.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",2.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",2.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",28108.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",32614.1,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",35202.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",36639.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",44854.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",49040.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",54643.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",55530.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",56121.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",64723.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",83853.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",71737.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",90072.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",55.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",67.4,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",72.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",74,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",78.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",75,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",80.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",85.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",87.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",92.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",105.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",94.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",103.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",78.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",93.7,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",101.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",104.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",122.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",125.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",137.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",139.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",141.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",161.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",200.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",164.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",205.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",3.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",3.9,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",4.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",4.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",4.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",4.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",4.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",4.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",4.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",4.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",5.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",4.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",5.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",4.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",5.4,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",5.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",5.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",6.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",7.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",7.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",7.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",8.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",10.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",8.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",10.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",3.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",2.8,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",2.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",2.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",2.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",2.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",2.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",2.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",2.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",3.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",3.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",11.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",11.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",11.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",12.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",12.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",12.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",12.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",11.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",12.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",12.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",13.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",14,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",14.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",15.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",15.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",15.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",16.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",17.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",13.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",13.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",13.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",14.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",14.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",15.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",16.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",15.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",22.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",21.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",22.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",23.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",24.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",23,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",23.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",21.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",22.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",23.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",26.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",25.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",25.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",11.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",11.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",11.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",12.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",13,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",10.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",10.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",10.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",10.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",10.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",11.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",12.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",11.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",17.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",16.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",17.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",18.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",18.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",17.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",17.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",16.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",17.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",18,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",19.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",19.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",19.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",5.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",5.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",5.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",5.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",4.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",4.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",3.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",3.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",3.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",3.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",3.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",3.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",54.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",51.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",47,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",42.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",33.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",30,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",28.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",28.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",28.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",30,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",31.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",32.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",35.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",72.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",71.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",60.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",56.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",44.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",33.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",31.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",32.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",34,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",33.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",35.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",38.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",37.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",86.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",82.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",77.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",72,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",57.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",50.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",48.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",49.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",50.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",54.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",57.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",58.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",64,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",35.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",35,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",29.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",27.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",21.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",16.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",15.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",15.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",16.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",16.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",17.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",18.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",17.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",42,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",40.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",37.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",35,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",27.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",24.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",23.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",24.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",24.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",26,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",27.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",27.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",30.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",11.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",11,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",10.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",9.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",7.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",6.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",5.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",5.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",5.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",5.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",5.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",5.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",1680,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",1756,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",1538,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",1288,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",1028,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",820,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",709,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",674,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",657,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",639,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",642,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",646,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",1541.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",1811.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",1592.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",1243.4,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",926.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",616,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",527.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",516.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",490.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",444.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",441.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",485.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",1117.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",1162.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",998.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",890,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",707.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",556.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",488.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",456.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",446.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",431.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",441.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",446.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",69.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",81.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",70,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",53.8,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",39.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",25.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",21.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",21,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",19.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",17.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",17.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",18.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",50.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",52,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",43.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",38.5,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",30.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",23.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",20.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",18.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",17.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",17,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",17.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",17.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",17.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",17.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",14.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",10.9,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",8.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",6.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",4.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",4.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",4.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",4.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",3.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",3.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",96.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",102.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",102.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",90,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",91.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",94.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",102.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",110.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",108.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",101.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",97.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",102.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",127.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",142.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",131.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",119.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",122,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",105.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",113.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",125,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",128.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",113.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",111.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",120.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",114.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",123.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",125.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",113,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",115,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",118.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",131.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",142.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",142.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",135,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",130.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",135,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",15.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",17,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",15.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",14.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",14.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",12.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",12.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",14.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",14.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",12.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",12.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",13.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",13.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",14.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",14.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",13.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",13.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",13.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",15.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",16.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",16.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",15.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",14.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",15.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",3.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",3.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",3.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",3.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",3.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",3.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",3.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",3.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",3.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",2.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",2.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",313.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",328,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",295.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",253.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",226.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",219.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",218.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",212.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",167.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",156.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",152.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",154.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",176.6,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",416.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",456.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",379.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",337.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",300.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",243.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",241.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",240.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",197.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",175.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",174.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",183,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",186,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",375.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",394.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",359.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",314.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",282.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",274.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",279.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",274.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",218.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",209.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",209.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",210.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",247.4,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",38.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",41.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",34.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",30.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",26.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",21.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",21.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",21.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",17.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",15.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",15.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",15.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",16,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",34.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",35.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",32.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",28.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",25.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",24.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",24.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",24.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",19.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",18.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",18.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",18.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",21.3,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",5.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",5.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",4.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",3.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",3.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",3.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",3.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",2.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",2.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",1.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",2,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1823.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1484.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1370.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1237.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1239.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1229.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",978.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",912.4,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",958.7,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",1014.6,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",1085.5,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1824.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1441,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1240.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",967.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",934.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",947.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",755.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",687.6,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",714.8,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",809.1,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",834,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1465,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",1212.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",1113.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",991.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1026.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1014.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",811.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",738.9,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",778.8,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",819.4,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",865.8,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",52.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",41.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",35,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",27.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",25.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",25.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",20.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",18.3,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",18.8,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",21.2,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",21.5,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",42.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",34.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",31.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",27.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",28.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",27.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",21.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",19.7,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",20.5,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",21.4,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",22.3,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",7.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",5.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",4.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",4.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",4.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",3.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",2.9,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",2.8,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",2.8,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",2.7,"E; D","Estimated value; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",2875.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",2950.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",3248.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",2840.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",2107.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",2029.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",2070.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",2015.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",1993.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",1986.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",1561.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",1516.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",150.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",166.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",165.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",145.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",101.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",82.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",84.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",86.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",91.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",86.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",67.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",69.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",210.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",221.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",244.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",222.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",165.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",156.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",164.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",162.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",161.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",161.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",125.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",119,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",14.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",15.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",15.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",13.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",9.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",7.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",8.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",8.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",8.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",6.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",6.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",20.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",21.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",23.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",21.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",15.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",14.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",15.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",15.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",15.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",15.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",11.7,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",11.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",3.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",3.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",3.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",3.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",2.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",2.4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",2.4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",2.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",1.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",1.8,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",1.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",34.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",29.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",35.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",41.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",49.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",58.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",66.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",65.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",45.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",31.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",23.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",22.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",46.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",41.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",45.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",55.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",65.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",65.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",73.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",73.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",53.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",35,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",27.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",26.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",38.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",33.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",38.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",46.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",54.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",64.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",75.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",75.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",52.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",37.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",28.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",26.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",8.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",7.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",8.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",10.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",11.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",11.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",13.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",13.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",9.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",6.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",4.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",4.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",7.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",6.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",7.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",8.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",9.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",11.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",13.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",13.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",9.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",6.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",5.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",4.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",1.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",1.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",1.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",2.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",2.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",2.7,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",2.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",2.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",1.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",708.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",672.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",641.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",594,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",587,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",596.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",665.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",733.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",792.7,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",779.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",775.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",800,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",939.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",936.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",824.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",788.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",779.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",662.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",736.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",828.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",936.1,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",873,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",885.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",946.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",880.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",852.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",815.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",766.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",763.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",767.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",884.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",985,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",1077.8,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",1070.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",1069.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",1086.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",11.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",11.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",10.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",9.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",9.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",8.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",8.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",10,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",11.3,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",10.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",10.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",11.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",10.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",10.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",10.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",9.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",9.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",9.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",10.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",11.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",13,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",12.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",12.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",13.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",2.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",2.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",2.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",1.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",1.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",1.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",1.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",1.8,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",1.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",1.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",1.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",543.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",480.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",434.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",362,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",348.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",304.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",344.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",311.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",328.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",331.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",306.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",330.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",264.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",720.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",668.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",558.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",480.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",463,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",337.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",381.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",352.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",388.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",371.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",350.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",391,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",278.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",752.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",673.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",635.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",573.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",570.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",499.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",585.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",542.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",582.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",603.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",563.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",605.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",500.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",64.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",60.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",50.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",43.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",42.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",31.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",35.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",32.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",36.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",34.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",32.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",37,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",26.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",67.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",60.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",57.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",52.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",52.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",46.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",54.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",50.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",54.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",56.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",52.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",57.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",47.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",37190,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",37000.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",27959.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",22838.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",19830.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",18929.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",19032,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",19139.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",18500.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",17695.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",18469.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",18235.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",20344.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",178.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",184,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",124.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",102.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",85.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",67.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",67.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",69.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",68.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",60.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",60,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",60.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",54.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",294.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",297.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",222.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",182.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",153.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",142.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",144.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",140.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",133,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",125.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",127.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",117.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",126.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",17.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",18.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",12.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",10.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",8.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",6.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",6.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",7.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",6.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",6.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",6.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",5.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",29.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",29.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",22.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",18.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",15.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",14.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",14.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",14.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",13.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",12.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",13,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",12.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",13,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",7.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",7.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",6.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",5.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",4.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",4.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",3.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",3.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",3.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",3.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",3.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",3.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",3.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",335.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",366,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",367.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",308.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",333.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",308.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",326.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",344.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",380,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",420.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",473.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",518.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",2.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",3.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",2.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",2.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",2.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",2.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",2.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",3.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",3.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",3.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",3.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",4.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",2.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",2.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",2.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",2.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",2.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",2.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",2.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",2.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",2.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",3.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",3.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",8.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",9.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",9.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",7.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",8.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",7.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",8.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",9.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",9.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",9.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",9.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",11,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",7.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",8.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",8.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",7.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",6.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",6.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",7.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",7.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",8.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",8.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",9.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",1.4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",1.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",1.4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",1.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",193.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",150.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",145.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",112.4,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",69.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",65.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",65.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",66.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",64.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",58.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",58.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",61.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",256.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",209.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",187.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",149.2,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",92.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",72.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",72.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",74.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",76,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",65.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",66.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",72.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",227.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",181.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",177.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",138.5,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",84.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",80.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",82.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",83.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",81.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",72.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",73.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",77.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",56.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",45.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",40.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",32.3,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",19.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",15.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",15.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",15.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",15.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",13.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",13.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",14.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",50,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",39.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",38.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",30,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",18.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",17.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",17.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",17.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",16.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",14.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",14.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",15.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",9.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",7.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",7.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",5.7,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",3.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",3.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",3.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",3.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",2.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",2.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",2.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",2.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",1377.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",1145,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",1033.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",1008.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",1012.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",1039.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",1092.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",875.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",830.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",890.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",955.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",1037.3,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",1917,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",1471.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",1372.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",1339.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",1123.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",1150.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",1233.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",1033.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",929.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",1017.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",1130.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",1092.4,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",1815.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",1531.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",1401.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",1363.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",1370.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",1483.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",1583.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",1284.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",1264.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",1375.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",1476,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",1680.1,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",32.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",24.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",22.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",22,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",18.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",19,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",20.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",17.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",15.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",17.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",19.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",18.5,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",30.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",25.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",23.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",22.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",22.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",24.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",26.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",21.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",21.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",23.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",25,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",28.5,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",7.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",5.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",5.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",4.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",4.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",4.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",3.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",3.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",3.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",4.2,"E","Estimated value" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",675149,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",782416.7,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",810160.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",892862.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",970126.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",1051102.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",1183828.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",1343510.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",1501571.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",1659196.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",1932203,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",2227864,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",583.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",706,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",719,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",815.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",921.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",929.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",1019.9,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",1187.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",1364.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",1423.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",1637.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",1947.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",802.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",915.6,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",947.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",1027.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",1112.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",1225.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",1378.5,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",1539.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",1756.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",1937.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",2306.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",2608.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",11.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",14.1,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",14.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",16.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",18.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",18.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",19.9,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",23.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",26.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",27.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",31.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",37.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",16.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",18.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",18.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",20.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",21.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",24,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",26.9,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",30,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",34.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",37.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",44.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",50.4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",3.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",3.5,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",3.7,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",4.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",4.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",4.7,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",5.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",5.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",5.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",6.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",15.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",17.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",17.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",15.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",13.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",12.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",12.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",11.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",8.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",10,"D; P","Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",21,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",24.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",22.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",20.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",17.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",14.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",13.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",13.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",10.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",9.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",10.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",10.5,"D; P","Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",17.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",19.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",19.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",17.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",14.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",14.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",14.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",13.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",10.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",9.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",9.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",10.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",12,"D; P","Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",44.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",50.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",45.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",41.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",34.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",27.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",26.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",24.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",19.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",16.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",16.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",18.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",17.9,"D; P","Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",36.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",40,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",39.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",34.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",29.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",27.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",28.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",25.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",19.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",17.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",16.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",18.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",20.5,"D; P","Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",8.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",9.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",8.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",6.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",6.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",6.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",4.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",3.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",3.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",3.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",3.9,"D; P","Difference in methodology; Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",298.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",309.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",242.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",213.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",213.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",396.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",431.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",311.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",283.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",283.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",349.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",370.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",294,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",267.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",264.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",23.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",25.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",18.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",16.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",16.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",21.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",22.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",17.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",15.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",15.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",5.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",5.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",5.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",4.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",37.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",53.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",76.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",30.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",17.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",17.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",11.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",9.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",7.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",8.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",8.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",27.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",42.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",62,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",24.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",14.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",12.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",8.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",6.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",5.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",4.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",4.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",5.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",5.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",25.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",36,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",51.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",20.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",12.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",11.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",8.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",6.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",5.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",5.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",6.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",6.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",9.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",14.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",5.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",3.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",2.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",1.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",1.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",1.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",1.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",1.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",5.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",8.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",11.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",4.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",2.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",2.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",1.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",1.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",1.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",1.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",1.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",5.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",6.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",8.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",3.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",1.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",1.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",1.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",440,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",405,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",375,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",391,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",377,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",406,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",473,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",504,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",509,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",493,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",473,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",502,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",554,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",72.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",72.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",64.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",66.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",59.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",50.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",56.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",60.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",62.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",56,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",50.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",58.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",57.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",48.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",44.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",41.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",43.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",40.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",40.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",47.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",51.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",53.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",51.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",47.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",52.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",51.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",14.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",14.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",12.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",13.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",11.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",9.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",10.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",11.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",11.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",10.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",9.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",10.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",10.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",9.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",8.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",8.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",7.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",7.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",9.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",10,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",9.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",8.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",9.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",9.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",2.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",2.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",1.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",1.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",1.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",1.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",1.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",1.7,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",1.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",1.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",1.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",256.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",202.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",163.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",153.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",157.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",161,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",166.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",160.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",143.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",149.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",160.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",170.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",188.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",340.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",281.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",210.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",203.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",209.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",178.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",184,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",181,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",169.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",167.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",182.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",201.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",198.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",411.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",324.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",270.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",262.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",272.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",275.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",291,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",278.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",251.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",267.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",287.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",300.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",342.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",32.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",26.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",20,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",19.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",20.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",17.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",17.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",17.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",16.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",16.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",17.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",19.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",19.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",38.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",30.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",25.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",25.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",26.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",26.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",28.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",27,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",24.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",26,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",27.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",29,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",33.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",7.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",6.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",6.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",6.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",6.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",6.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",6.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",6.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",5.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",5.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",5.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",5.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",5.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",32.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",32.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",26.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",22,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",21.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",23.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",25.8,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",27,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",27.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",27.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",29.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",32.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",43.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",45.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",33.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",29.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",28.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",25.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",28.6,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",30.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",32.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",30.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",34,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",38,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",65.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",64.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",51.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",44.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",44.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",47.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",51.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",52.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",51.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",53,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",57.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",60.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",8.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",8.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",6.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",5.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",5.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",4.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",5.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",5.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",5.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",5.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",6.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",12.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",11.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",9.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",8.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",8.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",8.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",9.5,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",9.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",9.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",9.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",10.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",11.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",2.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",2.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",2.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",1.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",1.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",1.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",1.6,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",1.7,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",1.7,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",1.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",1.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",1.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",1024,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",751.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",662,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",650.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",715.3,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",765.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",827.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",858.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",861,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",886.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",931.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",928.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",999.7,"P","Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",1357.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",1045.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",850.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",864,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",950.3,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",849.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",915.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",969.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",1016.8,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",992.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",1064,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",1097.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",1052.8,"P","Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",1408.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",1051.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",952.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",964.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",1080,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",1151.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",1287.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",1360.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",1362.8,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",1446.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",1499.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",1482.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",1676.8,"P","Provisional value" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",29.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",22.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",18.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",18.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",20.4,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",18.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",19.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",20.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",21.7,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",21.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",22.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",23.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",22.2,"P","Provisional value" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",30.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",22.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",20.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",20.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",23.2,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",24.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",27.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",29.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",29.1,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",30.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",31.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",31.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",35.4,"P","Provisional value" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",7.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",6.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",6.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",6.3,"B; D","Break; Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",6.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",7.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",4.5,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",4.4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",4.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",4.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",4.4,"P","Provisional value" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",722.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",767.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",558.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",440.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",480.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",482.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",522.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",587.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",451.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",468.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",525.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",585.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",730.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",100.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",118.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",82.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",67.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",70.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",57.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",61,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",68.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",51.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",49.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",57,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",68.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",72.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",80.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",86.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",64.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",51.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",55.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",54.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",59.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",66.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",50.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",53.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",60.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",67.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",84.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",10.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",12.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",8.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",7.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",5.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",6.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",6.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",5.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",4.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",5.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",6.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",6.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",8.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",9.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",6.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",5.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",5.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",5.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",6.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",5.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",5.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",6.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",8.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",2.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",1.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",1.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",1.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",449.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",329,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",207.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",140,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",138.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",152.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",180.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",235.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",302,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",377.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",527.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",679.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",298.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",196.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",115.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",73.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",63.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",55.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",59.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",64.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",62.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",66.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",75.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",76.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",488.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",340.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",203.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",130.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",125.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",130.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",145.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",170.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",185,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",202.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",243.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",241.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",4.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",2.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",1.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",6.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",4.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",2.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",1.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",1.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",1.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",1.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",2.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",2.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",2.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",2.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",2.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",2.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",2.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",1.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",1.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",19420.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",25005.3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",27634.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",30013.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",33677,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",39621.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",42911.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",35776.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",41618.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",40294.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",42777.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",41213.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",52646.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",38.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",51.7,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",56.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",60.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",59,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",60.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",63.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",55.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",64.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",57.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",54,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",54.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",60.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",54,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",71.9,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",79.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",85.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",91.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",101.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",108,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",90,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",105,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",100.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",102.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",94.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",120.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",2.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",3,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",3.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",3.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",3.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",3.4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",3.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",3.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",2.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",2.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",3.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",4.2,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",4.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",4.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",5.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",5.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",5.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",4.9,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",5.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",5.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",5.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",4.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",6.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",2.4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",2.1,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",2.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",2.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",2.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",2.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",2.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",1.7,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",1.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",1.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",1.6,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",1.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",1.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",5.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",3.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",3.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",3.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",3.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",3.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",3.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",3.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",3.7,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",4.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",4.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",5.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",7.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",5.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",5.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",4.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",4.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",3.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",3.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",3.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",3.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",4.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",4.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",5.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",5.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",10.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",7.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",7.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",6.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",6.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",5.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",5.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",6.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",6.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",8.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",8.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",5.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",4.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",3.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",3.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",3.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",2.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",2.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",2.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",3.1,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",3.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",4,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",7.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",5.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",5.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",4.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",4.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",4.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",4.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",4.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",5.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",6.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",6.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",6.7,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",2.7,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",1.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",1.8,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",1.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",1.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",1.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",1.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",1.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",1.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",31,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",27.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",25.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",24.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",14.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",14,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",14.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",14.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",14.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",15.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",17.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",18.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",20.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",41.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",38.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",32.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",32.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",19.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",15.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",15.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",16.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",17.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",17.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",19.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",21.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",21.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",48.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",44.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",41.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",41.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",24.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",23.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",24.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",25.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",25.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",28.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",31.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",32.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",36.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",20.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",18.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",15.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",15.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",9.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",7.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",7.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",7.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",8.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",8.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",9.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",10.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",10.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",23.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",21.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",20.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",20.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",11.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",11.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",11.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",12.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",12.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",13.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",15.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",15.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",17.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",6.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",5.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",5.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",5.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",3.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",3.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",2.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",2.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",3.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",138,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",143,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",155,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",225,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",240,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",298,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",359,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",362,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",367,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",383,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",404,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",438,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",126.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",147.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",160.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",217.2,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",216.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",223.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",266.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",277.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",274.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",266.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",278,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",329,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",91.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",94.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",100.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",155.5,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",165.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",202.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",247.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",245,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",249.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",258.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",277.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",302.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",5.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",6.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",7.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",9.4,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",9.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",9.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",11,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",11.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",11,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",10.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",10.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",12.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",4.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",4.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",4.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",6.7,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",8.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",10.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",10,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",10,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",10.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",10.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",11.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",1.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",1.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",1.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",1.9,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",2.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",2.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",2.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",2.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",43.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",43.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",45.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",45.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",45.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",45.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",46.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",46.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",43.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",44.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",40.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",40.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",57.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",61.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",58.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",60.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",60.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",50.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",51.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",52.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",50.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",49.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",46.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",47.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",51.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",52.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",55.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",56.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",56.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",57,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",60,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",59.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",56.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",59.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",54.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",53.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",6.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",7.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",6.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",7.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",5.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",5.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",5.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",5.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",5.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",5.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",5.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",6.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",6.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",6.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",6.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",6.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",6.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",6.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",6.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",6.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",6.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",6.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",1.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",1.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",1.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",1.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",1.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",1.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",1.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",1.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",1.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",1.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",1.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",1.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",239.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",241.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",236.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",232,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",226.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",224.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",225.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",223.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",217.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",226.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",216,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",219.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",224.2,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",317.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",336.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",303.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",308.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",301.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",249.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",249.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",252.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",257.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",253.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",246.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",259.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",236.1,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",286.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",290.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",287.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",287.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",283.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",280.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",288.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",288.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",284.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",303.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",295.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",298.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",314,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",29.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",30.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",27.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",27.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",26.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",22.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",22,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",22.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",22.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",22.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",21.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",22.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",20.3,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",26.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",26.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",25.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",25.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",25.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",24.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",25.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",25.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",24.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",26.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",25.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",25.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",27,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",4.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",3.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",3.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",3.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",3.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",3.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",3.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",3.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",2.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",2.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",2.5,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1430.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1473.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1512.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1511.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1485,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1517.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",1563.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",1543,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",1532.3,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",1550.1,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",1566.4,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1431.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1430.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1369.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",1181.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",1120.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",1169.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",1206.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",1163,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",1142.5,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",1236.2,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",1203.5,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1149.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",1204.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",1229.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",1210.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1230.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1251.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",1295.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",1249.7,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",1244.7,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",1251.9,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",1249.3,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",41.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",40.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",38.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",33.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",31,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",32,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",32.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",30.9,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",30,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",32.3,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",31,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",33.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",34.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",34.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",33.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",34.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",34.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",35,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",33.2,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",32.7,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",32.7,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",32.1,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",5.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",5.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",5.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",5.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",5.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",5.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",4.8,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",4.5,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",4.2,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",3.9,"E; D","Estimated value; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",4979.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",4855,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",5036,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",4559.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",4503.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",4399.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",4373.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",4303.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",4442.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",4467.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",2158.7,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",2049,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",260.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",274.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",257.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",233,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",216.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",178.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",178.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",184.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",204.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",194.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",93,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",94.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",364.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",363.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",378.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",356.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",354.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",340.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",347.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",346.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",359.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",364,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",173.2,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",160.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",24.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",26.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",24.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",22.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",20.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",17,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",16.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",17.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",19.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",18.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",8.7,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",34.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",34.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",36,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",33.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",33.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",32.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",32.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",32.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",33.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",34.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",16.2,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",15.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",6.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",5.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",5.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",5.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",4.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",4.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",4.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",2.5,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",2.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",1041.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",946.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",978,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",870.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",813.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",834.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",831.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",830.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",798.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",808.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",784.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",790,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",185.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",176.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",168.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",155,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",144.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",124.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",123.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",125.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",126.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",121.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",120,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",125.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",137.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",126.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",129.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",118.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",110.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",114.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",117.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",120.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",118,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",121.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",119.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",119.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",33.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",31.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",30.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",27.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",25.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",21.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",21.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",21.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",21.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",20.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",20.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",21.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",24.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",22.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",23.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",21.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",19.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",20.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",20.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",21,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",20.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",21,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",20.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",20.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",4.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",4.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",4.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",3.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",3.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",3.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",3.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",3.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",3.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",3.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",3.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",108.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",105,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",105.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",108.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",111.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",112,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",114.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",112.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",110.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",112.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",104.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",92,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",143.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",146.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",135,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",144.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",148,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",124.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",127,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",127.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",130.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",126.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",119.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",108.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",120,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",116.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",115.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",120.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",122.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",123.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",130.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",130.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",129.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",134.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",126.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",111.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",26.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",27.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",24.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",26.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",27.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",22.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",23.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",23.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",23.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",22.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",21.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",19.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",22.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",21.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",21.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",22.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",22.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",22.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",23.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",23.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",23.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",24.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",22.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",20.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",5.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",5.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",5.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",5.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",5.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",5.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",4.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",4.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",4.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",3.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",3.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",1033.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",1438.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",1228.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",22.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",18.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","FRA","France","2011","2011",3.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",812.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",788.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",779.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",780.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",815.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",829.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",784.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",751,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",781.8,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",815.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",797.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",805.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",1076.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",1097.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",1001.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",1036.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",1083.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",920.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",868.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",848.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",923.3,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",912.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",911.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",952.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",1008.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",1000,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",990.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",1007.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",1060.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",1066.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",1042.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",1008.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",1063,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",1119.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",1100.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",1094.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",13.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",13.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",12.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",12.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",13.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",11.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",10.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",10.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",11.1,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",11,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",11,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",11.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",12.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",12.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",12.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",12.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",13.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",13.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",12.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",12.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",12.8,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",13.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",13.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",13.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",2.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",2.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",2.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",2.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",2.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",1.8,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",1.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",1.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",1.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",211.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",191.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",161.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",149,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",152.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",125.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",155.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",166.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",167.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",175.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",159.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",164.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",133.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",280.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",266,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",207.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",197.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",202.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",139.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",172.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",188.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",197.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",196.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",181.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",194.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",140.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",292.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",268,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",235.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",236,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",249.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",206.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",264.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",290,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",296.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",319.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",292.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",302.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",252.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",25.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",24,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",18.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",18,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",18.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",12.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",16,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",17.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",18.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",18.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",17,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",18.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",13.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",26.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",24.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",21.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",21.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",22.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",19.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",24.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",27,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",27.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",29.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",27.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",28.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",24.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",7875,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",8316,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",8098.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",9141.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",9549.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",10463.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",11251.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",11937,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",12197.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",12269,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",12167.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",12856.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",13703.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",37.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",41.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",36,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",40.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",41.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",37.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",40,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",43.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",45.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",42.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",39.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",42.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",36.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",62.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",66.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",64.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",73.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",73.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",78.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",85.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",87.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",87.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",87.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",83.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",83.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",85,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",3.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",4.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",3.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",4.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",4.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",3.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",4.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",4.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",4.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",4.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",4.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",4.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",3.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",6.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",6.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",6.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",7.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",7.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",8.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",8.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",8.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",8.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",8.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",1.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",1.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",1.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",2.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",2.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",2.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",2.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",1497.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",1436.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",1476.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",1498.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",1343.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",1315.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",1335,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",1308.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",1441.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",1549.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",1691.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",1807,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",12.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",12.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",11.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",12.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",11.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",10,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",11.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",12.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",13.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",12.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",12.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",14.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",11.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",10.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",10.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",10.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",9.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",9.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",9.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",9.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",10.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",11,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",11.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",12.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",38.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",38.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",36.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",37.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",35.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",30.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",32.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",35.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",37.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",35.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",34.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",38.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",35.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",33.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",33.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",33.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",29.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",28,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",28.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",27.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",29,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",30.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",31.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",32.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",5.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",6.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",5.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",5.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",5.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",5.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",4.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",4.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",4.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",84.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",82.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",85.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",79.7,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",74.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",74.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",76.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",71.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",73.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",77.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",79.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",93.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",111.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",115.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",110.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",105.8,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",98.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",82.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",84.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",80.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",86.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",87.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",90.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",110.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",99.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",99.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",104.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",98.2,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",90.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",91.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",96.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",89.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",92.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",96.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",100,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",117.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",24.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",25.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",24,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",22.9,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",21.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",17.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",17.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",16.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",17.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",17.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",18.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",22,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",21.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",21.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",22.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",21.2,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",19.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",19.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",20.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",18.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",19,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",19.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",20.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",23.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",4.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",4.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",4.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",4.1,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",3.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",3.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",3.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",3.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",3.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",503.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",500.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",516.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",532.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",548,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",560.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",514.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",437.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",441.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",396.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",409.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",405,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",700.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",643.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",686,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",707.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",608.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",620.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",581.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",516.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",494.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",452.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",484.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",426.5,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",663.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",669.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",700.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",720.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",741.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",800.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",746,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",642.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",672.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",611.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",632.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",655.9,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",11.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",10.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",11.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",11.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",10,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",10.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",9.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",8.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",8.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",7.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",8.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",7.2,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",11.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",11.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",11.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",11.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",12.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",13.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",12.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",10.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",11.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",10.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",10.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",11.1,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",2.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",2.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",2.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",2.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",2.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",2.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",2.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",1.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",1.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",1.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",1.6,"E","Estimated value" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",158560,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",156118,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",176807,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",168011,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",152239,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",147680,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",134491,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",162419,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",157943,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",167072,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",178904,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",158339,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",1806.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",1956.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",2215.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",1721.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",1437,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",1220.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",1236.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",1448,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",1430.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",1532.6,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",1675.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",1442.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",1419.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",1452.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",1695.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",1658.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",1477.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",1427.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",1274.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",1545.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",1516.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",1603,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",1746.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",1551.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",14.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",15.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",17.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",13.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",11.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",9.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",9.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",11.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",11.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",12.1,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",13.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",11.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",11.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",11.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",13.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",13,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",11.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",11.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",10,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",12.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",12,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",12.7,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",13.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",12.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",2.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",2.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",2.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",1.8,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",1.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",1.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",540467,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",643575.9,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",636824.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",646627.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",706494.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",742741.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",731218.5,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",789700.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",842916.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",904006.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",976925.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",1048571.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",467.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",580.7,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",565.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",590.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",671,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",656.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",629.9,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",698.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",766.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",775.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",827.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",916.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",642.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",753.1,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",744.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",744,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",810.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",866.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",851.4,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",905,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",986,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",1055.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",1166.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",1227.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",9.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",11.6,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",11.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",11.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",13.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",12.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",12.3,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",13.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",14.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",15,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",16,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",17.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",13,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",15.1,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",14.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",14.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",16,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",17,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",16.6,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",17.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",19.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",20.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",22.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",23.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",2.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",2.9,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",2.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",2.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",2.9,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",2.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",2.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",2.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",6.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",6.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",8.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",8.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",8.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",8.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",8.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",9.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",10.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",9.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",10,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",9.4,"D; P","Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",9.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",10.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",10.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",10.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",9.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",9.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",10,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",11.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",11.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",10.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",11.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",9.9,"D; P","Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",7.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",7.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",8.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",9.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",9.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",10.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",10.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",11.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",12,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",11.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",11.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",11.3,"D; P","Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",19.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",19.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",21,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",21.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",21.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",17.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",18.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",18.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",20.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",20.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",19.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",20.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",16.8,"D; P","Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",15.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",15.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",18,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",17.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",18.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",18.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",19.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",19.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",20.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",21.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",19.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",20.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",19.2,"D; P","Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",3.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",3.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",4.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",4.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",4.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",4.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",4.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",4.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",4.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",4.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",4.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",4.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",3.6,"D; P","Difference in methodology; Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",206,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",149.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",147.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",136.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",105,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",273.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",208.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",189.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",181.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",139.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",241.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",179.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",179.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",171.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",129.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",16.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",12.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",11.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",10.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",8.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",14.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",10.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",10.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",10.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",7.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",2.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",18,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",21.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",22.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",21,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",21.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",22.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",21.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",20.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",19.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",17.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",21.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",26.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",27.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",13,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",16.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",18.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",17.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",17.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",15.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",15,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",14.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",13.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",11.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",14,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",18.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",17.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",12,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",14.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",15.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",14.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",14.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",15.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",15,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",14.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",13,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",12.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",15.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",18.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",19,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",3.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",4.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",3.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",3.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",3.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",2.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",2.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",3.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",3.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",2.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",3.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",3.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",3.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",3.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",2.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",2.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",3.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",3.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",2.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",2.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",2.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",2.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",2.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",1.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",1.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",1.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",1.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",1.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",1.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",914,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",925,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",948,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",983,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",1015,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",1082,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",1162,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",1228,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",1182,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",1204,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",1301,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",1317,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",1298,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",151.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",165,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",163,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",167.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",161.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",134.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",138.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",148.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",145.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",136.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",138.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",153.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",135,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",99.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",101.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",104.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",108.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",109.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",108.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",115.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",126,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",123.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",125.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",131.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",138.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",120.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",30.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",33.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",32.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",32.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",31.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",25.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",26.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",28.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",27.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",25.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",25.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",28.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",24.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",20.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",20.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",20.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",21.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",21.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",21,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",22.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",23.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",23.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",23.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",24.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",25.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",22.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",5.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",5.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",5.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",4.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",4.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",4.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",4.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",4.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",4.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",3.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",3.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",180.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",172.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",159.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",149.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",151.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",151.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",157.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",159,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",156.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",163.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",154.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",158.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",164.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",238.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",239.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",204.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",198.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",200.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",168.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",174.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",179.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",185.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",182.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",176.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",187.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",173,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",289.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",276.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",262.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",255.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",261.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",259,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",275.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",276.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",274.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",292.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",277.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",278.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",298.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",22.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",22.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",19.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",19,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",19.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",16.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",16.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",17.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",18,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",17.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",17.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",18.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",16.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",27.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",26.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",25,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",24.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",25.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",25,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",26.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",26.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",26.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",28.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",27,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",26.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",28.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",5.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",5.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",6.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",6.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",6.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",6.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",6.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",6.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",5.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",5.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",5.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",5.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",44.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",45.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",43.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",48.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",50.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",51.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",51.3,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",49.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",47.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",46.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",44.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",47.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",59,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",63.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",55.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",64.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",67.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",56.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",56.8,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",55.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",56.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",52.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",50.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",55.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",88.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",90,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",86.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",99.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",104.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",104.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",101.9,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",95.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",90.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",90.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",84.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",88.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",10.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",11.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",10.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",12,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",12.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",10.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",10.5,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",10.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",10.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",9.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",9.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",10.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",16.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",16.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",15.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",18.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",19.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",19.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",18.8,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",17.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",16.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",16.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",15.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",16.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",3.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",3.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",3.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",3.3,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",3.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",2.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",2.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",2.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",2.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",512.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",502.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",478.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",487,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",515.1,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",534.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",571.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",600.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",627.8,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",593.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",555.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",595.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",630,"P","Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",679,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",699.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",614.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",646.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",684.3,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",593.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",632.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",677.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",741.4,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",664.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",634.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",704.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",663.5,"P","Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",704.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",703.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",688,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",721.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",777.6,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",804.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",889.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",951.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",993.7,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",968,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",894.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",951.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",1056.7,"P","Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",14.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",15,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",13.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",13.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",14.7,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",12.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",13.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",14.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",15.8,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",14.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",13.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",14.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",14,"P","Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",15.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",15.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",14.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",15.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",16.7,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",17.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",19.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",20.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",21.2,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",20.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",18.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",20.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",22.3,"P","Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",3.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",4.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",4.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",4.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",4.6,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",4.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",4.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",3.3,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",2.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",2.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",2.7,"P","Provisional value" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",1715.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",1722.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",1757.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",1729,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",1684.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",1676.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",1693.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",1719.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",1739.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",1772.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",1738.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",1761.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",1854.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",238,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",265.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",259.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",265.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",245.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",198.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",197.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",201.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",200.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",187.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",188.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",205.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",183.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",190.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",194.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",203,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",201.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",193,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",189.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",192,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",194.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",196.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",203.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",200.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",201.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",214,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",25.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",28.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",27.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",27.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",25.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",20.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",19.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",20,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",19.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",18.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",18.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",19.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",17.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",20.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",20.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",21.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",20.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",19.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",19.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",19.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",19.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",19.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",19.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",19.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",19.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",20.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",4.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",4.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",4.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",4.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",4.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",4.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",3.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",3.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",3.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",3.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",3.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",3.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",344.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",349,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",353,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",353,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",346,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",348,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",351,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",347,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",341,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",336,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",331,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",331,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",331,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",330,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",393,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",376.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",380.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",377.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",361.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",356.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",352.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",348.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",338.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",352.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",362.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",346.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",234.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",249.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",260.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",269,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",269.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",281.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",292,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",292.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",289.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",292.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",291.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",299.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",310.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",42.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",49.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",47.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",47.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",46.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",43.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",42.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",41.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",41,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",39.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",40.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",41.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",39.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",30,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",31.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",32.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",33.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",33,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",34,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",34.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",34.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",34,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",34.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",33.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",34.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",35.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",5.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",5.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",5.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",5.5,"B; D","Break; Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",5.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",5.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",4.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",4.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",4.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",719.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",618.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",645.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",665.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",731.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",840.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",983.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",1193.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",1485.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",1898,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",2006.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",2871.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",478.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",369.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",359.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",349.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",334.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",309.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",325.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",327.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",307.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",334.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",286.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",324.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",781.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",640,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",633.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",621.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",662.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",723.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",792.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",862.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",909.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",1018.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",927,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",1022.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",6.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",4.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",4.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",4.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",4.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",3.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",4.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",3.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",3.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",10.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",8.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",8.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",8.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",8.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",9.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",10,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",10.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",11.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",12.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",11.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",12.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",4.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",4.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",4.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",4.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",4.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",4.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",4.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",684.3,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",680.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",680.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",707.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",711.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",757.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",724.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",1081,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",1063.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",1120.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",1081.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",960.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",975.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",966.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",975.3,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",978.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",974.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",1022.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",1032.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",1106.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",1052.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",17,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",16.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",17.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",16.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",14.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",14.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",14.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",15.3,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",15.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",15.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",15.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",15.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",16.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",15.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",5,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",4.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",4.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",3.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",3.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",3.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",81496.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",111351.6,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",122348.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",134181.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",145380,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",165236.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",191680.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",178137.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",188269,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",193008.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",208701.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",241722.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",222620.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",159.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",230.2,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",251.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",270.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",254.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",252.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",283.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",274.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",293.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",274.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",263.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",318.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",254.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",226.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",320,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",352.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",383.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",395.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",422.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",482.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",447.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",475.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",480.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",498.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",555.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",508.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",9.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",13.3,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",14.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",15.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",14.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",14.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",15.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",14.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",15.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",14.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",13.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",16.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",12.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",13.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",18.5,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",20.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",21.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",22.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",23.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",26.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",24.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",25.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",25.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",25.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",28.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",25.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",9.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",9.4,"B","Break" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",9.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",9.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",9.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",9.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",9.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",8.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",8.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",7.7,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",7.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",8.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",7.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",10.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",10.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",11.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",11.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",11.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",11.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",11.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",11.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",11.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",12.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",11.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",12.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",12.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",14.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",15,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",14.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",15.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",15.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",12.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",12.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",13,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",13.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",13.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",13.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",14.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",13.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",20.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",21.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",21.5,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",21.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",21.8,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",21.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",22,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",21.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",21.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",23,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",22.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",22.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",22.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",10.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",11.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",10.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",11.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",11.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",9.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",9.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",9.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",10.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",10.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",10.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",10.7,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",10.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",15.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",15.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",16.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",16.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",16.6,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",16.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",16.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",16.4,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",16.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",17.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",17.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",16.7,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",17,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",5.5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",5.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",5,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",4.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",4.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",3.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",3.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",3.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",3.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",3,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",26.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",26.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",24.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",23.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",23.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",22.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",23.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",23.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",22.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",22.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",21.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",19.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",19.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",34.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",36.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",31.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",31.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",31.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",25.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",26,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",26.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",26.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",25.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",24.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",22.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",20.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",41.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",42.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",40.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",39.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",40.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",38,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",40.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",41.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",39.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",41.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",39.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",34.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",35.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",17,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",17.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",15.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",15.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",15.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",12.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",12.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",13,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",12.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",12.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",11.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",10.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",9.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",20.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",20.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",19.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",19.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",19.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",18.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",19.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",20.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",19.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",19.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",18.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",16.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",16.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",5.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",5.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",5.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",5.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",5.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",5.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",4.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",4.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",4.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",3.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",3.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",2.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",100,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",100,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",103,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",160,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",167,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",220,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",278,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",271,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",272,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",282,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",295,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",321,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",91.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",103.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",106.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",154.5,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",150.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",165.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",206.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",207.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",203.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",196,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",203,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",241.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",66.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",66.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",66.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",110.6,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",115,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",149.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",191.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",183.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",185,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",190.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",202.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",221.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",4.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",4.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",4.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",6.7,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",6.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",6.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",8.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",8.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",7.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",7.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",9.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",2.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",4.8,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",4.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",7.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",7.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",7.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",7.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",7.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",8.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",1.4,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",1.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",14.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",13.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",13.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",14,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",13.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",13,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",13.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",13.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",12.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",12.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",11.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",11.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",19.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",19.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",17.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",18.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",17.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",14.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",14.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",15.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",14.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",13.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",13.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",14.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",17.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",16.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",16.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",17.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",16.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",16.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",17.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",17.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",15.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",16.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",15.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",15.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",2.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",2.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",2.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",0.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",0.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",0.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",0.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",0.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",0.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",0.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",0.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",0.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",0.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",135.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",132.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",124.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",118,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",113.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",111,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",109.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",108,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",106.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",109.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",105.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",106.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",108.9,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",179.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",184.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",159.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",156.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",151,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",123.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",121,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",122,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",125.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",122.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",120.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",125.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",114.7,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",162.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",159.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",151,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",146.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",142,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",138.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",140,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",139.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",139,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",147.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",144.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",144.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",152.6,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",16.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",16.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",14.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",14,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",13.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",10.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",10.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",10.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",11,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",10.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",10.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",10.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",9.9,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",14.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",14.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",13.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",13.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",12.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",12.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",12.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",12.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",12.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",12.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",12.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",12.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",13.1,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",2.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",1.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",1.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",1.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",1.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",1.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",1.2,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",751.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",784.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",798.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",809.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",804.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",813.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",827.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",813.7,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",787,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",767.7,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",761.9,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",751.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",761.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",722.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",632.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",607.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",626.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",638.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",613.3,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",586.8,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",612.3,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",585.4,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",603.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",641.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",648.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",648.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",666.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",671,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",686,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",659.1,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",639.3,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",620,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",607.7,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",21.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",21.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",20.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",17.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",16.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",17.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",17.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",16.3,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",15.4,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",16,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",15.1,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",17.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",18.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",18.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",18.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",18.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",18.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",18.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",17.5,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",16.8,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",16.2,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",15.6,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",3.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",3.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",3.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",2.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",2.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",2.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",2.6,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",2.3,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",2.1,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",1.9,"E; D","Estimated value; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",2853.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",2666.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",2720.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",2500.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",2387.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",2238.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",2154.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",2125.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",2118.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",2124.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",795,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",800.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",149.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",150.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",139,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",127.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",115,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",91,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",88.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",90.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",97.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",92.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",34.3,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",36.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",208.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",199.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",204.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",195.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",187.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",173,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",171.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",171.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",171.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",173.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",63.8,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",62.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",14.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",14.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",13.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",12.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",10.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",8.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",8.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",8.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",9.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",8.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",3.2,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",3.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",19.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",19,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",19.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",18.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",17.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",16.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",16.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",16.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",16.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",16.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",6,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",3.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",3.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",3.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",3.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",2.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",2.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",2.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",2.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0.9,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",54.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",55.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",55.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",56.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",57.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",58.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",57.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",57.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",57.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",59.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",56.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",50.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",72.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",77.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",71.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",75.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",76.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",64.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",63.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",65.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",68.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",66.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",64.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",59.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",60.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",62,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",61.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",62.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",63.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",64.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",65.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",66.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",67.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",71.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",68.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",60.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",13.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",14.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",13.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",13.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",14,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",11.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",11.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",11.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",12.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",12.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",11.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",10.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",11.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",11.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",11.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",11.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",11.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",11.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",11.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",12.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",12.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",12.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",12.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",11,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",2.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",2.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",2.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",2.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",2.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",2.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",419.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",395.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",383.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",377.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",395.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",407.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",401.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",388.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",375.5,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",400,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",396.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",399.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",556.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",550.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",492.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",501.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",524.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",452,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",444.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",438.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",443.4,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",447.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",452.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",472.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",521.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",501.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",487.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",487.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",513.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",523.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",533.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",521.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",510.6,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",549.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",546.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",542.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",6.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",6.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",6.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",6.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",6.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",5.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",5.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",5.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",5.3,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",5.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",5.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",5.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",6.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",6.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",6.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",6.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",6.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",6.2,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",6.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",6.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",6.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",1.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",1.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",1.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",1.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",1.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",1.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",0.8,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",0.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",0.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",67.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",65.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",50.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",38.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",40.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",33.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",37.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",38,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",41.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",41.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",42.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",45.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",38,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",89.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",90.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",64.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",51.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",53.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",37.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",41.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",42.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",48.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",46.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",48.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",53.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",40,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",93.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",91.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",73.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",61.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",66.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",55.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",63.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",66.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",73.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",75,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",78.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",83.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",71.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",8.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",5.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",4.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",4.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",3.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",3.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",4.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",4.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",4.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",5.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",3.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",8.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",8.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",6.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",5.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",6.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",5.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",5.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",6.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",6.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",7.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",7.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",6.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",3352.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",3483,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",3423.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",4108.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",4324.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",4957.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",5426.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",5743.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",5644.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",5361.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",5013.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",6016.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",6388,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",16.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",17.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",15.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",18.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",18.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",17.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",19.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",20.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",20.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",18.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",16.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",19.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",17.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",26.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",28,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",27.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",32.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",33.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",37.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",41.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",42.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",40.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",38.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",34.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",38.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",39.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",2.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",2.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",2.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",3.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",3.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",3.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",4.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",4.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",4.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",3.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",3.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",4.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",0.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",0.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",0.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",1.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",846.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",845,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",865.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",853.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",754.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",723.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",729.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",705.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",770.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",832.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",902.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",968.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",6.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",7.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",6.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",6.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",5.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",6.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",7.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",6.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",6.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",7.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",6.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",6.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",6.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",6.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",5.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",5.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",5.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",5.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",5.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",5.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",6.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",6.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",21.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",22.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",21.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",21.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",19.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",16.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",18,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",19.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",20.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",18.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",18.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",20.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",20,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",19.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",19.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",19.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",16.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",15.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",15.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",14.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",15.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",16.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",16.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",17.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",3.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",3.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",3.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",3.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",2.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",2.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",2.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",2.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",2.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",35.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",34.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",34.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",33.9,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",32.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",34.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",35.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",32.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",33.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",36.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",38.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",51,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",46.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",47.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",44.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",45,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",43.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",38.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",39,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",37,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",39.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",40.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",43.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",60.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",41.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",41.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",42.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",41.8,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",40,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",42.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",44.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",41.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",42.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",45.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",48,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",64.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",10.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",10.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",9.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",9.7,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",9.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",8.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",7.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",8.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",8.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",8.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",12,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",9.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",9,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",8.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",9.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",8.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",8.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",9.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",9.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",12.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",1.7,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",176.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",169.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",163.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",154.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",149.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",136.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",123.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",112.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",113.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",91.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",108,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",105,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",245.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",218,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",217.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",205.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",165.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",150.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",139.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",132.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",126.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",104.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",127.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",110.6,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",232.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",227,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",222.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",209.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",202.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",194.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",179.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",164.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",172.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",141.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",166.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",170.1,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",4.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",3.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",3.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",2.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",2.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",2.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",1.9,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",3.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",3.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",3.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",3.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",3.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",2.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",2.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",2.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",2.9,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",0.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",0.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",0.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",0.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",0.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",0.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0.4,"E","Estimated value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",151191,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",152836.8,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",156433.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",176123.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",195737.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",194402,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",189297.4,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",199206.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",213761.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",231920.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",245225.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",272487.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",130.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",137.9,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",138.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",160.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",185.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",171.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",163.1,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",176.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",194.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",199,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",207.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",238.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",179.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",178.8,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",183,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",202.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",224.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",226.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",220.4,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",228.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",250.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",270.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",292.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",319,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",2.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",2.8,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",3.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",3.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",3.2,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",3.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",3.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",4.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",3.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",3.6,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",3.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",4.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",4.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",4.3,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",4.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",4.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",5.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",5.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",6.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.7,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.7,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",2.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",2.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",3.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",3.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",3.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",3.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",3.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",3.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",3.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",4.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",4.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",4.1,"D; P","Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",3.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",3.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",4.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",4.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",4.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",3.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",3.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",4.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",4.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",4.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",4.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",5.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",4.3,"D; P","Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",2.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",2.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",3.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",3.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",3.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",3.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",4.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",4.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",4.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",5.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",4.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",5.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",5,"D; P","Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",6.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",7.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",9.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",8.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",8.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",7.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",7.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",7.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",8.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",8.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",9.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",7.4,"D; P","Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",5.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",5.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",7.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",7.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",7.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",7.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",7.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",8.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",9.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",8.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",8.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",8.5,"D; P","Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",1.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",1.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",1.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",1.6,"D; P","Difference in methodology; Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",122.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",72.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",68.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",59.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",28.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",162.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",100.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",87.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",79.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",37.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",143.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",86.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",82.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",75.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",34.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",9.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",5.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",4.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",2.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",8.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",5.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",4.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",4.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",2.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",1.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",1.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",0.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",12.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",13.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",13.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",11.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",11.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",12.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",12.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",11.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",10.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",12.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",12.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",13.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",15.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",8.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",10.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",11,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",9.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",9.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",8.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",7.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",9.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",10,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",8.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",9.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",7.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",7.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",8.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",8.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",7.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",7.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",8.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",8.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",9.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",10.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",2.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",2.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",1.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",1.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",1.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",1.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",433,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",436,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",441,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",454,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",471,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",512,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",545,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",562,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",559,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",580,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",596,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",598,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",576,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",71.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",77.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",75.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",77.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",74.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",63.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",64.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",67.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",68.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",65.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",63.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",69.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",59.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",47.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",48,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",48.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",50.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",50.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",51.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",54.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",57.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",58.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",60.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",60.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",62.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",53.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",14.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",15.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",15.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",15.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",14.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",12.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",12.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",12.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",12.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",12.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",11.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",12.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",11,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",9.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",9.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",9.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",9.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",9.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",9.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",10.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",10.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",11,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",11.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",11.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",11.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",9.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",2.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",2.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",2.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",2.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",81.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",78.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",74.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",66.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",63.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",60.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",61,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",61.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",60.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",61.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",58.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",61.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",62.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",108,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",108.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",95.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",88.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",84.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",67.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",67.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",69.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",71.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",68.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",66.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",72.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",66,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",130.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",125.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",123.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",114.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",109.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",104.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",106.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",107,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",106.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",109.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",105.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",108,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",114,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",10.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",10.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",9.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",8.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",6.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",6.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",6.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",6.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",6.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",6.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",12.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",11.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",11.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",11,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",10.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",10.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",10.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",10.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",10.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",10.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",10.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",10.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",11,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",2.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",2.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",2.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",2.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",2.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",2.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",2.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",2.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",2.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",2.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",21,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",20.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",19.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",19.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",17.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",17.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",19,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",18.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",18.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",17.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",16,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",18.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",27.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",28.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",24.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",26.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",23.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",19.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",21,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",21.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",21.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",19.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",18.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",21.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",41.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",41,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",37.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",40,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",36.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",35.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",37.7,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",36.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",34.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",34.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",30.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",33.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",5.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",5.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",4.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",4.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",4.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",3.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",3.9,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",3.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",3.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",3.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",3.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",7.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",7.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",7.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",6.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",6.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",6.9,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",6.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",6.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",6.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",5.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",6.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",1.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",1.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",1.2,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",1.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",124.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",114.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",125.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",121.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",103.4,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",96.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",99.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",107.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",105.6,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",108.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",95,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",106.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",113.9,"P","Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",165.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",159.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",160.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",161.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",137.4,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",107.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",110,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",121.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",124.7,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",121.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",108.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",125.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",120,"P","Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",171.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",160.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",179.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",180.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",156.1,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",145.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",154.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",170.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",167.1,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",177,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",152.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",169.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",191.1,"P","Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",3.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",3.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",3.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",3.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",3,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",2.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",2.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",2.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",2.7,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",2.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",2.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",2.5,"P","Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",3.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",3.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",3.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",3.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",3.4,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",3.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",3.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",3.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",3.6,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",3.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",3.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",3.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",4,"P","Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",0.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",0.9,"B; D","Break; Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0.6,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0.5,"P","Provisional value" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",895.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",898.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",922.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",928.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",923.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",925.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",924.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",927,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",920.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",951.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",931,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",958.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",1010.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",124.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",138.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",136.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",142.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",134.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",109.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",108,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",108.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",105.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",100.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",101.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",111.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",99.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",99.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",101.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",106.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",108,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",105.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",104.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",104.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",104.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",103.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",109.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",107.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",109.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",116.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",13.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",14.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",14.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",14.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",13.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",11.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",10.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",10.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",10.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",9.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",9.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",10.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",9.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",10.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",10.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",11.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",11.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",10.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",10.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",10.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",10.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",10.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",10.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",10.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",10.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",11.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",2.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",2.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",2.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",2.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",2.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",2.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",2.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",1.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",1.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",1.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",188.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",187,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",197.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",230.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",263.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",305.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",335.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",406.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",494.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",656.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",721.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",1104.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",125.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",111.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",110,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",121.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",120.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",112.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",111,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",111.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",102.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",115.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",102.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",124.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",204.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",193.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",193.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",215.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",238.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",262.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",270.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",293.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",302.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",352.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",333.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",393.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",1.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",1.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",1.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",1.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",1.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",1.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",1.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",1.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",1.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",2.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",2.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",3.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",3.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",3.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",4.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",4.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",1.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",1.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",1.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",1.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",1.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",1.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",1.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",1.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",64724.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",80168.5,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",87798.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",95808.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",102222,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",117332.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",139368.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",124650.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",130609.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",139258.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",154941.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",189704.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",162563.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",126.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",165.8,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",180.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",193.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",179.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",179.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",205.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",192.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",203.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",198.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",195.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",250,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",186.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",179.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",230.4,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",252.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",274,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",278.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",299.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",350.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",313.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",329.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",346.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",370.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",435.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",371.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",7.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",9.6,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",10.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",11,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",10.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",10,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",11.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",10.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",10.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",10.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",10,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",12.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",9.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",10.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",13.4,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",14.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",15.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",15.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",16.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",19.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",17,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",17.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",18.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",19,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",22.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",18.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",7.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",6.8,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",6.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",6.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",6.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",6.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",5.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",5.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",5.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",6.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",5.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",6.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",6.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",6.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",6.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",6.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",5.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",5.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",5.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",5.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",5.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",5.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",5.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",8.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",9.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",8.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",8.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",8.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",6.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",6.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",6.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",6.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",6.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",5.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",6.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",6.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",12.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",12.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",12.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",12.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",11.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",11.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",11,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",10.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",9.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",10.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",9.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",9.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",10.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",6.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",6.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",6.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",6.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",6.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",5.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",4.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",4.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",4.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",4.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",4.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",4.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",4.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",9.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",9.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",9.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",9.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",8.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",8.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",8.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",7.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",7.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",7.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",7.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",7.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",7.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",3.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",2.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",2.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",1.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",1.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",1.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",10.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",9.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",9.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",8.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",7.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",7.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",7.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",7.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",7.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",6.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",6.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",5.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",13.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",13.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",11.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",10.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",10.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",8.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",8.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",8.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",8.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",8.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",7.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",7.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",15.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",15.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",14.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",14,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",13.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",12.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",13,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",13.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",12.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",13.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",11.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",10.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",10.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",6.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",6.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",5.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",5.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",5.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",4.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",4.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",3.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",3.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",3.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",7.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",7.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",7.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",6.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",6.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",5.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",5.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",5.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",1.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",1.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",1.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",1.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",79,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",86,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",98,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",156,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",168,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",191,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",224,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",237,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",246,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",258,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",264,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",272,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",72.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",88.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",101.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",150.6,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",151.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",143.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",166.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",181.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",183.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",179.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",181.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",204.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",52.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",56.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",63.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",107.8,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",115.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",129.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",154.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",160.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",167.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",174.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",181.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",187.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",4.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",6.5,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",6.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",7.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",7.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",7.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",7.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",2.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",2.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",4.7,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",4.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",5.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",6.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",6.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",6.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",7.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",7.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",0.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",1.3,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",1.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",1.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",1.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",1.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",1.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",47.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",47.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",48.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",50.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",51.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",52.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",55,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",56.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",58.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",61.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",64.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",60.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",63,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",66.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",61.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",66.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",67.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",58.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",60.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",63.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",69.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",68.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",73.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",72.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",56.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",57.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",59.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",63,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",64,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",65.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",70.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",73,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",76.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",81.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",86.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",80.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",7.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",7.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",7.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",7.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",6.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",7.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",7.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",7.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",8.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",6.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",6.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",7.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",7.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",7.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",8.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",8.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",8.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",9.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",9.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",1.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",122.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",125.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",124.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",124.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",123.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",126.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",126.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",128.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",125.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",132.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",127.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",127.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",132.8,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",162.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",174.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",159.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",165.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",163.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",140.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",139.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",144.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",148.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",148.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",145.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",151.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",139.9,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",146.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",150.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",151.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",154.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",153.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",158.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",161.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",165.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",164.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",177.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",174.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",173.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",186,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",14.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",15.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",14.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",14.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",14.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",12.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",12.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",12.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",13,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",12.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",12.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",13,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",12,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",13.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",13.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",13.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",13.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",13.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",14.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",14.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",14.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",14.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",15.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",15.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",15,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",16,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",1.5,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",413.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",435.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",453.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",474,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",498.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",521.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",560.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",598.3,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",625.1,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",652.4,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",680.7,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",414.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",422.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",410.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",370.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",376,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",401.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",432.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",450.9,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",466.1,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",520.3,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",523,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",332.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",355.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",368.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",379.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",412.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",430,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",464.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",484.6,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",507.7,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",526.9,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",542.9,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",11.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",12,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",11.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",10.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",10.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",11,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",11.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",12,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",12.3,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",13.6,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",13.5,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",9.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",10.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",10.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",10.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",11.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",11.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",12.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",12.9,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",13.3,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",13.8,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",14,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",1.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",1.9,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",1.8,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",1.8,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",1.7,"E; D","Estimated value; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",1641.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",1575.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",1709.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",1668.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",1742.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",1764.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",1814.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",1969.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",2011,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",2032.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",1982.8,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",2011.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",86,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",89,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",87.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",85.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",83.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",71.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",74.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",84.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",92.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",88.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",85.4,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",92.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",120.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",118.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",128.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",130.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",137.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",136.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",144.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",158.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",162.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",165.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",159.1,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",157.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",8.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",8.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",8.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",8.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",6.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",8.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",8.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",8,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",8.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",11.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",11.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",12.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",12.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",13,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",12.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",13.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",15,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",15.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",15.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",14.9,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",15,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",2.3,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",497.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",497.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",482.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",437,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",465.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",459.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",466.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",477.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",500.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",504.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",485.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",468,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",88.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",92.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",83.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",77.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",83,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",68.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",69.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",72.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",79.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",75.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",74.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",74.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",65.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",66.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",63.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",59.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",63.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",62.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",66,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",69.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",73.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",76.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",74.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",71,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",15.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",16.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",14.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",13.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",14.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",12,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",12.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",12.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",13.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",13,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",12.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",12.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",11.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",12,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",11.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",10.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",11.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",11.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",11.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",12.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",12.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",13.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",12.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",12.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",38.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",41.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",42.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",39.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",41,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",42.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",45.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",44.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",47,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",48.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",49.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",46.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",51.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",57.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",54.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",51.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",54.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",46.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",50.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",49.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",55.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",54.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",56.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",54.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",43,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",46.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",47,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",43.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",45.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",46.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",51.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",51.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",55.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",57.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",60.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",55.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",9.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",10.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",10.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",9.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",10,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",8.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",9.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",9.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",10.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",9.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",10.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",9.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",8.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",8.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",7.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",8.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",8.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",9.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",9.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",10,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",10.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",10.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",10.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",502.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",700,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",597.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",10.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",9.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","FRA","France","2011","2011",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",987.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",994,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",1019.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",1046.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",1085.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",1111.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",1115.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",1132,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",1181.9,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",1244.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",1257.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",1265.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",1308.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",1383.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",1309.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",1389.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",1442.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",1233.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",1234.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",1278.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",1395.8,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",1393.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",1436.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",1496.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",1226.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",1260.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",1294.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",1350.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",1411.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",1428.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",1481.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",1519.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",1607,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",1709.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",1734.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",1718.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",16,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",17.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",16.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",17.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",17.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",15.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",15,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",15.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",16.8,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",16.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",17.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",18,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",15,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",15.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",16.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",16.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",17.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",17.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",18,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",18.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",19.4,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",20.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",20.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",20.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",3.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",3.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",3.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",2.7,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",2.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",2.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",169.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",157.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",136.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",114.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",115.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",99.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",122.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",129.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",132.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",142.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",150.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",159.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",123.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",224.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",218.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",175.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",152.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",153.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",110.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",135.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",146,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",157,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",159.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",171.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",188.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",130.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",234.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",220.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",199.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",181.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",189.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",163.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",208.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",224.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",235.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",259.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",276.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",291.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",233.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",20.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",19.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",15.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",13.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",14.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",10.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",12.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",13.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",14.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",14.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",16,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",17.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",12.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",21.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",19.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",18,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",16.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",17.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",15.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",19.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",20.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",21.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",24.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",25.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",27.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",22.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",6945,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",7875.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",8192.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",8307.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",9057.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",9969.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",10611,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",10907.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",11179.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",11577.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",11553.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",11391.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",11177.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",33.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",39.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",36.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",37.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",38.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",35.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",37.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",39.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",41.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",39.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",37.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",37.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",30,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",54.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",63.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",65.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",66.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",70,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",75.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",80.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",80.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",80.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",82.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",79.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",73.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",69.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",3.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",3.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",3.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",3.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",3.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",3.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",4.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",4.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",4.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",3.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",3.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",3.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",5.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",6.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",6.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",6.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",7.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",7.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",8.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",8.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",8.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",8.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",8.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",7.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",7.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",1.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",2.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",2.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",2.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",585.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",623.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",617.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",665,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",656.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",636,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",670.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",690.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",761.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",864.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",931.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",998.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",4.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",5.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",4.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",5.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",5.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",4.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",5.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",6.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",7.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",6.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",7.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",4.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",4.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",4.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",4.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",4.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",5.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",6.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",6.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",6.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",15.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",16.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",15.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",16.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",17.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",14.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",16.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",18.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",19.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",19.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",18.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",21.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",13.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",14.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",14.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",15,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",14.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",13.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",14.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",14.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",15.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",17,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",17.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",17.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",2.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",2.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",2.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",2.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",2.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",2.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",2.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",2.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",44.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",45.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",48.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",50.1,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",51.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",53.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",55.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",55.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",56.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",60,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",60,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",59.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",58.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",63.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",62.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",66.6,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",68.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",59.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",61.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",62.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",67.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",67.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",68.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",70.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",52.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",55.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",59,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",61.8,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",62.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",65.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",70.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",69.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",71.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",74.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",75.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",75,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",12.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",13.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",13.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",14.4,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",14.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",12.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",13,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",13,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",13.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",13.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",13.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",14,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",11.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",12,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",12.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",13.4,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",13.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",14,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",14.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",14.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",14.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",15.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",15.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",14.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",2.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",2.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",2.6,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",2.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",2.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",2.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",462.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",478.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",484.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",488.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",481.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",489.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",509.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",520.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",534.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",520.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",481.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",490.8,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",644.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",614.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",643.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",649.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",533.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",542.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",575.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",614.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",598.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",594,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",569.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",516.8,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",610.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",639.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",657.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",661,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",651.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",699,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",738,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",763.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",813.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",802.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",743.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",794.9,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",10.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",10.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",10.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",10.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",8.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",8.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",9.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",10.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",10,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",10,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",9.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",8.8,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",10.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",10.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",10.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",10.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",10.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",11.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",12.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",12.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",13.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",13.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",12.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",13.5,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",2.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",2.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",2.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",2,"E","Estimated value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",114985,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",139935,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",152914,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",166912,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",158691,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",182902,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",159150,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",175173,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",155562,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",259390,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",253995,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",275742,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",1309.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",1753.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",1916.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",1710.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",1497.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",1511,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",1462.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",1561.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",1408.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",2379.5,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",2378.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",2512.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",1029.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",1302.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",1466.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",1647.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",1539.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",1767.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",1508.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",1666.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",1493.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",2488.7,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",2479.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",2702,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",10.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",13.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",15,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",13.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",11.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",11.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",12.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",11.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",18.9,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",18.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",20,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",10.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",12.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",12.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",13.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",11.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",13.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",11.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",19.7,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",19.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",21.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",2.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",2.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",2.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",2.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",2.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",2.7,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",137957,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",232848.8,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",245185.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",251932.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",254331.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",259131.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",198179,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",196953.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",233107,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",275688.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",278416.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",336313.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",119.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",210.1,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",217.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",230.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",241.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",229.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",170.7,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",174.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",211.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",236.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",235.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",294,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",164,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",272.5,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",286.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",289.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",291.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",302.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",230.8,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",225.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",272.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",321.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",332.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",393.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",4.2,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",4.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",4.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",4.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",3.3,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",3.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",4.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",5.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",3.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",5.5,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",5.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",5.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",5.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",5.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",4.5,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",5.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",6.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",6.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",7.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",1.1,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",1.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",1.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",1.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",1.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.8,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",4.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",4.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",4.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",5.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",5.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",5.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",5.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",5.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",5.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",5.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",5.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",5.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",5.6,"D; P","Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",5.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",6.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",6.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",7.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",5.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",5.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",6.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",6.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",6.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",5.8,"D; P","Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",4.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",4.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",5.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",5.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",5.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",6.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",6.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",6.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",6.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",6.7,"D; P","Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",12.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",12.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",13.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",13.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",11,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",11.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",11.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",11.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",11.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",11.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",11.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",10,"D; P","Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",9.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",9.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",10.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",11.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",11.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",11.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",11.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",11.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",11.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",11.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",11.4,"D; P","Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",2.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",2.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",2.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",2.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",2.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",2.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",2.2,"D; P","Difference in methodology; Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",169.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",174.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",174.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",127.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",129.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",224.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",242.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",223.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",169.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",172.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",197.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",208.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",211.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",160.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",160.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",13.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",14.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",13.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",10.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",10.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",11.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",12.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",12.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",9.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",9.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",3.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",3.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",18.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",18.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",21.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",22.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",24.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",28.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",28.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",25,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",24.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",25.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",26.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",29.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",25.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",13.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",14.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",17.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",18.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",20.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",19.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",19.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",17.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",17,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",16.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",17.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",20.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",16,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",12.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",12.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",14.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",15.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",17,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",19.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",19.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",17.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",16.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",17.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",18.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",20.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",17.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",3.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",3.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",3.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",4.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",4.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",4.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",4.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",3.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",3.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",3.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",4.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",3.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",2.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",2.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",3.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",3.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",3.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",4.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",4.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",3.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",3.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",3.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",3.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",3.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",3.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",2.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",2.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",2.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",2.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",1.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",1.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",440,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",445,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",468,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",485,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",516,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",549,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",570,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",543,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",571,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",624,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",610,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",609,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",582,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",72.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",79.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",80.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",82.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",81.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",68.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",67.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",65.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",70.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",70.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",64.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",70.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",60.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",48.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",49,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",51.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",53.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",55.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",55.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",56.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",55.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",59.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",64.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",61.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",64,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",54.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",14.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",16,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",16,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",16.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",15.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",13.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",13,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",12.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",13.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",13.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",12,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",13.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",11.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",9.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",9.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",10.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",10.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",10.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",10.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",10.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",10.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",11.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",12.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",11.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",11.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",10,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",2.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",24,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",22.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",20.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",20,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",21.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",23.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",24.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",25.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",26.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",27.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",25.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",27.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",29.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",31.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",31.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",26.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",26.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",28.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",25.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",27.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",29,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",31.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",30.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",29.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",32.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",31.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",38.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",36.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",34.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",34.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",37.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",39.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",42.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",44.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",47.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",49.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",46.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",48.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",54.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",2.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",2.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",2.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",2.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",3.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",2.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",3.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",3.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",3.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",3.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",3.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",3.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",4.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",4.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",4.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",4.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",4.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",4.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",5.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",0.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",0.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",0.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",0.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",0.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",0.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",20.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",17.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",19.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",22.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",25.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",24.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",27.2,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",26.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",27.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",28.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",26.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",28.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",27.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",24.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",24.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",29.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",33.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",27.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",30.1,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",30.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",32.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",31.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",30.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",33.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",40.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",35.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",38.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",45.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",52.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",50,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",54,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",52.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",52.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",54.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",51.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",53.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",5.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",6.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",5.5,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",5.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",5.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",5.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",6.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",7.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",6.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",7.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",8.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",9.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",9.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",10,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",9.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",9.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",10.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",9.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",9.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",1.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",1.7,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",256.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",258.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",235.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",206.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",224.5,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",228.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",236.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",247.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",391.2,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",407.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",386.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",408.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",428.2,"P","Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",340.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",360.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",302.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",273.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",298.2,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",253.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",261.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",279.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",462,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",456.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",441.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",482.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",450.9,"P","Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",353.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",362.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",339.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",305.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",338.9,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",343.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",368.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",392.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",619.2,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",664.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",621.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",652,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",718.2,"P","Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",7.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",7.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",5.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",6.4,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",5.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",5.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",9.9,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",9.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",9.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",10.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",9.5,"P","Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",7.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",7.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",7.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",6.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",7.3,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",7.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",7.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",8.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",13.2,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",14.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",13.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",13.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",15.1,"P","Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",2.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",2.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",2,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",2.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",2.1,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",1.9,"P","Provisional value" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",919.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",934.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",965.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",973.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",967.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",983.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",1026.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",1054.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",1090.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",1116.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",1102.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",1088.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",1109.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",127.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",144,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",142.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",149.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",141,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",116.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",119.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",123.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",125.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",118,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",119.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",126.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",109.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",101.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",105.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",111.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",113.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",110.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",111.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",116.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",119.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",123,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",128.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",127.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",124.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",128,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",13.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",15.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",15,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",15.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",14.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",11.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",12.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",12.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",12.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",11.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",11.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",12.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",10.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",10.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",11.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",11.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",11.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",11.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",11.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",11.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",11.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",12.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",12.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",12.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",12,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",12.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",2.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",2.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",71.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",73,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",83,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",84,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",85,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",87,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",91,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",93,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",86,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",86,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",89,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",85,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",89,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",68.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",82.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",88.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",90.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",92.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",90.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",92.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",94.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",87.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",86.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",94.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",93,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",93.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",48.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",52.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",61.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",64,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",66.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",70.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",75.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",78.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",73,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",74.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",78.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",76.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",83.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",8.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",10.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",11.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",11.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",11.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",10.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",11,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",11.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",10.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",10.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",11,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",10.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",10.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",6.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",6.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",7.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",7.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",8.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",8.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",9.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",8.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",8.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",9.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",8.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",9.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",1.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",1.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",1.4,"B; D","Break; Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",1.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",1.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",1.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",1.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",1.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",237.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",246.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",240.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",258,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",297.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",352.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",411.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",476.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",614.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",753.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",861.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",1151.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",157.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",147,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",133.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",135.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",135.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",129.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",136.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",130.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",127.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",132.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",122.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",130.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",257.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",254.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",235.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",241.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",269.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",303.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",331.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",344.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",376.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",404.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",397.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",410.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",3.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",3.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",3.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",3.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",3.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",3.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",4.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",4.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",4.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",4.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",4.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",338.3,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",391.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",478.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",589.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",607.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",532.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",442.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",534.4,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",612.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",787,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",900.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",820,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",685.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",590.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",482.2,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",563.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",684.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",851.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",881.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",778.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",644,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",8.4,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",9.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",12.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",13.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",12.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",10.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",8.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",7.6,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",8.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",10.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",13.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",13.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",11.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",9.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",2.5,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",3.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",3.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",12798,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",18495.4,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",27115.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",23741.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",38190.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",43736.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",50996.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",55462.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",62490.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",49123.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",58708.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",74745.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",76368.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",25.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",38.2,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",55.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",47.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",67,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",66.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",75.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",85.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",97.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",69.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",74.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",98.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",87.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",35.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",53.1,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",78.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",67.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",104,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",111.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",128.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",139.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",157.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",122.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",140.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",171.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",174.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",2.2,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",3.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",3.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",3.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",4.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",5.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",3.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",3.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",2.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",3.1,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",4.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",3.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",5.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",6.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",7.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",7.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",8.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",6.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",7.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",8.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",8.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",1.6,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",2.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",2.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",2.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",3.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",3.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",3.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",3.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",4.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",4.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",5.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",5.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",3.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",3.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",3.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",4.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",3.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",4.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",4.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",5.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",5.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",5.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",6.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",5.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",4.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",5.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",5.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",6.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",6.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",6.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",7.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",8.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",8.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",8.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",9.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",9.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",9.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",2.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",2.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",2.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",3.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",3.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",3.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",3.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",4.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",4.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",4.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",3.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",4.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",4.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",5.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",5.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",6.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",6.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",6.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",7.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",7.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",7.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",1.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",1.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",1.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",1.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",1.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",9.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",8.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",8.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",9.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",9.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",10.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",10.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",11.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",11,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",10.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",11.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",12.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",11.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",12.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",11,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",11.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",12.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",13.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",13,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",12.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",12.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",12.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",14.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",14.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",14.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",15,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",15.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",16.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",18.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",19,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",20.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",21,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",20,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",19.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",20.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",5.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",6.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",5.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",5.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",5.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",5.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",5.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",6.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",6.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",5.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",6.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",7.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",7.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",7.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",7.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",8.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",9.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",9.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",10.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",9.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",9.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",9.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",2.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",2.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",2.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",2.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",1.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",354,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",386,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",446,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",790,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",801,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",822,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",3422,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",2540,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",1794,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",1378,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",1133,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",1030,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",324.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",398.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",461.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",762.7,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",722,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",617.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",2543.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",1946.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",1340.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",957.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",779.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",773.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",235.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",255.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",289.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",545.9,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",551.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",557.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",2359.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",1719.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",1220.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",931.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",779.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",711.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",14.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",17.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",20.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",33,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",30.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",25.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",105.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",79.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",53.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",37.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",30.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",30.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",10.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",11.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",12.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",23.6,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",23.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",23.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",97.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",69.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",48.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",36.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",30.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",27.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",3.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",3.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",4.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",6.7,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",6.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",6.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",22.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",17.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",12,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",8.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",6.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",5.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",162.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",166.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",177.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",182.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",241.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",294.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",260.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",265.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",247.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",213.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",188,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",182.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",215.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",231.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",228.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",242.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",320.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",326.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",288.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",300.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",292.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",238.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",214.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",215.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",193.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",200.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",218.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",229.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",302.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",368.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",335.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",343.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",323.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",284.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",251.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",240.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",25.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",27.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",27.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",28.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",37.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",37.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",33,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",34.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",33.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",26.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",24.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",24,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",23.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",23.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",25.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",27.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",35.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",42.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",38.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",39,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",36.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",32.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",28.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",26.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",6.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",6.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",6.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",6.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",8.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",10.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",8.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",8.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",7.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",6.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",5.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",4.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",571.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",586.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",583.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",581.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",576.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",680.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",634.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",674.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",638.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",701.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",638.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",632.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",678,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",757.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",815.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",750,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",772,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",765.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",755.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",702.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",761.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",754.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",785,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",729.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",747.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",714,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",683.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",704.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",710,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",721,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",720.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",851,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",812.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",869.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",833.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",939.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",874.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",858,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",949.7,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",69.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",73.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",67.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",69.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",68.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",67,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",62,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",66.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",66,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",68.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",63.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",64.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",61.5,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",62.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",63.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",63.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",64.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",64.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",75.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",71.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",76.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",72.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",81.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",75.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",74.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",81.7,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",9.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",9.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",9.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",9.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",9.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",11,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",10.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",10.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",9.6,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",9.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",8.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",7.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",7.5,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1441.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1482.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1678.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",2447.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",2295.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",2328,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",2435.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",2275.2,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",1981,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",1952.7,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",2066.1,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1442.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1438.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1519,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",1913.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",1731.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",1793.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",1879.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",1714.8,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",1477.1,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",1557.3,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",1587.4,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1158.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",1210.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",1363.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",1960.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1901.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1920.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",2018.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",1842.7,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",1609.2,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",1577.1,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",1647.9,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",41.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",41,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",42.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",53.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",47.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",49.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",50.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",45.6,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",38.8,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",40.7,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",40.8,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",33.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",34.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",38.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",54.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",52.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",52.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",54.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",49,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",42.3,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",41.2,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",42.4,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",5.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",6.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",8.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",7.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",7.1,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",5.8,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",5.3,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",5.2,"E; D","Estimated value; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",7138.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",7669,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",7424.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",6568.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",6451.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",6692.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",7213.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",7622.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",8324.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",9284.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",7833.4,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",8201.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",373.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",433.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",379.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",335.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",310.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",272.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",295.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",326.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",383.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",404.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",337.5,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",378.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",522.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",574.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",558.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",513.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",507.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",517.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",573.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",613.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",672.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",756.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",628.6,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",643.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",35.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",41.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",36.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",31.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",29.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",25.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",27.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",30.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",36,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",37.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",31.5,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",36,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",49.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",54.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",53.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",48.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",48.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",49.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",54.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",57.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",63.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",70.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",58.8,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",61.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",8.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",9.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",8.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",8.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",7.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",8.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",8.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",8.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",8.9,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",8.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",2056.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",2036.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",2015.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",2066.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",2107.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",2220.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",2066,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",1983.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",1929.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",2032.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",2186.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",2006,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",365.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",379.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",348,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",367.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",375.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",330,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",306.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",300.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",305.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",304.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",334.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",319.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",270.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",272.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",266.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",280.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",287.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",303.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",291.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",288.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",285.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",306.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",333.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",304.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",65.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",68.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",62.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",65.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",66.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",58.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",53.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",52.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",52.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",52.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",57.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",54.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",48.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",49,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",47.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",50,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",51,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",53.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",50.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",50.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",49.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",52.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",57.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",52,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",9.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",9.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",9.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",10.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",9.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",10.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",9.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",8.6,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",8.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",8.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",8.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",7.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",148.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",152.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",140.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",144.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",145.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",182.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",184.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",196.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",246.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",268,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",256.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",245.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",197.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",212.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",180.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",191.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",193.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",202,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",203.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",222.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",291.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",300,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",293.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",290,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",165.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",170.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",155,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",159.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",160.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",200.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",209,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",228,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",289.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",319.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",312,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",296.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",36.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",39.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",33.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",35.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",35.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",36.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",37.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",40.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",52.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",54.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",53,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",52.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",30.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",31.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",28.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",29.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",29.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",36.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",38,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",41.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",52.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",57.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",56.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",53.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",7.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",7.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",7.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",7.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",8.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",8.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",9.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",10.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",9.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",8.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",3056.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",4254.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",3632.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",65.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",55.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","FRA","France","2011","2011",11.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",2029,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",2098.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",2411.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",2395.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",2966.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",3743.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",3238.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",2922.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",2898.8,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",2717.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",2544.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",2623,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",2689.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",2921.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",3097.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",3181.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",3940.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",4153.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",3584.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",3301.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",3423.3,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",3042.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",2906,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",3102.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",2520.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",2661.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",3062.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",3091.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",3857.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",4811.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",4302.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",3924.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",3941.5,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",3731.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",3509.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",3562.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",32.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",36.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",38.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",39.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",48.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",50.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",43.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",39.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",41.3,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",36.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",34.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",37.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",30.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",33.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",38.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",38.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",47.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",58.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",52.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",47.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",47.5,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",44.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",42.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",42.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",6.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",7.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",7.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",7.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",8.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",10.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",7.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",6.6,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",5.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",5.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",4.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",748.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",693.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",600.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",518.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",548.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",538.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",633.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",653.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",685.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",700.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",702,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",666.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",735.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",992.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",965.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",771.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",688.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",728.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",597.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",701.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",737.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",809.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",784,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",801.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",788.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",774.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",1036.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",972.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",877.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",821.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",897,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",883.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",1076.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",1135.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",1213.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",1275.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",1290.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",1221.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",1392.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",89.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",86.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",69.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",62.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",66.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",55.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",65.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",68.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",75.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",73.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",74.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",74.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",74.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",93.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",87.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",79.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",74.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",82.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",81.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",99.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",105.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",113.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",119,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",120.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",115.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",133.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",22127.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",22409.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",21233.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",24081.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",26838.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",31313.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",39211.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",29379.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",22607.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",22177.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",19574.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",20729.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",23726.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",106.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",111.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",94.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",107.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",115.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",112.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",139.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",107.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",83.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",76.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",63.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",68.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",63.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",175,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",180.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",169,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",192.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",207.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",236.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",297,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",216,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",162.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",157.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",134.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",134,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",147.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",10.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",11.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",9.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",10.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",11.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",11.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",14.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",10.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",8.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",7.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",6.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",6.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",17.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",18.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",17,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",19.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",21,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",24,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",30.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",22.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",16.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",16.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",13.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",13.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",15.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",4.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",4.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",4.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",5.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",6.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",6.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",7.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",4.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",4.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",3.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",3.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",2185.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",2615.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",2794.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",2618.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",2663.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",2857.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",3055.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",3067.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",3463.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",4032.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",4515.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",5216.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",17.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",22.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",22.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",21.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",22.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",21.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",25.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",28.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",32,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",32.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",33.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",41.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",16.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",19.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",20.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",19.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",19.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",20.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",21.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",22.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",24.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",28.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",30.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",34.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",56.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",70.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",69.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",66.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",69.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",65.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",75.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",83.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",90.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",91.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",91,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",110.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",51.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",60.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",63.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",59,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",58.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",60.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",65,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",64.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",69.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",79.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",84,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",93.6,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",8.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",10,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",11.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",10.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",11.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",11.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",12,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",11.6,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",11.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",12,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",11.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",11.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",66.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",60.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",69.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",64.3,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",68.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",89.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",102.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",113.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",122.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",102.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",75.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",77.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",87.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",83.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",89.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",85.4,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",91,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",99.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",113.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",128.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",144.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",114.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",86.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",91.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",77.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",72.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",84.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",79.3,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",83.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",110.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",129.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",143,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",154.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",127.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",94.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",97.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",19.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",18.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",19.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",18.5,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",19.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",21.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",23.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",26.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",29.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",23.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",17.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",18.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",17.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",15.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",18.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",17.2,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",18,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",23.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",27.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",29.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",31.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",25.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",19,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",19.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",3.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",3.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",3.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",3.3,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",3.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",4.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",5.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",5.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",4.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",3.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",2396.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",2356.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",2435.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",2447.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",4373.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",4413.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",3501.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",2918,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",2728.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",2478.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",2504,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",2603.1,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",3335.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",3027.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",3234.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",3251.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",4852.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",4885.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",3955.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",3446.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",3054.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",2831,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",2961.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",2741.2,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",3158.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",3151.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",3302.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",3309,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",5920.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",6300.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",5075.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",4283.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",4154.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",3826.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",3866.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",4216.1,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",56.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",50.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",53.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",53.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",79.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",80.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",65.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",57,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",51.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",47.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",50.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",46.4,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",53.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",52.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",54.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",54.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",97.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",103.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",83.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",70.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",69.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",64.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",65.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",71.4,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",12.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",12.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",12.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",12.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",19.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",19.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",15.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",13,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",11.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",10.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",10.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",10.5,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",240226,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",265932,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",251567,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",234817,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",236305,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",219483,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",209885,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",169135,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",125509,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",155485,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",157486,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",115171,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",2736.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",3332.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",3152.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",2406,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",2230.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",1813.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",1929.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",1507.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",1136.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",1426.3,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",1474.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",1049.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",2150.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",2474.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",2412.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",2318,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",2293.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",2121.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",1989.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",1609.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",1205,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",1491.8,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",1537.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",1128.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",21.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",26.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",24.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",18.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",17.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",14.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",15.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",11.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",11.3,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",11.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",8.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",16.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",19.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",18.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",18.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",18,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",16.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",15.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",12.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",9.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",11.8,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",12.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",3.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",3.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",3.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",3.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",3.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",3.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",3.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",2.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",1.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",1.6,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",1.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",1.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",2549474,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",2880536.3,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",2716710.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",2795930.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",2840189.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",2908070.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",3044109.3,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",3072355.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",3031844.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",3112659.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",3021018.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",2889419.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",2204.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",2599.2,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",2411,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",2553.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",2697.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",2571.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",2622.5,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",2716.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",2755.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",2671,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",2559.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",2525.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",3031.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",3370.7,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",3177.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",3217.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",3257.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",3391.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",3544.6,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",3520.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",3546.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",3634.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",3606.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",3383,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",44.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",52.1,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",48,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",50.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",53.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",50.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",51.2,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",52.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",53.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",51.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",49.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",48.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",61.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",67.5,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",63.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",63.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",64.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",66.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",69.2,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",68.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",68.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",70.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",69.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",65.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",12.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",13.1,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",12.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",12.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",12,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",11.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",12,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",11.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",10.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",10,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",9.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",8.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",10.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",10.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",11.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",10.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",9.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",9.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",8.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",9.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",9.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",9.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",14.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",16.7,"D; P","Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",14.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",14.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",14.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",13.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",12.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",10.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",10,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",10,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",11.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",10.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",10.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",17.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",17.6,"D; P","Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",11.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",11.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",12.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",11.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",10.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",10.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",10.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",10.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",11.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",11.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",11.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",17.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",20.1,"D; P","Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",29.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",30.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",28.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",27.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",24.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",20,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",19,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",18.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",21.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",19.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",19.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",30.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",30,"D; P","Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",24.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",24.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",24.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",23.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",20.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",20.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",20.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",19.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",21.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",20.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",19.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",30,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",34.2,"D; P","Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",5.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",5.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",5.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",5.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",4.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",4.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",4.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",4.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",4.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",4.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",6.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",6.5,"D; P","Difference in methodology; Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2010","2010",7478,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2011","2011",7936,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2012","2012",12173,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2013","2013",18213,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2014","2014",17720,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2015","2015",19023,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2016","2016",20942,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2017","2017",22564,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2018","2018",23071,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2019","2019",22621,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2020","2020",24725.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2021","2021",22990.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","MEX","Mexico","2022","2022",23059.8,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2010","2010",591.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2011","2011",638.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2012","2012",924.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2013","2013",1426,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2014","2014",1333.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2015","2015",1200.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2016","2016",1122,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2017","2017",1192.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2018","2018",1198.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2019","2019",1174.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2020","2020",1150.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2021","2021",1134.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2022","2022",1145.7,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2010","2010",973.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2011","2011",1034.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2012","2012",1549,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2013","2013",2310,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2014","2014",2202.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2015","2015",2284.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2016","2016",2479.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2017","2017",2531.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2018","2018",2487.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2019","2019",2340.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2020","2020",2462.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2021","2021",2210.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2022","2022",2180.4,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2010","2010",5.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2011","2011",5.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2012","2012",7.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2013","2013",12,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2014","2014",11.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2015","2015",9.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2016","2016",9.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2017","2017",9.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2018","2018",9.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2019","2019",9.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2020","2020",9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2021","2021",8.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2022","2022",8.8,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2010","2010",8.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2011","2011",9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2012","2012",13.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2013","2013",19.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2014","2014",18.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2015","2015",18.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2016","2016",20.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2017","2017",20.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2018","2018",19.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2019","2019",18.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2020","2020",19.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2021","2021",17.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2022","2022",16.8,"E","Estimated value" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","MEX","Mexico","2013","2013",12.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","MEX","Mexico","2018","2018",10.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",350.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",358.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",375.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",393.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",387.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",465.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",498.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",482.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",522.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",515,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",410.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",428.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",455.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",493.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",479.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",28,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",29.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",28.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",31.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",30.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",24.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",25.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",27.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",29.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",28.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",6.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",6.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",8.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",9.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",43.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",50,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",53.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",98.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",101.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",109.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",114.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",170.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",133.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",173.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",151.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",109.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",91.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",31.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",39.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",43.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",80.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",84.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",76.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",80,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",121,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",92.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",114.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",98.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",77.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",58.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",28.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",33.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",35.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",67.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",70.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",74.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",79.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",119,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",90.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",122.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",107.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",75.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",63.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",7.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",9.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",18.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",18.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",16.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",17,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",25.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",18.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",23,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",19.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",15.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",11.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",6.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",7.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",8.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",15.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",15.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",16.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",16.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",24.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",18.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",24.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",21.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",14.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",12.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",5.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",6.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",5.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",10.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",10.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",11.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",10.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",13.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",10.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",11.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",9.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",6.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",4.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",1256,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",1426,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",1534,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",1514,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",1830,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",2214,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",2279,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",2352,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",2198,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",2135,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",1710,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",3055,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",3511,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",207.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",254.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",263.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",257.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",290.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",274.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",271.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",284.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",270.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",242.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",181.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",355.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",365.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",137.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",157,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",169.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",167.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",197.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",222.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",226.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",241.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",229.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",221.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",173.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",321.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",326.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",42.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",51.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",52.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",50.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",56.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",52.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",51.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",53.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",50.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",45.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",33.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",65.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",67.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",28.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",31.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",33.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",33,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",38.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",43,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",43.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",45.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",43.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",41.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",32.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",59.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",60.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",7.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",8.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",7.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",8.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",9.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",9.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",8.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",7.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",5.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",9.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",9.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",182.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",163.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",130,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",116.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",119,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",133.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",118.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",116.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",121.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",129.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",121.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",103.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",118.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",241.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",227.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",167,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",154.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",158.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",148.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",130.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",131.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",143.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",145.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",138.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",122.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",125.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",292.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",262.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",214.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",198.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",205.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",228.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",206.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",202.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",212.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",232.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",217.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",182.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",215.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",22.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",21.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",15.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",14.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",15.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",14.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",12.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",12.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",13.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",14.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",13.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",11.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",12.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",27.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",24.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",20.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",19,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",19.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",22,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",20,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",19.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",20.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",22.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",21.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",17.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",20.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",5.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",5.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",4.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",5.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",4.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",4.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",4.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",4.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",4.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",3.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",3.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",106.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",115.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",120.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",111.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",122,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",134.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",114.8,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",112.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",116.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",118.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",110.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",135.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",140.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",160.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",155,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",148.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",162.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",148.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",127.1,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",126.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",138.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",133.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",126.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",160.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",211.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",228,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",239.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",227.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",251.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",273,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",228.2,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",217.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",222.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",229.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",213.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",254.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",26.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",29.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",28.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",27.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",29.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",27.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",23.4,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",23.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",25.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",24.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",23.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",29.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",39.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",42.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",44.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",42.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",46.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",50.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",42,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",40,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",40.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",42.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",39.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",46.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",9.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",10.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",10.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",9.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",9.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",9.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",7.3,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",7.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",7.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",6.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",6.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",7.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",365.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",311.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",274.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",274.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",302.2,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",302.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",297.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",293.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",1868.6,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",1850.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",1794.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",1794.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",1780.6,"P","Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",485,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",433.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",353.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",364.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",401.5,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",335.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",329.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",331.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",2206.7,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",2072,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",2049.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",2122.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",1875,"P","Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",503.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",436.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",395.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",406.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",456.2,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",455,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",463.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",464.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",2957.6,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",3019.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",2887.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",2867.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",2986.5,"P","Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",10.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",9.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",7.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",7.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",8.6,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",7.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",7.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",7.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",47.2,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",44,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",43.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",44.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",39.5,"P","Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",10.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",9.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",8.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",8.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",9.8,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",9.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",10,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",10,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",63.2,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",64.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",61,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",60.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",63,"P","Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",2.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",2.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",2.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",2.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",2.7,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",2.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",2.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",2.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",9.8,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",9.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",8.6,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",8.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",7.8,"P","Provisional value" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",2649.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",2551,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",2540.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",2367.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",3029.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",3983.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",3888.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",3285.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",4538.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",3807.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",3307.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",3341.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",3543.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",367.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",392.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",374.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",363.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",441.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",472.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",454.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",384.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",522.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",402.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",359.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",389.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",350.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",293.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",288.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",293.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",275.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",347.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",449.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",440.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",371.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",511.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",437.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",381.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",383.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",408.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",39.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",41.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",39.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",37.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",45.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",48.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",45.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",38.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",51.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",39.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",34.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",37.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",33.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",31.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",30.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",30.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",28.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",35.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",45.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",44.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",36.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",50.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",42.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",36.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",36.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",39.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",7.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",6.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",6.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",9.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",9.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",7.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",9.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",7.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",6.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",6.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",6.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",437.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",445,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",463,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",449,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",459,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",569,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",546,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",554,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",553,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",551,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",490,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",476,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",523,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",419.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",501.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",493.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",484.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",501,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",591.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",554.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",562.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",565.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",554.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",521.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",520.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",547.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",298.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",318.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",341.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",342.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",358.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",460.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",454.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",466.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",469.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",479,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",431.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",430.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",490.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",53.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",63.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",61.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",59.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",61.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",71.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",66.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",66.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",66.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",64.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",60.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",59.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",62.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",38.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",40.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",42.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",42.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",43.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",55.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",54.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",55.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",55.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",55.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",49.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",49.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",56.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",7.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",7.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",7.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",7.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",7.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",9.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",8.6,"B; D","Break; Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",8.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",8.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",8.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",7.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",6.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",6.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",2580.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",1976.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",1910.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",1992.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",2049.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",2341.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",2699.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",3002.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",3895.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",5252,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",5511.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",6853.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",1717.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",1180,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",1063.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",1046.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",936.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",860.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",893.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",823,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",806.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",925.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",786.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",774.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",2803.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",2045.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",1873.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",1861.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",1855.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",2014.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",2174.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",2169.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",2386.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",2817.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",2546.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",2440.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",23.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",15.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",14.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",13.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",12.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",11,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",11.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",10.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",9.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",11.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",9.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",9.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",38.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",27.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",24.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",24.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",24,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",25.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",27.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",27,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",29.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",34.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",30.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",29,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",16.6,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",14,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",14.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",13.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",13.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",12.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",12.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",11.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",12.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",12.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",11,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",10.6,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",1606,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",1729.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",1844.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",2079.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",2346.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",2615.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",2657.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",2536.9,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",2703.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",3034.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",3177,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",3168.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",3366.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",3545.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",2288.9,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",2487.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",2640.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",3002.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",3408.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",3820.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",3864.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",39.8,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",42.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",47,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",48.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",48.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",51,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",53.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",35.9,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",38.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",40.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",46.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",51.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",57.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",58.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",11.7,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",11.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",11.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",11.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",12.6,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",13.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",13,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",58760.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",177900.9,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",132266.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",209955.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",180250.2,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",241797.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",281371,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",255295,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",351495.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",359508.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",433351.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",310910.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",391011.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",115.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",367.8,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",271.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",423.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",316,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",369.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",415.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",393.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",548.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",511.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",546.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",409.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",447.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",163.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",511.2,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",380.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",600.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",490.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",618.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",708.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",641.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",887.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",895.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",1035.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",714.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",893.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",6.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",21.3,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",15.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",24.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",17.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",20.6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",22.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",21.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",29.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",26.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",28.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",20.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",22.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",9.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",29.6,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",21.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",34.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",27.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",34.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",39,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",34.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",47.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",46.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",53.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",36.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",45.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",7.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",15.1,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",10.6,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",14.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",11.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",13.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",13.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",12.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",15.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",14.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",16.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",11.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",13.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",19.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",22.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",24.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",23.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",28,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",31.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",44.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",43.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",46.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",48.4,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",44,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",75.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",60.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",26.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",31.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",31.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",31.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",37.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",35.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",49.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",49.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",55.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",54.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",50.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",89.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",63.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",38.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",43.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",47.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",45.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",53.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",59.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",84,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",81.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",87.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",90.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",84.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",139.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",106.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",19.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",23.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",23.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",24.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",28.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",26.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",37.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",37.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",41.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",40.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",37.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",67.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",47.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",29.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",32.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",35.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",34.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",40.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",45,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",63.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",62.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",65.9,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",68,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",63.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",104.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",79.7,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",10.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",10.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",11.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",10.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",11.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",12,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",15.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",14.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",14.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",14.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",12.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",18.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",14,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",19,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",19.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",19.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",21.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",19.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",26.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",29.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",27.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",29.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",27.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",22.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",22.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",25.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",25.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",27.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",25.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",28.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",26.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",29.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",32.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",30.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",34.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",31,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",25.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",26.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",27.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",29.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",31.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",32.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",36,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",33.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",44.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",51.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",47.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",51.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",50.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",40.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",39.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",46.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",12.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",13.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",12.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",13.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",12.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",14.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",15.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",14.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",16.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",14.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",12.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",12.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",12.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",14.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",15.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",15.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",17.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",16.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",21.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",24.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",23.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",25,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",24,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",19.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",18.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",22.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",4.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",4.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",4.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",4.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",6.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",5.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",5.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",5.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",3.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",3.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",3.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",194,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",198,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",184,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",320,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",320,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",363,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",392,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",395,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",389,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",400,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",311,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",323,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",178,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",204.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",190.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",308.9,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",288.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",272.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",291.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",302.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",290.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",278.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",214,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",242.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",129,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",131,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",119.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",221.1,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",220.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",246.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",270.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",267.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",264.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",270.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",213.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",223.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",8.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",9.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",8.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",13.4,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",12.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",11.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",12,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",12.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",11.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",11,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",8.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",9.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",5.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",5.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",5.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",9.6,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",9.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",10.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",11.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",10.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",10.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",10.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",8.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",8.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",1.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",1.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",2.7,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",1.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",1.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",74.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",71.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",68.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",69.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",66.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",65.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",62.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",59.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",58.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",54.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",43.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",41.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",98.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",100,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",87.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",92.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",87.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",72.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",69.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",67.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",68.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",60.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",49.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",49.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",88.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",86.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",83.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",87.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",82.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",81.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",80.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",77.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",75.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",72.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",58.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",55.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",11.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",11.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",10.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",10.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",10.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",8.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",7.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",7.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",7.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",6.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",5.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",5.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",10.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",10.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",9.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",10.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",9.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",9.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",9.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",8.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",8.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",8.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",6.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",6.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",2.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",1.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",1.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",1.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",1.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",1.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",251.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",244.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",225.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",218.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",213.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",215.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",197.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",189.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",186.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",193.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",168.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",177.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",203,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",333.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",340.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",290.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",290.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",283.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",239.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",218.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",214.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",220.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",216.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",192.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",209.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",213.8,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",300.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",294.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",274.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",271.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",266.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",269.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",252.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",244.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",243.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",258.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",231.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",240.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",284.3,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",30.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",30.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",26.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",26.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",25.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",21.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",19.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",18.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",19.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",18.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",16.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",18.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",18.4,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",27.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",26.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",24.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",24.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",23.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",23.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",22.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",21.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",21.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",22.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",20,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",20.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",24.5,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",4.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",4.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",3.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",3.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",3.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",3.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",3.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",2.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",2.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",2.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",2.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",2.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",2.3,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",694.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",678.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",683.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",678.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",687.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",694.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",646.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",564.5,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",460.8,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",445.2,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",494.8,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",694.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",658.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",618.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",530.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",518.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",535.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",498.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",425.5,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",343.6,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",355.1,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",380.2,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",557.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",554.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",555.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",543.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",569.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",573,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",535.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",457.2,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",374.3,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",359.6,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",394.6,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",20,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",18.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",17.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",14.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",14.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",14.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",13.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",11.3,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",9,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",9.3,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",9.8,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",16.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",15.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",15.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",15.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",15.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",15.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",14.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",12.2,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",9.8,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",9.4,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",10.1,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",2.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",2.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",2.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",1.8,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",1.3,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",1.2,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",1.2,"E; D","Estimated value; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",2686.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",2528.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",2592,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",2544.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",2245.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",2167.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",2101,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",2230.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",2392.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",2440.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",2014.9,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",2113.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",140.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",142.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",132.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",130,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",108.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",88.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",86,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",95.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",110.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",106.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",86.8,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",97.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",196.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",189.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",194.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",199.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",176.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",167.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",167.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",179.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",193.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",198.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",161.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",165.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",13.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",13.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",12.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",12.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",10.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",8.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",8.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",10.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",10,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",8.1,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",9.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",18.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",18.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",18.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",18.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",16.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",15.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",15.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",16.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",18.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",18.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",15.1,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",15.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",3.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",3.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",3.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",3.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",2.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",2.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",2.3,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",2.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",67.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",65.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",55,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",53.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",50.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",51.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",55.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",52.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",49.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",44.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",41.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",39,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",89,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",91.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",70.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",71.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",66.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",57.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",61.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",59.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",58.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",50,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",47.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",46.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",74.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",73,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",60.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",59.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",55.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",57.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",62.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",60.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",58.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",53.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",50.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",47.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",16.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",16.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",13.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",13.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",12.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",10.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",11.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",10.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",10.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",9.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",8.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",8.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",13.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",13.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",11.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",10.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",10.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",10.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",11.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",11.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",10.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",9.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",9.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",8.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",3.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",3.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",2.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",2.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",2.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",1.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",1.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",1.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",740.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",712.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",772.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",828.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",782.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",769.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",754.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",732.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",746,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",713.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",576.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",541,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",981.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",991.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",993,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",1099.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",1039.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",854,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",835.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",827.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",881,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",798.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",658.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",639.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",919.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",903.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",981.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",1068.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",1017.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",989.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",1002.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",983.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",1014.3,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",979.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",795.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",734.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",12,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",12.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",12.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",13.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",12.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",10.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",10.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",10,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",10.6,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",9.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",7.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",7.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",11.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",11.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",12.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",13.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",12.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",12.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",12.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",11.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",12.2,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",11.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",9.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",8.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",2.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",1.7,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",1.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",1.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",366.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",340.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",294.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",227.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",235.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",228.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",231.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",226.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",224.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",227.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",211.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",223.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",209.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",485.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",474.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",377.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",301.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",313.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",253.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",256.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",255.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",265.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",254.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",241.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",264.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",220.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",507.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",477.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",429.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",360.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",385.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",375.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",393.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",393.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",397.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",414,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",388.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",410.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",396,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",43.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",42.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",34.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",27.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",28.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",23.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",23.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",23.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",24.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",23.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",22.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",25.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",21.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",45.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",43,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",38.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",32.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",35.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",34.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",36.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",36.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",37.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",38.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",36.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",38.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",37.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",14338.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",14278.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",12925.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",12938.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",13239.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",13565.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",12865.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",12714.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",12637.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",11775.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",9059.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",9655,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",12042.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",69,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",71,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",57.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",57.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",56.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",48.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",45.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",46.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",46.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",40.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",29.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",31.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",32.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",113.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",114.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",102.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",103.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",102.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",102.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",97.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",93.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",90.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",83.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",62.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",62.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",74.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",6.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",7.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",5.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",5.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",5.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",4.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",4.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",4.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",4.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",4.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",3.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",3.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",11.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",11.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",10.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",10.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",10.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",10.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",9.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",9.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",8.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",6.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",6.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",7.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",2.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",2.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",2.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",1.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",1.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",942.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",966.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",1031.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",1047.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",997.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",1040.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",1062.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",1066.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",1161.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",1102.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",1063.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",1195.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",7.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",8.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",8.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",8.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",8.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",7.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",8.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",10,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",10.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",7.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",9.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",7.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",7.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",7.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",7.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",7.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",7.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",7.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",7.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",8.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",7.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",7.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",24.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",26.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",25.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",26.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",26.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",23.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",26.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",29.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",30.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",24.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",21.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",25.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",22.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",22.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",23.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",23.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",22,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",22.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",22.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",22.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",23.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",21.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",19.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",21.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",3.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",3.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",4.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",4.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",4.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",4.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",3.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",3.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",2.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",2.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",48.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",44.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",54.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",48.1,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",48,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",47.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",44.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",42.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",41.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",39.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",33.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",38.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",64,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",61.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",69.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",63.8,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",63.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",53,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",49.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",48.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",49,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",44,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",38.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",45.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",56.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",53.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",65.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",59.2,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",58.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",58.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",56.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",54,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",52.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",48.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",42.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",48.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",14,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",13.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",15.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",13.8,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",13.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",11.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",10.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",10.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",10.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",8.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",7.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",9.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",12.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",11.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",14.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",12.8,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",12.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",12.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",11.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",11.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",10.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",9.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",8.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",9.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",2.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",2.5,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",2.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",1.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",1.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",1.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",1.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",1124.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",998.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",979.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",974.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",956.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",884.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",871,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",864.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",839.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",689.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",653.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",740.5,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",1565.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",1282.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",1300.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",1294.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",1060.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",978.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",983.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",1020.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",939.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",787.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",773.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",779.7,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",1482.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",1334.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",1328.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",1317.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",1294.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",1262.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",1262.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",1268.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",1277.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",1064.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",1009.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",1199.3,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",26.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",21.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",21.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",21.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",17.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",16.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",16.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",16.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",15.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",13.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",13.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",13.2,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",25,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",22.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",22.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",21.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",21.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",20.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",20.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",21,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",21.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",17.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",17.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",20.3,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",5.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",5.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",4.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",4.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",3.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",3.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",3.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",3.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",2.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",3,"E","Estimated value" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",1524345,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",1553418.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",1384956.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",1321304.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",1328207.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",1345422.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",1264533.9,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",1268716.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",1313986.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",1306743.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",1093254.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",1064966.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",1318.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",1401.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",1229.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",1206.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",1261.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",1189.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",1089.4,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",1121.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",1194.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",1121.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",926.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",931,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",1812.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",1817.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",1620,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",1520.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",1523.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",1569,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",1472.4,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",1453.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",1537.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",1525.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",1305.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",1246.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",26.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",28.1,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",24.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",23.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",24.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",23.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",21.3,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",21.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",23.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",21.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",17.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",18,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",36.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",36.4,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",32.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",30.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",30,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",30.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",28.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",28.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",29.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",29.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",25.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",24.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",7.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",6.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",5.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",5.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",5.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",5,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",4.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",4.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",4.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",3.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",3.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",7.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",6.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",6.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",6.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",5.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",5.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",5.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",5.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",5.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",4.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",4.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",4.5,"D; P","Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",9.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",8.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",8.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",7.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",6.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",6.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",6.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",6.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",4.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",4.7,"D; P","Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",7.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",7.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",7.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",6.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",6.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",6.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",6.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",6.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",6.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",4.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",5.4,"D; P","Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",19.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",19.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",16.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",16.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",15.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",12.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",12.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",11.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",12,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",10.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",8.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",8.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",8.1,"D; P","Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",16.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",15.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",14.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",14,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",13.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",12.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",12.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",12,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",12,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",11.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",8.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",8.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",9.2,"D; P","Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",3.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",3.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",3.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",3.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",3.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",1.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",1.8,"D; P","Difference in methodology; Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",131.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",126.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",120.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",120.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",102.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",174.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",176.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",155,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",159.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",136.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",154.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",151.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",146.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",150.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",127.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",10.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",10.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",9.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",8.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",9.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",9.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",8.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",7.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",2.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",2.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",16.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",18.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",18.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",15.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",15,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",17,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",18.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",15.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",13.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",14.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",15.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",16.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",16.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",12,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",14.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",15.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",13,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",12.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",11.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",12.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",10.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",9.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",9.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",11.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",10.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",11.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",12.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",12.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",11,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",10.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",11.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",12.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",10.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",9.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",10.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",10.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",11.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",11.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",3.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",3.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",2.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",1.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",1.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",2.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",2.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",1.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",1.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",1.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",1.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",1.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",1.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",454,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",448,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",458,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",423,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",454,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",460,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",469,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",434,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",414,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",409,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",413,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",403,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",495,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",75.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",79.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",78.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",72,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",72,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",57,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",55.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",52.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",50.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",46.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",43.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",46.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",51.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",49.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",49.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",50.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",46.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",48.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",46.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",46.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",44.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",43.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",42.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",41.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",42.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",46.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",15.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",16.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",15.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",14.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",14,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",11,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",10.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",9.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",9.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",8.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",8.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",8.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",9.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",10.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",10,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",10.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",9.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",9.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",8.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",8.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",8.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",8.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",7.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",7.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",8.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",2.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",2.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",2.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",2.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",1.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",1.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",1.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",1.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",1.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",1.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",1.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",102.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",91.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",75.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",68.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",64.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",66.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",63.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",59.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",61.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",60.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",45.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",45.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",57.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",135.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",127.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",97.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",91.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",86.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",74.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",70.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",67.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",72.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",67.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",52.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",53.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",61,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",164.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",146.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",125.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",117.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",112,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",114.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",110.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",104.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",108,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",108.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",82,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",80,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",105.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",12.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",12,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",9.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",8.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",8.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",7.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",6.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",6.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",7.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",6.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",5.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",5.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",5.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",15.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",13.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",11.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",11.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",10.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",11,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",10.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",10.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",10.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",10.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",7.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",10.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",3.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",3.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",2.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",2.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",1.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",1.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",1.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",52.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",64.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",74.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",55.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",60.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",65.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",42.3,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",41,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",41.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",40.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",32.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",38.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",69.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",89.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",95.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",73.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",80.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",72.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",46.8,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",46.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",49.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",45.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",37.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",45.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",104.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",126.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",147.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",113.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",125.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",132.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",84.1,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",79.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",79.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",78.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",62.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",71.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",13,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",16.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",17.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",13.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",14.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",13.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",8.6,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",8.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",9.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",8.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",6.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",8.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",19.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",23.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",27.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",20.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",23.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",24.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",15.5,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",14.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",14.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",14.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",11.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",13.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",4.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",5.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",6.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",4.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",4.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",4.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",2.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",2.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",2.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",2.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",2.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",305.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",260.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",227.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",227.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",250.8,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",249.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",243,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",237.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",480,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",488.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",449.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",466.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",486.7,"P","Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",404.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",363.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",292.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",302.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",333.1,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",277.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",268.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",268.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",566.9,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",546.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",513.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",551.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",512.5,"P","Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",419.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",365.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",327.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",337.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",378.6,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",375.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",378.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",376.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",759.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",796.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",723,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",745,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",816.3,"P","Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",8.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",7.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",6.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",6.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",7.2,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",5.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",5.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",12.1,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",11.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",10.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",11.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",10.8,"P","Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",7.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",7.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",8.1,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",8.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",8.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",8.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",16.2,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",16.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",15.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",15.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",17.2,"P","Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",2.2,"B; D","Break; Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",2.5,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",2.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",2.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",2.1,"P","Provisional value" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",1003,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",934.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",850.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",720.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",710.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",749.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",724.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",694.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",692.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",738.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",713.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",686.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",728.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",139.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",143.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",125.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",110.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",103.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",88.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",84.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",81.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",79.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",78.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",77.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",80.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",72,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",111.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",105.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",98.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",83.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",81.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",84.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",82.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",78.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",78.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",84.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",82.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",78.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",84.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",14.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",15.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",13.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",11.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",10.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",9.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",8.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",8.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",7.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",7.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",7.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",7.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",6.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",11.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",11.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",10.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",8.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",8.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",8.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",8.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",7.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",7.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",8.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",7.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",7.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",2.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",2.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",1.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",1.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",1.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",1.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",1.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",1.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",1.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",1.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",1.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",1925.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",1340.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",1246.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",1182.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",1141.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",1289.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",1450.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",1448.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",1701.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",2350.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",1985.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",2387.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",1281.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",800.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",694.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",621.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",521.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",474,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",480.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",397.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",352.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",414.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",283.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",269.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",2091.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",1387.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",1222.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",1105.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",1033.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",1109.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",1169,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",1046.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",1042.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",1260.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",917.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",850.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",17.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",10.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",9.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",8.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",6.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",6.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",6.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",4.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",4.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",3.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",3.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",28.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",18.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",16.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",14.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",13.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",14.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",14.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",13,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",12.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",15.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",11,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",10.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",12.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",9.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",9.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",8.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",7.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",6.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",5.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",5.3,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",5.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",3.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",38463.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",60319.9,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",67944,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",70741,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",72295.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",79384.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",83434.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",79791.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",77671.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",79619.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",71250.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",77557.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",100217.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",75.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",124.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",139.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",142.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",126.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",121.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",123.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",123,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",121.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",113.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",89.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",102.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",114.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",106.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",173.3,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",195.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",202.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",196.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",202.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",210,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",200.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",196,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",198.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",170.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",178.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",229,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",4.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",7.2,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",8.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",7.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",6.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",6.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",6.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",6.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",5.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",4.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",5.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",5.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",6.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",10,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",11.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",11.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",11.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",11.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",11.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",10.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",10.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",10.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",8.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",9.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",11.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",4.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",5.1,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",5.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",4.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",4.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",4.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",4.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",3.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",3.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",3.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",2.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",2.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",3.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",7.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",8.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",7.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",7.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",6.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",6.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",6.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",6.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",6.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",6.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",6.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",7.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",10.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",11.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",10.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",9.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",9.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",7.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",7.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",7.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",7.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",7.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",7.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",7.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",7.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",15.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",15.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",15.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",14,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",13.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",12.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",13,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",12.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",12.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",12.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",12.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",11.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",12.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",7.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",8.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",7.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",7.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",7.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",5.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",5.8,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",5.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",5.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",5.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",5.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",5.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",11.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",11.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",11.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",10.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",10.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",9.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",9.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",9.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",9.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",9.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",9.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",8.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",9.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",3.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",3.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",3.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",2.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",2.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",2.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",2.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",1.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",1.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",1.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",1.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",11.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",11.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",11.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",11.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",11.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",11.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",11.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",11.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",11.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",11.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",9.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",12.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",15.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",16.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",14.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",15.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",14.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",12.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",12.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",12.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",13.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",13.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",10.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",11.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",12.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",18.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",18.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",18.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",19.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",18.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",19.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",19.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",19.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",19.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",21.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",17.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",17.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",22.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",7.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",7.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",7.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",7.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",6.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",6.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",6.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",6.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",5.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",5.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",6.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",9.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",9.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",9.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",9.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",9.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",9.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",9.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",10.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",8.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",8.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",10.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",2.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",2.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",2.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",1.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",1.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",1.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",324,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",309,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",312,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",378,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",383,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",401,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",426,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",429,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",500,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",535,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",570,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",584,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",297.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",318.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",323,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",364.9,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",345.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",301.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",316.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",328.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",373.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",371.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",392.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",438.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",215.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",204.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",202.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",261.2,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",263.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",272.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",293.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",290.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",340,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",361.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",392,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",403.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",13.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",14.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",14.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",15.8,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",14.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",12.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",13.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",13.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",15,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",14.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",15.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",17.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",9.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",9.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",8.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",11.3,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",11.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",11.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",12.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",11.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",13.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",14.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",15.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",15.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",3.2,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",2.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",2.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",109.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",109.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",107.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",101.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",100.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",100.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",102.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",105.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",105.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",107.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",106.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",116.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",145.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",152.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",138.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",134.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",133.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",111.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",113.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",119.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",124.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",120.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",121.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",137.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",130.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",131.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",132.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",127,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",125.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",125.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",132.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",136.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",137.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",143.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",142.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",154.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",17.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",18.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",16.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",15.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",15.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",12.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",13,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",13.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",14,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",13.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",13.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",15.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",15.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",15.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",15.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",15,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",14.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",14.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",15.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",15.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",15.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",16.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",16,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",17.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",4.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",4.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",4.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",3.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",3.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",3.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",3.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",250.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",250.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",249.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",251.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",254.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",256.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",254.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",247.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",236.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",253.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",231.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",218.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",242.6,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",331.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",349.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",320.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",334.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",338.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",284.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",281.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",279.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",279.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",283.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",264.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",258.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",255.4,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",299.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",301.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",303.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",312.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",318.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",320.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",325.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",319.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",308.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",339.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",316.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",296.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",339.7,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",30.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",31.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",28.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",30,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",30.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",25.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",24.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",24.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",24.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",24.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",22.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",22.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",22,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",27.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",27.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",27.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",28,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",28.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",28.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",28.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",28.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",27,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",29.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",27.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",25.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",29.2,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",4.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",4.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",4.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",4.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",4.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",4.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",4.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",3.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",3.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",3.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",2.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",2.7,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",980.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",989.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",988,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",907,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",910.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",929.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",978,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",1061.5,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",1060.8,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",1182.8,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",1176.3,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",981.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",960.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",894.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",709.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",687.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",716.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",754.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",800,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",791,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",943.3,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",903.8,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",788,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",808.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",803,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",726.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",754.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",766.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",810.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",859.7,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",861.7,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",955.3,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",938.2,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",28.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",27.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",25.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",19.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",19,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",19.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",20.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",21.3,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",20.8,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",24.7,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",23.2,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",22.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",23,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",22.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",20.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",20.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",21,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",21.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",22.9,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",22.7,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",25,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",24.1,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",3.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",3.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",3.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",3.3,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",3.1,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",3.2,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",2.9,"E; D","Estimated value; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",4066.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",3994.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",4113.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",4023.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",4051.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",3999.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",4145.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",4340.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",5176.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",5269.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",2204.5,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",2384.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",212.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",225.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",210.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",205.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",195.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",162.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",169.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",185.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",238.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",229.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",95,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",110,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",297.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",299.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",309.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",314.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",319,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",309.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",329.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",349.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",418.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",429.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",176.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",187.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",20.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",21.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",20,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",19.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",18.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",15.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",16.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",17.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",22.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",21.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",8.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",10.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",28.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",28.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",29.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",29.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",30.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",29.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",31.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",33,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",39.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",40.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",16.5,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",17.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",4.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",4.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",4.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",4.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",4.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",5.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",5.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",2.5,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",2.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",618.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",646,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",543.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",551.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",534.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",578.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",593.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",598.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",630.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",713.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",667.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",610,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",109.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",120.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",93.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",98.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",95.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",86,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",88.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",90.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",99.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",107,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",102,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",97,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",81.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",86.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",71.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",75,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",72.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",79.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",83.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",87,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",93.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",107.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",101.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",92.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",19.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",21.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",16.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",17.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",16.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",15.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",15.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",15.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",17.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",18.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",17.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",16.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",14.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",15.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",12.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",13.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",12.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",13.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",14.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",15.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",16.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",18.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",17.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",15.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",2.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",3.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",2.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",2.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",2.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",2.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",2.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",2.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",2.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",2.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",2.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",91,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",91,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",96.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",96.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",98.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",98.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",97.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",96.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",101.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",102.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",97.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",99.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",120.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",126.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",123.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",128.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",131.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",109,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",108.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",108.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",120.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",114.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",111.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",117.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",101.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",101.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",105.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",106.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",109,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",108.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",111,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",111.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",119.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",122.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",118.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",120.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",22.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",23.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",22.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",23.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",24.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",19.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",19.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",19.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",21.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",20.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",20.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",21.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",18.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",18.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",19.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",19.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",20,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",19.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",20.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",20.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",21.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",22.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",21.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",21.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",4.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",4.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",4.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",4.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",4.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",4.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",4.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",4.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",4.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",3.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",3.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",3.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",934.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",1301.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",1111.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",20,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",17.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","FRA","France","2011","2011",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",1336.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",1285.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",1338.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",1361.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",1386,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",1397.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",1405.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",1390.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",1295.1,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",1296.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",1242.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",1413.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",1771.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",1788.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",1719.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",1808.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",1841.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",1550.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",1555.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",1570.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",1529.5,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",1451.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",1419.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",1671.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",1659.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",1629.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",1699.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",1757.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",1802.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",1795.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",1867,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",1866.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",1761,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",1780,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",1714.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",1919.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",21.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",22.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",21.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",22.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",22.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",19,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",18.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",19,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",18.4,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",17.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",17.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",20.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",20.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",20.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",21.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",21.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",22.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",22,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",22.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",22.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",21.2,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",21.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",20.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",23.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",4.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",4.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",4.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",4.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",4.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",3.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",3.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",2.9,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",2.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",2.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",2.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",317.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",275.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",245,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",221,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",211.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",187.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",215.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",212.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",236.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",233.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",237.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",243.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",228.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",420.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",383.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",314.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",293.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",280.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",207.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",238.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",239.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",279.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",261.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",271.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",288.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",240.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",439.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",386.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",357.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",350.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",345.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",307.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",366.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",368.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",419.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",426.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",437.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",446.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",432.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",37.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",34.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",28.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",26.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",25.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",19.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",22.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",22.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",26.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",24.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",25.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",27.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",23,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",39.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",34.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",32.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",31.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",31.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",28.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",34,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",34.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",39.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",39.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",40.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",42.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",41.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",22271.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",21144.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",19341.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",18632.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",17751.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",17492.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",17665.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",17723.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",17843.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",18397.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",17674.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",17380.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",18106.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",107.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",105.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",85.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",83.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",76.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",62.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",62.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",64.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",66,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",63.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",57.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",57.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",48.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",176.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",170.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",154,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",149.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",137.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",132,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",133.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",130.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",128.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",130.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",121.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",112.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",112.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",10.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",10.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",8.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",8.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",7.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",6.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",6.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",6.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",6.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",6.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",5.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",5.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",17.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",17.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",15.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",15.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",13.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",13.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",13.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",13.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",13.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",13.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",12.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",11.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",11.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",4.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",4.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",4.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",4.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",3.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",3.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",3.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",3.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",3.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",3.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",1220.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",760.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",765,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",945.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",699.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",645.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",697.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",698.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",761.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",936.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",1184.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",1260.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",10,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",6.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",6.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",7.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",4.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",5.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",6.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",7.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",8.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",9.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",9.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",5.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",5.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",6.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",5.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",4.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",5.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",5.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",6.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",8.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",8.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",31.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",20.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",19.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",23.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",18.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",14.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",17.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",19,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",19.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",21.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",23.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",26.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",28.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",17.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",17.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",21.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",15.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",13.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",14.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",14.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",15.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",18.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",22,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",22.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",4.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",2.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",3.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",3.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",2.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",2.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",2.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",2.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",2.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",88.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",74.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",74.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",67.1,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",66,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",66.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",67.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",67.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",68.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",70.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",71.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",75.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",116.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",104.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",96.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",89.1,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",87.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",73.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",74.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",76.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",80.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",79.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",81.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",89.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",103.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",90.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",90.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",82.7,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",80.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",81.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",84.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",85,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",86.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",87.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",89.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",95.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",25.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",22.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",20.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",19.3,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",18.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",15.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",15.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",15.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",16.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",16,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",16.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",17.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",22.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",19.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",19.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",17.9,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",17.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",17.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",17.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",17.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",17.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",17.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",18,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",18.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",4.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",3.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",3.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",3.4,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",2.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",2.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",2.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",640.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",589.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",551.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",505.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",485.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",467.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",462,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",534.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",538.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",521.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",533.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",579.1,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",891,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",757.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",732,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",672.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",538.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",517.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",521.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",630.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",603,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",595.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",631.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",609.8,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",843.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",788.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",747.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",683.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",656.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",667.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",669.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",784,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",820.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",804.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",824.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",937.9,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",15,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",12.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",12.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",11.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",8.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",8.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",8.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",10.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",10.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",10,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",10.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",10.3,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",14.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",13.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",12.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",11.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",10.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",11,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",11.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",13,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",13.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",13.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",13.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",15.9,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",3.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",3.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",2.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",2.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",2.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",2.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",2.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",2.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",2.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",2.3,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",1236172,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",1380748.4,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",1278113.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",1291743.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",1352796.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",1360086.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",1350832.8,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",1415318.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",1521399.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",1642015.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",1708187.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",1819792.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",1068.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",1245.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",1134.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",1179.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",1284.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",1202.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",1163.7,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",1251.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",1382.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",1409,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",1447.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",1590.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",1469.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",1615.7,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",1495.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",1486.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",1551.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",1586.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",1572.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",1621.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",1779.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",1917.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",2039.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",2130.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",21.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",24.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",22.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",23.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",25.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",23.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",22.7,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",24.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",26.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",27.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",27.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",30.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",29.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",32.4,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",29.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",29.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",30.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",31.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",30.7,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",31.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",34.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",37,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",39.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",41.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",6.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",6.3,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",5.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",5.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",5.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",5.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",5.3,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",5.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",5.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",5.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",5.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",5.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",9.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",9.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",9.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",10.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",10.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",10.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",11.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",10.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",10.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",9.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",8.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",9.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",9.1,"D; P","Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",12.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",12.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",12.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",13.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",14.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",11.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",12.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",12.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",12.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",11.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",9.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",10.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",9.6,"D; P","Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",10.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",10.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",10.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",11.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",12.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",12.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",13.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",12.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",12.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",11.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",10.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",10.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",11,"D; P","Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",27,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",26.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",25.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",27.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",27.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",23,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",23.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",22.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",22.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",20,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",17.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",18.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",16.4,"D; P","Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",22,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",21.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",21.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",23.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",23.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",23.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",25,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",23.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",22.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",21.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",17.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",18.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",18.7,"D; P","Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",5.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",4.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",5.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",5.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",5.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",5.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",5.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",5.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",4.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",4.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",3.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",3.5,"D; P","Difference in methodology; Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2010","2010",5495,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2011","2011",4208,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2012","2012",4445,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2013","2013",3553,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2014","2014",3091,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2015","2015",3283,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2016","2016",2604,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2017","2017",2708,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2018","2018",2023,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2019","2019",2559.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2020","2020",2274.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2021","2021",2395.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","MEX","Mexico","2022","2022",2280.5,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2010","2010",434.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2011","2011",338.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2012","2012",337.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2013","2013",278.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2014","2014",232.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2015","2015",207.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2016","2016",139.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2017","2017",143.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2018","2018",105.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2019","2019",132.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2020","2020",105.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2021","2021",118.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2022","2022",113.3,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2010","2010",715.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2011","2011",548.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2012","2012",565.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2013","2013",450.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2014","2014",384.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2015","2015",394.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2016","2016",308.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2017","2017",303.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2018","2018",218.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2019","2019",264.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2020","2020",226.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2021","2021",230.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2022","2022",215.6,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2010","2010",3.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2011","2011",2.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2012","2012",2.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2013","2013",2.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2014","2014",1.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2015","2015",1.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2016","2016",1.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2017","2017",1.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2018","2018",0.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2019","2019",1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2020","2020",0.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2021","2021",0.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2022","2022",0.9,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2010","2010",6.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2011","2011",4.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2012","2012",4.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2013","2013",3.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2014","2014",3.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2015","2015",3.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2016","2016",2.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2017","2017",2.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2018","2018",1.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2019","2019",2.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2020","2020",1.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2021","2021",1.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2022","2022",1.7,"E","Estimated value" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","MEX","Mexico","2013","2013",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","MEX","Mexico","2018","2018",0.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",160.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",148.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",136.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",133.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",121.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",212.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",206.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",175.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",177.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",160.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",187.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",177.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",165.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",167.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",149.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",12.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",12.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",10.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",10.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",9.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",11.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",10.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",9.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",9.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",8.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",3.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",2.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",3.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",2.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",25.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",26.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",23.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",24.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",24.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",21.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",21.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",21.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",23.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",24,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",12.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",14.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",18.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",18.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",20.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",18.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",19.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",20.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",15.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",15.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",15.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",16.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",15.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",8.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",10.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",12,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",17.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",17.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",15.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",16.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",17.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",14.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",15.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",15.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",16,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",16.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",10.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",13.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",4.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",4.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",4.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",4.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",4.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",1.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",2.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",3.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",3.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",3.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",3.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",1.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",2.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",2.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",2.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",2.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",2.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",1.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",1.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",1.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",609,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",630,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",661,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",714,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",754,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",833,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",922,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",998,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",1137,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",1165,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",1152,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",1336,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",1417,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",100.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",112.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",113.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",121.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",119.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",103.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",109.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",120.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",139.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",132.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",122.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",155.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",147.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",66.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",69.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",73.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",79.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",81.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",83.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",91.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",102.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",118.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",121.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",116.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",140.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",131.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",20.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",22.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",22.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",23.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",23.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",19.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",21,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",22.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",26.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",24.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",22.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",28.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",27.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",13.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",14,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",14.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",15.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",15.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",16.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",17.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",19.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",22.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",22.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",21.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",26,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",24.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",3.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",3.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",3.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",3.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",3.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",3.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",3.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",3.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",4.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",4.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",3.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",3.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",252.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",226.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",204.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",184.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",172.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",169.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",167,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",161.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",161,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",165.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",151.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",160.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",176.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",334.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",315.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",262.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",245.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",229.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",187.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",184.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",182,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",190.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",185,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",173.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",190,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",185.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",405.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",363.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",337.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",316.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",298,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",289.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",292.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",279.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",281.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",295.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",272.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",282.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",321.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",31.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",29.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",25,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",23.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",22,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",18.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",17.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",17.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",18.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",18,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",16.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",18.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",18,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",38.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",34.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",32.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",30.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",28.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",27.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",28.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",27.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",27.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",28.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",26.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",27.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",31,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",7.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",7.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",7.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",7.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",7.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",6.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",6.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",6.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",6.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",5.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",5.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",5.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",5.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",62.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",63.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",59.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",65.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",69.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",67,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",76.7,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",79.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",84.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",98.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",94.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",107.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",83.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",87.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",77,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",87.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",91.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",74.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",84.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",90.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",99.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",109.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",108.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",127.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",125.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",124.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",118.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",133.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",142.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",136.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",152.4,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",154.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",160.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",189.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",182,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",201.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",15.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",16.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",14.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",16.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",16.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",13.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",15.6,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",16.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",18.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",20.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",19.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",23.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",23.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",23.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",22,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",24.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",26.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",25.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",28.1,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",28.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",29.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",34.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",33.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",37,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",5.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",5.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",5.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",5.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",5.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",4.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",4.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",5.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",5.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",5.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",5.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",845.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",759.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",635.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",548.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",509.4,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",461.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",465.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",448.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",512.4,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",531.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",511.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",560.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",611,"P","Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",1121,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",1056.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",816.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",728.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",676.7,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",512.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",515.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",506.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",605.1,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",595.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",584.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",662.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",643.4,"P","Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",1163.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",1063,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",914.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",812.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",769.1,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",694.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",724.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",710.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",811,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",867.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",823.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",895.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",1024.7,"P","Provisional value" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",24.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",22.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",17.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",15.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",14.6,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",11,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",11.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",10.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",12.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",12.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",12.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",14,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",13.6,"P","Provisional value" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",25,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",22.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",19.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",17.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",16.5,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",14.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",15.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",15.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",17.3,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",18.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",17.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",18.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",21.6,"P","Provisional value" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",6.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",6.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",5.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",5.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",4.5,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",3.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",3.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",2.7,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",2.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",2.7,"P","Provisional value" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",1241.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",1181.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",1188.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",1249.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",1287.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",1375.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",1502.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",1595.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",1751.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",1913.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",1861.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",1920.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",1984.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",172.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",182,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",175.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",191.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",187.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",163,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",175.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",186.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",201.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",202.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",202.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",224,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",196.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",137.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",133.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",137.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",145.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",147.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",155.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",170.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",180.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",197.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",219.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",214.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",220.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",229,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",18.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",19.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",18.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",20,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",19.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",16.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",17.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",18.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",19.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",19.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",19.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",21.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",18.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",14.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",14.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",14.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",15.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",15.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",15.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",17.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",17.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",19.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",21.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",20.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",21.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",21.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",3.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",3.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",3.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",3.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",3.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",3.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",3.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",3.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",3.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",3.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",3.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",3.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",3.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",346.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",345,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",356,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",355,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",383,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",398,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",416,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",427,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",418,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",430,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",408,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",421,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",412,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",331.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",388.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",379.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",383,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",418.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",413.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",422.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",433.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",427.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",432.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",434.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",460.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",431.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",236.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",246.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",262.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",270.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",298.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",322.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",346.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",359.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",354.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",373.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",359.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",380.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",386.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",42.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",49.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",47.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",47.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",51.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",49.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",50.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",51.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",50.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",50.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",50.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",52.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",49.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",30.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",31.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",32.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",33.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",36.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",38.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",41.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",42.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",41.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",43.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",41.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",43.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",44.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",6.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",6.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",6.5,"B; D","Break; Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",6.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",6.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",6.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",5.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",5.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",1085.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",954.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",911,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",913.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",955.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",1082.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",1295.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",1578.9,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",1915.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",2441.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",2509.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",3327.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",722.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",569.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",507.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",479.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",436.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",398.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",428.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",432.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",396.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",430.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",358,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",376,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",1179.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",987.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",893.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",853.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",865.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",931.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",1043.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",1140.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",1173,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",1309.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",1159.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",1185.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",9.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",7.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",6.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",6.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",5.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",5.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",5.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",5.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",4.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",5.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",4.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",4.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",16.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",13.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",11.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",11.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",11.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",11.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",13.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",14.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",14.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",15.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",13.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",14.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",6.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",6.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",6.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",6.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",5.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",5.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",6.2,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",5.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",5.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",359.8,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",374.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",402.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",440.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",457.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",492.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",532.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",568.4,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",585.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",661.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",672.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",618.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",634.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",710.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",512.8,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",538.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",575.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",635.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",664.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",719.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",774,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",8.9,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",9.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",10.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",10.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",9.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",9.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",10.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",8,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",8.4,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",8.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",9.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",10.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",10.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",11.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",2.6,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",2.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",2.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",2.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",68438.5,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",61502,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",86133.7,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",87138.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",107902.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",123321.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",120374.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",116144,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",121434.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",98242.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",105910.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",151550.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",129489.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",134.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",127.2,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",177.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",175.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",189.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",188.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",177.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",179,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",189.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",139.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",133.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",199.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",148.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",190.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",176.7,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",248.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",249.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",293.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",315.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",303,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",292,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",306.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",244.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",253.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",348.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",295.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",7.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",7.4,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",10.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",10,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",10.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",10.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",9.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",9.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",10.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",7.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",6.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",10.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",7.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",11.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",10.2,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",14.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",14.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",16.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",17.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",16.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",15.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",16.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",12.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",13,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",17.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",14.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",8.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",5.2,"B","Break" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",6.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",6.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",5.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",5.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",5.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",3.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",3.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",5.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",4.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",10.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",11.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",12.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",13.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",14.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",15.6,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",16.4,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",16.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",17.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",18.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",18.2,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",19.3,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",24.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",14.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",15.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",15.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",17.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",19.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",17.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",18.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",19,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",20.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",20.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",20.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",22.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",26.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",21.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",21.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",23.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",25.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",27.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",29.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",31,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",31.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",31.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",33.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",34.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",35.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",43.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",10.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",11.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",11.9,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",13.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",14.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",13.2,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",13.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",14.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",15.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",15.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",15.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",17.1,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",19.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",15.8,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",16.3,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",17.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",19.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",20.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",22.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",23.6,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",23.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",24.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",25.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",26.2,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",26.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",32.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",5.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",5.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",5.5,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",5.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",5.8,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",5.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",5.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",5.6,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",5.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",5.3,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",5.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",4.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",5.8,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",21,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",19.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",18.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",17.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",15.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",15.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",15.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",16.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",17.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",18.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",19,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",19.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",29.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",27.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",26.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",23.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",23.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",20.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",17.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",17.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",18.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",20.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",21.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",21.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",23.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",30.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",32.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",31,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",30.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",29.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",26.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",26.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",27,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",28.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",31.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",34.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",34.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",35.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",52.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",13.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",13.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",11.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",11.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",10.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",8.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",8.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",10.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",10.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",10.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",11.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",14.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",16.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",15.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",14.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",14.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",12.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",12.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",13.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",13.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",15,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",16.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",16.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",16.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",25.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",4.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",4.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",4.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",3.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",3.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",3.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",3.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",3.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",3.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",3.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",4.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",102,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",93,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",85,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",128,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",122,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",119,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",115,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",104,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",104,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",102,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",103,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",103,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",93.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",95.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",88,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",123.6,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",110,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",89.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",85.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",79.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",77.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",70.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",70.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",77.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",67.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",61.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",55.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",88.5,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",84,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",80.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",79.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",70.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",70.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",68.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",70.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",71.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",4.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",4.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",3.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",5.3,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",4.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",3.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",3.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",3.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",3.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",2.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",3.8,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",3.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",3.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",3.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",2.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",2.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",1.1,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",0.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",42.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",42.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",43.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",43.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",42.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",41.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",41.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",40.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",37.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",37.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",35.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",35.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",55.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",59.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",55.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",57.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",56.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",46.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",46,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",45.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",44.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",41.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",40.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",42.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",50,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",51.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",53.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",54.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",53.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",52.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",53.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",52.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",49.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",49.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",47.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",47.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",6.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",7.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",6.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",6.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",6.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",5.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",5.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",5.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",4.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",4.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",4.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",6.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",6.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",6.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",6.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",6.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",6.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",5.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",5.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",5.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",5.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",5.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",1.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",1.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",1.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",1.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",1.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",1.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",1.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",1.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",112,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",117.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",117.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",114.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",110.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",109.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",109,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",104.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",96,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",96.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",79.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",81.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",94.3,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",148.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",163.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",150.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",151.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",147.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",121.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",120.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",118.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",113.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",107.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",90.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",95.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",99.3,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",133.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",141.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",142.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",141.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",138.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",137.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",139.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",134.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",125.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",128.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",108.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",110.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",132,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",13.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",14.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",13.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",13.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",13.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",10.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",10.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",10.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",9.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",7.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",8.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",8.5,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",12.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",12.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",12.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",12.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",12.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",12.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",12.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",11.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",11,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",11.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",9.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",9.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",11.4,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",1.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",1.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",1.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",1.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",1.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",1,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",454.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",455.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",450.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",338,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",321.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",308.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",331.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",361.6,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",292.3,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",336.6,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",305.7,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",454.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",441.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",407.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",264.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",242.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",237.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",256,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",272.5,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",217.9,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",268.4,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",234.9,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",364.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",371.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",365.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",270.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",266.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",254.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",275,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",292.8,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",237.4,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",271.8,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",243.8,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",13.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",12.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",11.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",7.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",6.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",6.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",6.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",7.2,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",5.7,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",7,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",6,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",10.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",10.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",10.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",7.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",7.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",7.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",7.8,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",6.2,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",7.1,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",6.3,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",1.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",1.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",1.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",1.1,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",0.9,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",0.9,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",0.8,"E; D","Estimated value; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",1746.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",1757.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",1849,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",1848.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",1840.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",1783.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",1788.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",1841.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",1941.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",1973.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",884.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",898.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",91.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",99.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",94.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",94.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",88.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",72.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",73.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",78.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",89.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",86.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",38.1,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",41.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",127.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",131.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",139,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",144.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",144.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",137.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",142.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",148.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",157,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",160.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",71,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",70.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",8.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",9.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",8.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",6.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",6.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",7.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",8.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",8.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",3.6,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",3.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",12.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",12.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",13.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",13.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",13.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",13.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",13.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",14,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",14.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",15.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",6.6,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",6.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",2.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",2.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",1,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",51.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",53.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",55.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",53.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",54,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",52.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",52.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",49.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",45.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",45.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",42.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",42.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",68.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",74.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",71.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",71.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",71.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",58.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",57.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",55.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",53.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",51.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",48.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",49.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",57.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",59.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",61.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",59.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",59.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",57.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",59.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",57,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",53.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",54.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",52,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",50.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",12.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",13.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",13.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",13.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",13.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",10.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",10.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",10.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",9.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",9.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",8.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",10.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",11,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",11.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",10.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",10.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",10.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",10.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",10.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",9.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",9.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",9.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",2.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",2.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",2.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",2.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",2.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",1.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",1.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",1.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",1.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",555.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",555,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",591.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",617.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",620.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",606.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",588.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",556.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",531.4,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",517.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",482.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",496.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",735.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",772.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",759.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",820.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",824.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",672.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",651.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",628.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",627.6,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",579.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",550.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",586.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",689.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",703.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",751.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",797.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",806.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",779.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",782.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",747.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",722.6,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",710.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",665,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",673.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",9.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",9.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",10.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",10.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",8.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",7.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",7.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",7.6,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",6.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",7.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",8.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",8.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",9.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",9.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",10,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",9.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",9.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",8.7,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",8.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",8.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",1.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",1.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",1.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",1.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",1.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",1.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",1.2,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",101.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",83.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",74.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",67.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",66,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",62.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",66.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",64.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",65.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",63.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",55.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",57,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",55.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",134.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",115.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",95.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",89.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",87.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",69.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",73.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",72.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",77.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",71.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",63.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",67.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",58.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",140.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",116.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",108.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",107.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",108.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",102.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",112.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",111.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",116,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",116.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",102.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",104.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",104.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",12.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",10.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",8.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",8.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",8.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",6.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",6.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",6.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",7.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",6.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",6.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",5.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",12.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",10.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",9.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",9.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",9.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",10.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",10.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",10.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",10.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",9.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",10,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",6442.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",5672.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",5181.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",5250,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",5568.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",5542.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",5595.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",5629.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",5578.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",5610.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",5439.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",5220.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",4952.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",31,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",28.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",23,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",23.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",23.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",19.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",19.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",20.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",20.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",19.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",17.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",17.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",13.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",51,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",45.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",41.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",42,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",43,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",41.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",42.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",41.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",40.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",39.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",37.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",33.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",30.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",3.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",2.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",2.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",2.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",2.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",2.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",1.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",5.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",4.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",4.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",4.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",4.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",4.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",4.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",4.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",4.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",4.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",3.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",3.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",1.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",1.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",903.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",485.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",482.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",638.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",446,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",430.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",431.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",431.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",404.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",426.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",504.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",550.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",7.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",4.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",3.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",5.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",3.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",3.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",3.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",3.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",3.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",3.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",4.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",6.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",3.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",3.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",4.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",3.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",3.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",3.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",2.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",3.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",3.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",23.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",13.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",12,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",16.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",11.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",10.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",11.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",10.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",9.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",10.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",11.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",21.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",11.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",11,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",14.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",9.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",9.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",9.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",9.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",8.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",8.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",9.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",3.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",2.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",1.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",1.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",1.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",1.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",1.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",1.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",1.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",34.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",29.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",27.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",21.3,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",19.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",19.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",19.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",17.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",15.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",15,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",14.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",15.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",45.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",41.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",35.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",28.3,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",26.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",21.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",21.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",20.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",18.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",16.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",17,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",18,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",40.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",36,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",33.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",26.3,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",24.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",24.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",24.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",22.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",19.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",18.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",18.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",19.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",10,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",9.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",7.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",6.1,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",5.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",4.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",4.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",4.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",3.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",3.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",3.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",8.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",7.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",7.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",5.7,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",5.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",5.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",5.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",4.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",1.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",1.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",1.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",1.1,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",250,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",234.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",235.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",232.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",209.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",195.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",174.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",152.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",149.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",139.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",146.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",155.9,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",347.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",301.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",312.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",309,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",232,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",216,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",197.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",180.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",167.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",159.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",173.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",164.1,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",329.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",313.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",319,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",314.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",283.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",278.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",253.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",223.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",228.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",215.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",226.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",252.4,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",5.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",5.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",5.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",5.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",3.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",3.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",3.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",2.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",2.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",2.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",2.8,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",5.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",5.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",5.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",5.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",4.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",4.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",4.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",3.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",3.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",3.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",3.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",4.3,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",1.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",1.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",1.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",1.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",0.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",0.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",0.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0.6,"E","Estimated value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",621791,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",637074,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",576586.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",574582.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",610839.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",633297.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",598544.4,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",619492.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",668448,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",705416.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",713909.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",747821.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",537.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",574.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",511.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",524.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",580.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",560,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",515.6,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",547.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",607.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",605.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",604.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",653.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",739.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",745.5,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",674.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",661.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",700.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",738.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",696.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",709.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",781.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",823.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",852.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",875.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",10.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",11.5,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",10.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",10.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",11.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",11,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",10.1,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",10.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",11.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",11.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",11.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",12.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",14.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",14.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",13.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",13.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",13.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",14.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",13.6,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",13.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",15.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",15.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",16.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",16.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",3.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",2.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",2.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",2.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",2.4,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",5.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",5.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",6.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",6.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",5.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",5.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",5.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",5.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",4.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",4.1,"D; P","Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",7.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",7.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",7.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",8.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",8.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",6.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",6.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",6.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",6.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",5.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",4.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",4.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",4.3,"D; P","Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",6.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",6.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",6.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",6.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",6.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",6.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",6.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",5.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",4.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",4.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",4.9,"D; P","Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",15.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",15.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",15.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",16.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",15.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",12.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",12.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",11.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",11.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",9.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",8.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",7.3,"D; P","Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",12.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",12.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",13.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",13.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",13.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",12.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",13.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",12,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",11.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",10.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",8.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",8.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",8.4,"D; P","Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",2.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",2.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",3.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",3.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",3.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",3.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",2.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",2.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",1.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",1.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",1.6,"D; P","Difference in methodology; Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",94.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",91.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",83.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",80.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",69,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",125,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",127.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",107.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",107.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",91.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",110.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",109.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",101.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",101.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",85.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",7.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",7.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",6.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",6.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",5.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",6.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",6.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",6.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",5.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",1.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",1.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",6.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",6.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",7.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",7.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",7.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",7.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",7.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",6.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",7.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",6.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",6.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",10.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",4.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",5.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",5.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",6.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",5.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",5.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",4.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",4.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",4.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",4.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",6.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",4.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",4.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",4.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",5.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",5.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",5.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",5.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",4.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",4.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",5.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",4.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",4.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",7.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",1.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",1.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",1.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",1.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",1.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",1.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",1.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",0.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",425,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",437,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",446,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",464,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",474,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",515,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",537,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",550,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",514,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",528,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",540,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",594,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",620,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",70.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",78,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",76.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",79,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",75.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",63.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",63.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",66.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",63.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",60,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",57.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",69.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",64.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",46.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",48.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",49.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",51.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",51.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",51.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",53.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",56.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",53.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",54.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",54.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",62.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",57.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",14.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",15.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",15.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",15.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",14.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",12.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",12.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",12.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",11.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",11.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",10.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",12.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",11.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",9.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",9.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",9.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",10.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",10,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",10.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",10.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",10.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",10.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",10.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",11.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",10.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",2.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",1.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",1.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",1.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",127.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",112.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",105,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",99.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",98.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",97.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",96.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",93,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",92,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",92.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",80.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",81.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",94.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",169.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",156.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",135,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",132.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",130.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",108.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",107.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",105.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",108.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",103.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",92.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",96.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",99.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",205.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",180.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",173.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",171,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",169.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",166.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",169.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",161.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",161.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",164.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",145.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",144.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",171.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",16,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",14.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",12.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",12.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",12.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",10.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",10.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",10.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",10.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",10,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",9.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",9.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",19.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",17.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",16.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",16.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",16.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",16.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",16.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",15.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",15.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",16,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",14.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",13.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",16.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",3.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",4.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",4.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",3.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",3.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",3.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",3.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",2.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",2.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",28.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",28.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",25.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",29.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",30.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",28.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",34.1,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",28.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",35.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",36.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",36,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",41.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",37.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",39.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",33.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",38.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",40.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",32.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",37.7,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",32.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",41.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",40.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",41.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",49.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",56.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",55.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",51.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",59.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",62.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",58.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",67.7,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",55.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",66.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",70.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",69.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",78,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",7.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",6.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",7.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",7.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",5.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",6.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",5.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",7.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",7.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",7.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",10.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",10.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",9.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",11,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",11.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",10.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",12.5,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",10.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",12.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",12.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",12.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",14.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",2.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",2.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",2.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",2.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",2.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",2.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",2.2,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",1.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",2.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",403,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",385,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",352.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",332.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",309.3,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",272.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",269.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",246.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",225.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",222.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",209.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",232.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",257.3,"P","Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",534.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",535.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",452.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",441.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",410.9,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",302,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",298.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",278.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",266.8,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",248.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",239.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",275.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",271,"P","Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",554.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",539,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",507.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",493,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",467,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",409.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",420,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",391.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",357.6,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",362.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",337.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",372,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",431.6,"P","Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",11.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",11.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",9.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",9.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",8.8,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",6.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",6.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",5.7,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",5.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",5.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",5.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",5.7,"P","Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",11.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",11.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",10.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",10.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",10,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",8.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",8.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",7.6,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",7.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",7.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",7.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",9.1,"P","Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",3.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",3.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",3.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",2.7,"B; D","Break; Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",2.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",2.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",1.2,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",1.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",1.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",1.1,"P","Provisional value" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",739.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",710,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",722.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",715.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",718.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",752.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",800.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",761.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",746.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",756.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",658.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",639.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",722.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",102.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",109.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",106.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",109.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",104.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",89.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",93.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",89,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",85.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",80,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",71.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",74.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",71.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",82,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",80.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",83.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",83.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",82.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",85,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",90.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",86,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",84.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",86.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",76,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",73.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",83.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",10.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",11.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",11.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",11.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",10.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",9.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",9.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",8.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",8.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",7.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",6.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",7.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",6.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",8.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",8.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",8.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",8.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",8.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",8.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",9.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",8.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",8.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",8.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",7.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",2.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",1.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",1.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",1.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",1.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",1.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",1.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",492.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",413.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",403.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",377,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",402.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",458.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",557.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",668.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",766.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",1119.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",1180.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",1320.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",327.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",246.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",224.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",198,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",184.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",168.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",184.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",183.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",158.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",197.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",168.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",149.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",535,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",428,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",395.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",352.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",364.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",394.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",449.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",482.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",469.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",600.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",545.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",470.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",4.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",3.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",1.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",1.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",7.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",5.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",5.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",4.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",4.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",5.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",5.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",7.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",6.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",5.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",3.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",2.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",2.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",2.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",2.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",35363.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",47430.8,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",50640.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",54075.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",57880.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",65023.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",61219.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",57012.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",56688.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",40188.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",65698.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",88252.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",97525.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",69.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",98.1,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",104.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",109.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",101.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",99.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",90.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",87.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",88.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",57.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",82.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",116.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",111.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",98.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",136.3,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",145.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",154.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",157.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",166.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",154.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",143.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",143.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",100.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",157,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",202.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",222.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",4.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",5.7,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",6.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",5.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",5.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",4.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",4.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",4.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",5.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",5.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",5.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",7.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",8.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",8.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",8.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",9.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",8.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",7.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",7.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",5.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",8.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",10.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",11.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",4.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",4,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",4.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",3.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",3.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",3.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",2.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",2.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",1.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",3.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",3.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",6.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",6.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",7.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",7.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",8.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",9.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",9.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",9.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",9.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",9.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",9.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",11.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",8.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",8.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",9.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",10.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",11.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",10.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",10.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",10.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",11.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",10.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",11.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",11.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",11.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",11.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",12.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",13.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",15.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",16.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",17.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",18,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",17.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",17.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",18.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",18.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",18.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",19.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",6.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",6.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",6.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",8.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",7.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",8.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",8.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",8.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",8.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",8.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",8.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",9.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",10.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",11.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",12.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",13.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",13.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",13.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",13.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",13.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",14.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",13.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",14.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",3.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",3.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",3.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",3.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",3.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",3.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",3.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",3.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",2.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",2.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",2.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",9.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",8.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",7.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",8.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",8.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",8.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",8.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",8.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",8.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",8.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",7.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",7.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",8.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",12.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",11.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",10.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",10.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",11.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",9.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",9.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",9.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",9.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",9.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",8.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",9.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",9.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",14.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",13.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",12.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",13.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",14.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",15,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",14.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",14.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",14.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",15,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",14.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",14.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",15.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",5.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",4.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",5.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",5.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",4.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",4.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",4.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",4.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",4.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",4.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",4.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",4.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",7.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",6.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",6.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",6.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",7.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",7.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",7.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",6.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",7.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",6.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",6.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",7.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",1.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",1.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",1.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",1.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",1.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",1.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",1.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",1.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",1.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",1707,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",1790,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",1768,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",1998,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",1924,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",1926,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",1899,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",1920,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",1944,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",1940,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",2007,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",2072,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",1565.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",1846.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",1830.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",1928.9,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",1734.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",1446.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",1411.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",1471.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",1452.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",1348.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",1381.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",1556.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",1135.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",1184.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",1148,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",1380.7,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",1324.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",1306.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",1309.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",1299.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",1322.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",1310.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",1380.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",1431.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",71.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",82.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",80.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",83.4,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",73.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",60.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",58.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",59.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",58.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",53.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",53.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",60.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",51.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",53,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",50.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",59.7,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",56.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",54.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",54.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",52.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",53,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",51.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",53.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",55.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",17.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",17.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",17.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",16.9,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",16.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",15.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",12.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",13,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",13,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",12.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",12.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",11.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",467.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",490.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",487.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",473.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",477.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",465.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",443.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",439.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",439.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",433.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",456.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",501.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",619.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",682.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",625.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",629.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",634.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",516,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",491.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",496.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",518.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",485.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",521.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",593.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",554.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",589.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",598.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",594.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",597.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",582.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",571.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",567.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",573.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",579.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",611.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",663.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",74.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",81.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",74.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",74.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",74.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",59.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",56.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",56.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",58.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",54.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",58.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",66.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",66.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",70.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",71,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",70.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",70,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",67.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",65.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",64.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",64.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",65.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",68.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",74.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",18.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",19.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",18.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",18,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",17.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",15.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",14.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",14.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",13.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",13.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",13.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",13.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",1019.6,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",1050.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",1005.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",978.6,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",958.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",940.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",910.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",901,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",861.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",865.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",862.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",884.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",999.7,"E","Estimated value" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",1351.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",1462.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",1291.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",1299.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",1273.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",1043.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",1008.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",1017.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",1017.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",969.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",984.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",1046.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",1052.7,"E","Estimated value" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",1218.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",1263,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",1223.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",1213.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",1197.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",1176,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",1166.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",1161.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",1123.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",1159.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",1180.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",1201.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",1400.2,"E","Estimated value" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",124.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",132.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",116.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",116.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",113.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",92.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",89,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",89.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",89,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",84.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",85.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",90.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",90.6,"E","Estimated value" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",111.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",114.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",110.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",108.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",106.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",104.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",102.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",102.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",98.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",100.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",102.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",103.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",120.5,"E","Estimated value" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",17.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",17.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",16.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",16.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",16.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",15.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",14.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",13.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",12.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",11.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",11.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",11,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",11.1,"E","Estimated value" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",5200.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",5224.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",5321.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",5435.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",5608.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",5705.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",5547.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",5554.1,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",6017.4,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",6528.7,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",7071.4,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",5203.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",5071.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",4817.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",4250.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",4230.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",4395.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",4280.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",4186.1,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",4486.7,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",5206.8,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",5433,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",4178.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",4268.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",4325.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",4355.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",4646.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",4706.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",4597.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",4498.3,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",4888,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",5272.9,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",5639.8,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",149.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",144.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",135.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",119.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",117.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",120.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",115.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",111.3,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",118,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",136.1,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",139.7,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",120.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",121.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",122.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",122,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",128.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",128.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",124,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",119.6,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",128.5,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",137.9,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",145,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",21.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",21.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",20.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",20,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",19.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",19.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",18.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",17.4,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",17.6,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",17.7,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",17.7,"E; D","Estimated value; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",9951.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",9889.6,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",10162,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",9599,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",9618.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",9677,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",9666,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",10331.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",10668.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",10951.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",8569.9,"B","Break" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",9038.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",521.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",558.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",519.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",490.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",463.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",393.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",395.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",442,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",490.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",477.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",369.2,"B","Break" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",417,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",727.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",741.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",764.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",750.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",757.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",747.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",768.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",831.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",862.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",892.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",687.7,"B","Break" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",709.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",49.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",53.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",49.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",46.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",44,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",37.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",37.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",41.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",46.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",44.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",34.5,"B","Break" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",39.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",69.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",70.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",72.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",71.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",71.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",70.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",72.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",78.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",81.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",83.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",64.3,"B","Break" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",67.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",12.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",12.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",12.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",12,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",11.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",11.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",11.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",11.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",10.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",10.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",9.8,"B","Break" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",9.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",4646,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",4583.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",4090.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",3689.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",3658.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",3596.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",3484.1,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",3316.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",3354.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",3397.1,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",3478.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",3456.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",826.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",853.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",706.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",657,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",651.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",534.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",517.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",502.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",531.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",509.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",531.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",549.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",612,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",613.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",540.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",501.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",499.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",492.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",492.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",482.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",495.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",512.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",531,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",524.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",148.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",153.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",126.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",117,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",115.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",94.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",90.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",87.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",91.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",87.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",91.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",93.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",110.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",110.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",96.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",89.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",88.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",86.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",85.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",83.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",85.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",88.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",91.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",89.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",21.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",22.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",20,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",18.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",17.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",16.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",15.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",14.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",14.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",13.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",13.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",13.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",344,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",353.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",350.6,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",341.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",335.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",319.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",307,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",297.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",294.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",306.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",320.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",395.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",456,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",492.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",450.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",453.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",445.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",354.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",339.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",335.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",347.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",343,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",366,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",468.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",382,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",394,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",385.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",376.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",369.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",352.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",348.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",344.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",344.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",365.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",389.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",478.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",85,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",91.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",83.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",83.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",81.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",64.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",61.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",61,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",63,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",62.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",66.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",84.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",71.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",73.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",71.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",69.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",67.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",64.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",63.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",62.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",62.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",66.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",70.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",86.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",18.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",18.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",17.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",17,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",16,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",14.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",13.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",12.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",11.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",11.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",11.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",13.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",3898.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",5427.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",4634,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",83.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",71.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","FRA","France","2011","2011",14.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",5688.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",5679.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",5439.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",5380.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",5672.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",5401.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",5260.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",5004.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",5091.8,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",5267.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",5384.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",5731.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",7540.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",7905.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",6989.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",7145.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",7536.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",5993.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",5822.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",5653.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",6013.2,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",5896.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",6150.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",6779.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",7065.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",7200.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",6910,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",6944.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",7377.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",6942.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",6989.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",6719,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",6923.4,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",7232.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",7426.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",7784.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",92.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",98.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",86.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",88.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",93.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",73.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",70.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",68.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",72.5,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",71,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",74,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",81.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",86.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",89.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",85.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",86.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",91.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",85,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",84.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",81.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",83.5,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",87,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",89.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",93.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",19.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",19.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",17.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",17.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",16.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",15.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",14.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",13.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",11.5,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",11.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",11,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",10.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",1043.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",914.1,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",790,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",706.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",665.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",564.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",680.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",647,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",671.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",692.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",663.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",670.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",546.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",1383.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",1272.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",1015,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",938.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",883.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",626.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",753,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",730.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",792.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",775,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",758.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",792.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",575.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",1445.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",1281.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",1153.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",1119.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",1088.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",926.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",1155.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",1125.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",1188.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",1261.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",1219.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",1228.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",1034.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",124.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",114.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",91.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",85.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",81.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",57.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",69.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",68,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",73.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",72.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",70.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",75,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",55,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",130,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",115.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",104.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",102.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",99.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",85.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",107.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",104.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",110.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",117.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",114,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",116.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",98.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",62105.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",64409,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",58615.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",58867.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",59797.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",60933.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",59756.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",59790.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",60008.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",60953,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",60723.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",59597.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",53713.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",298.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",320.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",260.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",263.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",257.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",218.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",212.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",217.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",222.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",209.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",197.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",196.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",144.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",491.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",518.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",466.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",471,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",462.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",459.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",452.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",439.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",431.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",432.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",417.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",385.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",333.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",29.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",32.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",26.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",26.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",26.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",22.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",21.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",22.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",22.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",21.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",20.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",20.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",14.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",49.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",52,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",47,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",47.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",46.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",46.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",46.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",44.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",44.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",44.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",42.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",39.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",34.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",12.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",12.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",13.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",13.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",13.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",13.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",12,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",12.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",12,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",11.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",10.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",10.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",6783.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",5703.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",5666.6,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",6429.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",5314.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",5341.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",5561.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",5265,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",5364.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",5953.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",7013.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",7969.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",55.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",49.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",45.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",52.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",45.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",40.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",46,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",49.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",49.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",48.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",51.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",62.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",51,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",42.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",41.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",46.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",38.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",37.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",39.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",38.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",38.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",42.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",47.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",53.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",174.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",154.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",141.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",162.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",139,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",122.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",137.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",143.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",140.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",134.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",141.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",168.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",160.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",132.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",129,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",144.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",117.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",113.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",118.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",110.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",107.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",117.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",130.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",142.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",27.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",21.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",23.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",24.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",22.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",21.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",21.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",19.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",17.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",17.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",17.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",17.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",345.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",358.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",387.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",357.7,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",352.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",349.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",338.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",311.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",288.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",280,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",278,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",279.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",457.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",498.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",498.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",475.1,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",468.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",387.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",375,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",351.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",340.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",313.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",317.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",330.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",406.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",430.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",471.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",441,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",430.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",431.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",426.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",391.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",363.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",347.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",349.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",352.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",100.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",108.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",108.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",102.8,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",100.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",82.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",78.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",73.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",69.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",63.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",63.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",65.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",89.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",94.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",102.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",95.4,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",92.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",91.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",89.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",81.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",74.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",70.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",70,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",70,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",16.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",18.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",19,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",18.3,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",18.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",17.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",16.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",14.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",12.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",11.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",11.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",10.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",1995.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",1936.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",1897.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",1881.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",1902,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",1807.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",1787.6,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",1793.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",1852.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",1888,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",1918.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",1990.7,"E","Estimated value" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",2778,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",2488.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",2520.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",2499.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",2110.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",2000.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",2019.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",2118.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",2074.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",2156.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",2269.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",2096.3,"E","Estimated value" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",2630.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",2590.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",2574.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",2544.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",2574.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",2579.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",2591.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",2633.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",2820.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",2914.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",2962.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",3224.2,"E","Estimated value" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",46.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",41.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",41.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",41.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",34.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",33,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",33.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",35.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",34.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",36.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",38.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",35.5,"E","Estimated value" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",44.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",43.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",42.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",41.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",42.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",42.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",42.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",43.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",47.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",49,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",50.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",54.6,"E","Estimated value" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",10.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",10.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",9.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",9.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",8.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",7.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",7.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",8.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",8.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",8,"E","Estimated value" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",812255,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",890011,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",884343,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",830706,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",821393,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",814267,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",830000,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",779318,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",806949,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",1151962,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",1086297,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",971269,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",9253.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",11152,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",11083.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",8511.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",7753,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",6727,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",7629.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",6947.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",7307.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",10567.5,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",10173.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",8849.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",7271.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",8282.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",8481,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",8200.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",7970.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",7869.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",7865.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",7414.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",7747.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",11052.5,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",10605.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",9517.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",72.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",87.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",86.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",66.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",60.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",52.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",60.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",54.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",57.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",83.8,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",80.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",70.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",56.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",64.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",66.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",64.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",62.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",61.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",62,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",58.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",61.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",87.6,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",84.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",75.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",12,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",12.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",12.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",12,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",12.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",12.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",12.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",11.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",11.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",12.1,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",11.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",10.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",1551504,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",1818155.8,"B","Break" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",1787843.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",1891529.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",2006379.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",2123722.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",2089238.2,"B","Break" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",2269880.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",2464267.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",2711705.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",3009813.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",3272920.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",1341.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",1640.6,"B","Break" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",1586.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",1727.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",1905.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",1877.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",1799.9,"B","Break" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",2007,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",2239.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",2326.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",2550.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",2861.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",1844.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",2127.5,"B","Break" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",2091.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",2176.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",2301.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",2476.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",2432.7,"B","Break" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",2601.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",2882.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",3166.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",3593.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",3832,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",27.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",32.9,"B","Break" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",31.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",34.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",37.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",36.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",35.1,"B","Break" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",39.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",43.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",45,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",49.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",55.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",37.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",42.6,"B","Break" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",41.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",43.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",45.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",48.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",47.5,"B","Break" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",50.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",55.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",61.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",69.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",74.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",7.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",8.2,"B","Break" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",8.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",8.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",8.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",8.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",8.2,"B","Break" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",8.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",8.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",8.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",9.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",9.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",32.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",33.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",32.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",31.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",31.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",33.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",31.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",31.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",31.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",32.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",33.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",35.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",36.1,"D; P","Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",43.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",46.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",42.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",42,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",42.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",36.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",35.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",35.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",37.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",36.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",38.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",42.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",38.1,"D; P","Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",35.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",37,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",36.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",35.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",36,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",37.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",37.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",37.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",37.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",39.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",39.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",41.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",43.5,"D; P","Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",91.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",96.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",85.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",83.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",82.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",71.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",66.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",66.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",69,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",66.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",68.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",73.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",64.9,"D; P","Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",74.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",76.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",73.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",70.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",70.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",72.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",70.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",69.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",68.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",70.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",69.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",72.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",74.1,"D; P","Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",17.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",17.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",16.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",16.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",16.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",17.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",16.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",16.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",16,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",16.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",16.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",14.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",14,"D; P","Difference in methodology; Provisional value" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2010","2010",14077,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2011","2011",12584,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2012","2012",12804,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2013","2013",13836,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2014","2014",14128,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2015","2015",14984,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2016","2016",15668,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2017","2017",16565,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2018","2018",15443,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2019","2019",17275.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2020","2020",18357.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2021","2021",18875.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","MEX","Mexico","2022","2022",20539.3,"E","Estimated value" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2010","2010",1114,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2011","2011",1012.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2012","2012",972.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2013","2013",1083.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2014","2014",1062.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2015","2015",945.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2016","2016",839.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2017","2017",875.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2018","2018",802.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2019","2019",896.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2020","2020",854.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2021","2021",931.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2022","2022",1020.5,"E","Estimated value" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2010","2010",1833,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2011","2011",1640,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2012","2012",1629.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2013","2013",1754.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2014","2014",1756.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2015","2015",1799.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2016","2016",1855.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2017","2017",1858.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2018","2018",1664.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2019","2019",1787.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2020","2020",1828.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2021","2021",1814.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2022","2022",1942,"E","Estimated value" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2010","2010",9.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2011","2011",8.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2012","2012",8.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2013","2013",9.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2014","2014",8.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2015","2015",7.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2016","2016",6.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2017","2017",7.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2018","2018",6.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2019","2019",7.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2020","2020",6.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2021","2021",7.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2022","2022",7.8,"E","Estimated value" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2010","2010",16.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2011","2011",14.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2012","2012",13.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2013","2013",14.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2014","2014",14.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2015","2015",14.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2016","2016",15.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2017","2017",15,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2018","2018",13.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2019","2019",14.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2020","2020",14.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2021","2021",14.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2022","2022",14.9,"E","Estimated value" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","MEX","Mexico","2013","2013",9.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","MEX","Mexico","2018","2018",6.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",598.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",630.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",592.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",568.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",571.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",793.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",877.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",761.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",754.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",759.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",700.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",753.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",719.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",711.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",706.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",47.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",52.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",45.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",44.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",45,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",42.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",45.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",42.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",42.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",41.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",11.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",12.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",12.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",13.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",13.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",164.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",182.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",156.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",147.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",136,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",167.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",171.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",167.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",174,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",173.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",169.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",189.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",197.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",118.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",144.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",126.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",120.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",112.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",116.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",119.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",119.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",120.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",114.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",110,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",134,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",125.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",109.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",122.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",104.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",101.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",94.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",113.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",119.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",117.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",118.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",122.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",119.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",129.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",137.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",27.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",32.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",28.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",27.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",25,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",25.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",25.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",24.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",24.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",22.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",21.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",26.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",24.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",25.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",28,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",23.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",22.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",20.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",24.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",25.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",24.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",24.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",24.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",23.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",25.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",26.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",22,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",22.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",17,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",16,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",14.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",17,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",16,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",13.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",13.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",11.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",10.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",10.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",10.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",3463,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",3458,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",3599,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",3570,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",3753,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",3929,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",4133,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",4277,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",4313,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",4521,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",5159,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",5550,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",5871,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",572.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",617,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",618.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",607.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",595.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",487.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",492,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",517.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",530.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",513.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",547.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",646.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",610.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",378.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",380.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",398.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",395.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",404.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",395.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",411.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",438.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",450,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",470,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",522.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",583.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",546.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",117.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",124.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",123.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",119.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",115.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",93.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",94,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",98,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",99.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",96.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",101.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",119.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",112.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",77.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",76.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",79.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",77.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",78.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",76.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",78.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",83.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",84.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",87.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",97.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",107.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",100.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",19.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",19,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",19.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",18.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",17.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",17.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",16.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",16,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",15.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",15.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",17.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",16.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",16.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",700.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",645.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",571.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",512.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",511.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",509.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",506.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",517.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",527.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",552.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",562.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",576.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",601.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",928.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",898.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",734.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",680.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",678.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",565,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",561,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",584.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",622.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",618.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",642.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",681.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",633.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",1124,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",1035.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",944.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",877.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",882.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",870.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",887,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",898.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",922.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",989.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",1010.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",1014.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",1093.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",87.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",85.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",69.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",65.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",65.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",54.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",54.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",56.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",60.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",60.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",62.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",65.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",61.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",106.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",98.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",89.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",83.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",84.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",84,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",85.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",87.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",89.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",96.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",98.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",97.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",105.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",21.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",21.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",21.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",21.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",21.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",20.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",20,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",20.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",20.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",19.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",20,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",19.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",18.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",134.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",135.1,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",124.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",136.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",139.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",140,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",156.6,"B","Break" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",147.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",145.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",147.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",148.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",157.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",178,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",188,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",160.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",180.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",185.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",155.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",173.4,"B","Break" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",166.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",172.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",164.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",169.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",186.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",267.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",266.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",247.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",277.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",287,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",284.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",311.3,"B","Break" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",285.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",277.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",284.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",285,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",295.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",33,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",34.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",29.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",33.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",34.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",28.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",31.9,"B","Break" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",30.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",31.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",30.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",31,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",34.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",49.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",49.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",45.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",51.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",53,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",52.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",57.3,"B","Break" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",52.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",50.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",52.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",52.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",54.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",12,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",12,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",11.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",11.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",10.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",10.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",10,"B","Break" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",9.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",8.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",8.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",8.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",3140.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",3080.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",2838.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",2862.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",3043.9,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",2946.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",3022.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",3070.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",3413.3,"B","Break" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",3390,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",3561.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",3674.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",3713.2,"P","Provisional value" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",4163.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",4287.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",3647.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",3802.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",4043.9,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",3268.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",3345.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",3468.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",4031,"B","Break" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",3795.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",4067.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",4345.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",3910.2,"P","Provisional value" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",4320.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",4313.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",4084.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",4242.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",4595.6,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",4432.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",4702.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",4866.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",5402.6,"B","Break" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",5530.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",5731.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",5869.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",6228,"P","Provisional value" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",89.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",91.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",78,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",81.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",87,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",70.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",72,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",74.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",86.1,"B","Break" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",80.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",85.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",91.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",82.4,"P","Provisional value" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",92.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",92.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",87.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",91,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",98.9,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",95.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",101.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",104.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",115.4,"B","Break" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",117.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",121,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",123.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",131.3,"P","Provisional value" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",23.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",24.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",25.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",26.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",26.9,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",25.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",25.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",25.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",18,"B","Break" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",16.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",17.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",16.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",16.2,"P","Provisional value" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",7256.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",7595.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",7234.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",7295,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",7342.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",7485.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",7411.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",7573.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",7843.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",8349.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",8805.1,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",8532.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",9178.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",1006.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",1169.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",1067.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",1119.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",1070.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",887.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",865.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",885.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",902.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",882.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",956,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",994.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",907.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",804.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",858.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",835.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",848.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",841.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",845.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",840.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",855.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",884.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",958.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",1015.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",978.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",1059.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",107.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",123.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",112.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",116.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",110.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",90.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",87.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",88.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",88.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",85.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",92.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",95.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",86.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",85.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",90.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",87.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",88.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",86.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",86.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",84.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",85.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",86.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",93.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",98.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",93.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",101.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",20.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",20.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",20,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",20.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",19.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",18.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",17.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",17.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",16.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",16.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",16.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",15.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",15.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",1042.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",1063,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",1060,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",1045,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",1028,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",1036,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",1221,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",1214,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",1224,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",1174,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",1194,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",1217,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",1250,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",999.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",1197,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",1130.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",1127.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",1122.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",1076.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",1239.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",1232.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",1251.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",1181.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",1271.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",1331.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",1309.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",710.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",760.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",782.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",796.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",802,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",838.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",1015.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",1022.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",1038.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",1020.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",1051.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",1099.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",1172.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",127.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",151.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",141.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",139.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",137,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",130,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",148,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",145.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",147,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",137.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",147.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",153,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",149.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",90.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",96.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",97.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",98.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",97.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",101.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",121.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",120.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",121.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",119,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",121.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",126.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",134.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",18.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",18.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",17.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",17.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",17.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",16.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",19.1,"B; D","Break; Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",18.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",18.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",17.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",17.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",17.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",16.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",1782.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",1661.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",1498.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",1583,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",1693.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",1972,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",2512.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",3002.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",3607.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",4659.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",5563.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",7050.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",1186,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",992,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",834.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",831.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",773.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",725,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",832,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",823,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",747.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",821.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",793.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",796.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",1936.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",1719.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",1469.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",1479,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",1533.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",1696.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",2024.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",2169.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",2209.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",2499.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",2570.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",2511,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",16.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",13.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",11.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",10.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",10,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",9.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",10.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",10.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",9.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",9.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",9.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",9.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",26.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",23.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",19.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",19.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",19.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",21.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",25.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",27,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",27.1,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",30.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",30.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",29.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",11.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",11.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",11.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",11,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",10.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",10.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",11.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",11.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",11.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",11.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",11.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",10.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",2581.8,"B","Break" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",2760.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",2955.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",3222.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",3253,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",3191.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",3170.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",4078.4,"B","Break" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",4315.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",4863.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",4923.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",4392.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",4107.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",4229.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",3679.7,"B","Break" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",3970.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",4232.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",4652.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",4724.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",4661.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",4609.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",64,"B","Break" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",67.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",75.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",75.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",66.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",62.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",63.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",57.8,"B","Break" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",61.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",65.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",71.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",72,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",70.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",69.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",18.7,"B","Break" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",18.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",18.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",18.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",17.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",16.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",15.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",154950.4,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",187215,"B","Break" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",205981.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",214727.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",249601.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",283661.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",303392,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",310804,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",321757.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",331298.1,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",380815.7,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",446706.8,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",424777.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",303.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",387.1,"B","Break" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",423.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",433.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",437.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",433.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",448.2,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",479,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",501.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",471.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",480.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",588.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",486.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",430.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",537.9,"B","Break" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",593.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",614.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",679.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",725.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",763.7,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",781.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",812,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",824.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",910.1,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",1026.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",970.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",17.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",22.4,"B","Break" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",24.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",24.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",24.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",24.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",24.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",26,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",26.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",24.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",24.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",29.9,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",24.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",25.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",31.2,"B","Break" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",34,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",34.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",38.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",40.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",42,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",42.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",43.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",43.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",46.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",52.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",49,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",18.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",15.9,"B","Break" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",16.5,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",14.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",16.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",15.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",15,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",15,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",14,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",13.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",14.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",15.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",15.1,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",21.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",22.1,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",22.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",23.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",23.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",25,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",25.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",26.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",28.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",30.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",32.2,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",34.5,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",38.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",28.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",30.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",29.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",30.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",31.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",27.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",28,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",29.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",33.3,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",33.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",36.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",40.8,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",40.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",42,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",43.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",43.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",44.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",45.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",46.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",47.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",49,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",52.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",56.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",61.5,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",63.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",68.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",21.4,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",23.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",22.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",23.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",24.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",21.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",21.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",22.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",25.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",25.5,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",27.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",30.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",30.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",31.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",32.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",33.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",33.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",34.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",35.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",36.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",37.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",39.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",42.5,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",46.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",47.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",51.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",11.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",10.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",10.3,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",10,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",9.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",9.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",8.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",8.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",8.7,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",8.8,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",8.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",80.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",79.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",74.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",71.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",69.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",65.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",65.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",63.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",64.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",65.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",67.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",70.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",75.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",106.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",111.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",95.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",95.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",92.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",73.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",72.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",71.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",76.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",73.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",77.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",83.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",79.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",126,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",128.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",122.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",121.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",117.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",110.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",112.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",110.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",114.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",118.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",123.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",125.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",136.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",52,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",54.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",46.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",46.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",44.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",35.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",34.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",34.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",36.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",35.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",36.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",39.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",37.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",61.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",62.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",59.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",59.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",57.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",53.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",54.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",53.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",55,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",56.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",58.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",59.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",64.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",16.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",17,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",16.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",15.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",16.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",14.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",14,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",13.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",12.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",12.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",11.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",11.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",11.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",378,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",408,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",433,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",503,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",516,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",554,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",497,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",512,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",516,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",499,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",498,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",525,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",346.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",420.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",448.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",485.6,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",465.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",416.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",369.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",392.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",385.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",346.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",342.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",394.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",251.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",270,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",281.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",347.6,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",355.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",375.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",342.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",346.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",350.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",337.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",342.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",362.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",15.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",18.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",19.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",21,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",19.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",17.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",15.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",16,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",15.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",13.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",13.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",15.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",11.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",12.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",12.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",15,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",15.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",15.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",14.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",14.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",14.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",13.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",13.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",14.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",3.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",4.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",4.3,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",4.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",4.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",3.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",3.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",3.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",3.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",61.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",59.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",60.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",58.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",61.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",63.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",65.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",67.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",66.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",68.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",74.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",81.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",82,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",82.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",77.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",78.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",81.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",70.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",72.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",76.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",79,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",76.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",85,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",96.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",73.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",71.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",74.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",73.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",77.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",79.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",84.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",87.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",87.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",90.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",99.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",108.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",9.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",9.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",9.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",9.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",9.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",8.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",8.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",8.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",8.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",8.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",9.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",10.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",8.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",8.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",8.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",8.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",9.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",9.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",9.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",9.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",10.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",11.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",12.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",2.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",2.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",2.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",245.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",255.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",250.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",245.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",236.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",239.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",246.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",246.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",240.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",239,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",238.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",253,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",286.3,"E","Estimated value" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",325.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",355.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",321.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",326.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",314,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",266.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",273.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",278.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",284.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",267.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",272.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",299.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",301.5,"E","Estimated value" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",293.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",306.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",304.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",304.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",295.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",299.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",316,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",318,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",314,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",320.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",326.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",343.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",401,"E","Estimated value" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",29.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",32.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",28.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",29.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",28,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",23.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",24.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",24.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",24.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",23.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",23.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",25.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",26,"E","Estimated value" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",26.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",27.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",27.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",27.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",26.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",26.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",27.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",28,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",27.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",27.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",28.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",29.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",34.5,"E","Estimated value" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",4.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",4.3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",4.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",4.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",3.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",3.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",3.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",3.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",3.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",3.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",3.2,"E","Estimated value" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1115.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1093.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1107.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1117.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1117.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1077.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",995.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",937.1,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",1016,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",1048.8,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",1069.4,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1116.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1061.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1002.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",873.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",842.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",829.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",768,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",706.3,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",757.6,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",836.4,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",821.6,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",896.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",893.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",900.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",895.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",925.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",888.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",824.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",759,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",825.3,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",847.1,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",852.9,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",32.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",30.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",28.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",24.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",23.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",22.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",20.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",18.8,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",19.9,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",21.9,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",21.1,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",25.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",25.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",25.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",25.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",25.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",24.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",22.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",20.2,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",21.7,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",22.1,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",21.9,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",4.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",4.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",4.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",4.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",3.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",3.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",3.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",2.9,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",3,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",2.8,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",2.7,"E; D","Estimated value; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",2309.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",2704.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",2841.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",2923.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",2967.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",3119.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",3154.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",3451.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",3532.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",3331.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",2331,"B","Break" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",2423.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",120.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",152.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",145.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",149.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",143,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",126.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",129.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",147.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",162.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",145.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",100.4,"B","Break" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",111.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",168.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",202.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",213.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",228.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",233.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",241.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",250.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",277.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",285.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",271.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",187.1,"B","Break" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",190.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",11.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",14.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",13.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",14.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",13.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",12,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",12.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",13.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",15.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",13.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",9.4,"B","Break" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",10.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",16.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",19.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",20.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",21.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",22.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",22.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",23.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",26.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",26.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",25.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",17.5,"B","Break" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",18.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",2.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",3.3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",3.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",3.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",3.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",3.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",3.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",3.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",3.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",3.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",2.7,"B","Break" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",2.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",66.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",67.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",70.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",69.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",70.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",71.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",72.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",66.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",63.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",74.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",82.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",81.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",87.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",94.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",91,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",92.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",93.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",79.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",79.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",75.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",75.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",83.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",93.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",96.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",73.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",75.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",77.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",77,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",77.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",79.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",82,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",77.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",74.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",88.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",99.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",98.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",16.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",17.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",16.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",17,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",17.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",14.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",14.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",13.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",13.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",15.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",17,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",17.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",13.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",14,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",14.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",14.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",14.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",14.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",14.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",14,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",13.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",16.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",18.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",17.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",3.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",3.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",3.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",3.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",3.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",3.3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",3.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",2.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",2.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",2.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",3.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",2.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",1561.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",1574.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",1629.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",1654.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",1675.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",1692,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",1735.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",1763.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",1818.4,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",1883.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",1873.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",2252.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",2069.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",2192.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",2093,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",2197.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",2226.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",1877.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",1921.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",1992.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",2147.4,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",2108.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",2140,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",2663.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",1939.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",1996.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",2069.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",2135.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",2179.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",2174.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",2306.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",2368.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",2472.5,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",2585.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",2584.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",3059,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",25.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",27.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",26,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",27.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",27.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",23,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",23.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",24.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",25.9,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",25.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",25.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",32,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",23.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",24.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",25.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",26.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",26.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",26.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",28,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",28.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",29.8,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",31.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",31.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",36.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",5.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",5.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",5.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",5.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",4.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",4.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",4.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",4.1,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",3.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",4.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",76.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",80.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",84.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",82.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",89.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",84.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",143.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",141.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",147.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",169.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",127.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",115.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",115.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",101.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",112.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",108.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",110.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",119.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",93.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",158.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",160.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",174.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",189.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",145.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",136.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",121.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",106,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",113.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",123.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",131.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",146.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",138.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",243.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",246.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",261.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",308.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",234.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",211.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",218.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",9.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",10.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",9.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",10,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",10.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",8.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",14.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",14.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",16.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",17.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",13.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",12.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",11.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",9.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",10.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",11.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",12,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",13.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",12.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",22.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",22.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",24.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",28.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",21.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",20,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",20.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",5356.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",5439.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",5276.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",5228.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",5304.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",5270.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",5247.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",5346.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",5501.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",5247.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",5043.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",4857.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",4869.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",25.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",27.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",23.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",23.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",22.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",18.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",18.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",19.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",20.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",18.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",16.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",16,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",13.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",42.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",43.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",42,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",41.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",41,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",39.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",39.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",39.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",39.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",37.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",34.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",31.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",30.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",2.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",2.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",2.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",2.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",2.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",1.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",1.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",1.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",1.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",1.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",1.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",4.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",4.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",4.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",4.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",4.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",3.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",3.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",3.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",3.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",1.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",1.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",1.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",1.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",1.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",1.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",1.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",1.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",1.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",1011.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",789.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",787.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",998.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",843.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",841.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",873.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",903,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",899.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",974.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",1100.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",1218.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",8.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",6.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",6.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",8.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",7.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",6.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",7.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",8.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",8.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",7.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",8.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",9.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",7.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",5.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",5.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",7.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",6.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",5.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",6.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",6.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",6.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",6.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",7.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",8.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",26,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",21.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",19.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",25.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",22.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",19.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",21.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",24.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",23.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",22,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",22.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",25.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",23.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",18.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",17.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",22.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",18.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",17.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",18.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",19,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",18.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",19.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",20.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",21.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",3.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",3.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",3.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",3.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",3.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",3.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",2.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",2.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",2.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",55.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",57.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",59.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",54.7,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",54.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",57.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",58,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",54.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",54,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",53.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",55.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",56.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",73.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",79.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",76,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",72.7,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",73,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",63.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",64.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",61.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",63.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",59.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",63.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",66.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",64.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",68.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",71.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",67.5,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",67.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",71,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",73,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",69,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",68.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",66.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",69.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",70.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",16,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",17.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",16.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",15.7,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",15.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",13.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",13.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",12.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",13.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",12.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",12.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",13.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",14.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",15,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",15.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",14.6,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",14.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",15.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",15.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",14.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",14,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",13.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",13.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",14.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",2.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",2.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",2.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",2.8,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",2.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",2.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",2.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",2.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",2.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",285,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",306.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",326.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",346.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",337.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",358.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",372.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",380.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",386.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",377.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",390.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",369.8,"E","Estimated value" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",396.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",393.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",433.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",460.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",374,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",396.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",421.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",448.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",432.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",431.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",461.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",389.4,"E","Estimated value" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",375.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",409.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",442.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",468.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",456.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",511.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",540.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",557.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",588.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",582.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",602.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",598.9,"E","Estimated value" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",6.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",6.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",7.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",7.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",6.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",6.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",7.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",7.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",7.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",7.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",6.6,"E","Estimated value" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",6.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",6.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",7.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",7.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",7.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",8.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",8.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",9.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",9.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",9.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",10.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",10.1,"E","Estimated value" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",1.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",1.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",1.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",1.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",1.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",1.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",1.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",1.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",1.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",1.5,"E","Estimated value" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",313776,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",323074.3,"B","Break" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",323368.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",341579.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",368535.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",373609.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",381135.2,"B","Break" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",395424.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",419795.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",460197.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",487736.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",548535.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",271.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",291.5,"B","Break" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",287,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",311.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",350,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",330.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",328.3,"B","Break" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",349.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",381.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",394.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",413.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",479.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",373.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",378,"B","Break" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",378.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",393,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",422.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",435.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",443.8,"B","Break" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",453.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",491.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",537.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",582.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",642.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",5.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",5.8,"B","Break" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",5.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",6.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",6.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",6.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",6.4,"B","Break" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",6.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",7.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",7.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",9.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",7.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",7.6,"B","Break" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",7.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",7.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",8.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",8.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",8.7,"B","Break" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",8.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",9.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",10.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",11.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",12.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",1.5,"B","Break" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",1.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",1.5,"B","Break" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",1.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",1.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",6.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",7.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",7.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",7.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",7.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",7.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",7.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",7.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",8.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",8.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",9.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",10.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",10.7,"D; P","Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",10.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",9.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",10.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",10.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",8.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",8.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",8.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",9.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",9.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",11,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",12.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",11.2,"D; P","Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",7.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",8.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",8.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",8.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",8.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",9.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",9.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",9.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",10.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",11.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",12.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",12.8,"D; P","Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",19.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",21,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",19.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",20.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",19.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",16.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",16.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",16.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",17.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",17.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",19.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",21.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",19.1,"D; P","Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",15.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",16.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",16.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",17,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",16.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",16.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",17.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",17,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",17.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",18.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",19.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",21.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",21.9,"D; P","Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",3.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",3.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",3.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",3.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",4.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",4.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",4.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",4.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",4.1,"D; P","Difference in methodology; Provisional value" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",146.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",159.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",162.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",148.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",143.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",194.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",222.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",208.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",197.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",190.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",171.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",191.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",197.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",186.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",177.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",11.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",13.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",12.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",11.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",11.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",10.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",11.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",11.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",11.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",10.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",2.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",3.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",3.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",3.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",3.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",29.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",29.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",28.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",23.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",21.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",20.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",19.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",16.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",18.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",17.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",16.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",25.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",25,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",21.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",23.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",23.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",19.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",17.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",14.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",13.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",12,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",12.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",11.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",10.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",18.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",15.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",19.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",20.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",19.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",16.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",14.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",13.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",13.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",11.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",12.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",12.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",11.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",17.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",17.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",4.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",5.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",5.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",4.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",3.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",3.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",2.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",2.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",2.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",2.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",3.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",3.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",4.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",4.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",4.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",3.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",3.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",2.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",2.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",2.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",2.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",2.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",3.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",3.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",3.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",3.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",2.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",1.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",1.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",1.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",1.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",1.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",1.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",1194,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",1219,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",1256,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",1255,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",1317,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",1391,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",1465,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",1482,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",1459,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",1520,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",1818,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",2006,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",2213,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",197.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",217.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",215.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",213.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",209,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",172.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",174.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",179.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",179.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",172.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",193.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",233.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",230.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",130.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",134.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",139,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",139,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",141.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",140,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",145.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",152,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",152.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",158,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",184,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",210.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",206.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",40.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",43.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",43,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",42.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",40.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",33.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",33.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",34,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",33.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",32.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",35.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",43.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",42.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",26.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",27.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",27.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",27.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",27.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",27,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",27.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",28.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",28.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",29.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",34.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",39,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",38,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",6.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",6.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",6.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",6.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",6.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",6.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",5.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",5.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",5.3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",5.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",6.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",6.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",110.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",108.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",111.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",108.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",121.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",122.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",119.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",125,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",128.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",138.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",140.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",144.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",164.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",146.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",150.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",143.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",144.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",161.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",135.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",131.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",141.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",151.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",154.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",160.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",170.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",172.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",176.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",173.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",184.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",186.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",210,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",209.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",208.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",217.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",224.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",247.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",252.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",254,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",298.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",13.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",14.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",13.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",13.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",15.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",13.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",12.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",13.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",14.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",15,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",15.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",16.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",16.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",16.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",16.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",17.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",17.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",20.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",20.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",20.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",21.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",21.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",24.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",24.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",24.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",28.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",3.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",3.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",4.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",4.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",5.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",4.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",4.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",4.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",4.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",4.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",5.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",28.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",31.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",30.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",33.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",32,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",32.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",40.8,"B","Break" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",40.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",41,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",41.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",42.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",44.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",38.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",43.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",39.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",44.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",42.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",35.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",45.1,"B","Break" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",45.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",48.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",46.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",48.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",53,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",57.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",62.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",60.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",68.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",65.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",65.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",81,"B","Break" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",77.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",77.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",79.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",81.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",84,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",7.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",8.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",7.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",8.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",7.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",6.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",8.3,"B","Break" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",8.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",8.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",8.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",8.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",9.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",10.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",11.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",11.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",12.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",12.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",12.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",14.9,"B","Break" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",14.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",14.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",14.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",14.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",15.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",2.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",2.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",2.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",2.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",2.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",2.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",2.6,"B","Break" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",2.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",2.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",2.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",2.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",2.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",485,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",482.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",468.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",489.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",570.2,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",620,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",687.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",718.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",749.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",773.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",796.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",831.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",857,"P","Provisional value" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",643,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",671.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",602.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",649.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",757.6,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",687.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",760.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",811.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",885.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",866,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",909.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",983.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",902.5,"P","Provisional value" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",667.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",675.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",674.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",725,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",860.9,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",932.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",1069.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",1138.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",1186.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",1262.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",1281.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",1328.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",1437.4,"P","Provisional value" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",13.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",14.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",12.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",13.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",16.3,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",14.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",16.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",17.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",18.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",18.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",19.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",20.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",19,"P","Provisional value" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",14.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",14.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",14.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",15.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",18.5,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",20.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",23,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",24.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",25.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",26.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",27.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",28,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",30.3,"P","Provisional value" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",3.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",3.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",4.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",4.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",5,"B; D","Break; Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",5.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",5.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",3.9,"B","Break" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",3.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",3.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",3.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",3.7,"P","Provisional value" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",2021.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",2016.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",1936.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",1972,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",1985.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",2044.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",2020,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",1969.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",2291.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",2453.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",2538.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",2487,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",2726.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",280.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",310.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",285.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",302.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",289.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",242.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",235.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",230.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",263.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",259.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",275.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",290,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",269.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",223.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",228,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",223.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",229.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",227.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",230.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",229,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",222.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",258.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",281.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",292.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",285.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",314.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",29.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",32.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",30,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",31.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",29.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",24.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",23.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",22.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",25.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",25.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",26.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",27.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",25.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",23.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",24.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",23.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",23.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",23.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",23.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",23.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",22.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",25.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",27.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",28.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",27.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",30.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",5.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",5.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",5.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",5.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",5.3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",4.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",4.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",4.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",4.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",4.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",4.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",4.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",306.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",291.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",264.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",295.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",320.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",352.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",447.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",582.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",696.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",936.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",1051.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",1401.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",204.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",174.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",147.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",155.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",146.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",129.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",148.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",159.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",144.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",165,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",150,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",158.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",333.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",302.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",259.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",276.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",290.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",303.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",360.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",420.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",426.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",502.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",485.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",499,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",2.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",2.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",1.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",1.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",1.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",1.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",1.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",1.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",4.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",4.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",3.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",3.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",3.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",3.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",4.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",5.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",5.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",6.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",5.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",5.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",2.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",2.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",1.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",2.3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",2.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",2.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",2.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",2.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",54002.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",58995.7,"B","Break" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",64056.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",63983.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",66475.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",75558.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",85860.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",79662.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",84241.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",73963.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",75501.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",89508.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",84258.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",105.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",122,"B","Break" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",131.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",129.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",116.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",115.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",126.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",122.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",131.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",105.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",95.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",117.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",96.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",150.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",169.5,"B","Break" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",184.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",183,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",181,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",193.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",216.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",200.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",212.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",184.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",180.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",205.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",192.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",6.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",7.1,"B","Break" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",7.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",7.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",6.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",6.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",6.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",5.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",4.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",4.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",8.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",9.8,"B","Break" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",10.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",10.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",10.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",10.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",11.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",10.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",11.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",9.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",9.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",10.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",9.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",6.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",5,"B","Break" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",5.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",4.4,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",4.3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",4.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",4.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",3.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",3.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",2.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",2.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",3.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",5.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",5.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",5.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",5.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",6.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",6.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",7.5,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",7.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",8.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",9.4,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",10.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",10.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",13.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",6.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",7.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",7.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",7.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",8.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",7.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",8.3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",10.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",10.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",11.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",12.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",14.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",10.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",10.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",10.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",11.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",12,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",12.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",14.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",14.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",16.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",17.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",19.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",19.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",23.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",5.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",5.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",5.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",6.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",5.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",6.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",6.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",7.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",8.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",9.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",10.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",7.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",7.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",8.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",9.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",9.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",10.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",11.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",12.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",13.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",14.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",15,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",17.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",2.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",2.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",2.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",2.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",2.5,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",2.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",2.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",2.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",2.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",2.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",2.9,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",2.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",3.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",17.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",16.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",16,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",17.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",17.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",18.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",18.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",18.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",18.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",18.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",20.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",22.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",24.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",22.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",23.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",20.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",22.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",23.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",20.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",20.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",20.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",21.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",20.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",23.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",26.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",26.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",26.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",26.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",26.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",29.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",30.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",30.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",32.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",32.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",32.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",33.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",37.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",39.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",45.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",11.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",11.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",10,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",11.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",11.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",9.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",10,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",10,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",10.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",9.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",11.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",12.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",12.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",13.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",13,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",12.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",14.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",14.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",15,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",15.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",15.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",15.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",16.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",17.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",18.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",21.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",3.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",3.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",3.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",3.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",4.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",4.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",3.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",3.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",3.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",3.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",3.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",3.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",29,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",28,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",27,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",34,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",33,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",39,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",45,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",48,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",50,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",48,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",48,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",46,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",26.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",28.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",28,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",32.8,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",29.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",29.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",33.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",36.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",37.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",33.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",33,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",34.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",19.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",18.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",17.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",23.5,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",22.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",26.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",31,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",32.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",34,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",32.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",33,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",31.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",1.4,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",1,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",0.3,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",6.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",6.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",6.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",6.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",7.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",6.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",6.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",6.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",6.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",5.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",5.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",8.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",8.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",9.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",7.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",7.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",7.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",8.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",7.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",6.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",6.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",7.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",7.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",8.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",8.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",8.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",8.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",8.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",9.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",8.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",7.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",7.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",64.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",65,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",63.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",68.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",70.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",69.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",72.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",68.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",66.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",63.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",63.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",63.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",63.4,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",85.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",90.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",82,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",90.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",93.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",77.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",80.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",77.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",78.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",70.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",72.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",75.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",66.7,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",76.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",78.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",77.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",84.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",87.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",87.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",92.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",88.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",87,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",84.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",86.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",86.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",88.8,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",7.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",8.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",7.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",8.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",8.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",6.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",7.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",6.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",6.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",6.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",6.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",6.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",5.7,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",7.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",7.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",7.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",7.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",7.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",8.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",7.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",7.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",7.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",7.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",7.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",7.6,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",1.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",1.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",0.9,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0.7,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",164.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",164.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",163.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",163.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",163.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",160.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",155.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",151,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",152.8,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",146.9,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",141.6,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",164.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",159.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",148.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",127.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",123.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",123.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",119.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",113.8,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",113.9,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",117.1,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",108.8,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",132.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",134.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",133.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",130.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",135.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",132.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",128.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",122.3,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",124.1,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",118.6,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",112.9,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",4.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",4.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",4.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",3.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",3.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",3,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",3,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",3.1,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",2.8,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",3.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",3.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",3.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",3.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",3.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",3.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",3.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",3.3,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",3.3,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",3.1,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",2.9,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",0.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",0.5,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",0.4,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",0.4,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",0.4,"E; D","Estimated value; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",344.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",372.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",421.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",424.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",414.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",397.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",396.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",397,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",381.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",393.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",255.9,"B","Break" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",264.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",18,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",21.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",21.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",21.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",20,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",16.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",16.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",17,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",17.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",17.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",11,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",12.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",25.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",27.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",31.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",33.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",32.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",30.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",31.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",32,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",30.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",32.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",20.5,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",20.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",1.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",2.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",2.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",1.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",1.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",1.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",1.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",1.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",1.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",1,"B","Break" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",1.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",2.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",2.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",3.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",3.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",2.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",2.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",1.9,"B","Break" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0.3,"B","Break" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",8.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",8.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",8.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",7.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",7.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",7.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",7.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",6.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",6.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",6.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",7.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",11,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",11.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",10.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",10.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",10.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",8.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",7.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",7.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",6.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",7.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",8.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",9.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",9.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",8.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",8.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",8.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",8.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",8.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",7.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",7.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",7.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",8.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",8.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",2.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",2.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",1.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",1.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",1.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",1.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",1.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",1.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",1.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",1.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",1.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",1.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",1.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",1.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",1.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",1.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",1.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",1.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",1.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",1.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",1.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",1.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",1.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",85,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",80.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",78.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",77,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",76.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",73.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",68.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",65.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",65.2,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",63.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",62.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",62.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",112.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",111.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",101.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",102.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",102,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",81.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",76.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",74.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",77,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",71.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",71,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",73.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",105.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",101.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",100.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",99.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",99.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",94.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",91.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",88.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",88.7,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",87.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",85.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",84.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",0.9,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",1.1,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",0.1,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",22.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",22.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",21.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",21.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",20.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",20.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",21.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",22.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",22.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",21.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",25.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",23.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",15.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",29.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",31.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",27.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",29,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",26.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",23,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",23.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",25.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",26.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",24.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",28.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",27.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",16.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",30.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",31.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",30.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",34.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",33.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",34,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",36.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",38.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",40,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",39.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",46.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",42.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",29.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",2.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",2.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",2.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",2.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",2.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",2.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",2.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",2.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",2.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",2.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",2.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",2.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",1.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",2.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",2.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",2.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",3.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",3.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",3.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",3.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",3.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",3.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",4.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",4.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",2.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",2903.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",3057.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",2947,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",2974.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",2958.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",2888.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",2872.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",2831.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",2756.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",2709.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",2664.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",2500.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",2400.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",14,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",15.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",13.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",13.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",12.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",10.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",10.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",10.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",10.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",9.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",8.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",8.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",6.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",23,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",24.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",23.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",23.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",22.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",21.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",21.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",20.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",19.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",19.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",18.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",16.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",14.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",1.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",262.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",214.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",256.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",270.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",263.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",268,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",265.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",276.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",286,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",282.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",316.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",345.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",2.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",1.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",2.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",2.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",2.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",2.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",2.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",2.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",2.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",2.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",2.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",1.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",1.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",1.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",1.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",2.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",2.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",6.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",5.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",6.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",6.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",6.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",6.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",6.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",7.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",7.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",6.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",6.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",7.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",6.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",5.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",6.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",5.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",5.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",5.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",5.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",5.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",5.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",5.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",6.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",0.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",0.9,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",0.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",0.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",0.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",9.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",9.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",9.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",9.5,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",9.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",9.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",9.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",8.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",8.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",8.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",8.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",12.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",13.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",12.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",12.6,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",12.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",10.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",10.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",10.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",10.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",9.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",9.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",10.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",11.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",11.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",11.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",11.7,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",11.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",11.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",11.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",11.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",11,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",10.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",10.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",10.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",2.7,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",2.5,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",0.5,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",3.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",3.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",3.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",3.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",3.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",3.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",3.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",4.5,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",5.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",5.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",4.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",3.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",3.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",3.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",3.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",3.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",4.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",4.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",4.8,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",4.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",5.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",5.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",4.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",4.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",4.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",4.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",4.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",5.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",5.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",6.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",7.4,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",0.1,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",0.1,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0,"E","Estimated value" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",70183,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",69662.7,"B","Break" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",65916.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",63671.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",63182.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",63755.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",59216.6,"B","Break" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",59332.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",60670.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",61587.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",65347.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",68390.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",60.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",62.9,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",58.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",58.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",60,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",56.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",51,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",52.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",55.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",52.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",55.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",59.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",83.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",81.5,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",77.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",73.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",72.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",74.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",69,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",68,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",71,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",71.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",78,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",80.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",1.3,"B","Break" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",1.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",1,"B","Break" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",1.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",1.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",1.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",1.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",1.6,"B","Break" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",1.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",1.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",1.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",1.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",1.3,"B","Break" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",1.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",1.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",1.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",1.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",1.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.3,"B","Break" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.2,"B","Break" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",2.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",2.3,"D; P","Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",3.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",3.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",3.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",3.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",2.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",2.4,"D; P","Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",2.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",2.8,"D; P","Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",6.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",6.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",6.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",6.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",6.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",5.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",5.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",5.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",5.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",5.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",4.1,"D; P","Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",5.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",5.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",5.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",5.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",5.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",5.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",5.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",5.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",5.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",5.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",5.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",4.7,"D; P","Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",0.9,"D; P","Difference in methodology; Provisional value" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",21.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",20.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",19.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",20.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",20.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",28.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",28.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",25.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",26.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",27.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",25,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",24.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",23.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",25.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",25.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",1.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",1.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",1.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",1.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",1.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",1.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",1.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",1.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",122,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",118,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",116,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",114,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",121,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",115,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",119,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",116,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",113,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",136,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",142,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",151,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",145,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",20.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",21.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",19.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",19.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",19.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",14.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",14.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",14,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",13.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",15.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",15.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",17.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",15.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",13.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",13,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",12.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",12.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",13,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",11.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",11.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",11.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",11.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",14.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",14.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",15.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",13.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",4.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",4.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",3.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",3.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",2.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",2.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",2.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",2.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",2.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",2.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",3.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",2.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",2.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",2.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",2.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",2.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",2.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",2.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",2.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",2.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",2.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",2.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",2.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",2.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",2.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",0.7,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",61.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",57.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",56.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",54.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",54.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",54.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",52.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",51.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",50.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",49.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",49.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",49.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",48.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",81.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",80.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",72.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",71.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",72.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",60.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",58.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",58,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",59.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",55.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",56.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",58.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",51.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",98.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",92.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",92.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",92.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",94.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",92.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",92,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",89.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",88.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",88.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",88.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",86.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",88.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",7.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",7.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",6.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",6.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",5.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",5.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",5.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",5.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",5.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",5.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",5.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",4.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",9.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",8.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",8.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",8.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",9.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",8.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",8.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",8.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",8.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",8.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",8.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",8.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",1.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",1.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",1.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",5.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",4.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",5.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",5.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",6.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",7.4,"B","Break" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",6.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",7.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",8.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",9.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",10.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",6.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",5.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",6.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",7.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",7.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",8.2,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",7.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",8.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",9.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",10.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",12.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",10,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",10,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",9.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",10.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",11.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",13,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",14.7,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",13.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",14.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",16.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",17.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",19.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",1.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",1.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",1.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",1.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",1.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",1.5,"B","Break" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",1.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",1.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",1.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",1.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",2.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",1.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",1.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",1.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",1.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",2.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",2.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",2.7,"B","Break" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",2.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",2.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",3.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",3.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",0.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",0.5,"B","Break" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",0.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",122,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",113.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",98.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",98.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",103.8,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",100.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",100.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",100.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",101.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",101.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",105.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",109,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",108,"P","Provisional value" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",161.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",157.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",126.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",130.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",137.9,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",111.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",111.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",113.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",119.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",113.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",120.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",128.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",113.8,"P","Provisional value" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",167.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",158.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",141.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",145.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",156.8,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",151.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",157,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",159.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",160.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",165.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",169.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",174.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",181.2,"P","Provisional value" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",3.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",3,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",2.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",2.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",2.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",2.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",2.4,"P","Provisional value" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",3.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",3.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",3.4,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",3.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",3.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",3.5,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",3.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",3.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",3.8,"P","Provisional value" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",0.9,"B; D","Break; Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0.5,"B","Break" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0.5,"P","Provisional value" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",187.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",190.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",191.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",200.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",201.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",199.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",198.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",197,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",188.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",185.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",176.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",167.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",168,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",26,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",29.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",28.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",30.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",29.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",23.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",23.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",23,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",21.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",19.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",19.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",19.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",16.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",20.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",21.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",22.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",23.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",23.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",22.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",22.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",22.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",21.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",21.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",20.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",19.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",19.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",2.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",3.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",3.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",2.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",2.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",2.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",2.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",1.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",1.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",1.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",1.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",2.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",2.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",2.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",2.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",2.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",2.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",2.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",2.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",2.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",2.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",1.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",1.9,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",0.3,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",0.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",14.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",14.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",12.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",13.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",15.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",17.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",14.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",16,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",25.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",34,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",44.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",57.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",9.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",8.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",6.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",6.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",6.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",4.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",4.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",5.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",6.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",6.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",15.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",14.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",12.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",12.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",13.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",15.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",11.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",11.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",15.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",18.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",20.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",20.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",0.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",0.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",0.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",0.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",8596,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",9773,"B","Break" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",10633.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",11038.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",11744.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",12721.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",13974.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",15592.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",16516.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",15342.7,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",15030.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",17699.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",17471.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",16.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",20.2,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",21.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",22.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",20.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",19.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",20.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",24,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",25.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",21.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",19,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",23.3,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",20,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",23.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",28.1,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",30.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",31.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",32,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",32.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",35.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",39.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",41.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",38.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",35.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",40.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",39.9,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",1.2,"B","Break" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",1.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",1.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",1.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",1.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",1.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",1.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",1.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",1.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",1.6,"B","Break" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",1.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",1.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",1.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",1.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",1.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",2.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",2.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",1.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",2.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0.8,"B","Break" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",0.9,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",0.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0.7,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0.7,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0.7,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",0.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",1.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",1.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",1.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",1.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",1.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",1.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",1.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",1.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",1.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",1.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",1.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",1.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",1.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",1.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",1.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",1.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",1.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",1.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",1.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",2.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",2.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",2.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",2.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",2.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",2.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",2.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",2.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",2.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",2.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",2.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",2.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",2.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",1.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",1.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",1.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",1.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",1.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",1.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",1.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",1.7,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",1.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",1.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",1.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",2.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",2.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",2.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",0.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",0.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",0.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",0.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",4.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",3.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",3.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",3.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",3.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",3.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",3.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",3.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",4.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",4.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",4.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",4.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",4.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",4.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",4.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",4.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",5.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",5.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",5.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",5.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",1.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",1.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",1.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",1.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",1.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",1.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",1.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",0.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",19,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",18,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",17,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",21,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",21,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",24,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",28,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",28,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",28,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",27,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",26,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",24,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",17.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",18.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",17.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",20.3,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",18.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",18,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",20.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",21.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",20.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",18.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",17.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",18,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",12.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",11.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",11,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",14.5,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",14.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",16.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",19.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",19,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",19,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",18.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",17.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",16.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",0.9,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",0.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",0.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",0.6,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",0.2,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",2.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",2.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",3.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",3.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",3.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",3.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",3.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",3.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",3.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",67.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",71.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",70.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",75.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",75.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",78,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",77.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",77.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",74,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",66.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",72.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",74.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",73.6,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",89.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",99.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",90.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",100.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",100,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",86.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",85.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",87.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",87.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",74.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",82.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",88.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",77.5,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",80.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",85.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",85.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",93.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",94,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",97.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",99.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",99.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",96.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",89.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",99.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",101.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",103.1,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",8.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",8.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",8.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",7.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",7.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",7.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",7.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",6.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",7.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",7.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",6.7,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",7.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",7.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",7.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",8.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",8.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",8.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",8.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",8.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",8.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",7.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",8.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",8.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",8.9,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",0.8,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",187,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",193.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",199.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",204.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",203.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",202.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",179.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",173.9,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",179.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",190.2,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",202.4,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",187.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",187.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",180.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",159.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",153.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",156.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",138.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",131.1,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",133.8,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",151.7,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",155.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",150.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",157.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",162.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",163.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",168.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",167.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",148.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",140.9,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",145.8,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",153.6,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",161.4,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",5.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",5.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",5.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",4.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",3.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",3.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",3.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",4,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",4,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",4.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",4.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",4.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",4.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",4.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",3.7,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",3.8,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",4,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",4.2,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",0.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",0.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",0.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",0.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",0.5,"E; D","Estimated value; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",454.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",459.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",468.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",455.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",460.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",436.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",430.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",463.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",477.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",497.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",44.2,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",58.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",23.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",26,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",23.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",23.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",22.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",17.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",17.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",19.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",22,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",21.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",1.9,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",2.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",33.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",34.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",35.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",35.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",36.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",33.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",34.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",37.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",38.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",40.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",3.5,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",4.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",2.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",2.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",2.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",2.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",0.2,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",3.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",3.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",3.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",3.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",3.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",3.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",3.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",0.3,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",0.1,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",9.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",10.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",12.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",12.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",12.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",12.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",12.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",12.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",13.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",14,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",14.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",14.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",13,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",14.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",15.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",16.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",17,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",13.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",13.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",14.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",16.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",15.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",16.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",16.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",10.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",11.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",13.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",13.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",14.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",13.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",13.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",14.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",15.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",16.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",17.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",17.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",2.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",2.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",2.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",3.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",3.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",2.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",2.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",2.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",2.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",3.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",2.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",2.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",2.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",2.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",3.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",3.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",110.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",103.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",99.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",97.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",97.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",94.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",90.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",89.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",81.3,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",84.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",87.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",94.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",146.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",144.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",127.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",129.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",129.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",104.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",100.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",101.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",96,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",95,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",100.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",111.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",137,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",131.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",126.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",125.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",126.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",121.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",120.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",120.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",110.5,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",116.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",121.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",128.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",1.2,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",1.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",1.3,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",1.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",0.2,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",10.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",10.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",8.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",8.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",8.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",7.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",8.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",8.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",8.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",9.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",10,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",14.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",10.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",14.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",14.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",11.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",10.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",11.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",8.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",9.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",9.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",10.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",10.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",11.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",16.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",11.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",14.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",14.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",13,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",13,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",14.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",12.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",13.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",14.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",15.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",16.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",18.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",25.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",19.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",1.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",1.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",9.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",0.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",2.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",3.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",0,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",461.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",466.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",463.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",449.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",451.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",460.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",471.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",509.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",572.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",623,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",736.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",838.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",3.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",3.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",3.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",3.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",3.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",3.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",4.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",5.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",5.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",5.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",6.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",3.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",3.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",3.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",3.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",3.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",3.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",4.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",4.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",5.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",11.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",12.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",11.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",11.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",11.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",10.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",11.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",13.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",15,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",14.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",14.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",17.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",10.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",10.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",10.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",10.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",10,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",9.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",10,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",10.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",11.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",12.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",13.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",15,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",16.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",17,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",17.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",18.2,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",18.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",18.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",18.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",18.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",18,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",17.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",18.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",17.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",22.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",23.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",22.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",24.2,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",24.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",20.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",20.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",20.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",21.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",19.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",20.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",20.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",19.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",20.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",21.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",22.5,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",22.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",22.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",23.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",23.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",22.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",22.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",23,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",22.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",4.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",5.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",4.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",5.2,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",5.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",4.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",4.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",4.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",4.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",4.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",4.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",4.9,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",4.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",4.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",4.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",4.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",4.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",4.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",4.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",0.9,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",3.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",3.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",3.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",4.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",7.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",10.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",11.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",12.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",19.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",13.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",8.6,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",4.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",4.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",4.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",3.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",4.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",7.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",11.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",13.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",14.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",22.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",16.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",9,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",4.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",5.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",4.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",5.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",10.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",14.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",17.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",19.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",30,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",21.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",13.9,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",0.2,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",0.2,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",0,"E","Estimated value" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",37011,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",40290.3,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",36827.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",39454.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",42828.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",47029,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",48946.6,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",50664.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",49591.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",60192.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",68593.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",77611,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",32,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",36.4,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",32.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",36,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",40.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",41.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",42.2,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",44.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",45.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",51.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",58.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",67.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",44,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",47.1,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",43.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",45.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",49.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",54.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",57,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",58.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",58,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",70.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",81.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",90.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",0.7,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",0.8,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",0.9,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",1.1,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",1.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.2,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.2,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",3.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",3.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",3,"D; P","Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",4.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",3.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",4.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",3.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",3.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",3.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",3.1,"D; P","Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",3.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",3.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",3.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",3.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",3.5,"D; P","Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",8.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",8.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",7.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",8.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",7.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",7.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",7.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",6.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",6.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",6.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",5.3,"D; P","Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",6.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",6.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",6.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",6.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",7.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",7.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",7.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",6.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",6.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",6.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",6.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",6,"D; P","Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",1.4,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",1.1,"D; P","Difference in methodology; Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",11.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",12.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",12.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",12.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",13.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",15.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",17.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",16,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",16.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",18.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",13.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",14.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",15.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",16,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",17.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",1.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",1.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",1.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",4.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",5.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",6.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",6.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",1.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",2.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",4.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",3.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",1.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",3.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",4.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",4.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",0.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",0.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",172,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",172,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",194,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",191,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",211,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",222,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",254,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",257,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",263,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",275,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",364,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",385,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",375,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",28.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",30.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",33.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",32.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",33.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",27.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",30.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",31.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",32.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",31.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",38.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",44.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",39,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",18.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",18.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",21.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",21.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",22.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",22.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",25.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",26.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",27.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",28.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",36.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",40.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",34.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",5.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",6.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",6.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",6.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",6.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",5.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",5.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",5.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",6.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",5.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",7.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",8.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",7.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",3.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",3.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",4.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",4.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",4.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",4.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",4.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",5.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",5.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",6.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",7.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",6.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",18.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",17.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",18.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",20.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",21.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",20.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",19.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",19,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",18.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",18,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",18,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",18.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",18.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",24.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",24.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",24,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",26.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",28.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",23.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",22,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",21.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",21.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",20.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",20.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",21.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",19.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",29.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",28.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",30.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",34.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",36.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",35.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",34.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",32.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",31.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",32.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",32.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",32.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",34.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",2.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",2.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",2.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",2.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",2.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",1.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",2.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",3.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",3.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",3.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",3.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",3.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",3.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",0.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",4.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",4.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",3.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",4.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",4.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",4.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",6.3,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",4.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",6.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",6.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",6.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",7.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",5.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",4.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",5.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",6.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",5.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",6.9,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",5.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",7.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",7.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",7.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",9.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",8.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",8.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",7.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",9.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",9.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",10,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",12.4,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",8.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",12.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",12.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",12.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",14.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",1.3,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",1.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",2.3,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",1.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",2.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",2.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",2.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",2.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",0.4,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",42.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",41.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",40.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",41.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",44.7,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",45.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",46.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",47.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",54.7,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",58.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",69.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",66.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",59.8,"P","Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",55.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",57.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",51.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",55.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",59.4,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",50.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",51.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",53.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",64.6,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",65.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",79.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",78.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",63,"P","Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",57.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",57.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",57.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",62.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",67.6,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",68.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",73,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",75.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",86.6,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",95.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",112.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",105.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",100.4,"P","Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",1.3,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",1.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",1.4,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",1.3,"P","Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",1.5,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",1.9,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",2.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",2.1,"P","Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",0.4,"B; D","Break; Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",0.3,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",0.3,"P","Provisional value" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",271.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",280.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",298.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",314.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",342.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",364.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",433.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",523.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",607.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",690.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",816.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",604.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",663.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",37.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",43.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",44,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",48.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",49.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",43.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",50.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",61.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",69.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",73,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",88.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",70.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",65.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",30.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",31.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",34.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",36.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",39.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",41.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",49.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",59.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",68.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",79.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",94.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",69.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",76.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",4.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",4.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",5.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",4.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",5.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",6.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",6.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",7.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",8.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",6.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",6.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",3.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",3.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",3.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",4.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",5.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",6.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",7.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",9.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",6.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",7.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",1.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",1.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",7.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",8.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",9.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",10.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",11.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",12,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",19.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",21.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",18.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",20.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",29.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",51.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",5.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",5.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",5.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",5.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",5.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",4.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",6.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",5.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",3.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",3.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",4.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",5.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",8.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",8.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",9.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",9.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",10.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",10.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",16.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",15.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",11.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",11.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",13.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",18.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",3361.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",5170.6,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",5909.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",7153.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",8655.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",9241.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",10849.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",12193.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",14373.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",20030,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",33988.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",37671.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",29554.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",6.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",10.7,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",12.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",14.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",15.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",14.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",16,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",18.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",22.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",28.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",42.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",49.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",33.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",9.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",14.9,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",17,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",20.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",23.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",23.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",27.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",30.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",36.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",49.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",81.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",86.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",67.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",0.6,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",0.9,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",1.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",2.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",4.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",4.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",0.4,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",0.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",2.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",2.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",2.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",2.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",1.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",2.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",2.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",2.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",2.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",3.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",2.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",2.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",2.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",2.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",3.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",3.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",3.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",3.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",4.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",4.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",5.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",4.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",1.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",1.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",1.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",1.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",1.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",2.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",2.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",2.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",2.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",2.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",2.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",2.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",2.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",3.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",3.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",3.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",3.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",3.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",0.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",2.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",2.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",2.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",2.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",2.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",2.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",4.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",4.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",4.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",4.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",4.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",4.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",4.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",4.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",4.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",4.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",1.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",1.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",1.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",1.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",2.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",2.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",0.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",0.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",0.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",0.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",0.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",0.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",468,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",488,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",446,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",524,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",464,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",438,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",441,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",433,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",445,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",464,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",506,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",549,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",429.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",503.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",461.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",505.9,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",418.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",329.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",327.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",331.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",332.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",322.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",348.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",412.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",311.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",323,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",289.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",362.1,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",319.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",297.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",304.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",293.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",302.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",313.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",348,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",379.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",19.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",22.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",20.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",21.9,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",17.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",13.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",13.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",13.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",13.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",12.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",13.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",16.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",14.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",14.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",12.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",15.7,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",13.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",12.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",12.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",11.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",12.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",12.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",13.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",14.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",4.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",4.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",4.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",4.4,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",3.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",3.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",2.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",2.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",3.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",94,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",99.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",103.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",107.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",109.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",95.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",85.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",80.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",77.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",77,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",75.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",74.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",124.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",138.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",132.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",142.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",145.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",105.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",94.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",90.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",91.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",86.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",86.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",88.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",111.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",119.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",126.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",134.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",137.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",119.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",110,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",103.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",100.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",102.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",101.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",98.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",14.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",16.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",15.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",16.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",17,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",12.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",10.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",10.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",10.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",9.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",9.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",9.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",13.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",14.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",15,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",15.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",16,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",13.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",12.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",11.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",11.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",11.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",11.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",11,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",3.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",3.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",3.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",4.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",3.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",3.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",2.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",2.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",2.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",2.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",186.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",188.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",185.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",181.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",179.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",155.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",130.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",125.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",119.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",122.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",115.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",113.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",122.1,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",247.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",262.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",238.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",240.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",238,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",172.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",144,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",141.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",141.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",137.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",132.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",134.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",128.5,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",223.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",226.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",225.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",224.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",223.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",194.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",166.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",161.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",156.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",164.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",158.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",154.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",171,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",22.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",23.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",21.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",21.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",21.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",15.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",12.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",12.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",12.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",12,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",11.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",11.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",11.1,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",20.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",20.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",20.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",20.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",20,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",17.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",14.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",14.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",13.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",14.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",13.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",13.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",14.7,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",3.2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",3.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",3.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",2.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",2.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",1.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",1.4,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1444.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1456.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1496.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1432.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1418,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1391.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",1283.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",1316.6,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",1385.1,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",1488.4,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",1609.1,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1445.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1413.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1354.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",1120.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",1069.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",1072.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",990.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",992.3,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",1032.7,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",1187,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",1236.3,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1160.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",1189.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",1216.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",1148.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1174.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1148,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",1063.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",1066.3,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",1125.1,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",1202.1,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",1283.4,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",41.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",40.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",38.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",31.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",29.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",29.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",26.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",26.4,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",27.2,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",31,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",31.8,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",33.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",33.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",34.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",32.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",32.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",31.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",28.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",28.4,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",29.6,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",31.4,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",33,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",5.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",4.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",4.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",4.1,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",4,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",4,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",4,"E; D","Estimated value; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",1740.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",1649.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",1714.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",1496.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",1423,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",1238.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",1163.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",1307.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",1447,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",1543.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",1536.4,"B","Break" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",1621.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",91.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",93.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",87.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",76.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",68.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",50.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",47.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",55.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",66.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",67.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",66.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",74.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",127.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",123.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",128.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",117.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",112,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",95.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",92.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",105.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",117,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",125.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",123.3,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",127.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",8.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",8.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",8.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",7.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",6.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",4.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",4.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",5.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",6.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",6.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",6.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",7.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",12.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",11.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",12.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",11.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",10.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",9.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",8.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",9.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",11,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",11.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",11.5,"B","Break" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",12.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",2.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",1.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",1.8,"B","Break" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",1.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",31.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",29.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",29.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",30.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",32.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",32.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",30.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",30.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",31.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",33.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",36,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",38.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",42,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",40.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",37.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",40.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",43.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",35.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",34.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",34.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",37.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",37.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",41.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",45.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",35.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",32.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",32.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",34,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",36.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",35.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",35,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",35.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",36.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",40,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",43.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",46.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",7.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",7.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",7.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",6.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",6.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",6.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",6.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",6.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",7.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",8.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",6.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",6.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",6.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",6.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",6.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",6.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",6.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",6.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",7.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",7.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",8.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",1.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",798.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",765.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",746.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",791.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",832.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",805.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",759.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",702.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",716.7,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",737.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",711,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",714,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",1058.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",1065.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",959.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",1051.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",1106.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",894,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",840.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",793.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",846.4,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",825.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",812.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",844.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",991.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",970.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",948.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",1021.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",1082.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",1035.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",1008.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",943.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",974.5,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",1012.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",980.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",969.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",12.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",13.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",11.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",13,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",13.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",10.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",10.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",9.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",10.2,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",9.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",9.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",10.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",12.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",12.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",11.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",12.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",13.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",12.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",12.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",11.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",11.8,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",12.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",11.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",11.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",2.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",2.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",2.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",1.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",1.6,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",1.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",1.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",186.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",156.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",137,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",134.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",119.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",105.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",107.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",100,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",106.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",110.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",113.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",114,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",93.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",247.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",217.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",176,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",179.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",158.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",116.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",119.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",112.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",125.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",124.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",129.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",134.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",98.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",258.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",218.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",200,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",213.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",195.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",172.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",182.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",173.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",188,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",202.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",208.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",208.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",177.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",22.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",19.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",15.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",16.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",14.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",10.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",11.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",10.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",11.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",11.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",12.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",12.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",9.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",23.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",19.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",18.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",19.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",17.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",16,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",17,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",16.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",17.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",18.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",19.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",19.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",17,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",11947.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",12569.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",11070.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",10723.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",10500.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",9404.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",8047.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",8013.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",8189.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",8103.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",7985.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",7905.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",8264,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",57.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",62.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",49.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",47.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",45.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",33.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",28.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",29.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",30.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",27.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",25.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",26.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",22.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",94.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",101.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",88.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",85.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",81.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",71,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",61,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",58.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",58.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",57.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",54.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",51.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",51.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",5.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",4.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",4.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",3.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",2.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",3.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",2.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",2.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",2.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",9.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",10.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",8.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",8.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",8.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",7.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",6.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",5.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",5.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",5.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",2.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",2.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",2.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",1.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",1.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",1.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",1.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",1101.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",865.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",842.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",767.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",730.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",759.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",744.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",769.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",854.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",960.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",1119.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",1217.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",7.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",6.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",6.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",6.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",5.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",6.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",7.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",7.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",7.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",8.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",9.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",8.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",6.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",6.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",5.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",5.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",5.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",5.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",5.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",6.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",6.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",7.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",8.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",28.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",23.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",21,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",19.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",19.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",17.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",18.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",21,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",22.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",21.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",22.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",25.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",26.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",20.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",19.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",17.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",16.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",16.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",15.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",16.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",17.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",18.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",20.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",21.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",4.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",3.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",3.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",2.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",3.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",3.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",2.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",2.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",2.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",2.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",2.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",2.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",67.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",67.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",72.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",72.7,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",70.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",56.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",49.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",44.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",44.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",45.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",47.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",49.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",89.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",93.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",93.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",96.6,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",93.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",62.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",55,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",50.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",52.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",50.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",54.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",59.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",79.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",80.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",88.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",89.7,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",85.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",69.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",62.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",55.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",56.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",56.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",59.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",62.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",19.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",20.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",20.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",20.9,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",20,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",13.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",11.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",10.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",10.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",10.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",10.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",11.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",17.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",17.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",19.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",19.4,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",18.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",14.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",13.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",11.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",11.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",11.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",11.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",12.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",3.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",3.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",3.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",3.7,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",3.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",2.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",2.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",2.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",1.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",1.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",1.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",497.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",493,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",493.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",464.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",406.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",359.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",369,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",382.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",391.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",399.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",406.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",413.3,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",692.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",633.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",655,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",617.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",450.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",397.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",416.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",451.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",438.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",456.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",481.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",435.2,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",655.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",659.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",668.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",628,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",550,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",512.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",534.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",560.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",596.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",616.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",628.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",669.4,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",11.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",10.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",10.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",10.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",7.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",6.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",6.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",7.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",7.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",7.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",8.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",7.4,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",11,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",11.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",11.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",10.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",9.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",8.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",8.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",9.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",10,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",10.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",10.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",11.3,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",2.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",2.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",2.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",2.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",1.7,"E","Estimated value" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",151818,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",175161.8,"B","Break" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",165576.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",175592.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",188434.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",205375.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",177097.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",194400.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",214513.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",240231.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",272925.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",315802.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",131.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",158.1,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",146.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",160.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",179,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",181.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",152.6,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",171.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",195,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",206.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",231.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",276.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",180.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",205,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",193.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",202,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",216.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",239.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",206.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",222.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",250.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",280.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",325.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",369.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",2.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",3.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",2.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",3.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",3.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",3.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",3,"B","Break" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",3.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",3.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",4.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",5.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",3.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",4.1,"B","Break" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",3.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",4.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",4.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",4,"B","Break" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",4.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",4.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",5.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",6.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",7.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",0.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",0.8,"B","Break" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",0.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",0.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",0.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",0.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",0.7,"B","Break" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",0.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",0.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",0.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",0.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",0.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",7.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",6.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",6.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",6.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",5.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",5.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",5.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",5.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",4.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",4.3,"D; P","Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",9.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",9.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",8.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",8.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",8.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",5.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",5.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",5.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",5.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",4.6,"D; P","Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",7.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",7.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",7.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",7.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",7.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",6.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",6.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",5.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",5.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",5.2,"D; P","Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",19.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",19.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",17.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",17.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",16.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",12.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",11.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",10.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",10.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",10.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",10.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",9.7,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",7.8,"D; P","Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",16.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",15.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",15.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",14.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",13.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",12.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",11.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",11.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",10.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",10.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",10.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",9.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",8.9,"D; P","Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",3.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",3.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",3.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",3.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",3.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",2.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",2.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",2.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",1.7,"D; P","Difference in methodology; Provisional value" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",91.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",95.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",94.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",98.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",99.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",121.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",133.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",121.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",130.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",132.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",107.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",114.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",115.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",123.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",123.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",7.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",7.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",7.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",7.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",6.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",6.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",6.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",7.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",7.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",1.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",1.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",2.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",29.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",32.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",32.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",29.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",17.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",15.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",13.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",13.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",8.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",9.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",9.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",10.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",11.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",21.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",25.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",26.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",24,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",14.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",10.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",9.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",9.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",6.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",7.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",7.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",19.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",21.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",22,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",20.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",12.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",10.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",9.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",9.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",5.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",6.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",6.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",7.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",7.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",4.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",5.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",5.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",3.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",2.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",1.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",1.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",1.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",1.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",4.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",4.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",4.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",2.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",1.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",1.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",1.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",3.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",3.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",3.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",3.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",1.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",1.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",1.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",1.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",0.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",0.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",0.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",0.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",0.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",324,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",266,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",266,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",261,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",263,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",264,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",267,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",277,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",280,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",291,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",311,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",307,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",316,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",53.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",47.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",45.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",44.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",41.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",32.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",31.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",33.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",34.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",33.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",33,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",35.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",32.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",35.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",29.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",29.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",28.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",28.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",26.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",26.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",28.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",29.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",30.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",31.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",32.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",29.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",11,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",9.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",9.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",8.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",8.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",6.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",6.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",6.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",6.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",6.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",6.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",6.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",6.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",7.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",5.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",5.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",5.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",5.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",5.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",5.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",5.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",5.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",5.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",5.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",5.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",1.2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",1.2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",1.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",0.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",0.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",158.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",140.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",116.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",97.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",95.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",92.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",93.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",96,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",99.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",107.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",111.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",119.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",128.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",209.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",195.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",149.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",129.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",126.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",103.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",103.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",108.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",117.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",119.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",127.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",141,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",135.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",254.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",225.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",192.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",167.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",164.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",158.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",163.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",166.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",174.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",191.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",200.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",210,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",233.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",19.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",18.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",14.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",12.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",12.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",10,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",10,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",10.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",11.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",11.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",12.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",13.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",13.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",24,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",21.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",18.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",16,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",15.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",15.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",15.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",16.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",17,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",18.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",19.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",20.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",22.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",4.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",4.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",4.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",4.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",3.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",3.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",3.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",3.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",3.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",4.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",16.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",15.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",12.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",12.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",14,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",14.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",16.7,"B","Break" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",15.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",16.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",16.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",16.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",17.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",21.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",20.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",16.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",16.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",18.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",16.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",18.5,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",17.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",19.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",18.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",19.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",20.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",32.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",29.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",25.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",25.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",28.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",30.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",33.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",30.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",31,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",32.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",32.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",32.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",3.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",3.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",3.4,"B","Break" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",3.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",3.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",3.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",3.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",3.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",5.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",4.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",4.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",5.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",5.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",6.1,"B","Break" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",5.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",5.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",5.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",5.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",5.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",1.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",1.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",1.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",1.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",1.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",1.1,"B","Break" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",687.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",590.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",488.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",500.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",535.3,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",484.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",483.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",500.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",526.6,"B","Break" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",538.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",568.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",610.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",655.9,"P","Provisional value" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",911,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",821.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",627.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",664.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",711.2,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",537.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",535.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",565.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",621.9,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",602.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",649,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",721.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",690.7,"P","Provisional value" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",945.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",826.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",703.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",741.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",808.2,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",729,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",753,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",793.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",833.5,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",877.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",914.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",975.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",1100.1,"P","Provisional value" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",19.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",17.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",13.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",14.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",15.3,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",11.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",11.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",12.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",13.3,"B","Break" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",12.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",13.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",15.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",14.6,"P","Provisional value" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",20.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",17.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",15,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",15.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",17.4,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",15.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",16.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",17,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",17.8,"B","Break" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",18.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",19.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",20.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",23.2,"P","Provisional value" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",5.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",4.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",4.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",4.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",4.7,"B; D","Break; Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",4.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",4.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",4.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",2.8,"B","Break" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",2.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",2.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",2.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",2.9,"P","Provisional value" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",625.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",660.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",678.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",744.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",721.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",668.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",590.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",618.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",724.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",788.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",842.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",754.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",753.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",86.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",101.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",100.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",114.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",105.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",79.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",68.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",72.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",83.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",83.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",91.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",88,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",74.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",69.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",74.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",78.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",86.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",82.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",75.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",66.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",69.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",81.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",90.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",97.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",86.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",86.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",9.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",10.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",10.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",11.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",10.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",8.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",6.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",7.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",8.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",8.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",8.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",8.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",7.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",7.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",7.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",8.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",8.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",7.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",6.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",8.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",9.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",8.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",8.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",1.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",1.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",1.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",372.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",338.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",269.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",263,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",278.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",317.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",367.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",446.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",527.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",664.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",974.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",1043.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",248.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",202.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",150.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",138.2,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",127.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",116.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",121.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",122.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",109.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",117.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",139.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",117.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",405.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",350.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",264.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",245.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",252.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",273.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",296.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",322.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",323.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",356.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",450.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",371.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",3.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",2.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",1.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",1.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",1.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",1.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",1.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",1.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",1.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",1.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",1.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",5.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",4.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",3.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",3.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",3.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",3.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",3.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",4.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",5.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",4.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",2.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",2.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",1.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",31955.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",25714.6,"B","Break" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",28119.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",30007.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",48805.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",56272,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",60183.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",62830.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",64587.1,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",67892.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",79843.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",92278.8,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",104325.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",62.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",53.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",57.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",60.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",85.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",86,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",88.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",96.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",100.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",96.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",100.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",121.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",119.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",88.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",73.9,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",81,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",85.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",132.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",143.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",151.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",158,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",163,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",169,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",190.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",212.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",238.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",3.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",3.1,"B","Break" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",3.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",3.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",4.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",4.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",4.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",5.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",5.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",5.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",5.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",6.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",5.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",4.3,"B","Break" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",4.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",4.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",7.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",8.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",8.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",8.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",8.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",9.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",10.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",12,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",3.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",2.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",2.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",2.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",3.2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",3.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",2.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",2.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",3.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",3.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",2.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",2.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",2.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",3.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",3.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",3.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",3.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",3.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",4.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",4.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",5.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",4.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",3.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",3.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",4.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",3.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",3.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",3.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",4.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",4.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",4.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",5.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",5.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",5.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",5.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",5.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",5.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",5.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",6.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",6.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",7.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",8.5,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",3.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",2.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",2.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",3.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",2.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",2.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",2.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",3.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",3.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",3.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",4.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",4.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",4.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",4.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",4.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",4.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",4.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",4.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",4.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",4.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",5.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",5.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",6.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",6.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",1.2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",1.2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",1.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",1.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",1.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",1.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",1.2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",1.1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",1.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",15.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",15.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",14.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",14.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",13.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",11.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",11.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",10.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",11.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",11.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",11.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",11.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",12.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",20.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",22.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",18.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",19.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",17.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",13,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",12.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",11.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",13.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",13.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",13.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",14,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",12.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",24.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",25.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",24.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",24.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",22.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",19.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",19.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",18.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",19.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",21.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",21.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",21,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",21.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",10.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",10.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",9.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",9.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",8.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",5.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",6.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",6.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",11.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",12.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",11.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",11.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",11.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",9.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",9.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",9.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",10.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",10.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",10,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",10.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",3.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",3.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",3.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",3.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",3.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",2.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",2.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",2.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",2.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",2.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",1.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",1.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",551,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",572,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",598,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",638,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",659,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",697,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",710,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",729,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",728,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",908,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",1067,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",1088,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",505.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",590,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",619.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",615.9,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",594,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",523.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",527.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",558.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",543.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",631.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",734.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",817.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",366.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",378.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",388.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",440.9,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",453.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",473,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",489.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",493.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",495.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",613.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",733.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",751.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",22.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",26.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",27.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",26.6,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",25.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",22,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",21.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",22.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",21.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",24.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",28.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",31.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",16.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",16.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",17.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",19.1,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",19.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",19.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",20.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",20.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",19.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",24.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",28.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",29.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",5.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",5.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",5.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",5.4,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",5.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",5.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",4.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",4.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",4.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",5.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",6.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",154.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",159.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",161.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",164.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",163.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",168.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",172.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",177.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",186.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",202.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",219.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",251.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",205.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",222.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",207.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",218.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",217.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",186.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",190.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",200.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",220.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",226.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",251,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",296.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",183.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",192,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",198.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",206.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",205,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",210.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",221.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",228.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",244,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",270.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",294.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",331.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",24.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",26.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",24.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",25.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",25.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",21.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",21.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",22.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",24.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",25.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",28.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",33.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",22,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",22.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",23.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",24.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",24,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",24.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",25.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",26,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",27.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",30.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",33,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",37.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",6.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",5.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",5.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",5.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",5.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",5.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",6.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",6.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",6.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",512.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",522.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",517.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",530.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",505.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",525.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",510.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",509.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",520,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",539,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",497,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",511.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",716.2,"E","Estimated value" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",679.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",726.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",664.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",705.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",671.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",583.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",565.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",575.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",614,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",603.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",567.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",604.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",754.2,"E","Estimated value" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",612.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",627.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",629,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",658.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",631.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",657.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",653.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",657.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",678.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",721.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",680.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",693.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",1003.2,"E","Estimated value" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",62.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",65.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",59.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",63.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",59.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",51.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",49.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",50.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",53.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",52.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",49.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",52.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",64.9,"E","Estimated value" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",56.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",56.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",56.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",59,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",56.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",58.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",57.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",57.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",59.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",62.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",59,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",59.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",86.4,"E","Estimated value" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",8.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",8.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",8.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",8.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",8.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",8.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",8.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",7.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",7.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",7.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",6.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",6.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",8,"E","Estimated value" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1676.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1729.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1794.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1874.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1936,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1991.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",2127.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",2246.9,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",2423.6,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",2380.1,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",2624.3,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1677.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1678.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1624.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",1465.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",1460.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",1534.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",1642.1,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",1693.5,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",1807.1,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",1898.2,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",2016.3,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1346.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",1412.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",1458.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",1502,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1603.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1642.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",1763.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",1819.7,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",1968.7,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",1922.3,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",2093,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",48.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",47.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",45.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",41.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",40.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",42,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",44.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",45,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",47.5,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",49.6,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",51.9,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",38.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",40.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",41.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",42.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",44.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",44.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",47.6,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",48.4,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",51.8,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",50.3,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",53.8,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",6.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",6.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",6.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",6.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",7.1,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",7.1,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",6.5,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",6.6,"E; D","Estimated value; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",6506.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",6696.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",6786.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",6744.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",6900.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",7138.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",6983.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",7450.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",7632.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",7854.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",5139.3,"B","Break" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",5237.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",340.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",378.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",346.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",344.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",332.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",290.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",285.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",318.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",351.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",342.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",221.4,"B","Break" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",241.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",475.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",501.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",510.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",527.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",543.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",551.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",555.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",599.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",616.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",639.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",412.4,"B","Break" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",411,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",32.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",36.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",33,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",32.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",31.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",27.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",27,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",30.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",33,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",32.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",20.7,"B","Break" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",23,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",45.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",47.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",48.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",50.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",51.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",52.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",52.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",56.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",58,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",60,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",38.6,"B","Break" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",39.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",8.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",8.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",8.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",8.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",8.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",8.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",7.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",7.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",5.9,"B","Break" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",5.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",1917.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",1913.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",1977.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",1909.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",1944.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",1968.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",1954.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",1925.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",1989.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",2074.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",2121.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",2168.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",341,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",356.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",341.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",340,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",346.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",292.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",290.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",291.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",315.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",311,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",324.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",344.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",252.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",256.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",261.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",259.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",265.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",269.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",276.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",280.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",294.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",312.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",323.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",329.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",61.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",64,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",61.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",60.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",61.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",51.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",50.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",50.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",54.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",53.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",55.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",58.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",45.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",46,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",46.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",46.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",47,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",47.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",48.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",48.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",50.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",53.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",55.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",56.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",9.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",9.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",9.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",9.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",9.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",8.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",8.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",8.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",8.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",8.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",8.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",147.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",148.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",154.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",146.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",148.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",144.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",150.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",150.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",154.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",152.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",148.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",151,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",195.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",207,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",198.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",194.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",197.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",160.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",166.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",169.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",182.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",171.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",169.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",178.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",163.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",165.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",170,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",161.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",164,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",159.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",170.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",173.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",180.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",182.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",180.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",182.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",36.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",38.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",36.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",35.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",36.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",29.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",30.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",30.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",33,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",31,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",30.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",32.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",30.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",30.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",31.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",29.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",30,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",29,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",31,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",31.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",32.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",33,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",32.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",33,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",7.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",7.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",7.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",7.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",7.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",6.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",6.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",6.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",6.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",5.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",5.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",5.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","FRA","France","2011","2011",2016,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","FRA","France","2011","2011",2806.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","FRA","France","2011","2011",2396.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","FRA","France","2011","2011",43.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","FRA","France","2011","2011",36.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","FRA","France","2011","2011",7.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",2051.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",1987.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",1927.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",2036.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",2047.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",2054.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",2134.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",2146.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",2313,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",2508,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",2620.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",2931.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",2719.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",2766.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",2476.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",2704.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",2720.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",2279.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",2362.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",2424.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",2731.5,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",2807.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",2992.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",3467.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",2548.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",2519.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",2448.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",2628.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",2662.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",2640.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",2835.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",2881.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",3145,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",3443.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",3614.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",3982.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",33.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",34.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",30.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",33.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",33.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",27.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",28.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",29.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",32.9,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",33.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",36,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",41.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",31.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",31.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",30.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",32.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",32.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",32.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",34.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",34.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",37.9,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",41.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",43.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",47.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",6.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",6.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",6.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",6.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",6.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",5.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",5.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",5.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",5.2,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",5.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",5.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",5.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",459.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",451.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",398.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",359.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",365.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",331.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",405.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",410.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",419.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",430.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",418,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",405.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",471.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",609.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",628.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",511.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",477,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",485.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",367.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",448.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",463.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",495.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",481.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",477.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",479.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",496.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",636.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",633.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",581.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",568.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",597.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",544.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",688.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",713.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",742.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",784.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",768.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",742.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",892.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",54.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",56.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",46.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",43.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",44.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",34,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",41.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",43.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",46.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",44.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",44.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",45.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",47.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",57.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",57,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",52.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",51.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",54.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",50.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",63.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",66.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",69.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",73.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",71.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",70.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",85.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",34020,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",35728.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",33762.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",34278.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",34198.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",33515.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",34173.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",34496.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",35063.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",35957,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",37471.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",35884.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",36809.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",163.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",177.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",150,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",153.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",147,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",120,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",121.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",125.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",129.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",123.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",121.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",118.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",98.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",269.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",287.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",268.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",274.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",264.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",252.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",258.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",253.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",252.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",255.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",257.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",231.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",228.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",16.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",17.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",15.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",15.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",14.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",12.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",12.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",12.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",13.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",12.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",12.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",12.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",10.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",26.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",28.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",27.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",27.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",26.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",25.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",26.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",25.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",25.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",26.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",26.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",23.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",23.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",6.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",6.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",7.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",7.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",6.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",6.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",6.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",6.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",1762.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",1558.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",1582.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",1836.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",1516.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",1444.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",1508.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",1532.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",1706.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",1899.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",2155,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",2301.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",14.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",13.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",12.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",15,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",13,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",11,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",12.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",14.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",15.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",15.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",15.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",18.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",13.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",11.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",11.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",13.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",10.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",10.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",10.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",11.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",12.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",13.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",14.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",15.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",45.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",42.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",39.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",46.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",39.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",33.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",37.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",41.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",44.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",43,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",43.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",48.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",41.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",36.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",36,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",41.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",33.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",30.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",32.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",32.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",34.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",37.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",40.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",41.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",6.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",7.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",6.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",5.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",5.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",5.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",5.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",5.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",5.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",5.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",158.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",151,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",156,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",163.5,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",165,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",169.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",167.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",181.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",225.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",243.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",216.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",213,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",210.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",210.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",200.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",217.1,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",219.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",188.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",185.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",205.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",266.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",272.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",247.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",251.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",186.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",181.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",189.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",201.5,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",201.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",209.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",211.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",228.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",284.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",302.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",272.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",268,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",46.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",45.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",43.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",47,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",47.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",40,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",39.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",42.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",54.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",55.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",49.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",50.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",40.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",39.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",41.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",43.6,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",43.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",44.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",44.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",47.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",58.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",61.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",54.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",53.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",7.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",8.3,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",8.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",8.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",8.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",8.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",9.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",10.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",8.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",8.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",1136.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",1109.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",1076.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",1103.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",1125.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",1107.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",1119.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",1166.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",1242.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",1308.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",1294.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",1426.1,"E","Estimated value" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",1582.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",1425.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",1429.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",1465.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",1248.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",1225.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",1265,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",1377.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",1391,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",1494.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",1530.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",1501.7,"E","Estimated value" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",1498.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",1484.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",1459.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",1491.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",1523.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",1580.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",1623.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",1712.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",1891.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",2019.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",1998.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",2309.8,"E","Estimated value" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",26.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",23.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",23.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",24.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",20.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",20.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",20.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",22.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",23.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",25.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",25.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",25.4,"E","Estimated value" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",25.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",24.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",24.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",24.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",25.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",26.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",26.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",28.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",31.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",34,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",33.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",39.1,"E","Estimated value" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",5.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",5.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",5.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",5.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",4.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",5.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",5.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",5.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",5.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",5.8,"E","Estimated value" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",123160,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",123835,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",127386,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",118406,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",98066,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",119017,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",119619,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",135053,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",112068,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",138720,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",124575,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",97931,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",1403.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",1551.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",1596.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",1213.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",925.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",983.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",1099.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",1204,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",1014.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",1272.5,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",1166.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",892.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",1102.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",1152.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",1221.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",1168.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",951.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",1150.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",1133.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",1285,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",1075.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",1331,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",1216.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",959.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",11,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",12.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",12.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",9.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",7.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",8.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",9.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",10.1,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",9.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",7.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",8.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",9.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",9.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",7.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",9.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",8.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",10.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",8.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",10.5,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",9.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",7.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",1.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",1.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",1.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",1.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",1.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",1.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",1.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",1.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",1.5,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",1.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",1.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",1005103,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",989661.7,"B","Break" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",955295.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",951300.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",1026144.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",1048376.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",1097011.9,"B","Break" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",1125767.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",1217876.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",1244223.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",1098631,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",1036337.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",869.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",893,"B","Break" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",847.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",868.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",974.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",927,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",945.1,"B","Break" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",995.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",1107,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",1067.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",930.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",905.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",1195.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",1158.1,"B","Break" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",1117.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",1094.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",1176.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",1222.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",1277.4,"B","Break" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",1290.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",1424.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",1452.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",1311.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",1213.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",17.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",17.9,"B","Break" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",16.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",17.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",19.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",18.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",18.5,"B","Break" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",19.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",21.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",20.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",18,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",17.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",24.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",23.2,"B","Break" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",22.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",21.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",23.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",24,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",24.9,"B","Break" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",25.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",27.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",28.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",25.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",23.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",4.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",4.5,"B","Break" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",4.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",4.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",4.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",4.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",4.3,"B","Break" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",4.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",4.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",3.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",15.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",15,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",15.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",15.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",14.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",14.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",14.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",13.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",13.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",13.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",13.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",17.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",19.3,"D; P","Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",20.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",20.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",19.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",20.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",19.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",16.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",15.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",14.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",16.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",15.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",15.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",20.8,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",20.3,"D; P","Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",16.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",16.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",16.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",17.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",16.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",16.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",16.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",15.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",16.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",16.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",16.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",20.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",23.2,"D; P","Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",42.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",43.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",39.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",41.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",38.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",31.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",29.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",27.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",29.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",27.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",27.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",36.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",34.6,"D; P","Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",34.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",34.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",33.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",34.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",32.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",31.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",31.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",28.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",29.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",29.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",28.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",35.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",39.5,"D; P","Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",8.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",7.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",7.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",7.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",6.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",6.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",6.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",6.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",7.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",7.5,"D; P","Difference in methodology; Provisional value" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2010","2010",8936,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2011","2011",7354,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2012","2012",7999,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2013","2013",7254,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2014","2014",6950,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2015","2015",5656,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2016","2016",6149,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2017","2017",5570,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2018","2018",5722,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2019","2019",5741.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2020","2020",5030.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2021","2021",3975.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","MEX","Mexico","2022","2022",5965,"E","Estimated value" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2010","2010",707.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2011","2011",592,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2012","2012",607.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2013","2013",568,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2014","2014",522.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2015","2015",356.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2016","2016",329.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2017","2017",294.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2018","2018",297.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2019","2019",298,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2020","2020",234.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2021","2021",196.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2022","2022",296.4,"E","Estimated value" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2010","2010",1163.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2011","2011",958.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2012","2012",1017.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2013","2013",920,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2014","2014",863.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2015","2015",679.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2016","2016",728,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2017","2017",624.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2018","2018",616.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2019","2019",594.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2020","2020",501.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2021","2021",382.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2022","2022",564,"E","Estimated value" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2010","2010",6.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2011","2011",5.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2012","2012",5.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2013","2013",4.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2014","2014",4.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2015","2015",2.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2016","2016",2.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2017","2017",2.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2018","2018",2.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2019","2019",2.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2020","2020",1.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2021","2021",1.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2022","2022",2.3,"E","Estimated value" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2010","2010",10.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2011","2011",8.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2012","2012",8.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2013","2013",7.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2014","2014",7.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2015","2015",5.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2016","2016",5.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2017","2017",5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2018","2018",4.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2019","2019",4.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2020","2020",3.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2021","2021",3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2022","2022",4.3,"E","Estimated value" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","MEX","Mexico","2013","2013",5.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","MEX","Mexico","2018","2018",2.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",566.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",586.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",559.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",540.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",516.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",751,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",816.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",719,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",718,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",686.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",663.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",701.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",678.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",677.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",638.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",45.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",48.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",42.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",42.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",40.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",39.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",42,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",40.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",40.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",37.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",10.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",11.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",12.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",12.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",11.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",75.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",83.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",88.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",90,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",92.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",100.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",103.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",97.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",107.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",111.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",122.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",133.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",157.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",54.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",65.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",71.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",73.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",76.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",70.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",71.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",69.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",74.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",73.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",79.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",94.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",100.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",50.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",56,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",59.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",62.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",63.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",68.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",71.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",68.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",73.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",78.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",86.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",91.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",109.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",12.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",15,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",16.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",16.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",16.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",15.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",15.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",14.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",15.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",14.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",15.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",18.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",19.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",11.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",12.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",13.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",14,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",14.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",14.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",15.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",14.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",14.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",15.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",17,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",17.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",21.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",10.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",10.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",9.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",9.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",9.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",10.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",9.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",8.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",7.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",7.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",7.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",8.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",1917,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",1902,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",1928,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",1859,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",2001,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",2093,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",2273,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",2421,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",2484,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",2653,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",2716,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",2924,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",3355,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",317.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",339.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",331.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",316.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",317.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",259.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",270.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",292.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",305.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",301.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",288.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",340.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",349,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",209.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",209.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",213.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",205.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",215.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",210.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",226.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",248.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",259.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",275.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",274.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",307.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",312.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",64.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",68.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",66,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",62.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",61.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",50,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",51.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",55.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",57.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",56.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",53.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",62.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",64.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",42.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",42.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",42.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",40.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",42,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",40.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",43.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",47.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",48.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",51.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",51.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",56.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",57.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",10.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",10.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",10.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",9.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",9.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",9.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",9.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",9.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",9.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",9.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",8.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",9.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",214.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",213.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",214.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",201.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",192.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",214.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",222.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",222.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",232.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",244.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",232.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",223.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",272.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",284.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",297,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",275.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",268.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",255.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",237.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",246.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",251.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",274.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",274.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",265.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",264.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",286.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",344.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",342.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",354.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",346,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",332.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",366.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",389.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",386.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",406.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",438.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",417.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",394,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",495.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",26.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",28.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",26.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",25.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",24.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",23,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",23.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",24.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",26.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",26.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",25.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",25.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",27.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",32.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",32.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",33.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",33.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",31.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",35.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",37.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",37.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",39.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",42.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",40.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",38,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",47.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",6.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",7.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",8.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",8.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",8.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",8.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",8.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",8.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",8.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",8.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",8.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",83.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",86.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",76.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",87.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",91.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",97.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",119.3,"B","Break" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",120.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",118.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",122.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",112.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",133.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",110.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",120.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",97.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",116.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",121.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",108.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",132,"B","Break" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",135.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",140.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",136.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",128.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",158.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",166,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",171.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",151,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",178.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",188.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",198.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",237,"B","Break" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",232.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",225.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",236.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",216.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",250.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",20.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",22.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",18.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",21.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",22.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",20,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",24.3,"B","Break" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",25,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",25.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",25.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",23.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",29.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",30.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",31.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",27.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",32.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",34.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",36.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",43.6,"B","Break" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",42.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",41.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",43.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",39.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",46.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",7.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",7.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",6.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",7.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",6.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",7.6,"B","Break" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",7.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",7.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",7.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",6.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",7.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",1304.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",1311.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",1201.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",1092.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",1150.2,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",1182.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",1161.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",1134.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",1340.1,"B","Break" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",1384.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",1454.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",1470.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",1655.1,"P","Provisional value" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",1729.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",1825.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",1543.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",1451.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",1528,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",1312.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",1285.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",1281.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",1582.6,"B","Break" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",1550.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",1661.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",1738.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",1742.9,"P","Provisional value" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",1794.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",1836.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",1729,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",1619.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",1736.5,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",1779.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",1807.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",1798.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",2121,"B","Break" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",2259.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",2340.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",2348.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",2776,"P","Provisional value" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",37.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",39.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",33,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",31.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",32.9,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",28.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",27.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",27.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",33.8,"B","Break" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",32.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",35.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",36.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",36.7,"P","Provisional value" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",38.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",39.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",37,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",34.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",37.4,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",38.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",38.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",38.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",45.3,"B","Break" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",47.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",49.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",49.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",58.5,"P","Provisional value" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",9.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",10.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",10.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",10.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",10.2,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",10.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",9.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",9.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",7.1,"B","Break" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",6.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",6.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",7.2,"P","Provisional value" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",3323.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",3447.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",3572.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",3551.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",3534.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",3332.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",3456.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",3523.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",3803.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",4222.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",4310.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",4261,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",4814.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",461.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",530.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",527.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",545.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",515.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",395.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",403.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",412.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",437.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",446.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",468,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",496.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",476,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",368.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",389.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",412.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",413,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",405,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",376.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",391.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",398.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",429,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",484.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",497.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",488.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",555.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",49.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",56.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",55.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",56.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",53.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",40.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",40.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",41,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",43,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",43.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",45.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",47.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",45.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",39.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",41.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",43.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",43,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",41.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",38.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",39.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",39.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",42.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",47.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",48,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",46.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",53.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",9.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",9.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",9.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",9.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",9.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",8.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",8.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",8.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",8.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",8.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",7.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",8.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",484.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",487,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",494,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",513,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",476,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",503,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",497,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",507,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",521,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",527,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",486,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",457,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",593,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",464.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",548.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",526.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",553.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",519.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",522.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",504.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",514.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",532.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",530.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",517.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",500.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",621.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",330.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",348.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",364.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",390.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",371.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",407,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",413.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",426.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",442,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",458.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",427.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",413,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",556.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",59.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",69.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",65.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",68.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",63.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",63.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",60.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",60.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",62.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",61.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",59.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",57.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",71.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",42.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",44,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",45.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",48.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",45.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",49.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",49.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",50.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",51.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",53.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",49.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",47.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",63.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",8.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",8.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",8.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",8.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",8.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",7.8,"B; D","Break; Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",7.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",7.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",7.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",7.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",6.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",7.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",1716.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",1627.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",1382.8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",1432,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",1549.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",1685.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",2002.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",2431.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",3020,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",3906.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",4172,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",5267.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",1142.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",971.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",769.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",752.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",708,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",619.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",663,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",666.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",625.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",688.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",595.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",595.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",1865,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",1684.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",1355.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",1337.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",1403,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",1450.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",1613.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",1756.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",1849.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",2095.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",1927.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",1876.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",15.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",13.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",10.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",9.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",9.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",7.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",8.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",8.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",7.7,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",8.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",7.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",7.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",25.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",22.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",18,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",17.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",18.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",18.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",20.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",21.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",22.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",25.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",23.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",22.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",11,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",11.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",10.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",10,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",9.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",9.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",9.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",9.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",9.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",9.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",8.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",8.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2012","2012",1440.3,"B","Break" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2013","2013",1526.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2014","2014",1581.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2015","2015",1618.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2016","2016",1653,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2017","2017",1666.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","GBR","United Kingdom","2018","2018",1630.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2012","2012",2275.2,"B","Break" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2013","2013",2386.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2014","2014",2601.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2015","2015",2473.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2016","2016",2231.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2017","2017",2144.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","GBR","United Kingdom","2018","2018",2174.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2012","2012",2052.8,"B","Break" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2013","2013",2195.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2014","2014",2263.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2015","2015",2337.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2016","2016",2400.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2017","2017",2433.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","GBR","United Kingdom","2018","2018",2370.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2012","2012",35.7,"B","Break" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2013","2013",37.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2014","2014",40.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2015","2015",38,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2016","2016",34,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2017","2017",32.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","GBR","United Kingdom","2018","2018",32.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2012","2012",32.2,"B","Break" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2013","2013",34.3,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2014","2014",35,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2015","2015",35.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2016","2016",36.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2017","2017",36.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","GBR","United Kingdom","2018","2018",35.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","GBR","United Kingdom","2012","2012",10.5,"B","Break" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","GBR","United Kingdom","2013","2013",10.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","GBR","United Kingdom","2014","2014",9.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","GBR","United Kingdom","2015","2015",9.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","GBR","United Kingdom","2016","2016",8.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","GBR","United Kingdom","2017","2017",8.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","GBR","United Kingdom","2018","2018",8,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",108206.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",124669.7,"B","Break" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",133945.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",140586,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",153706.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",175733,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",190353.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",200656.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",207557.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",206047.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",163545.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",181298.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",237300,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",212.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",257.8,"B","Break" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",275.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",283.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",269.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",268.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",281.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",309.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",323.7,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",293.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",206.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",238.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",271.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",300.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",358.2,"B","Break" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",385.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",402,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",418.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",449.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",479.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",504.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",523.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",513,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",390.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",416.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",542.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",12.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",14.9,"B","Break" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",15.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",16.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",15.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",14.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",15.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",16.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",17.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",15.3,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",10.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",12.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",13.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",17.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",20.8,"B","Break" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",22.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",22.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",23.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",25,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",26.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",27.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",27.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",26.9,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",20.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",21.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",27.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",13.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",10.6,"B","Break" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",10.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",9.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",9.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",9.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",9.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",9.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",8.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",6.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",6.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",8.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",14.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",15.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",16.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",18.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",19.7,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",20.4,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",21.3,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",22.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",24.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",24.6,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",24.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",26.1,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",32.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",19.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",21,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",21.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",24.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",26.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",22.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",23.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",25,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",28.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",27.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",27.6,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",30.9,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",34.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",28.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",29.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",32,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",35.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",37.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",37.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",40.4,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",41.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",44.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",45.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",46.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",48,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",57,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",14.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",15.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",16.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",18.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",20,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",17.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",17.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",18.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",21.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",20.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",20.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",23.2,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",25.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",21.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",22.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",24.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",27.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",28.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",28.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",30.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",31.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",33.8,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",34.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",34.7,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",36.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",42.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",7.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",7.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",7.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",8.1,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",7.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",7.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",7.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",7.3,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",7.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",7.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",6.7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",6.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",7.5,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",29.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",29.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",28.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",27.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",26.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",26.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",27.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",25.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",24.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",25.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",27.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",36.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",40.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",38.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",40.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",36.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",36.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",35.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",29.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",30.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",28.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",28.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",28.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",31.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",42.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",42.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",45.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",46.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",46.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",46.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",45.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",44.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",47.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",44.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",42.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",46.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",50.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",64.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",73.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",18.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",19.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",17.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",17.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",17.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",14.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",14.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",14,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",13.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",13.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",15,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",20.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",20.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",22.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",22.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",22.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",22.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",21.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",21.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",22.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",21.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",20.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",22.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",24.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",30.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",34.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",5.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",5.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",5.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",4.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",4.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",4.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",5.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",542,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",562,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",586,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",617,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",634,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",618,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",629,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",650,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",633,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",668,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",743,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",746,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",497.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",579.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",606.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",595.7,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",571.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",464.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",467.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",498.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",472.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",464.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",511.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",560.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",360.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",371.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",380.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",426.4,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",436.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",419.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",433.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",439.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",430.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",451.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",511,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",515.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",22.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",25.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",26.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",25.8,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",24.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",19.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",19.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",20.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",18.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",18.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",19.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",21.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",16.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",16.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",16.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",18.4,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",18.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",17.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",17.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",17.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",17.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",17.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",19.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",20.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",5.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",5.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",5.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",5.2,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",5.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",4.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",4.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",4.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",4.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",4.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",4.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",132.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",136.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",139.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",143.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",141.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",146.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",146.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",148.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",155.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",164.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",173.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",179,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",175.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",190.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",179.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",190.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",188.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",162.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",162.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",167.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",183.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",183.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",198,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",211.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",157.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",164.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",171.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",180.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",177.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",183.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",188.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",191.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",202.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",219.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",232.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",236.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",21,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",22.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",21.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",22.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",22.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",18.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",18.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",19,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",20.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",20.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",22.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",23.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",18.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",19.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",20.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",21.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",20.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",21.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",21.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",21.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",22.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",24.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",26,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",26.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",5.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",5.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",4.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",4.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",250.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",255.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",253.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",256.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",250.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",247.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",243.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",251.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",261.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",279.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",275.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",286.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",309.3,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",332.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",355.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",326,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",340.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",333.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",274.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",269.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",283.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",309.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",312.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",314.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",338.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",325.7,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",299.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",306.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",308.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",318,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",313.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",309.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",311.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",324,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",341.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",374.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",376.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",388.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",433.2,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",30.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",32.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",29.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",30.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",29.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",24.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",23.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",25,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",27.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",27.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",27.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",29.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",28,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",27.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",27.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",27.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",28.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",28,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",27.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",27.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",28.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",29.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",32.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",32.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",33.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",37.3,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",4.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",3.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",3.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",3.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",3.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",3.4,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",1350.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",1399.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",1464,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",1498.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",1540,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",1593.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",1695,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",1784.2,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",1926.8,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",1866.8,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",2060.8,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",1351.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",1358.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",1325.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",1171.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",1161.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",1227.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",1308,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",1344.8,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",1436.7,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",1488.8,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",1583.4,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",1085,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",1143.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",1189.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",1200.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",1275.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",1314.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",1404.8,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",1445.1,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",1565.1,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",1507.7,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",1643.6,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",38.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",38.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",37.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",32.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",32.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",33.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",35.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",35.8,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",37.8,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",38.9,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",40.7,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",31.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",32.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",33.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",33.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",35.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",36,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",37.9,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",38.4,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",41.1,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",39.4,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",42.3,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",5.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",5.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",5.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",5.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",5.5,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",5.6,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",5.6,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",5.1,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",5.2,"E; D","Estimated value; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",3200.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",3155.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",3344.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",3073.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",3286.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",3432,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",3470.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",3722.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",3754.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",3906.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",3877.4,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",3971.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",167.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",178.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",170.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",157.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",158.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",139.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",142,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",159.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",172.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",170.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",167.1,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",183.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",234.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",236.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",251.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",240.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",258.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",265.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",275.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",299.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",303.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",318.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",311.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",311.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",16,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",17,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",16.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",14.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",15,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",13.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",13.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",15,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",16.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",16,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",15.6,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",17.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",22.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",22.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",23.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",22.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",24.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",25.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",26.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",28.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",28.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",29.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",29.1,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",29.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",3.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",3.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",3.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",4.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",4.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",4.4,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2010","2010",95.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2011","2011",93.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2012","2012",95.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2013","2013",92.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2014","2014",90.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2015","2015",87.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2016","2016",90.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2017","2017",92.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2018","2018",93.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2019","2019",91,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2020","2020",93.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","FIN","Finland","2021","2021",90.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2010","2010",126.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2011","2011",130.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2012","2012",123.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2013","2013",122.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2014","2014",120.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2015","2015",97.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2016","2016",100.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2017","2017",104.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2018","2018",110.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2019","2019",101.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2020","2020",107.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","FIN","Finland","2021","2021",106.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2010","2010",106,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2011","2011",104.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2012","2012",105.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2013","2013",102.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2014","2014",100.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2015","2015",96.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2016","2016",102.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2017","2017",107,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2018","2018",109.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2019","2019",108.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2020","2020",114,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","FIN","Finland","2021","2021",109.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2010","2010",23.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2011","2011",24.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2012","2012",22.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2013","2013",22.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2014","2014",22.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2015","2015",17.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2016","2016",18.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2017","2017",19,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2018","2018",20,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2019","2019",18.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2020","2020",19.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","FIN","Finland","2021","2021",19.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2010","2010",19.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2011","2011",19.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2012","2012",19.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2013","2013",18.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2014","2014",18.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2015","2015",17.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2016","2016",18.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2017","2017",19.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2018","2018",19.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2019","2019",19.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2020","2020",20.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","FIN","Finland","2021","2021",19.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2010","2010",5.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2011","2011",4.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2012","2012",4.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2013","2013",4.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2014","2014",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2015","2015",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2016","2016",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2017","2017",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2018","2018",3.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2019","2019",3.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2020","2020",3.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","FIN","Finland","2021","2021",3.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",1723,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",1670.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",1625.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",1687.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",1708.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",1697.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",1743.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",1776.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",1903.7,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",2018.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",2103.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",2181.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",2284.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",2325.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",2088.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",2241.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",2270.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",1883.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",1929.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",2006.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",2248.2,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",2259.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",2402.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",2579.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",2140.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",2117.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",2065,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",2178.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",2222.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",2181.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",2316.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",2385,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",2588.5,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",2772,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",2901.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",2962.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",27.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",29,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",26,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",27.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",28,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",23.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",23.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",24.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",27.1,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",27.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",28.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",31,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",26.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",26.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",25.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",27,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",27.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",26.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",28.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",28.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",31.2,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",33.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",34.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",35.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",5.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",5.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",5.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",5.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",4.3,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",4.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",4.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",4.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2010","2010",322.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2011","2011",315,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2012","2012",277.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2013","2013",247.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2014","2014",247.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2015","2015",211.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2016","2016",260.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2017","2017",267.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2018","2018",279.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2019","2019",284.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2020","2020",295.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2021","2021",298.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","GRC","Greece","2022","2022",282.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2010","2010",427.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2011","2011",438.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2012","2012",356.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2013","2013",328.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2014","2014",328.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2015","2015",234.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2016","2016",288.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2017","2017",301.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2018","2018",330.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2019","2019",318.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2020","2020",337.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2021","2021",353.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","GRC","Greece","2022","2022",297.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2010","2010",446.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2011","2011",441.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2012","2012",405.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2013","2013",391.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2014","2014",404.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2015","2015",347.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2016","2016",442.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2017","2017",464.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2018","2018",495,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2019","2019",519,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2020","2020",542.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2021","2021",547.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","GRC","Greece","2022","2022",534,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2010","2010",38.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2011","2011",39.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2012","2012",32.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2013","2013",29.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2014","2014",30.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2015","2015",21.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2016","2016",26.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2017","2017",28.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2018","2018",30.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2019","2019",29.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2020","2020",31.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2021","2021",33.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","GRC","Greece","2022","2022",28.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2010","2010",40.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2011","2011",39.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2012","2012",36.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2013","2013",35.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2014","2014",37.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2015","2015",32.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2016","2016",41,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2017","2017",43.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2018","2018",46.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2019","2019",48.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2020","2020",50.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2021","2021",51.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","GRC","Greece","2022","2022",51.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2010","2010",27620.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2011","2011",29340.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2012","2012",28440.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2013","2013",29536.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2014","2014",29679.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2015","2015",28986.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2016","2016",29620.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2017","2017",29875.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2018","2018",30450.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2019","2019",31314.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2020","2020",33090.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2021","2021",31572.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HUN","Hungary","2022","2022",32216.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2010","2010",132.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2011","2011",145.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2012","2012",126.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2013","2013",132,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2014","2014",127.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2015","2015",103.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2016","2016",105.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2017","2017",108.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2018","2018",112.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2019","2019",107.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2020","2020",107.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2021","2021",104.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HUN","Hungary","2022","2022",86.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2010","2010",218.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2011","2011",236.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2012","2012",226.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2013","2013",236.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2014","2014",229.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2015","2015",218.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2016","2016",224.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2017","2017",219.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2018","2018",218.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2019","2019",222.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2020","2020",227.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2021","2021",204,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HUN","Hungary","2022","2022",199.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2010","2010",13.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2011","2011",14.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2012","2012",12.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2013","2013",13.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2014","2014",12.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2015","2015",10.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2016","2016",10.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2017","2017",11.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2018","2018",11.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2019","2019",11,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2020","2020",11,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2021","2021",10.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HUN","Hungary","2022","2022",8.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2010","2010",21.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2011","2011",23.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2012","2012",22.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2013","2013",23.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2014","2014",23.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2015","2015",22.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2016","2016",22.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2017","2017",22.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2018","2018",22.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2019","2019",22.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2020","2020",23.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2021","2021",21,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HUN","Hungary","2022","2022",20.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2010","2010",5.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2011","2011",5.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2012","2012",6.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2013","2013",6.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2014","2014",6.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2015","2015",6.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2016","2016",5.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2017","2017",6.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2018","2018",6.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2019","2019",5.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2020","2020",5.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2021","2021",5.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HUN","Hungary","2022","2022",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",1114.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",1180.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",1196.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",1215.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",1164.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",1085.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",1141.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",1136.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",1285.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",1458.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",1710.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",1809.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",9.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",10.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",9.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",9.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",10,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",8.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",9.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",10.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",11.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",11.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",12.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",14.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",8.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",8.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",8.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",8.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",8.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",7.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",8.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",8.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",9.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",10.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",11.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",12.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",28.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",31.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",29.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",30.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",30.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",24.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",28.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",31,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",33.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",33,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",34.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",38.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",26.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",27.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",27.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",27.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",25.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",23.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",24.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",23.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",25.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",28.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",31.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",32.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",4.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",4.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",4.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",4.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",4.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",4.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",4.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",134.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",129.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",132.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",119,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",113.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",115.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",111.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",102.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",101.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",102.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",108.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",106.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",178.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",179.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",170.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",158.1,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",150.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",128,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",123.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",116.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",120.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",114.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",123.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",125.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",158.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",155.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",161,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",146.7,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",138.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",142.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",140.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",129.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",128.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",127.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",135.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",133.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",39.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",39.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",37,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",34.2,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",32.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",27.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",25.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",24.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",24.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",23.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",24.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",25,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",34.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",33.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",35,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",31.7,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",29.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",30.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",29.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",26.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",26.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",25.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",27.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",26.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",6.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",6.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",6.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",6.1,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",5.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",5.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",4.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",4.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",4.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",4.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2011","2011",1030.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2012","2012",1008.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2013","2013",986.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2014","2014",1009.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2015","2015",1020.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2016","2016",991.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2017","2017",988.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2018","2018",1001.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2019","2019",1055.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2020","2020",1084.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2021","2021",1029.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ITA","Italy","2022","2022",1020.3,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2011","2011",1434.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2012","2012",1295.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2013","2013",1309.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2014","2014",1340.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2015","2015",1131.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2016","2016",1097.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2017","2017",1116.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2018","2018",1182.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2019","2019",1181.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2020","2020",1238.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2021","2021",1217.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ITA","Italy","2022","2022",1074.5,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2011","2011",1358.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2012","2012",1348.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2013","2013",1337.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2014","2014",1364.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2015","2015",1380.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2016","2016",1415.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2017","2017",1432.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2018","2018",1470,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2019","2019",1607.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2020","2020",1674,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2021","2021",1590,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ITA","Italy","2022","2022",1652.6,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2011","2011",24.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2012","2012",21.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2013","2013",21.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2014","2014",22.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2015","2015",18.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2016","2016",18.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2017","2017",18.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2018","2018",19.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2019","2019",19.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2020","2020",20.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2021","2021",20.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ITA","Italy","2022","2022",18.2,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2011","2011",22.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2012","2012",22.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2013","2013",22.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2014","2014",22.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2015","2015",22.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2016","2016",23.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2017","2017",23.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2018","2018",24.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2019","2019",26.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2020","2020",28.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2021","2021",26.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ITA","Italy","2022","2022",28,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2011","2011",5.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2012","2012",5.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2013","2013",5.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2014","2014",5.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2015","2015",4.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2016","2016",4.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2017","2017",4.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2018","2018",4.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2019","2019",4.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2020","2020",4.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2021","2021",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ITA","Italy","2022","2022",4.1,"E","Estimated value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",273823,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",307833.9,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",293533.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",287375.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",305537.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",314131.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",311925.5,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",311635,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",349710.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",368692.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",346455.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",346440.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",236.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",277.8,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",260.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",262.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",290.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",277.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",268.7,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",275.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",317.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",316.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",293.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",302.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",325.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",360.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",343.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",330.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",350.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",366.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",363.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",357.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",409.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",430.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",413.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",405.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",4.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",5.6,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",5.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",5.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",5.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",5.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",5.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",5.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",6.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",6.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",5.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",5.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",6.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",7.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",6.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",6.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",6.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",7.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",7.1,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",7.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",8.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",7.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",1.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",1.4,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",1.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",1.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",1.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",1.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",1.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",1.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",1.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",1.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",1.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2010","2010",10.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2011","2011",11,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2012","2012",11.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2013","2013",11.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2014","2014",10.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2015","2015",10.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2016","2016",10,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2017","2017",9.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2018","2018",9.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",9.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",10.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",11.1,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",11.4,"D; P","Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2010","2010",14.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2011","2011",15.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2012","2012",14.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2013","2013",15.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2014","2014",14.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2015","2015",11.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2016","2016",11,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2017","2017",10.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2018","2018",11.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",10.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",11.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",13.2,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",12,"D; P","Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2010","2010",11.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2011","2011",12.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2012","2012",12.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2013","2013",12.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2014","2014",12,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2015","2015",11.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2016","2016",11.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2017","2017",11.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2018","2018",11.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",11.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",11.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",13,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",13.6,"D; P","Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2010","2010",29.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2011","2011",31.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2012","2012",29.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2013","2013",30.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2014","2014",27.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2015","2015",22.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2016","2016",20.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2017","2017",19.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2018","2018",20.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",19.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",20.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",22.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",20.4,"D; P","Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2010","2010",24.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2011","2011",25.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2012","2012",25,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2013","2013",25.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2014","2014",23.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2015","2015",22.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2016","2016",22.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2017","2017",20.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2018","2018",20.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",20.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",20.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",22.5,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",23.3,"D; P","Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2010","2010",5.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2011","2011",5.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2012","2012",5.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2013","2013",5.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2014","2014",5.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2015","2015",5.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2016","2016",5.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2017","2017",4.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2018","2018",4.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",4.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",4.6,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",4.4,"D; P","Difference in methodology; Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NLD","Netherlands","2010","2010",436,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NLD","Netherlands","2011","2011",457.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NLD","Netherlands","2012","2012",445.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NLD","Netherlands","2013","2013",430.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NLD","Netherlands","2014","2014",414.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2010","2010",578,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2011","2011",636.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2012","2012",572.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2013","2013",571.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NLD","Netherlands","2014","2014",550.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2010","2010",510.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2011","2011",546.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2012","2012",540.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2013","2013",538.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NLD","Netherlands","2014","2014",512,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2010","2010",34.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2011","2011",38.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2012","2012",34.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2013","2013",34,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NLD","Netherlands","2014","2014",32.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2010","2010",30.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2011","2011",32.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2012","2012",32.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2013","2013",32.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NLD","Netherlands","2014","2014",30.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NLD","Netherlands","2010","2010",8.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NLD","Netherlands","2011","2011",8.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NLD","Netherlands","2012","2012",9.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NLD","Netherlands","2013","2013",10,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NLD","Netherlands","2014","2014",9.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",68.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",73.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",77.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",79.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",84.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",90.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",92.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",89.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",100.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",102,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",112.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",116.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",135.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",49.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",57.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",62.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",65.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",70.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",63.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",64.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",63.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",69.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",67.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",72.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",82.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",85.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",45.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",49.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",51.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",55,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",58.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",61.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",64.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",62.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",68.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",72,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",79.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",79.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",93.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",11.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",13.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",14.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",14.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",15.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",13.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",13.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",13.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",14.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",13.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",14.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",16.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",16.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",10.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",11.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",11.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",12.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",13,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",13.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",13.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",12.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",14,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",14.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",15.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",15.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",18.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",9.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",8.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",8.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",8.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",9.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",8.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",7.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",7.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",6.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",6.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",6.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",7.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",1156,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",1136,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",1119,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",1045,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",1098,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",1108,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",1186,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",1214,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",1212,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",1257,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",1347,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",1427,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",1490,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",191.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",202.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",192.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",177.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",174.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",137.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",141.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",146.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",149,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",142.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",143.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",166.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",155,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",126.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",125.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",123.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",115.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",118.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",111.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",118.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",124.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",126.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",130.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",136.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",150,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",138.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",39.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",40.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",38.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",35,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",33.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",26.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",27,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",27.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",28.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",26.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",26.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",30.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",28.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",25.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",25.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",24.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",22.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",23,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",21.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",22.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",23.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",23.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",24.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",25.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",27.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",25.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",6.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",6.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",5.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",5.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",4.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",4.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",4.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",4.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",4.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",4.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",4.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",131.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",132.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",130.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",124.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",117.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",124.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",130.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",131.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",135.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",143.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",147.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",141.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",152.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",174.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",183.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",167.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",165.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",155.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",138,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",144.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",148.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",159.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",160.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",168.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",167.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",160.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",211,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",212,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",215.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",212.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",202.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",212.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",228.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",228.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",236.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",256.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",265.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",249.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",277.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",16.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",17.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",16,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",15.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",15,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",13.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",14,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",14.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",15.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",15.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",16.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",16.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",15.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",20,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",20.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",20.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",20.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",19.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",20.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",22.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",22.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",23,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",24.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",25.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",24.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",26.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",4.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",4.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",5.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",4.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",5.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",5.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",5.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",5.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",5.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",34.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",36.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",34,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",38.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",41.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",42.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",49.8,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",48.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",43.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",44.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",42.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",41.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",45.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",51.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",43.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",51.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",55.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",47.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",55.1,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",54.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",51.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",49.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",48.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",48.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",68.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",72.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",67.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",78.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",85.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",87.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",99,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",93.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",82.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",85.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",81.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",77.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",8.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",9.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",8.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",9.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",10.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",8.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",10.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",10,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",9.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",9.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",8.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",12.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",13.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",12.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",14.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",15.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",16.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",18.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",17.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",15.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",15.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",15,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",14.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",3.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",3.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",3.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",3.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",3.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",3.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",3.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",3.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",2.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",2.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",2.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",2.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2010","2010",1043.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2011","2011",1063,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2012","2012",1009,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2013","2013",945,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2014","2014",985.8,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2015","2015",1007.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2016","2016",981.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2017","2017",961.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2018","2018",1143.7,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2019","2019",1176.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2020","2020",1191.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2021","2021",1189.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ESP","Spain","2022","2022",1243.9,"P","Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2010","2010",1383.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2011","2011",1479.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2012","2012",1296.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2013","2013",1255.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2014","2014",1309.6,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2015","2015",1117.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2016","2016",1086.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2017","2017",1085.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2018","2018",1350.7,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2019","2019",1317.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2020","2020",1361,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2021","2021",1406.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ESP","Spain","2022","2022",1309.9,"P","Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2010","2010",1435.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2011","2011",1488.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2012","2012",1451.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2013","2013",1400.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2014","2014",1488.3,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2015","2015",1515.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2016","2016",1527.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2017","2017",1523.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2018","2018",1810.3,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2019","2019",1919.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2020","2020",1917.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2021","2021",1899.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ESP","Spain","2022","2022",2086.3,"P","Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2010","2010",29.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2011","2011",31.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2012","2012",27.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2013","2013",26.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2014","2014",28.2,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2015","2015",24.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2016","2016",23.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2017","2017",23.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2018","2018",28.9,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2019","2019",28,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2020","2020",28.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2021","2021",29.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ESP","Spain","2022","2022",27.6,"P","Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2010","2010",30.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2011","2011",31.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2012","2012",31,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2013","2013",30,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2014","2014",32,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2015","2015",32.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2016","2016",32.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2017","2017",32.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2018","2018",38.7,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2019","2019",40.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2020","2020",40.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2021","2021",40.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ESP","Spain","2022","2022",44,"P","Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2010","2010",7.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2011","2011",8.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2012","2012",9.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2013","2013",8.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2014","2014",8.7,"B; D","Break; Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2015","2015",8.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2016","2016",8.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2017","2017",8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2018","2018",6,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2019","2019",5.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2020","2020",5.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2021","2021",5.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ESP","Spain","2022","2022",5.4,"P","Provisional value" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2010","2010",1932.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2011","2011",1999.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2012","2012",2058.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2013","2013",2029.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2014","2014",1982.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2015","2015",1702.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2016","2016",1741.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2017","2017",1731.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2018","2018",1807.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2019","2019",1920.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2020","2020",2097.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2021","2021",2019.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SWE","Sweden","2022","2022",2124.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2010","2010",268.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2011","2011",308,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2012","2012",303.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2013","2013",311.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2014","2014",289,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2015","2015",201.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2016","2016",203.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2017","2017",202.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2018","2018",208,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2019","2019",203.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2020","2020",227.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2021","2021",235.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SWE","Sweden","2022","2022",210,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2010","2010",214.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2011","2011",226.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2012","2012",237.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2013","2013",236,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2014","2014",227.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2015","2015",192.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2016","2016",197.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2017","2017",195.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2018","2018",203.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2019","2019",220.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2020","2020",242,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2021","2021",231.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SWE","Sweden","2022","2022",245.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2010","2010",28.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2011","2011",32.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2012","2012",31.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2013","2013",32.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2014","2014",29.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2015","2015",20.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2016","2016",20.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2017","2017",20.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2018","2018",20.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2019","2019",19.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2020","2020",22,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2021","2021",22.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SWE","Sweden","2022","2022",20.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2010","2010",22.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2011","2011",23.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2012","2012",25,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2013","2013",24.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2014","2014",23.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2015","2015",19.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2016","2016",19.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2017","2017",19.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2018","2018",20,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2019","2019",21.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2020","2020",23.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2021","2021",22.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SWE","Sweden","2022","2022",23.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2010","2010",5.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2011","2011",5.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2012","2012",5.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2013","2013",5.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2014","2014",5.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2015","2015",4.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2016","2016",4.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2017","2017",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2018","2018",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2019","2019",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2020","2020",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2021","2021",3.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SWE","Sweden","2022","2022",3.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",899,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",860,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",707.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",727.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",777,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",857.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",973.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",1171.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",1451.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",1853,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",2231.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",2679.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",598.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",513.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",393.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",382,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",355,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",315.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",322.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",321,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",300.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",326.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",318.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",302.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",976.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",890.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",693.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",679.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",703.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",737.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",784.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",846.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",888.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",994.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",1031.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",954.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",8.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",6.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",5.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",4.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",4.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",3.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",3.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",13.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",12,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",9.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",8.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",9.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",9.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",9.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",10.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",10.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",12,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",12.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",11.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",5.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",6.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",5.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",5.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",4.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",4.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",4.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",4.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",4.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",4.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",4.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",4.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",15206.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",26263.5,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",29207.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",30901.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",37615.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",46814.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",52879.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",56041,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",59206.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",57730.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",63661.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",80618.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",88464,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",29.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",54.3,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",60,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",62.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",66,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",71.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",78.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",86.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",92.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",82.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",80.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",106.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",101.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",42.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",75.5,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",84.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",88.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",102.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",119.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",133.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",140.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",149.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",143.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",152.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",185.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",202.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",1.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",3.1,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",3.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",3.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",3.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",4.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",4.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",4.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",4.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",5.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",5.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",2.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",4.4,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",4.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",5.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",6.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",7.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",7.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",7.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",7.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",9.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",10.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",1.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",2.2,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",2.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",2.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",2.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",2.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",2.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",2.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",2.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",2.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",2.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",2.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",3.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2010","2010",6.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2011","2011",6.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2012","2012",7.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2013","2013",8.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2014","2014",8.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2015","2015",8.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2016","2016",8.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2017","2017",9.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2018","2018",10.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2019","2019",10.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2020","2020",11.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2021","2021",11.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","EST","Estonia","2022","2022",11.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2010","2010",8.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2011","2011",9.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2012","2012",9.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2013","2013",11.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2014","2014",11.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2015","2015",9.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2016","2016",9.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2017","2017",10.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2018","2018",12,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2019","2019",11.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2020","2020",12.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2021","2021",13.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","EST","Estonia","2022","2022",12.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2010","2010",12.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2011","2011",13.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2012","2012",14.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2013","2013",16,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2014","2014",16.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2015","2015",16,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2016","2016",16.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2017","2017",17.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2018","2018",18.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2019","2019",19.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2020","2020",21.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2021","2021",20.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","EST","Estonia","2022","2022",20.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2010","2010",6.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2011","2011",7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2012","2012",7.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2013","2013",8.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2014","2014",8.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2015","2015",7.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2016","2016",7.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2017","2017",7.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2018","2018",9.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2019","2019",8.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2020","2020",9.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2021","2021",10.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","EST","Estonia","2022","2022",9.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2010","2010",9.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2011","2011",9.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2012","2012",10.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2013","2013",12.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2014","2014",12.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2015","2015",12.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2016","2016",12.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2017","2017",13.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2018","2018",14.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2019","2019",14.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2020","2020",15.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2021","2021",15.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","EST","Estonia","2022","2022",15.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2010","2010",3.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2011","2011",3.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2012","2012",3.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2013","2013",3.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2014","2014",3.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2015","2015",3.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2016","2016",3.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2017","2017",3.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2018","2018",3.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2019","2019",3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2020","2020",3.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2021","2021",2.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","EST","Estonia","2022","2022",2.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2010","2010",23,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2011","2011",23,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2012","2012",22.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2013","2013",22.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2014","2014",21.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2015","2015",21.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2016","2016",22.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2017","2017",20.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2018","2018",18.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2019","2019",20.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2020","2020",21.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2021","2021",23,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","SVN","Slovenia","2022","2022",24.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2010","2010",30.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2011","2011",32,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2012","2012",29.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2013","2013",29.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2014","2014",28.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2015","2015",23.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2016","2016",24.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2017","2017",23.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2018","2018",22.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2019","2019",22.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2020","2020",24.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2021","2021",27.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","SVN","Slovenia","2022","2022",25.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2010","2010",36,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2011","2011",36.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2012","2012",37.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2013","2013",37.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2014","2014",36.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2015","2015",35.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2016","2016",38.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2017","2017",36.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2018","2018",33.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2019","2019",36.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2020","2020",39.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2021","2021",40.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","SVN","Slovenia","2022","2022",43.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2010","2010",14.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2011","2011",15.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2012","2012",14.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2013","2013",14.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2014","2014",13.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2015","2015",11.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2016","2016",11.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2017","2017",11.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2018","2018",10.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2019","2019",10.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2020","2020",11.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2021","2021",12.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","SVN","Slovenia","2022","2022",12.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2010","2010",17.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2011","2011",18,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2012","2012",18.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2013","2013",18.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2014","2014",17.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2015","2015",17.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2016","2016",18.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2017","2017",17.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2018","2018",16,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2019","2019",17.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2020","2020",18.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2021","2021",19.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","SVN","Slovenia","2022","2022",20.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2010","2010",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2011","2011",4.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2012","2012",5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2013","2013",4.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2014","2014",4.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2015","2015",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2016","2016",4.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2017","2017",4.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2018","2018",3.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2019","2019",3.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2020","2020",3.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2021","2021",3.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","SVN","Slovenia","2022","2022",3.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2010","2010",2266,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2011","2011",2515,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2012","2012",2822,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2013","2013",3239,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2014","2014",3616,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2015","2015",3987,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2016","2016",4356,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2017","2017",4587,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2018","2018",5280,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2019","2019",5999,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2020","2020",6768,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUS","Australia","2021","2021",7354,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2010","2010",2078.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2011","2011",2594.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2012","2012",2921.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2013","2013",3126.9,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2014","2014",3259.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2015","2015",2995.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2016","2016",3238.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2017","2017",3515.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2018","2018",3945,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2019","2019",4170.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2020","2020",4657.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUS","Australia","2021","2021",5524.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2010","2010",1507,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2011","2011",1664.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2012","2012",1832.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2013","2013",2238.2,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2014","2014",2489.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2015","2015",2705.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2016","2016",3003.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2017","2017",3104.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2018","2018",3590.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2019","2019",4053.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2020","2020",4654.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUS","Australia","2021","2021",5080.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2010","2010",94.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2011","2011",116.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2012","2012",128.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2013","2013",135.2,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2014","2014",138.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2015","2015",125.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2016","2016",133.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2017","2017",142.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2018","2018",158,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2019","2019",164.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2020","2020",181.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUS","Australia","2021","2021",215.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2010","2010",68.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2011","2011",74.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2012","2012",80.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2013","2013",96.8,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2014","2014",106,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2015","2015",113.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2016","2016",124.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2017","2017",126.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2018","2018",143.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2019","2019",160,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2020","2020",181.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUS","Australia","2021","2021",197.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2010","2010",23.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2011","2011",24.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2012","2012",27.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2013","2013",27.4,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2014","2014",30.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2015","2015",32.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2016","2016",28.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2017","2017",31,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2018","2018",35.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2019","2019",38.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2020","2020",40.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUS","Australia","2021","2021",41.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2010","2010",583.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2011","2011",617.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2012","2012",664.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2013","2013",712.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2014","2014",767.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2015","2015",832.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2016","2016",920.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2017","2017",987.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2018","2018",1066,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2019","2019",1155.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2020","2020",1262,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","AUT","Austria","2021","2021",1380.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2010","2010",773.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2011","2011",859.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2012","2012",853.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2013","2013",946.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2014","2014",1020,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2015","2015",923.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2016","2016",1018.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2017","2017",1115.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2018","2018",1258.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2019","2019",1294,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2020","2020",1441.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","AUT","Austria","2021","2021",1632.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2010","2010",693,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2011","2011",743.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2012","2012",816.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2013","2013",893.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2014","2014",961.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2015","2015",1041.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2016","2016",1184.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2017","2017",1274.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2018","2018",1392.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2019","2019",1543,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2020","2020",1691,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","AUT","Austria","2021","2021",1824.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2010","2010",92.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2011","2011",102.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2012","2012",101.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2013","2013",111.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2014","2014",119.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2015","2015",106.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2016","2016",116.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2017","2017",126.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2018","2018",142.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2019","2019",145.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2020","2020",161.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","AUT","Austria","2021","2021",182.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2010","2010",82.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2011","2011",88.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2012","2012",96.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2013","2013",105.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2014","2014",112.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2015","2015",120.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2016","2016",135.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2017","2017",144.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2018","2018",157.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2019","2019",173.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2020","2020",189.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","AUT","Austria","2021","2021",203.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2010","2010",23.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2011","2011",24.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2012","2012",25.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2013","2013",27,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2014","2014",27.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2015","2015",28.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2016","2016",30.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2017","2017",31.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2018","2018",33.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2019","2019",34.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2020","2020",36.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","AUT","Austria","2021","2021",37.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2010","2010",1195.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2011","2011",1234.9,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2012","2012",1284.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2013","2013",1324.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2014","2014",1443.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2015","2015",1560.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2016","2016",1656.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2017","2017",1910.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2018","2018",2183.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2019","2019",2606.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2020","2020",2990.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2021","2021",3268.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","BEL","Belgium","2022","2022",3650.4,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2010","2010",1584.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2011","2011",1719,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2012","2012",1650.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2013","2013",1759.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2014","2014",1917.7,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2015","2015",1731.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2016","2016",1833.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2017","2017",2158.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2018","2018",2578.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2019","2019",2918.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2020","2020",3415.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2021","2021",3865.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","BEL","Belgium","2022","2022",3844.1,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2010","2010",1428.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2011","2011",1484.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2012","2012",1562.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2013","2013",1643.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2014","2014",1803.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2015","2015",1950.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2016","2016",2120.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2017","2017",2463.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2018","2018",2848.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2019","2019",3491.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2020","2020",4095.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2021","2021",4436.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","BEL","Belgium","2022","2022",5113.1,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2010","2010",145.5,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2011","2011",155.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2012","2012",148.6,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2013","2013",157.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2014","2014",171.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2015","2015",153.6,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2016","2016",161.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2017","2017",189.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2018","2018",225.6,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2019","2019",254,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2020","2020",296,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2021","2021",333.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","BEL","Belgium","2022","2022",330.9,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2010","2010",131.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2011","2011",134.5,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2012","2012",140.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2013","2013",147.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2014","2014",160.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2015","2015",173,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2016","2016",187.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2017","2017",216.6,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2018","2018",249.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2019","2019",303.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2020","2020",354.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2021","2021",382.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","BEL","Belgium","2022","2022",440.1,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2010","2010",20.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2011","2011",20.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2012","2012",21.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2013","2013",22.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2014","2014",24.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2015","2015",25.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2016","2016",26.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2017","2017",29.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2018","2018",32.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2019","2019",35.4,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2020","2020",39,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2021","2021",40.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","BEL","Belgium","2022","2022",40.5,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2012","2012",4584,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2013","2013",5143,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2014","2014",5547,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2015","2015",6123.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2016","2016",6771.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2017","2017",7576.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2018","2018",8470,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2019","2019",9393.8,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2020","2020",10533.4,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2021","2021",11654.6,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CAN","Canada","2022","2022",12657.3,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2012","2012",4586.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2013","2013",4992.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2014","2014",5021.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2015","2015",4788.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2016","2016",5108,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2017","2017",5837.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2018","2018",6536.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2019","2019",7080.1,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2020","2020",7854,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2021","2021",9294.8,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CAN","Canada","2022","2022",9724.8,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2012","2012",3683.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2013","2013",4201.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2014","2014",4508.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2015","2015",4906.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2016","2016",5609.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2017","2017",6249.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2018","2018",7020.2,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2019","2019",7608.1,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2020","2020",8556.3,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2021","2021",9412.8,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CAN","Canada","2022","2022",10094.9,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2012","2012",132.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2013","2013",142.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2014","2014",141.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2015","2015",134.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2016","2016",141.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2017","2017",159.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2018","2018",176.3,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2019","2019",188.3,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2020","2020",206.5,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2021","2021",243,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CAN","Canada","2022","2022",250.1,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2012","2012",106.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2013","2013",119.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2014","2014",127.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2015","2015",137.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2016","2016",155.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2017","2017",171,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2018","2018",189.4,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2019","2019",202.3,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2020","2020",224.9,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2021","2021",246.1,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CAN","Canada","2022","2022",259.6,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2012","2012",18.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2013","2013",20.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2014","2014",21.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2015","2015",22.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2016","2016",23.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2017","2017",25.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2018","2018",27.7,"E; B; D","Estimated value; Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2019","2019",29.5,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2020","2020",30.7,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2021","2021",31.6,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CAN","Canada","2022","2022",31.7,"E; D","Estimated value; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2010","2010",20004.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2011","2011",19111.1,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2012","2012",20008.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2013","2013",19385.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2014","2014",20371.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2015","2015",22839.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2016","2016",23953.9,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2017","2017",25531,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2018","2018",27722.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2019","2019",30142.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2020","2020",29470.5,"B","Break" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CZE","Czech Republic","2021","2021",31813.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2010","2010",1047.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2011","2011",1080,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2012","2012",1022,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2013","2013",990.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2014","2014",981.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2015","2015",928.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2016","2016",980.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2017","2017",1092.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2018","2018",1275.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2019","2019",1314.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2020","2020",1269.7,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CZE","Czech Republic","2021","2021",1467.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2010","2010",1463.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2011","2011",1432,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2012","2012",1504.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2013","2013",1516.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2014","2014",1603.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2015","2015",1765.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2016","2016",1904.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2017","2017",2054.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2018","2018",2240.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2019","2019",2455.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2020","2020",2365,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CZE","Czech Republic","2021","2021",2496.5,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2010","2010",100,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2011","2011",102.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2012","2012",97.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2013","2013",94.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2014","2014",93.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2015","2015",88,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2016","2016",92.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2017","2017",103.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2018","2018",120,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2019","2019",123.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2020","2020",118.7,"B","Break" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CZE","Czech Republic","2021","2021",139.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2010","2010",139.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2011","2011",136.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2012","2012",143.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2013","2013",144.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2014","2014",152.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2015","2015",167.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2016","2016",180.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2017","2017",194,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2018","2018",210.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2019","2019",230.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2020","2020",221.1,"B","Break" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CZE","Czech Republic","2021","2021",237.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2010","2010",24.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2011","2011",23.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2012","2012",23.9,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2013","2013",24.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2014","2014",25.1,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2015","2015",27,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2016","2016",27.4,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2017","2017",27.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2018","2018",28.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2019","2019",29.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2020","2020",33.6,"B","Break" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CZE","Czech Republic","2021","2021",34.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2010","2010",5687.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2011","2011",5610,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2012","2012",5976.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2013","2013",6538.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2014","2014",7193,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2015","2015",7278.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2016","2016",7562.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2017","2017",8416.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2018","2018",8988.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2019","2019",8869.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2020","2020",9157.9,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DNK","Denmark","2021","2021",9298,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2010","2010",1011.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2011","2011",1044.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2012","2012",1031.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2013","2013",1164.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2014","2014",1281.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2015","2015",1081.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2016","2016",1123.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2017","2017",1274.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2018","2018",1423.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2019","2019",1329.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2020","2020",1399.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DNK","Denmark","2021","2021",1478.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2010","2010",749.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2011","2011",751.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2012","2012",790.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2013","2013",889,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2014","2014",981.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2015","2015",996.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2016","2016",1068.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2017","2017",1224.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2018","2018",1328.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2019","2019",1337,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2020","2020",1397.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DNK","Denmark","2021","2021",1411,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2010","2010",182.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2011","2011",187.6,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2012","2012",184.5,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2013","2013",207.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2014","2014",227.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2015","2015",190.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2016","2016",196.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2017","2017",221.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2018","2018",245.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2019","2019",228.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2020","2020",240.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DNK","Denmark","2021","2021",252.5,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2010","2010",135,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2011","2011",134.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2012","2012",141.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2013","2013",158.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2014","2014",173.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2015","2015",175.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2016","2016",186.5,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2017","2017",212.5,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2018","2018",229.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2019","2019",229.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2020","2020",239.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DNK","Denmark","2021","2021",240.9,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2010","2010",26.9,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2011","2011",27.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2012","2012",29.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2013","2013",32,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2014","2014",33.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2015","2015",33.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2016","2016",34.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2017","2017",36.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2018","2018",37.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2019","2019",36.1,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2020","2020",36.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DNK","Denmark","2021","2021",36.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2010","2010",6585.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2011","2011",6791.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2012","2012",7344.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2013","2013",8022.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2014","2014",8741.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2015","2015",9719.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2016","2016",10572.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2017","2017",11759.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2018","2018",17675.4,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2019","2019",19221.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2020","2020",20725.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","DEU","Germany","2021","2021",22734.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2010","2010",8730.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2011","2011",9453.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2012","2012",9435.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2013","2013",10655.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2014","2014",11612.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2015","2015",10784,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2016","2016",11702.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2017","2017",13284.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2018","2018",20873.8,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2019","2019",21518.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2020","2020",23672.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","DEU","Germany","2021","2021",26888.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2010","2010",8179.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2011","2011",8610.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2012","2012",9328.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2013","2013",10354.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2014","2014",11368,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2015","2015",12491.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2016","2016",14047.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2017","2017",15788.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2018","2018",24033.5,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2019","2019",26394.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2020","2020",28586.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","DEU","Germany","2021","2021",30877.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2010","2010",106.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2011","2011",117.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2012","2012",117.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2013","2013",132.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2014","2014",143.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2015","2015",132,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2016","2016",142.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2017","2017",160.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2018","2018",251.8,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2019","2019",259,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2020","2020",284.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","DEU","Germany","2021","2021",323.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2010","2010",100,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2011","2011",107.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2012","2012",116,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2013","2013",128.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2014","2014",140.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2015","2015",152.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2016","2016",170.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2017","2017",191,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2018","2018",289.9,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2019","2019",317.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2020","2020",343.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","DEU","Germany","2021","2021",371.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2010","2010",22.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2011","2011",22.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2012","2012",24.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2013","2013",25.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2014","2014",26,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2015","2015",27.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2016","2016",29.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2017","2017",31.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2018","2018",40,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2019","2019",41,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2020","2020",42.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","DEU","Germany","2021","2021",42.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2010","2010",5683.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2011","2011",8260.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2012","2012",6983.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2013","2013",6524.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2014","2014",6288.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2015","2015",6869.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2016","2016",7341.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2017","2017",8027.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2018","2018",10229.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2019","2019",10845.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2020","2020",13383.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ISL","Iceland","2021","2021",15274.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2010","2010",46.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2011","2011",71.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2012","2012",55.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2013","2013",53.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2014","2014",53.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2015","2015",52.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2016","2016",60.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2017","2017",75.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2018","2018",94.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2019","2019",88.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2020","2020",98.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ISL","Iceland","2021","2021",120.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2010","2010",42.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2011","2011",61.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2012","2012",51,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2013","2013",47.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2014","2014",45.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2015","2015",48.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2016","2016",52.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2017","2017",58.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2018","2018",72.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2019","2019",77.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2020","2020",91.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ISL","Iceland","2021","2021",102,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2010","2010",146.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2011","2011",223.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2012","2012",174.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2013","2013",164.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2014","2014",164.5,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2015","2015",157.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2016","2016",181.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2017","2017",218.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2018","2018",267.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2019","2019",245.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2020","2020",269.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ISL","Iceland","2021","2021",322.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2010","2010",134.5,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2011","2011",191.6,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2012","2012",159,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2013","2013",147.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2014","2014",138.6,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2015","2015",146.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2016","2016",156.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2017","2017",169.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2018","2018",205.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2019","2019",213.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2020","2020",249,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ISL","Iceland","2021","2021",273.9,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2010","2010",22.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2011","2011",31.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2012","2012",28.8,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2013","2013",25.1,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2014","2014",26.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2015","2015",28.1,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2016","2016",28.9,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2017","2017",30.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2018","2018",33.9,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2019","2019",32.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2020","2020",33.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ISL","Iceland","2021","2021",33.9,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2010","2010",507.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2011","2011",514.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2012","2012",544.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2013","2013",565.6,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2014","2014",604.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2015","2015",663.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2016","2016",733.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2017","2017",783.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2018","2018",870.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2019","2019",1040.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2020","2020",1067.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","IRL","Ireland","2021","2021",1177.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2010","2010",673.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2011","2011",716.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2012","2012",699.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2013","2013",751.2,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2014","2014",803.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2015","2015",736.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2016","2016",811.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2017","2017",885.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2018","2018",1028,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2019","2019",1165.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2020","2020",1219.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","IRL","Ireland","2021","2021",1392.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2010","2010",597.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2011","2011",619.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2012","2012",661.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2013","2013",697.2,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2014","2014",738.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2015","2015",819.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2016","2016",923.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2017","2017",986.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2018","2018",1098.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2019","2019",1291.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2020","2020",1341.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","IRL","Ireland","2021","2021",1481.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2010","2010",147.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2011","2011",156.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2012","2012",152,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2013","2013",162.5,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2014","2014",172.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2015","2015",156.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2016","2016",170.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2017","2017",184.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2018","2018",211.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2019","2019",236.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2020","2020",244.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","IRL","Ireland","2021","2021",276.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2010","2010",131.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2011","2011",135.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2012","2012",143.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2013","2013",150.8,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2014","2014",158.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2015","2015",174.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2016","2016",194.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2017","2017",205.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2018","2018",225.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2019","2019",261.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2020","2020",269,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","IRL","Ireland","2021","2021",294.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2010","2010",24.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2011","2011",26.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2012","2012",26.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2013","2013",28.9,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2014","2014",31.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2015","2015",33.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2016","2016",35.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2017","2017",36.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2018","2018",38.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2019","2019",43.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2020","2020",43.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","IRL","Ireland","2021","2021",44.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2010","2010",2899512,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2011","2011",3029486,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2012","2012",3003413,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2013","2013",3090356,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2014","2014",3032529,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2015","2015",3250399,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2016","2016",3337024,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2017","2017",3541392,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2018","2018",3902278,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2019","2019",5374795,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2020","2020",5321541,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","JPN","Japan","2021","2021",5505328,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2010","2010",33031.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2011","2011",37960.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2012","2012",37641.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2013","2013",31664.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2014","2014",28623.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2015","2015",26853,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2016","2016",30673.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2017","2017",31572.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2018","2018",35339.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2019","2019",49305.7,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2020","2020",49839,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","JPN","Japan","2021","2021",50160.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2010","2010",25955.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2011","2011",28193.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2012","2012",28803.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2013","2013",30506.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2014","2014",29427.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2015","2015",31414.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2016","2016",31624.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2017","2017",33694.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2018","2018",37464.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2019","2019",51568.7,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2020","2020",51954.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","JPN","Japan","2021","2021",53947.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2010","2010",257.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2011","2011",296.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2012","2012",295,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2013","2013",248.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2014","2014",225,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2015","2015",211.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2016","2016",241.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2017","2017",249.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2018","2018",279.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2019","2019",390.8,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2020","2020",395.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","JPN","Japan","2021","2021",399.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2010","2010",202.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2011","2011",220.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2012","2012",225.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2013","2013",239.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2014","2014",231.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2015","2015",247.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2016","2016",249.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2017","2017",265.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2018","2018",296.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2019","2019",408.7,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2020","2020",411.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","JPN","Japan","2021","2021",429.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2010","2010",42.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2011","2011",43.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2012","2012",43,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2013","2013",44.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2014","2014",46,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2015","2015",48.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2016","2016",50.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2017","2017",52.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2018","2018",56.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2019","2019",56.6,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2020","2020",57.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","JPN","Japan","2021","2021",60,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2010","2010",5595610,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2011","2011",5991080.2,"B","Break" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2012","2012",6275160,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2013","2013",6613982.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2014","2014",7047389.1,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2015","2015",7318854.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2016","2016",7816107.1,"B","Break" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2017","2017",8367494.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2018","2018",9096656.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2019","2019",9936708.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2020","2020",10252126.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","KOR","Korea","2021","2021",11116136.7,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2010","2010",4838.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2011","2011",5406,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2012","2012",5569,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2013","2013",6040.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2014","2014",6693.7,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2015","2015",6471.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2016","2016",6733.6,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2017","2017",7398.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2018","2018",8268.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2019","2019",8526.7,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2020","2020",8686.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","KOR","Korea","2021","2021",9717.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2010","2010",6653.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2011","2011",7010.5,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2012","2012",7340.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2013","2013",7610.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2014","2014",8083,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2015","2015",8535.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2016","2016",9101.1,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2017","2017",9588.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2018","2018",10641,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2019","2019",11602.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2020","2020",12238.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","KOR","Korea","2021","2021",13015.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2010","2010",97.6,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2011","2011",108.3,"B","Break" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2012","2012",110.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2013","2013",119.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2014","2014",131.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2015","2015",126.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2016","2016",131.5,"B","Break" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2017","2017",144,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2018","2018",160.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2019","2019",164.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2020","2020",167.6,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","KOR","Korea","2021","2021",187.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2010","2010",134.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2011","2011",140.4,"B","Break" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2012","2012",146.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2013","2013",150.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2014","2014",159.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2015","2015",167.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2016","2016",177.7,"B","Break" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2017","2017",186.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2018","2018",206.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2019","2019",224.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2020","2020",236.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","KOR","Korea","2021","2021",251.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2010","2010",27.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2011","2011",27.2,"B","Break" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2012","2012",28.9,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2013","2013",29.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2014","2014",29.8,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2015","2015",29.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2016","2016",30.8,"B","Break" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2017","2017",31,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2018","2018",31.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2019","2019",32,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2020","2020",31.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","KOR","Korea","2021","2021",32,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2019","2019",40,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2020","2020",42.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2021","2021",55,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","LUX","Luxembourg","2022","2022",68.6,"D; P","Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2019","2019",44.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2020","2020",49,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2021","2021",65,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","LUX","Luxembourg","2022","2022",72.2,"D; P","Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2019","2019",47.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2020","2020",50.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2021","2021",64,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","LUX","Luxembourg","2022","2022",82.5,"D; P","Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2019","2019",80.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2020","2020",86.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2021","2021",113,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","LUX","Luxembourg","2022","2022",123.1,"D; P","Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2019","2019",85.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2020","2020",88.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2021","2021",111.3,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","LUX","Luxembourg","2022","2022",140.6,"D; P","Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","LUX","Luxembourg","2019","2019",19.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","LUX","Luxembourg","2020","2020",20.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","LUX","Luxembourg","2021","2021",22.9,"B; D; P","Break; Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","LUX","Luxembourg","2022","2022",26.7,"D; P","Difference in methodology; Provisional value" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2010","2010",17216,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2011","2011",17014,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2012","2012",15972,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2013","2013",17807.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2014","2014",17108.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2015","2015",17559.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2016","2016",19174.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2017","2017",19800.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2018","2018",19951.1,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2019","2019",20779.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2020","2020",20184.1,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2021","2021",21170.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","MEX","Mexico","2022","2022",24535.8,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2010","2010",1362.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2011","2011",1369.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2012","2012",1212.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2013","2013",1394.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2014","2014",1287.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2015","2015",1108,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2016","2016",1027.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2017","2017",1046.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2018","2018",1036.7,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2019","2019",1078.7,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2020","2020",939.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2021","2021",1044.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","MEX","Mexico","2022","2022",1219,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2010","2010",2241.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2011","2011",2217.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2012","2012",2032.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2013","2013",2258.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2014","2014",2126.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2015","2015",2108.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2016","2016",2270.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2017","2017",2221.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2018","2018",2150.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2019","2019",2150.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2020","2020",2010.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2021","2021",2035.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","MEX","Mexico","2022","2022",2319.9,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2010","2010",12,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2011","2011",11.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2012","2012",10.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2013","2013",11.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2014","2014",10.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2015","2015",9.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2016","2016",8.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2017","2017",8.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2018","2018",8.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2019","2019",8.5,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2020","2020",7.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2021","2021",8.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","MEX","Mexico","2022","2022",9.4,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2010","2010",19.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2011","2011",19.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2012","2012",17.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2013","2013",19.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2014","2014",17.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2015","2015",17.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2016","2016",18.5,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2017","2017",17.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2018","2018",17.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2019","2019",17,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2020","2020",15.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2021","2021",15.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","MEX","Mexico","2022","2022",17.8,"E","Estimated value" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","MEX","Mexico","2013","2013",12.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","MEX","Mexico","2018","2018",8.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2010","2010",186.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2011","2011",202.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2012","2012",290,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2013","2013",311.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2014","2014",323.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2015","2015",343.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2016","2016",383.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2017","2017",653.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2018","2018",614.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2019","2019",758.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2020","2020",904.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2021","2021",968.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NZL","New Zealand","2022","2022",1012.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2010","2010",134.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2011","2011",160,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2012","2012",234.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2013","2013",255.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2014","2014",268,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2015","2015",239.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2016","2016",267,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2017","2017",464.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2018","2018",425,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2019","2019",499.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2020","2020",586.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2021","2021",685.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NZL","New Zealand","2022","2022",641.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2010","2010",124.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2011","2011",136.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2012","2012",193.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2013","2013",215.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2014","2014",224.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2015","2015",232.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2016","2016",266.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2017","2017",456.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2018","2018",417.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2019","2019",535.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2020","2020",640.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2021","2021",664,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NZL","New Zealand","2022","2022",701.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2010","2010",30.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2011","2011",36.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2012","2012",53.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2013","2013",57.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2014","2014",59.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2015","2015",51.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2016","2016",56.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2017","2017",96.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2018","2018",86.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2019","2019",100.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2020","2020",115.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2021","2021",134.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NZL","New Zealand","2022","2022",125.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2010","2010",28.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2011","2011",31.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2012","2012",44,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2013","2013",48.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2014","2014",49.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2015","2015",50.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2016","2016",56.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2017","2017",94.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2018","2018",85.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2019","2019",107.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2020","2020",125.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2021","2021",129.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NZL","New Zealand","2022","2022",137,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2010","2010",24.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2011","2011",24.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2012","2012",31.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2013","2013",33.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2014","2014",33.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2015","2015",34.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2016","2016",35.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2017","2017",51.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2018","2018",46.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2019","2019",50.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2020","2020",54.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2021","2021",54.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NZL","New Zealand","2022","2022",53.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2010","2010",4403,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2011","2011",4498,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2012","2012",4842,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2013","2013",5243,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2014","2014",6014,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2015","2015",6491,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2016","2016",7112,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2017","2017",8018,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2018","2018",8422,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2019","2019",8490,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2020","2020",9002,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2021","2021",9822,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","NOR","Norway","2022","2022",9826,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2010","2010",728.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2011","2011",802.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2012","2012",832.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2013","2013",892.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2014","2014",954.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2015","2015",804.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2016","2016",846.7,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2017","2017",969.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2018","2018",1035.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2019","2019",964.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2020","2020",956,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2021","2021",1143.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","NOR","Norway","2022","2022",1022,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2010","2010",481.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2011","2011",495.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2012","2012",535.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2013","2013",580.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2014","2014",648.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2015","2015",653.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2016","2016",708.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2017","2017",822.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2018","2018",878.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2019","2019",882.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2020","2020",911.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2021","2021",1032.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","NOR","Norway","2022","2022",914.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2010","2010",149,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2011","2011",162,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2012","2012",165.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2013","2013",175.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2014","2014",185.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2015","2015",155.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2016","2016",161.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2017","2017",183.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2018","2018",195,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2019","2019",180.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2020","2020",177.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2021","2021",211.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","NOR","Norway","2022","2022",188.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2010","2010",98.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2011","2011",100,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2012","2012",106.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2013","2013",114.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2014","2014",126.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2015","2015",126,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2016","2016",135.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2017","2017",155.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2018","2018",165.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2019","2019",165,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2020","2020",169.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2021","2021",190.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","NOR","Norway","2022","2022",168.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2010","2010",24.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2011","2011",24.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2012","2012",25.8,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2013","2013",27.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2014","2014",28.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2015","2015",28.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2016","2016",28.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2017","2017",30.1,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2018","2018",30.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2019","2019",29.9,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2020","2020",30.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2021","2021",29.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","NOR","Norway","2022","2022",27.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2010","2010",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2011","2011",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2012","2012",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2013","2013",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2014","2014",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2015","2015",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2016","2016",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2017","2017",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2018","2018",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2019","2019",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2020","2020",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2021","2021",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","PRT","Portugal","2022","2022",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2010","2010",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2011","2011",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2012","2012",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2013","2013",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2014","2014",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2015","2015",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2016","2016",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2017","2017",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2018","2018",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2019","2019",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2020","2020",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2021","2021",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","PRT","Portugal","2022","2022",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2010","2010",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2011","2011",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2012","2012",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2013","2013",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2014","2014",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2015","2015",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2016","2016",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2017","2017",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2018","2018",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2019","2019",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2020","2020",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2021","2021",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","PRT","Portugal","2022","2022",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2010","2010",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2011","2011",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2012","2012",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2013","2013",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2014","2014",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2015","2015",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2016","2016",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2017","2017",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2018","2018",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2019","2019",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2020","2020",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2021","2021",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","PRT","Portugal","2022","2022",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2010","2010",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2011","2011",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2012","2012",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2013","2013",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2014","2014",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2015","2015",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2016","2016",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2017","2017",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2018","2018",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2019","2019",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2020","2020",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2021","2021",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","PRT","Portugal","2022","2022",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2010","2010",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2011","2011",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2012","2012",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2013","2013",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2014","2014",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2015","2015",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2016","2016",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2017","2017",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2018","2018",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2019","2019",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2020","2020",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2021","2021",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","PRT","Portugal","2022","2022",0,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2010","2010",262.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2011","2011",257.4,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2012","2012",275.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2013","2013",352,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2014","2014",390,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2015","2015",415.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2016","2016",466.6,"B","Break" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2017","2017",460.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2018","2018",489.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2019","2019",548.9,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2020","2020",505.1,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","SVK","Slovak Republic","2021","2021",556.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2010","2010",348.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2011","2011",358.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2012","2012",353.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2013","2013",467.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2014","2014",518.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2015","2015",461.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2016","2016",516.4,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2017","2017",520.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2018","2018",578.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2019","2019",614.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2020","2020",576.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","SVK","Slovak Republic","2021","2021",658.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2010","2010",523,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2011","2011",508.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2012","2012",545.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2013","2013",716.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2014","2014",803.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2015","2015",845.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2016","2016",927.2,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2017","2017",892,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2018","2018",930.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2019","2019",1060.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2020","2020",971.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","SVK","Slovak Republic","2021","2021",1043.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2010","2010",64.6,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2011","2011",66.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2012","2012",65.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2013","2013",86.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2014","2014",95.6,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2015","2015",85.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2016","2016",95.1,"B","Break" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2017","2017",95.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2018","2018",106.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2019","2019",112.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2020","2020",105.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","SVK","Slovak Republic","2021","2021",120.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2010","2010",97,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2011","2011",94.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2012","2012",100.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2013","2013",132.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2014","2014",148.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2015","2015",156,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2016","2016",170.7,"B","Break" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2017","2017",164,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2018","2018",170.9,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2019","2019",194.5,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2020","2020",178,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","SVK","Slovak Republic","2021","2021",191.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2010","2010",23.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2011","2011",22.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2012","2012",24.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2013","2013",28.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2014","2014",29.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2015","2015",30,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2016","2016",29.7,"B","Break" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2017","2017",29.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2018","2018",30,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2019","2019",31.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2020","2020",30.4,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","SVK","Slovak Republic","2021","2021",31.1,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2010","2010",980.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2011","2011",1030,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2012","2012",1180,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2013","2013",1238,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2014","2014",1258,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2015","2015",1291,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2016","2016",1218,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2017","2017",1298,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2018","2018",1377,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2019","2019",1454,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2020","2020",1631,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2021","2021",1772,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHE","Switzerland","2022","2022",1931,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2010","2010",940.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2011","2011",1159.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2012","2012",1258.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2013","2013",1335.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2014","2014",1373.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2015","2015",1341.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2016","2016",1236.1,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2017","2017",1318.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2018","2018",1408.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2019","2019",1463.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2020","2020",1737,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2021","2021",1939.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHE","Switzerland","2022","2022",2022.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2010","2010",668.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2011","2011",737,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2012","2012",871.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2013","2013",943.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2014","2014",981.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2015","2015",1044.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2016","2016",1013.3,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2017","2017",1092.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2018","2018",1168.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2019","2019",1263.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2020","2020",1436.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2021","2021",1601.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHE","Switzerland","2022","2022",1811.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2010","2010",120.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2011","2011",146.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2012","2012",157.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2013","2013",165.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2014","2014",167.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2015","2015",162,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2016","2016",147.6,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2017","2017",156,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2018","2018",165.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2019","2019",170.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2020","2020",201.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2021","2021",222.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHE","Switzerland","2022","2022",231.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2010","2010",85.5,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2011","2011",93.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2012","2012",109,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2013","2013",116.6,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2014","2014",119.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2015","2015",126.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2016","2016",121,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2017","2017",129.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2018","2018",137.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2019","2019",147.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2020","2020",166.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2021","2021",184,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHE","Switzerland","2022","2022",207.3,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2010","2010",17.1,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2011","2011",17.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2012","2012",19.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2013","2013",20.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2014","2014",21.2,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2015","2015",20.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2016","2016",19.1,"B; D","Break; Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2017","2017",19.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2018","2018",20.8,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2019","2019",21.7,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2020","2020",23.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2021","2021",24.9,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHE","Switzerland","2022","2022",25.4,"D","Difference in methodology" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2010","2010",2757.9,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2011","2011",2753.9,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2012","2012",2842.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2013","2013",3163,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2014","2014",3698.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2015","2015",4528.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2016","2016",5484.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2017","2017",5689.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2018","2018",7358.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2019","2019",9709.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2020","2020",11913.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","TUR","Türkiye","2021","2021",15726.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2010","2010",1835.1,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2011","2011",1644.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2012","2012",1582.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2013","2013",1661.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2014","2014",1689.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2015","2015",1664.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2016","2016",1815.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2017","2017",1559.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2018","2018",1524,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2019","2019",1711.3,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2020","2020",1699.9,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","TUR","Türkiye","2021","2021",1776.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2010","2010",2996.6,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2011","2011",2850.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2012","2012",2787.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2013","2013",2955.2,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2014","2014",3348.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2015","2015",3895.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2016","2016",4419,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2017","2017",4111.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2018","2018",4507.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2019","2019",5209.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2020","2020",5504.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","TUR","Türkiye","2021","2021",5600.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2010","2010",25.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2011","2011",22.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2012","2012",21.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2013","2013",21.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2014","2014",21.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2015","2015",21.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2016","2016",22.9,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2017","2017",19.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2018","2018",18.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2019","2019",20.7,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2020","2020",20.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","TUR","Türkiye","2021","2021",21.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2010","2010",41,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2011","2011",38.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2012","2012",37.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2013","2013",38.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2014","2014",43.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2015","2015",49.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2016","2016",55.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2017","2017",51.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2018","2018",55.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2019","2019",63.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2020","2020",66,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","TUR","Türkiye","2021","2021",66.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2010","2010",17.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2011","2011",19.4,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2012","2012",21,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2013","2013",22.1,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2014","2014",23.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2015","2015",24.7,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2016","2016",25,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2017","2017",22.4,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2018","2018",23,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2019","2019",23.1,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2020","2020",23.8,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","TUR","Türkiye","2021","2021",24.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2010","2010",95614.1,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2011","2011",166797.1,"B","Break" +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2012","2012",169953.3,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2013","2013",235364.6,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2014","2014",218422.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2015","2015",241259,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2016","2016",272690.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2017","2017",326087.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2018","2018",374177.7,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2019","2019",484298.5,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2020","2020",497444.1,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2021","2021",484621.8,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","CHL","Chile","2022","2022",444493.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2010","2010",187.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2011","2011",344.9,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2012","2012",349.4,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2013","2013",475.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2014","2014",383,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2015","2015",368.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2016","2016",402.8,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2017","2017",502.6,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2018","2018",583.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2019","2019",689,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2020","2020",627.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2021","2021",638.5,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","CHL","Chile","2022","2022",509,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2010","2010",265.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2011","2011",479.3,"B","Break" +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2012","2012",489.5,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2013","2013",673.1,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2014","2014",594.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2015","2015",616.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2016","2016",686.4,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2017","2017",820,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2018","2018",944.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2019","2019",1205.9,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2020","2020",1188.8,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2021","2021",1113.7,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","CHL","Chile","2022","2022",1015.8,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2010","2010",11,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2011","2011",20,"B","Break" +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2012","2012",20,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2013","2013",27,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2014","2014",21.5,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2015","2015",20.5,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2016","2016",22.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2017","2017",27.3,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2018","2018",31.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2019","2019",36.1,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2020","2020",32.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2021","2021",32.4,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","CHL","Chile","2022","2022",25.7,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2010","2010",15.6,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2011","2011",27.8,"B","Break" +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2012","2012",28.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2013","2013",38.2,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2014","2014",33.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2015","2015",34.3,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2016","2016",37.8,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2017","2017",44.5,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2018","2018",50.4,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2019","2019",63.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2020","2020",61.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2021","2021",56.6,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","CHL","Chile","2022","2022",51.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2010","2010",11.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2011","2011",14.1,"B","Break" +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2012","2012",13.6,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2013","2013",16.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2014","2014",14.1,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2015","2015",13.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2016","2016",13.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2017","2017",15.8,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2018","2018",16.3,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2019","2019",19.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2020","2020",18.5,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2021","2021",17.2,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","CHL","Chile","2022","2022",15.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",3.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",3.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",3.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",3.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",3.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",2.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",2.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",2.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",2.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",2.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",6.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",6.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",6.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",6.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",6.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",7.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",7.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",8.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",9.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",8.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",3.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",3.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",3.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",2.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",2.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",2.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",2.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",2.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",2.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",2.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",12,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",11.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",11.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",10.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",10.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",10.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",9.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",9.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",9.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",9.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",9.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",10,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",10.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",2.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",1.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",1.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",1.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",1.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",1.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",0.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",2.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",2.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",2.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",2.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",1.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",1.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",1.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",1.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",1.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",1.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",1.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",2.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",2.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",2.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",2.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",2.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",2.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",2.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",2.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",2.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",2.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",3.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",1.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",1.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",1.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",1.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",1.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",1.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",1.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",1.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",1.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",1.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",1.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",1.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",1.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",1.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",1.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",1.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",1.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",1.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",1.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",1.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",1.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",2.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",2.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",2.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",2.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",2.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",2.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",2.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",1.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",1.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",1.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",0.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",0.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",0.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",0.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",0.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",0.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",0.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",0.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",0.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",6.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",6.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",6.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",6.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",6.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",6.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",6.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",6.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",6.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",6.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",6.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",6.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",6.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",18.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",18.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",18.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",18,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",17.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",16.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",14.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",14.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",13.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",13.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",12.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",12.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",11.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",1.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",1.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",0.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",0.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",0.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",0.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",0.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",4.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",4.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",4.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",4.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",4.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",4.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",3.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",3.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",3.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",3.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",3.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",3.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",9.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",9.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",9.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",10.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",9.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",10.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",15,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",15.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",15.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",13,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",13.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",11.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",10.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",5.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",5.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",5.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",5.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",5.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",5.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",5.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",5.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",5.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",6.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",6.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",0.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",0.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",7.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",7.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",7.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",7.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",7.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",7.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",7.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",6.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",6.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",8.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",3.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",3.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",3.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",4.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",4.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",3.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",3.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",3.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",3.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",3.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",3.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",13,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",13.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",13.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",13.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",13.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",13.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",13.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",12.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",12.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",13.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",13.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",14.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",14.4,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",0,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",6.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",6.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",6.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",6.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",6.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",5.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",5.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",4.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",4.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",4.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",4.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",3.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2010","2010",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2011","2011",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2012","2012",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2013","2013",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2014","2014",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2015","2015",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2016","2016",0.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2017","2017",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2018","2018",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2019","2019",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2020","2020",0.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2021","2021",0.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","LVA","Latvia","2022","2022",0.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",276.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",289.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",295.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",307.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",315.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",331.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",369.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",392.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",411.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",426.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",447.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",458.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",521.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",35.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",38.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",38.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",40.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",42.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",45.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",49.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",50.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",52,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",56,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",60.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",65.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",75.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",4.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",4.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",4.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",4.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",4.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",5.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",5.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",5.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",6.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",6.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",6.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",7.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",15.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",16.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",16.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",17.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",18.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",19.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",21.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",22.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",22.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",24.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",27,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",29.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",34,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",18.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",18.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",19.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",20.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",22.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",23.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",24.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",28.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",31.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",38.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",40,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",43.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",45.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",52.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",53.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",55.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",55.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",54.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",53.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",54.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",56.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",56.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",59.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",57.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",58,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",60.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",2.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",3.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",3.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",3.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",3.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",3.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",3.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",3.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",2.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",2.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",2.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",3.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",6.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",6.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",7.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",7.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",7.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",7.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",7.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",7.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",7.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",6.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",6.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",6.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",3.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",3.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",3.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",3.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",2.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",2.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",2.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",2.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",1.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",1.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",1.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",18,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",18.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",19,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",19.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",19.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",18.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",18.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",19.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",20.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",20.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",19.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",18.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",18.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",7.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",7.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",7.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",6.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",5.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",5.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",5.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",6.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",6.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",7.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",8.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",9.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",10.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",12.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",13,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",13.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",13.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",14.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",14.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",14.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",14.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",14.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",15.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",14.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",14.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",16.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",5.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",5.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",5.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",6.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",6.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",6.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",6.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",6.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",7.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",6.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",6.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",8.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",4.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",5.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",6.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",5.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",5.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",6.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",6.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",6.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",6.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",25.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",26.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",29.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",32,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",31.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",35.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",55.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",60.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",65.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",55.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",62.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",51.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",57.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",9.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",9.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",9.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",9.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",10.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",10.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",10.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",10.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",9.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",9.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",10.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",18.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",19.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",19.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",20.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",20.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",21.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",22.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",24.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",25.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",28.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",29.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",31.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",35.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",10.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",11.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",11.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",12.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",13,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",13.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",14.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",15.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",15.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",16.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",16.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",16.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",19.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",33.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",33.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",33.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",33.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",33.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",34.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",35.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",37.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",39,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",41.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",43.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",46,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",52.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",7.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",7.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",7.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",7.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",7.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",7.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",7.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",8.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",8.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",9.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",10.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",12.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",16.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",2.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",2.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",3.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",3.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",2.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",2.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",2.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",2.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",2.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",3.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",3.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",4.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",4.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",2.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",2.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",2.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",2.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",3.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",3.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",4.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",20.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",21.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",22.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",23.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",24,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",24.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",25.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",27.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",28.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",29.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",27.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",28.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",43.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2010","2010",8.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2011","2011",8.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2012","2012",9.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2013","2013",9.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2014","2014",9.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2015","2015",9.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2016","2016",9.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2017","2017",9.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2018","2018",9.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2019","2019",9.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2020","2020",9.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2021","2021",9.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","LVA","Latvia","2022","2022",10.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",365.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",406.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",379.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",408.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",419.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",367.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",408.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",443.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",485.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",477.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",511.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",542.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",549.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",47.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",53.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",49.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",53.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",56.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",50.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",54.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",57,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",61.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",62.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",68.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",77.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",79.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",5.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",6.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",5.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",6.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",6.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",5.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",5.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",5.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",6.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",6.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",7.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",7.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",20.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",23.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",21.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",22.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",24,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",22,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",23.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",25.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",26.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",27.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",30.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",34.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",35.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",24.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",26.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",25.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",27.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",29.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",25.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",27.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",32,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",37.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",42.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",45.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",51.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",48.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",69.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",75.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",70.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",73.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",72,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",59.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",60.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",64.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",67.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",66.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",65.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",68.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",63.3,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",3.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",3.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",3.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",3.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",4.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",4.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",3.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",2.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",2.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",2.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",2.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",2.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",3.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",3.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",3.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",3.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",8.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",9.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",9.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",10,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",8.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",8.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",8.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",8.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",7.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",7.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",6.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",5.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",5.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",4.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",4.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",3.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",2.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",2.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",2.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",2.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",1.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",23.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",25.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",24.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",25.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",25.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",20.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",20.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",22.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",23.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",23,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",22.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",22.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",19.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",9.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",10.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",9.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",9.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",7.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",5.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",6.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",7.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",8.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",9.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",11.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",11.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",16.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",18.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",16.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",18.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",19,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",15.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",15.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",16.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",17.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",17,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",16.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",17.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",17.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",7.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",8.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",7.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",8.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",6.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",6.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",7.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",7.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",7.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",8.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",8.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",8.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",7.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",6.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",6.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",7.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",7.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",7.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",7.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",6.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",33.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",37.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",37.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",42.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",41.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",39.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",61.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",68.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",77,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",62.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",71.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",60.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",60.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",12.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",13.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",12.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",12.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",13,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",11,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",11.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",12,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",12.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",11.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",11.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",11.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",11.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",24.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",26.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",24.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",26.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",27.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",24.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",25.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",27.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",30.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",32.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",33.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",36.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",37.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",13.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",15.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",14.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",16.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",17.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",15.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",16.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",17.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",18.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",18.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",18.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",19.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",20.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",43.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",47,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",43,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",44.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",44.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",38.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",39.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",42.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",46.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",46.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",50.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",54.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",55.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",9.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",10.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",9.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",9.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",9.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",8.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",8.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",9.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",10.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",10.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",11.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",15.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",17.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",3.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",3.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",3.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",3.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",3.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",3.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",3.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",3.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",3.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",3.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",3.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",4.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",5.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",5.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",3.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",2.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",2.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",2.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",3.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",3.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",3.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",3.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",4.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",27.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",30,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",28.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",30.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",31.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",26.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",28.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",31.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",34.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",33.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",31.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",33.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",46,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2010","2010",11.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2011","2011",12.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2012","2012",11.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2013","2013",12.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2014","2014",12.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2015","2015",10.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2016","2016",10.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2017","2017",11,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2018","2018",11.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2019","2019",10.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2020","2020",11,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2021","2021",11.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","LVA","Latvia","2022","2022",11.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",567.2,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",581.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",583.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",616,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",634.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",666.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",762,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",810.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",839.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",876.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",926.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",901.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",1024.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",73.5,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",76.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",76.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",81.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",85.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",91.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",101.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",104,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",106.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",114.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",124.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",128.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",147.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",0.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",0.9,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",1.1,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",1.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",1.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",8.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",8.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",9.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",9.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",9.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",9.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",10.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",10.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",10.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",12.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",13.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",13.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",14.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",31.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",33.7,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",33,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",34.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",36.3,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",39.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",43.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",46.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",46.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",49.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",56,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",57.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",66.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",38.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",38,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",38.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",41.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",44.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",46.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",50.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",58.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",64.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",78.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",82.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",85.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",90.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",107.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",108.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",108.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",110.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",108.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",107.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",113.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",117.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",116.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",121.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",119.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",113.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",118.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",0.2,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",0.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",1.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",1.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",1.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",1.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",1.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",2.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",2.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",2.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",3.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",5.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",5.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",5.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",6.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",6.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",6.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",7.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",7.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",7.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",7.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",7.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",6.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",5.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",4.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",4.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",4.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",4.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",4.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",4.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",4.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",5.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",5.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",5.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",6.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",6.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",13.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",13.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",13.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",14.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",15.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",15.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",16.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",16.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",14.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",14.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",13.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",12.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",12.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",8.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",7.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",7.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",6.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",6.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",5.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",5.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",4.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",4.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",3.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",3.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",36.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",36.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",37.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",39,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",38.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",37.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",38.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",40.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",40.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",42.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",40.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",36.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",36,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",14.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",15.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",15,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",13.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",11.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",10.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",11.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",12.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",13.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",16.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",17.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",18.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",20.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",25.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",26.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",25.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",27.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",28.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",28.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",29.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",30.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",30.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",31.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",29.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",28.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",32,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",11.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",11.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",11.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",12.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",12.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",12.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",12.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",13.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",13.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",14.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",13.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",13.4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",15.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",9.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",10,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",10.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",12.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",11.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",11.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",12.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",12.6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",13,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",13.2,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",13.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",12.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",12.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",52.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",53.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",57.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",64,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",62.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",70.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",114.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",124.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",133,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",113.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",129,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",100.6,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",112.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",19.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",19.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",18.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",19.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",19.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",19.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",20.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",21.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",21.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",21.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",20.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",19,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",21,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",37.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",38.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",38.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",40.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",41.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",43.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",47.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",50.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",52.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",59.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",60.4,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",61.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",70.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",21.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",22.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",22.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",24.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",26.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",28,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",30.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",31.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",32.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",33.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",33.6,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",33,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",38.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",67.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",67.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",66.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",66.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",67.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",69.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",72.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",77.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",79.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",85.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",90.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",90.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",103.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",14.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",14.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",14.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",14.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",14.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",15.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",16.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",17.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",18,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",19.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",21.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",25.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",32,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",4.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",4.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",4.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",4.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",5.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",5.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",5.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",5.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",6.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",6.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",5.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",4.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",5.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",5.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",5.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",6.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",6.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",6.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",7.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",8.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",9.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",9.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",4.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",4.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",4.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",4.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",4.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",5.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",5.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",5.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",6.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",6.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",6.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",42.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",43,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",44.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",46.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",48.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",48.8,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",53,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",57.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",58.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",61.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",56.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",55.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",85.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2010","2010",17.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2011","2011",17.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2012","2012",18,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2013","2013",18.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2014","2014",19.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2015","2015",18.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2016","2016",19.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2017","2017",20.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2018","2018",19.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2019","2019",19.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2020","2020",19.9,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2021","2021",18.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","LVA","Latvia","2022","2022",21,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",174.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",197.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",186.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",202.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",210.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",186,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",208.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",228.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",252.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",249.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",268.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",288,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",293,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",22.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",25.9,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",24.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",26.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",28.4,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",25.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",27.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",29.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",31.8,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",32.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",36.2,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",41.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",42.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",0.2,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",0.3,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",0.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",2.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",2.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",3.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",3.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",2.8,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",2.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",3.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",3.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",4.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",4.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",9.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",11.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",10.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",11.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",12,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",11.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",11.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",13,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",13.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",14.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",16.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",18.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",19.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",11.8,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",12.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",12.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",13.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",14.7,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",13,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",13.9,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",16.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",19.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",22.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",24,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",27.2,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",25.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",33,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",36.7,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",34.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",36.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",36.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",30.1,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",31,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",33,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",34.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",34.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",34.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",36.4,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",33.8,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",0.3,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",0.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",1.6,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",2.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",1.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",2.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",2.4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",2.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",2.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",1.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",1.5,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",1.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",1.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",1.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",1.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",1.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",1.8,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",1.9,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",1.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",4.1,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",4.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",4.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",4.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",4.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",4.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",4.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",4.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",4.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",3.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",3.9,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",3.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",2.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",2.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",2.3,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",2.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",1.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",1.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",1.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",1.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",0.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",11.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",12.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",12,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",12.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",12.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",10.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",10.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",11.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",12.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",12,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",11.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",11.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",10.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",4.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",5.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",4.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",4.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",3.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",3.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",3.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",4.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",5.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",5.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",7.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",8.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",8.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",9.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",9.5,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",7.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",8.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",8.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",8.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",9.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",9.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",3.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",3.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",4.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",3.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",3.5,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",3.8,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",4.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",4,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",4.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",4.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",2.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",3.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",3.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",3.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",3.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",3.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",3.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",3.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",3.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",3.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",4.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",3.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",16.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",18.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",18.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",21.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",20.7,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",19.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",31.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",35.2,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",39.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",32.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",37.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",32.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",32.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",5.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",6.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",6.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",6.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",5.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",5.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",6.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",6.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",6.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",5.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",6.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",11.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",13,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",12.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",13.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",13.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",12.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",12.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",14.3,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",15.7,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",16.9,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",17.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",19.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",20,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",6.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",7.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",7.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",8.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",8.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",7.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",8.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",9.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",9.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",9.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",10.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",11,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",20.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",22.8,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",21.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",22,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",22.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",19.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",19.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",21.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",23.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",24.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",26.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",28.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",29.7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",4.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",4.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",4.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",4.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",4.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",4.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",4.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",5.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",5.6,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",6.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",8.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",9.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",1.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",1.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",1.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",1.5,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",1.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",1.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",1.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",1.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",1.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",1.5,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",1.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",1.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",1.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",1.7,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",1.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",1.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",2.1,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",2.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",1.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",1.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",1.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",1.4,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",1.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",1.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",1.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",1.8,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",1.9,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",2.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",2.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",13,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",14.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",14.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",15.3,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",16,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",13.6,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",14.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",16.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",17.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",17.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",16.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",17.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",24.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2010","2010",5.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2011","2011",6.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2012","2012",5.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2013","2013",6.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2014","2014",6.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2015","2015",5.1,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2016","2016",5.2,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2017","2017",5.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2018","2018",5.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2019","2019",5.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2020","2020",5.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2021","2021",6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","LVA","Latvia","2022","2022",6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",270.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",282.3,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",286.8,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",306.1,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",318.5,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",337,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",388.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",417.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",435.6,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",457.9,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",487.7,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",478.4,"D","Difference in methodology" +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",546.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",35,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",37.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",37.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",40.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",43,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",46.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",51.7,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",53.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",55,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",60.1,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",65.6,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",68.3,"D","Difference in methodology" +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",78.8,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",0.4,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",0.5,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",0.6,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",0.7,"D","Difference in methodology" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",0.7,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",4.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",4.3,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",4.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",4.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",4.9,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",5.4,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",5.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",5.6,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",6.5,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",7.2,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",7.1,"D","Difference in methodology" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",7.6,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",14.9,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",16.4,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",16.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",17.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",18.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",20.1,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",22.2,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",23.8,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",24,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",26,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",29.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",30.5,"D","Difference in methodology" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",35.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",18.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",18.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",19,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",20.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",22.3,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",23.5,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",26,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",30.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",33.4,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",41.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",43.6,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",45.1,"D","Difference in methodology" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",48,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",51.2,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",52.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",53.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",55,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",54.6,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",54.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",57.9,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",60.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",60.3,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",63.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",62.8,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",60.5,"D","Difference in methodology" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",63,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",0.1,"D","Difference in methodology" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",0.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",0.4,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",0.5,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",0.6,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",0.7,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",0.8,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",0.9,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",1.1,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",1.2,"D","Difference in methodology" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",1.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",2.5,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",2.8,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",2.9,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",3.3,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",3.7,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",4.1,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",4,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",3.2,"D","Difference in methodology" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",2.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",2.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",2.4,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",2.6,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",2.7,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",3.1,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",3.3,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",3.2,"D","Difference in methodology" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",3.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",6.4,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",6.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",6.8,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",7.2,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",7.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",7.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",8.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",8.3,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",7.7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",7.6,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",7,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",6.5,"D","Difference in methodology" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",6.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",3.8,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",3.6,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",3.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",3.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",2.9,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",2.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",2.5,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",2.4,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",2.2,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",2.1,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",1.7,"D","Difference in methodology" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",1.7,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",17.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",17.9,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",18.5,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",19.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",19.3,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",19,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",19.8,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",21.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",21.2,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",22.1,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",21.4,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",19.6,"D","Difference in methodology" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",19.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",7.1,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",7.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",7.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",6.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",5.7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",5.4,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",5.9,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",6.6,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",7,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",8.5,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",9.3,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",9.8,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",11.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",12.2,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",12.7,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",12.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",13.8,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",14.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",14.4,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",14.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",15.9,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",15.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",16.3,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",15.6,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",15.1,"D","Difference in methodology" +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",17.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",5.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",5.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",5.7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",6.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",6.3,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",6.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",6.9,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",7,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",7.6,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",7.2,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",7.1,"D","Difference in methodology" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",8.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",4.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",4.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",5.3,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",6.1,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",5.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",6,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",6.4,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",6.5,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",6.7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",6.9,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",7,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",6.8,"D","Difference in methodology" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",6.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",25,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",26.1,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",28.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",31.8,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",31.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",35.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",58.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",64.3,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",69,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",59.5,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",67.9,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",53.4,"D","Difference in methodology" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",59.8,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",9.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",9.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",9.2,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",9.5,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",9.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",10.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",10.6,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",11.3,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",10.9,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",11.4,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",10.7,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",10.1,"D","Difference in methodology" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",11.2,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",17.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",18.6,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",18.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",20,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",21,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",22.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",24,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",26.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",27.1,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",31,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",31.8,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",32.5,"D","Difference in methodology" +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",37.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",10.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",10.9,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",11.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",12.3,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",13.1,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",14.2,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",15.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",16.4,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",16.8,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",17.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",17.7,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",17.5,"D","Difference in methodology" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",20.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",32.4,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",32.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",32.5,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",33.1,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",34,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",35.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",37.2,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",39.7,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",41.3,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",44.6,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",47.9,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",48,"D","Difference in methodology" +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",55.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",7,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",7.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",7.1,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",7.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",7.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",7.8,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",8.4,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",8.9,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",9.3,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",10.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",11.2,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",13.5,"D","Difference in methodology" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",17,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",2.2,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",2.3,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",2.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",2.8,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",2.9,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",3.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",3.1,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",3.4,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",3.7,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",2.6,"D","Difference in methodology" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",2.4,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",2.6,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",2.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",2.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",3.2,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",3.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",3.8,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",4.3,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",4.9,"D","Difference in methodology" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",5.1,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",2.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",2.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",2.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",2.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",2.3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",2.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",2.7,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",3,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",3.2,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",3.5,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",3.6,"D","Difference in methodology" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",4.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",20.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",20.9,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",21.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",23.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",24.2,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",24.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",27,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",29.4,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",30.5,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",32.1,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",29.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",29.7,"D","Difference in methodology" +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",45.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2010","2010",8.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2011","2011",8.7,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2012","2012",8.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2013","2013",9.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2014","2014",9.6,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2015","2015",9.3,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2016","2016",9.8,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2017","2017",10.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2018","2018",10,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2019","2019",10.4,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2020","2020",10.5,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2021","2021",10,"D","Difference in methodology" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","LVA","Latvia","2022","2022",11.2,"D","Difference in methodology" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",3.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",3.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",4.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",3.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",5.5,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",3.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",3.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",3.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",4.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",4.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",4.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",4.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",3.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",4.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",5.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",5.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",6.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",7.2,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",6.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",5.5,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",6.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",6.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",5.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",6.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",5.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.1,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.3,"B","Break" +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",314.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",501.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",591.5,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",622.3,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",656.4,"B","Break" +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",830.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",868.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",941,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",809.4,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",624.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",555.8,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",827.2,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",786.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",14.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",14.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",14.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",15.4,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",19.2,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",16.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",16,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",19,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",21.8,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",28.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",26.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",29.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",24.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",1.6,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",1.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",1.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",3.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",2.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.2,"B","Break" +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",1.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",1.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",2.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",2.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",2.5,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",2.3,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",2.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",2.7,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",2.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",3.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",3.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",3.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",3.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",1900.8,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",1973.1,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",2104.9,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",1969.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",2949.9,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",1710.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",1683.6,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",1908.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",2382.3,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",2725.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",2369.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",2916.5,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",2082.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",2333.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",2218.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",2194.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",2416.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",2700.8,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",2298.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",2333.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",2446.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",2655.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",2947,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",2647.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",5575.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",5031.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",4.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",3.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",4.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",4.6,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",4.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",5.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",12.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",11.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",10.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",9.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",4.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",4.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",5,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",4.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",4.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",4.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",4.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",4.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",7.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",1.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",1.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",1.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",1.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",1.7,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",1.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",1.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",1.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",1.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",1.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",1.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",1.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",5.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",5.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",6.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",7.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",7.9,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",7.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",7.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",8.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",8.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",9.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",9.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",10.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",8.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.1,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.1,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",18.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",16.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",14.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",14.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",16.3,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",13.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",14.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",12.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",11.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",12.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",9.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",10.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",8.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",4.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",4.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",4.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",5,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",5.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",7.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",9.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",8.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",9.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",272.4,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",277.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",282.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",314,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",351.2,"B","Break" +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",348.3,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",355.5,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",399.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",477.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",602.8,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",557.9,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",418.6,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",394.8,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",2715.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",2834,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",3318.6,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",3557.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",4269.6,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",4018,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",4281.7,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",4591,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",4795,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",5364.2,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",5744.4,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",6260.3,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",5540.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",2.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",2.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",2.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",4.9,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",4.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",4.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",5.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",4.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",4.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",3.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",3.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",4.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",4.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",2.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",3.2,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",3.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",4.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",4.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",4.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",4.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",4.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",4.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",3.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",1.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",1.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",1.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",1.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",1.7,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",1.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",1.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",1.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",1.4,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",1.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",1.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.2,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.4,"B","Break" +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",7.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",6.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",6,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",6.6,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",6.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",7.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",7.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",7.5,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",7.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",7.9,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",6.8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",0.4,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",0.1,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",0.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",2.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",2.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",2.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",2.2,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",1.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",1.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",1.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",1.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",1.3,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",1.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",649.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",749.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",765.2,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",975.1,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",864,"B","Break" +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",882.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",927.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",1006.5,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",1082.3,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",1422.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",1514.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",1764.4,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",1483.9,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",11435.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",11848,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",12208.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",14811.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",18566,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",16694.8,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",15990.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",15352.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",17700.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",20126.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",16108.2,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",20289.6,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",19316.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",0.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",1.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",1.2,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",1.2,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",1.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",1.6,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",1.7,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",1.4,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",1.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",1.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",1.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",1.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",1.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",1.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",1.6,"B","Break" +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",1.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",1.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",1.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",1.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",2.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",2.6,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",2.8,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",2.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",21.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",23.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",24.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",29.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",34.5,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",31.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",29.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",27.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",30.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",34.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",27.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",32.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",29.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.7,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.6,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",1.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",1.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",1.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",55.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",73.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",74.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",114,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",71.7,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",64.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",75.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",76.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",91,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",131,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",136.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",154.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",121.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",3327.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",3103.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",3202.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",3657.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",4275.6,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",3675.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",3104.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",3015.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",2987.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",3517.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",4240,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",5193.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",4805.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",1.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",1.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",1.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",1,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",1.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",1.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",1.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",1.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",1.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",1.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",1.2,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",1.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",1.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",1.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",1.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",1.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",1.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",1.5,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",0.6,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",0.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",0.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",0.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",0.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.2,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",11.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",9.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",8.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",8.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",10,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",10.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",11.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",11.6,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",12.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",13.4,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",13.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",14.3,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",12.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",8.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",8.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",9.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",10.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",12.1,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",11.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",12.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",13.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",14.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",16.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",17.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",18.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",16,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",0.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",0.5,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",0.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",0.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",0.7,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",0.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",0.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",0.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",0.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",0.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",0.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",2.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",3.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",3.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",3.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",3.1,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",3.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",3.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",3.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",2.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",2.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",2.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.2,"B","Break" +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",2.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",2.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",2.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",2.6,"B","Break" +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",2.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",2.1,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",2.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",2.6,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",3.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",2.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",3.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",2.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.7,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",17239.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",14773.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",13948.3,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",14080.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",16847.2,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",17281.8,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",19042.5,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",19558.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",20937.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",22322,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",22117.7,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",25408.9,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",22871,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",1530.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",1662.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",1763.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",1915.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",1674.9,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",1858.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",1877.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",1901.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",1715.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",1506.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",1339.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",1681,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",1475.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",32.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",29.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",27.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",28.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",31.3,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",32.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",35,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",34.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",36.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",38,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",37.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",40.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",35.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",4.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",4.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",4.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",5.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",8,"B","Break" +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",7.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",7.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",8.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",9.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",14.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",14.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",14.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",15,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",2.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",2.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",2.5,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",2.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",1.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",1.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",1.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",2.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",2.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",2.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",2.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.4,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.5,"B","Break" +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",5.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",5.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",6.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",5.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",8.4,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",4.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",4.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",5.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",7.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",8.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",7.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",8.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",7.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",7.7,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",7.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",11,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",9.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",9.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",9.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",10.5,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",12.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",9.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",11.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",10.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",7.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",6.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",6.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",6.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",7.6,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",6.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",6.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",7.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",7.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",8.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",16.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",14.5,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",1.1,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.7,"B","Break" +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.7,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",0.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",1.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",1.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",1.4,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",1.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",1.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",1.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",2.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",2.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",2.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",2.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",2.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",0.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",0.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",0.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",0.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",0.9,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",0.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",1.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",1.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",1.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",1.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",1.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",1.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",1.1,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",1.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",1.7,"B","Break" +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",1.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",1.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",1.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",2.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",2.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",2.8,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",2.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",1.1,"B","Break" +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.6,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.9,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",3.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",2.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",1.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",2.1,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",2.1,"B","Break" +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",2.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",2.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",2.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",2.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",2.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",2.4,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",2.3,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",2.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",3.2,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",3.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",3.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",3.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",2.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",2.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",2.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",2.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",1.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",1450,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",1540.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",1696.3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",1924,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",2811.6,"B","Break" +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",2634.7,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",2631.2,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",2796.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",3307.8,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",4698.6,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",4616,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",5044.9,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",5191.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.1,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.3,"B","Break" +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.2,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",1617.5,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",1440.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",933.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",1043,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",1118.1,"B","Break" +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",1278.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",1494.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",1423.3,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",1429.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",1564.6,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",1400.7,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",1403.9,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",1269.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",2.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",3,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",3.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",3.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",5.2,"B","Break" +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",4.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",4.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",4.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",5.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",7.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",8.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",0.5,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",0.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",0.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",10.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",9.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",9.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",10.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",12.1,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",10.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",9.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",8.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",8.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",10.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",12.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",15.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",13.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",1,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",1.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",1.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",2.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",2.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",1.9,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",2.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",2.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",2.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",2.4,"B","Break" +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",2.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",2.7,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",3.2,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",4.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",4.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",5.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",4.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.4,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.3,"B","Break" +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.3,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.1,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",157,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",132.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",126.1,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",137.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",227.2,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",200.6,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",201.9,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",185.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",131.8,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",110.4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",96.3,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",114.7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",90.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",2.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",3.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",3.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",3.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",3.3,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",3.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",3.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",3.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",4.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",5.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",4.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",5.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",4.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",488,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",671.9,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",364.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",406.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",427.6,"B","Break" +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",413.6,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",427.5,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",405,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",426.4,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",470.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",474.1,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",516.7,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",461.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",2.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",2.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",2.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",3,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",2.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",3.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",4.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",6.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",5.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.1,"B","Break" +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.1,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",1443.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",996.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",1212.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",1436,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",1623.3,"B","Break" +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",1579.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",1357.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",1954.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",2352.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",4129.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",3669.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",3703.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",3442.2,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",0.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",1.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",0.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",0.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",0.8,"B","Break" +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",0.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",0.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",0.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",0.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",0.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",0.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",0.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",1471.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",1661.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",1597.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",1682.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",1766.7,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",1760.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",1812.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",2033.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",2534.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",3072.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",2721.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",3171,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",2788.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.7,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",6059.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",5512.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",4854,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",5081.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",5751.6,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",4904.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",5106.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",4383.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",3832.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",3984.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",3027.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",3675.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",3049.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",52.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",44.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",40.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",40.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",47.7,"B","Break" +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",48.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",55.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",57.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",62,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",67.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",67.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",73.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",66,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.2,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.3,"B","Break" +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",166.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",129.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",141.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",138.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",176.3,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",195.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",213,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",212,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",190.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",187,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",133.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",298,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",134.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",3.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",3.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",3.2,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",3.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",4,"B","Break" +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",3.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",3.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",3.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",4.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",5.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",5.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",5.7,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",4.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",6.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",6.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",6.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",7.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",7.9,"B","Break" +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",6.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",5.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",5.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",5.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",7.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",8.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",7.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",0.3,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",0.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",0.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",1,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",1.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",0.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",0.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",0.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",0.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",0.9,"B","Break" +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",1.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",1.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",1.3,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",1.4,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",1.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",1.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",9.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",9.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",10.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",10.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",12.6,"B","Break" +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",10.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",10.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",11.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",12.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",16,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",14.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",16.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",13.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",1.1,"B","Break" +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",1.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",4821.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",4872.5,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",5057.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",5356.4,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",6768.8,"B","Break" +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",5719.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",5484.2,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",6494.7,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",7363.9,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",9396,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",8609,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",10195,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",8505.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",924.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",886.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",1000.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",1381.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",1732.8,"B","Break" +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",1648.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",1689.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",1838.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",1590.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",1394.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",1250.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",1377.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",1170.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",4.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",5.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",5.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",4.7,"B","Break" +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",5.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",5.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",5.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",5.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",4.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",4.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",4.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",4.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",0.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",0.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",0.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",0.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",1,"B","Break" +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",1.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",1.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",1.8,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",1.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",1.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",1.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",1.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",1,"B","Break" +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",1.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",1.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",1.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",1.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",1.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",286.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",347.1,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",379.8,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",394,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",481.8,"B","Break" +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",519.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",539.3,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",625.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",703.5,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",755,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",837.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",968.4,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",833.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",35,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",35.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",35.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",42.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",52.6,"B","Break" +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",47.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",46.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",45,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",52.4,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",61.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",49.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",59,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",55.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2010","2010",175.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2011","2011",177.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2012","2012",204,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2013","2013",276.6,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2014","2014",319.1,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2015","2015",362.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2016","2016",298.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2017","2017",364,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2018","2018",425,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2019","2019",424.5,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2020","2020",459.7,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2021","2021",513.3,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","CRI","Costa Rica","2022","2022",444.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",0.2,"B","Break" +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",0.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",4.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",3.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",3.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",3.4,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",2.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",2.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",2.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",2.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",1.8,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",2.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",1.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",0.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",0.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",0.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",0.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",0.6,"B","Break" +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",0.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",0.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",0.6,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",0.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",0.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",0.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",0.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",0.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.7,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.4,"B","Break" +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.5,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",1.1,"B","Break" +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",1.1,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",1.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",1.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",1.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",1.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.2,"B","Break" +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0.2,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",0.1,"B","Break" +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",0,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",0,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2010","2010",1.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2011","2011",1.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2012","2012",1.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2013","2013",1.5,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2014","2014",1.7,"B","Break" +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2015","2015",1.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2016","2016",1.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2017","2017",1.6,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2018","2018",1.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2019","2019",1.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2020","2020",1.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2021","2021",2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","CRI","Costa Rica","2022","2022",1.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2010","2010",11.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2011","2011",10.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2012","2012",9.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2013","2013",10.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2014","2014",10.7,"B","Break" +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2015","2015",9.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2016","2016",9.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2017","2017",7.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2018","2018",6.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2019","2019",6.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2020","2020",5.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2021","2021",5.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","CRI","Costa Rica","2022","2022",4.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2010","2010",1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2011","2011",1.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2012","2012",1.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2013","2013",1.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2014","2014",1.9,"B","Break" +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2015","2015",2.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2016","2016",2.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2017","2017",2.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2018","2018",2.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2019","2019",1.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2020","2020",1.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2021","2021",2.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","CRI","Costa Rica","2022","2022",2.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2010","2010",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2011","2011",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2012","2012",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2013","2013",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2014","2014",0.1,"B","Break" +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2015","2015",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2016","2016",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2017","2017",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2018","2018",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2019","2019",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2020","2020",0.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2021","2021",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","CRI","Costa Rica","2022","2022",0.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",3.4,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",3.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",3.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",3.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",3.2,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",3.1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",2.9,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",2.8,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",2.6,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",2.3,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",2.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",2.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",2.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",2.3,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",1.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",1.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",1.4,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",1.2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",0.9,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0.7,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.6,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",0.9,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",0.9,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",1,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",0.9,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",0.7,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",0.8,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0.9,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0.1,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",13.2,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",13.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",14,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",13.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",13.8,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",13.7,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",13.3,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",13,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",12.5,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",11.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",10.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",9.3,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",9.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",9.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",8.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",8.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",8.2,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",7.8,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",8.4,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",9.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",9.1,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",9.3,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",8.5,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",14,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",2.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",2.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",2.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",2.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",2.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",1.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",4.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",4.9,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",4.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",3.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",2.5,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",2.4,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",2.3,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",2.1,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",1.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",1.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",1.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",1.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",1.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",1.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",1.2,, +"PATCCHLS","C10-Lipid modifying agents","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",4.4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",4.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",3.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",3.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",3.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",4.9,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",4.7,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",4,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",3.1,, +"PATCSKEL","M-Musculo-skeletal system","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",1.8,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",1.7,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",1.6,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",1.5,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",1.4,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",1.3,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",1.2,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",1,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0.9,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",3.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",3.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",3.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",3.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",3.7,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",3.6,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",3.2,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",3,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",2.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",2.8,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",2.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",20.2,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",19.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",19.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",18.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",15.5,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",14.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",13.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",12.8,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",12,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",10.7,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",10.3,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",8.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",4.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",3.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",3.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",2.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",2.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",1.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",1.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",1.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",1.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",1.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",1.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCDEPR","N06A-Antidepressants","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",16.2,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",16,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",16.1,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",15.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",15.9,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",15.4,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",14.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",13.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",13,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",11.6,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",11,, +"PATCCNSY","N-Nervous system","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",9.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",0.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",0.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.4,, +"PATCOTHR","Products not elsewhere classified","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0.4,, +"PATCCARV","C-Cardiovascular system","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",5.9,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",5.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",5.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",5.7,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",5.8,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",5.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",5.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",5.1,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",4.5,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",3.6,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",3.2,, +"PATCBIOT","J01-Antibacterials for systemic use","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",3.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",0.2,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0.1,, +"PATCACID","A02A-Antacids","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.1,, +"PATCANAL","N02-Analgesics","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCHYPO","C02-Antihypertensives","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",1.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",1.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",1.9,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",1.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",1.8,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",1.7,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",1.5,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",1.4,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",1.2,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",1.1,, +"PATCBETA","C07-Beta blocking agents","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",1,, +"PATCGENU","G-Genito urinary system and sex hormones","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",3.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",4.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",4.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",3.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",3.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",3.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",2.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",2.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",2.2,, +"PATCCCBR","C08-Calcium channel blockers","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",0.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",0.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",5.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",5.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",5.6,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",5.5,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",6.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",6.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",7.7,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",8.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",7.8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",8.1,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",8,, +"PATCBLOO","B-Blood and blood forming organs","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",7.9,, +"PATCINFC","J-Antiinfectives for systemic use","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",7,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",6.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",6.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",6.4,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",6.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",6.6,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",6.2,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",5.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",5.8,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",5.5,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",4.9,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",4.2,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",0.9,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",0.9,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",0.9,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",0.9,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",0.8,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0.7,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.6,, +"PATCALIM","A-Alimentary tract and metabolism","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0.2,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",0.1,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",1.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",1.7,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",1.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",1.7,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",1.8,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",1.7,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",1.6,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",1.5,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",1.4,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",1.2,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",1.1,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.9,, +"PATCANXO","N05B-Anxiolytics","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",5.1,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",5.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",5.8,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",6.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",6.5,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",6.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",6.7,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",6.3,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",5.6,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",5.4,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",4.9,, +"PATCDIAB","A10-Drugs used in diabetes","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",1.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",1.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",1.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",0.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",0.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",0.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2010","2010",7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2011","2011",6.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2012","2012",7.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2013","2013",6.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2014","2014",6.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2015","2015",6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2016","2016",5.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2017","2017",5.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2018","2018",4.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2019","2019",4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2020","2020",3.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","ATCPTTMT","% of total sales","HRV","Croatia","2021","2021",3.4,, +"PATCDIUR","C03-Diuretics","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCRESS","R-Respiratory system","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCGLYC","C01A-Cardiac glycosides","ATCPTTMT","% of total sales","ROU","Romania","2022","2022",0,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",3.2,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",1338515.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",83.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",91.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",96.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",101.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",105.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",110.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",116.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",120.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",122.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",128.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",133,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",130,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",32.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",0.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",0.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",13.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",204.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",227.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",213.6,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",221.3,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",214.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",188,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",205.4,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",220.1,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",242,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",248.7,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",250.8,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",275,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",6.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",5.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",6.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",5.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",6.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",5.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",5.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",5.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",5.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",4.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",3.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",609.1,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",126.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",151.8,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",152.4,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",129.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",133.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",126.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",107.3,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",129.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",167.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",177.2,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",199.7,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",201,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",414.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",467.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",494.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",462.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",430.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",423.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",349.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",362,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",358.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",369.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",348.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",369.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",401.6,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",120.9,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",121.4,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",135.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",142.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",152.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",181,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",238.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",272.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",287,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",356.2,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",396.1,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",456,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",11.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",55.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",470.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",501.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",507.9,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",472.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",314.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",356.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",327.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",337.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",352.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",370.3,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",395.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",400.2,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",76.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",85.3,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",83.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",93.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",98.1,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",89.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",102.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",112.4,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",121.7,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",120.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",128.9,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",144.9,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",53.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",57.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",55.4,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",58.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",59,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",52.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",57.6,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",60.3,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",66,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",63.7,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",71.8,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",75.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",4.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",4.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",3.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",4.5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",5,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",5.1,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",5.3,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",4.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",5.6,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",5.8,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",5.9,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",4.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",116.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",140.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",154.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",187.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",191.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",208.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",233.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",258.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",268.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",269.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",273.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",279.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",2.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",35.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",63.1,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",378.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",35.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",36.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",34.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",36.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",39,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",33.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",35,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",38.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",44.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",45.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",47,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",39.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",8.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",8.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",8.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",8.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",8.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",8.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",8.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",8.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",8.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",7.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",7.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",163,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",166,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",163,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",161,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",160,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",165,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",172,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",179,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",186,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",196,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",197,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",199.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",0,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",10.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",11.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",12.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",14.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",15.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",15.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",17.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",19.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",20.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",20.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",18.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",24,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",175.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",165.1,, +"PATCOTHR","Products not elsewhere classified","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",143.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",1583.2,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",27.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",28.6,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",26.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",27.3,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",27.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",23.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",24.4,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",24.8,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",26.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",26,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",26.5,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",27.9,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",146,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",145,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",137,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",123,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",114,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",102,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",98,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",83,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",79,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",68,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",63,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",57,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",1.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",27,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",97.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",12.4,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",13.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",13,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",13.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",13.9,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",12.5,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",13.8,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",14.6,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",16.1,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",15.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",17.7,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",19.2,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",361.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",389.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",392.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",398.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",393.4,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",401.1,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",409.9,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",414.7,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",452.8,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",506.3,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",564.5,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",548.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",2.2,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",261.9,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",296,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",1896.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",1975.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",2066.6,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",1993.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",1654.3,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",1677.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",1731,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",1779,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",1802.2,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",1915,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",2055.5,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",2035.7,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",1.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",389.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",407.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",377.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",389.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",377.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",326.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",333.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",354.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",358.8,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",310.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",304.2,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",361.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",41.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",44.5,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",46.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",46.6,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",45.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",45.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",45.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",47.7,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",50.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",52.4,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",55.3,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",55.1,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",86,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",87,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",89,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",88,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",90,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",91,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",92,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",90,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",91,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",93,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",94,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",93,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",153.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",383.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",401.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",413.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",343.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",267.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",244.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",249.5,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",262.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",277.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",300,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",285.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",300.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",22.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",27.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",32.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",36.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",44.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",45.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",49.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",56.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",62.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",65.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",66.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",67.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",70.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",2.7,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",32,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",109.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",117.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",119,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",111,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",74.3,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",84.6,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",78.5,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",81.8,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",86.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",91.1,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",97.7,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",101.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",111,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",110,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",113,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",118,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",126,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",129,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",132,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",139,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",152,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",163,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",167,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",133,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",3.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",6.9,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",241,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",259,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",278,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",302,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",317,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",344,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",386,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",408,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",415,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",432,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",458,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",483,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",410.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",417.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",421.5,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",438.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",423.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",437.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",483.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",516.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",735,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",846.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",807.4,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",718.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",285490.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",1151.1,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",476,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",463,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",428,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",429,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",408,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",411,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",487,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",609,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",604,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",714,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",714,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",1382,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",640,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",690,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",708,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",713,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",692,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",720,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",774,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",799,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",825,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",889,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",891,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",916.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",9408.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",10175.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",10435.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",10923.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",10644.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",11298.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",12928,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",13896.6,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",15077.8,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",17931.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",20028.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",22848.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",85,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",84.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",81.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",81.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",80,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",69.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",67.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",70.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",76.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",74,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",68.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",74.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",37.4,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",1.6,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",1.2,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",1.3,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",1.5,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",1.4,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",1.1,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",0.9,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",171.2,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",174.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",176.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",177,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",174.4,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",173.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",182.7,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",181.3,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",179.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",178.1,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",185.8,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",185.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",107.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",109.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",97.4,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",103.1,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",99.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",90.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",95.5,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",98.6,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",112.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",118,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",114.8,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",124.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",2.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",80.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",73.2,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",337,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",333,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",323,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",332,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",323,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",348,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",360,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",358,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",385,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",422,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",408,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",414.3,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",39,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",41,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",43,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",44,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",45,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",48,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",52,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",53,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",55,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",56,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",63,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",64,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",154.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",164.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",172.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",161.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",162.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",162.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",174.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",172.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",171.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",176.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",190.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",198.6,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",1525,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",1628.3,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",1677.9,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",1709.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",1690.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",1741.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",1891.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",1890,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",1957,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",2074.4,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",2200.8,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",2150.6,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",300.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",652.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",652.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",551.2,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",566.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",534.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",451.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",539.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",692.7,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",724.8,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",812.3,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",813.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",1637.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",19.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",17.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",19.2,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",20.7,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",21.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",22.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",24.5,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",27.8,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",29.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",30.6,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",32.3,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",37.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",37.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",83.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",235.2,, +"PATCCCBR","C08-Calcium channel blockers","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",47.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",60.5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",5,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",4,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",552.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",580.3,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",602.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",621.7,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",612.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",637.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",670.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",707.1,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",680.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",639.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",635.9,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",705.6,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",17.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",18.1,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",16.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",19,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",21.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",21.5,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",22.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",20.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",22.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",23.4,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",23.8,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",16.2,, +"PATCOTHR","Products not elsewhere classified","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",1018.5,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",1.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",10.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",200.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",204.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",176.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",162.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",149.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",112.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",108.5,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",94.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",94.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",77.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",71.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",67.5,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",0.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",62.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",65.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",60.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",50.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",39,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",29.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",29.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",31.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",35.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",35.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",33.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",39,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",4.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",0.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",15.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",1.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",311,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",323.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",303.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",293.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",240.7,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",204.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",206.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",216.2,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",232.3,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",228.5,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",242.9,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",264,, +"PATCINFC","J-Antiinfectives for systemic use","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",1066.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",59.3,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",63.9,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",57.6,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",58.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",57.2,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",48.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",48.8,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",50.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",58.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",60.4,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",66.7,, +"PATCANAL","N02-Analgesics","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",71.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",4.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",14992.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",28.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",28.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",25.9,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",26.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",25.4,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",21.1,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",21.8,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",22,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",23.2,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",21.3,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",22,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",24,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",223.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",234,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",209.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",212.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",209.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",181.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",190.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",203.6,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",223.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",223,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",224.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",236.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",13.7,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",15.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",15.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",16.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",16.1,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",12.8,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",11.4,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",12.9,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",15.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",16.5,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",20.3,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",21.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",330.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",365.2,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",358,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",398.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",415.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",377.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",427.3,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",464.1,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",498,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",491.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",521.7,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",572.2,, +"PATCOTHR","Products not elsewhere classified","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",53.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",152.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",155.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",145.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",155.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",165.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",141.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",146.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",158.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",182.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",185.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",190.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",157.6,, +"PATCDEPR","N06A-Antidepressants","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",1.2,, +"PATCOTHR","Products not elsewhere classified","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",4775,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",44.7,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",48.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",53.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",61.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",63.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",66.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",73.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",79.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",84.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",82,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",76.2,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",94.8,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",46.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",47.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",41.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",38.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",35.3,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",26.6,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",26,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",22.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",23.2,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",19,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",17.7,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",17.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",35,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",38.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",35,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",37.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",34,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",36.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",35.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",36.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",34.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",32.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",31,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",30.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",0.2,, +"PATCHYPO","C02-Antihypertensives","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",28.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",28.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",30.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",30.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",30.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",32.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",32.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",34,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",35.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",37.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",35.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",36.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",117.9,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",122.7,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",114.6,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",116.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",118,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",100,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",101.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",102.4,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",109.2,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",105.8,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",107.1,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",110.2,, +"PATCCNSY","N-Nervous system","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",699.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",52,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",54.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",49.2,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",50,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",49.5,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",43.1,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",45.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",49.3,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",54.6,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",54.8,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",55.4,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",60,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",104.9,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",89.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",519.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",520,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",579.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",604.8,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",644.3,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",761.5,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",993.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",1124.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",1174.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",1448.6,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",1602.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",1800.8,, +"PATCCARV","C-Cardiovascular system","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",15.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",8.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",15.6,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",284,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",289,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",293,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",295,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",288,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",297,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",301,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",312,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",299,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",273,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",267,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",305,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",270,, +"PATCBLOO","B-Blood and blood forming organs","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",574.1,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",1408.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",461.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",469.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",416,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",438.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",423.4,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",382.3,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",398.5,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",407.2,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",462,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",480.1,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",464.8,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",490.9,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",128.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",135.5,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",141.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",146.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",144.6,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",151.4,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",160.7,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",171.2,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",166.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",157.3,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",157.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",178.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",62,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",60,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",63,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",62,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",61,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",63,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",61,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",62,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",64,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",65,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",60,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",63,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",179,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",190.7,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",199.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",198.1,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",193.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",190.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",189.4,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",197.2,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",204.8,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",213.3,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",223.9,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",217.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",227.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",877.1,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",972.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",911.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",941.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",907,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",791,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",856.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",908.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",990,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",1011.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",1015,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",1086.1,, +"PATCDIUR","C03-Diuretics","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",5.1,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",341,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",351,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",359,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",326,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",323,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",318,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",327,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",315,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",308,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",306,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",324,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",339,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",359.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",393.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",413.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",432,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",448.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",465.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",487.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",498.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",502.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",522.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",538.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",513.6,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",354.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",380.2,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",393,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",401.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",399,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",413.9,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",453.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",457.7,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",478.4,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",510,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",543.8,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",544.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",12.3,, +"PATCACID","A02A-Antacids","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",0.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",289.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",293.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",264,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",274.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",260.8,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",224.1,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",240.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",259.3,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",387.6,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",410.7,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",386.2,, +"PATCSKEL","M-Musculo-skeletal system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",367.9,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",9.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",8,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",10.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",8.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",10.6,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",10.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",11.1,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",11.3,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",11.4,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",11.7,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",9.5,, +"PATCGLYC","C01A-Cardiac glycosides","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",6.9,, +"PATCCCBR","C08-Calcium channel blockers","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",0.5,, +"PATCBETA","C07-Beta blocking agents","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",87.9,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",29.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",31.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",29.3,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",29.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",28.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",23.2,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",22.6,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",24,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",26.4,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",25.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",26.5,, +"PATCBETA","C07-Beta blocking agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",28.2,, +"PATCACID","A02A-Antacids","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",0,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",411.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",163,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",23,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",24,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",26,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",29,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",30,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",31,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",33,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",35,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",37,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",35,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",32,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",41,, +"PATCANXO","N05B-Anxiolytics","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",2.6,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",167.3,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",174.7,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",183,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",185.5,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",191.4,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",195.2,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",205,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",204,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",207.1,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",218,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",223.9,, +"PATCANXO","N05B-Anxiolytics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",215.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",270,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",282,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",258.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",215.3,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",165.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",125.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",124,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",131.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",146.4,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",145.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",136.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",154,, +"PATCRESS","R-Respiratory system","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",110.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",77.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",82.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",74.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",69.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",45.8,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",43.3,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",39,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",41,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",45.5,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",44.2,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",46.7,, +"PATCCHLS","C10-Lipid modifying agents","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",51.9,, +"PATCRESS","R-Respiratory system","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",518.1,, +"PATCBIOT","J01-Antibacterials for systemic use","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",14.2,, +"PATCDIUR","C03-Diuretics","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",170.9,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",784,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",811,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",816,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",811,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",795,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",812,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",849,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",834,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",860,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",885,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",924,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",929.7,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",267,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",259,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",282,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",287,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",303,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",355,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",446,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",496,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",516,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",618,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",673,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",778.5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",73.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",77.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",78.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",79.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",80.3,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",84.1,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",91.8,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",98.2,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",103.5,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",113,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",115.9,, +"PATCGENU","G-Genito urinary system and sex hormones","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",117.1,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",254.9,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",273.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",246,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",249.6,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",242.5,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",205.4,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",203.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",208.2,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",238.8,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",245.7,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",270,, +"PATCANAL","N02-Analgesics","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",280.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",468.8,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",520,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",571.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",636.5,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",674,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",737.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",859.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",924.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",944.4,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",1012.6,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",1090.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",1117.3,, +"PATCCNSY","N-Nervous system","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",36.7,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",10,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",10,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",10,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",9,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",10,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",10,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",10,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",7,, +"PATCGLYC","C01A-Cardiac glycosides","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",4.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",215.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",217.1,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",206.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",212.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",204.8,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",209.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",260,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",334.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",336,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",411.5,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",420.2,, +"PATCINFC","J-Antiinfectives for systemic use","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",809.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",591.1,, +"PATCINFC","J-Antiinfectives for systemic use","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",11.9,, +"PATCDIAB","A10-Drugs used in diabetes","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",429.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",655.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",668.6,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",664.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",699.7,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",686.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",746.5,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",802,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",811.3,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",876.1,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",989.2,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",971.8,, +"PATCRESS","R-Respiratory system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",958.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",6628.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",7145.5,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",6536,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",6845.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",6561.7,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",5786.3,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",6424.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",6975.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",7950.9,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",8703.4,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",9579.2,, +"PATCTOTT","Total pharmaceutical sales","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",11700.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",59,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",64.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",60.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",63.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",65.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",56.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",58.1,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",60.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",64.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",62.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",63.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",66.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",82.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",98.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",96.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",117.5,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",118,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",106.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",116.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",129.7,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",141.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",130.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",131,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",143,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",5.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",6.3,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",5.1,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",5.6,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",5,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",4.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",4.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",4.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",4.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",3.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",3.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",3.9,, +"PATCGENU","G-Genito urinary system and sex hormones","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",0.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",23.6,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",92,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",95,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",97,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",94,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",91,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",89,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",85,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",87,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",90,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",91,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",94,, +"PATCBETA","C07-Beta blocking agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",94,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",18,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",19,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",17,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",18,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",16,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",17,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",16,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",16,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",15,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",14,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",13,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",13,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",152.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",156.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",155.6,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",164.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",162.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",177.4,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",192.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",196.5,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",214.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",243.2,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",240.1,, +"PATCRESS","R-Respiratory system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",242.7,, +"PATCANXO","N05B-Anxiolytics","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",0.1,, +"PATCDIUR","C03-Diuretics","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",36.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",58.9,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",67.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",65.7,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",70,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",68.2,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",53.8,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",47.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",53.5,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",63.6,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",67.1,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",82,, +"PATCHYPO","C02-Antihypertensives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",85.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",289.8,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",323.5,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",341,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",353.2,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",347.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",367,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",413.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",438.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",458.9,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",512.3,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",524.4,, +"PATCALIM","A-Alimentary tract and metabolism","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",537,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",1542.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",1668.4,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",1531,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",1609,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",1549,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",1375.1,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",1539.7,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",1688.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",1943.6,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",2139.9,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",2366.8,, +"PATCTOTT","Total pharmaceutical sales","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",2962.7,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",1336.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",1387.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",1294.3,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",1249.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",1019.8,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",859.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",860.2,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",892.9,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",950.4,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",929.5,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",983.1,, +"PATCCARV","C-Cardiovascular system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",1042.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",87.8,, +"PATCBLOO","B-Blood and blood forming organs","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",30.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",19.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",23,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",22.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",27.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",27.8,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",25.3,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",27.9,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",31.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",34.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",32.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",32.4,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",36.2,, +"PATCANXO","N05B-Anxiolytics","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",12.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",1.2,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",109.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",121.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",133.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",149.6,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",159.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",175.4,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",206.1,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",223.9,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",230.8,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",249,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",269.5,, +"PATCDIAB","A10-Drugs used in diabetes","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",282.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",50.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",51.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",54.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",58.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",63.2,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",65.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",70.5,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",76.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",84.6,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",93.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",98.3,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",77.9,, +"PATCSKEL","M-Musculo-skeletal system","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",216.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",0.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",110.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",120.6,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",122.7,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",110.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",110.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",107.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",89,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",90.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",91,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",94.8,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",86.5,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",88.9,, +"PATCDEPR","N06A-Antidepressants","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",94.8,, +"PATCDIAB","A10-Drugs used in diabetes","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",22.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",67.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",68.5,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",61.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",64.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",61.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",53.3,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",57.6,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",62.8,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",94.7,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",101,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",95.4,, +"PATCSKEL","M-Musculo-skeletal system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",93.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",120.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",120.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",129.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",130.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",129.7,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",135.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",135.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",140.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",145.6,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",152.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",142.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",145.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",0.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",149.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",38.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",40.8,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",42.9,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",43.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",45.2,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",46.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",49.1,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",49.4,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",50.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",53.6,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",55.3,, +"PATCANXO","N05B-Anxiolytics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",54.5,, +"PATCDIAB","A10-Drugs used in diabetes","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",2015.1,, +"PATCBETA","C07-Beta blocking agents","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",4.6,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",75.9,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",82.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",88.4,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",92.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",95.7,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",103,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",115.8,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",120.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",125.2,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",131.3,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",150.1,, +"PATCDIUR","C03-Diuretics","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",148.1,, +"PATCTOTT","Total pharmaceutical sales","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",764629.4,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",242,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",250,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",247,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",224,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",148,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",166,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",147,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",149,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",155,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",158,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",166,, +"PATCCHLS","C10-Lipid modifying agents","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",173,, +"PATCALIM","A-Alimentary tract and metabolism","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",31,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",663.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",704.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",738.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",687,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",686.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",682.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",728.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",713.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",700.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",717.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",771.7,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",784.2,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",94.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",8.6,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",2.3,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",1.9,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",2.4,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",2,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",2.5,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",2.5,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",2.7,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",2.7,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",2.8,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",2.9,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",2.4,, +"PATCGLYC","C01A-Cardiac glycosides","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",1.8,, +"PATCALIM","A-Alimentary tract and metabolism","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",2771.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",185,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",196,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",201,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",205,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",211,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",217,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",219,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",220,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",221,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",223,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",226,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",222,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",4.6,, +"PATCDEPR","N06A-Antidepressants","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",59.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",261.2,, +"PATCCHLS","C10-Lipid modifying agents","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",7.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",365.9,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",365.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",363.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",379,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",397.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",390,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",493.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",564.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",619.2,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",703.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",766.7,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",922.2,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",83.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",96.4,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",104.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",111.7,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",110.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",105.1,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",95.8,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",106.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",120.6,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",138.3,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",171.5,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",166.6,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",12.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",12.7,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",10.3,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",11.9,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",13.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",11,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",11.1,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",10.2,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",12,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",11.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",11.4,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",8.3,, +"PATCDIUR","C03-Diuretics","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",1.9,, +"PATCRESS","R-Respiratory system","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",5.8,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",285.4,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",108.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",115.5,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",108.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",101.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",99.9,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",83,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",86.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",86.8,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",90.3,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",85.6,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",91.2,, +"PATCARAS","C09-Agents acting on the Renin-Angiotensin system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",101.7,, +"PATCCARV","C-Cardiovascular system","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",804.4,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",24.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",26.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",21.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",23.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",21,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",18.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",17.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",18.2,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",18,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",15.9,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",14.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",15.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",2189.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",2375.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",2444.5,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",2567.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",2512.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",2685,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",3098.4,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",3364.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",3685.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",4408.8,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",4948.7,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",5785.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",31.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",33.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",33.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",38.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",39.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",34.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",36.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",39.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",44.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",39.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",36.5,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",48.6,, +"PATCANAL","N02-Analgesics","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",72.4,, +"PATCGLYC","C01A-Cardiac glycosides","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",0.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",1074.4,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",1143.5,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",1050.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",1071.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",1042.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",892.1,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",939.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",948.7,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",1032,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",1006.9,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",1052.6,, +"PATCCNSY","N-Nervous system","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",1101.3,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",19.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",19.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",19,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",19.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",18.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",16.4,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",16.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",17.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",18.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",18.2,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",16.9,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",18.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",14.8,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",14,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",211,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",208,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",205,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",208,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",199,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",204,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",217,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",228,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",323,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",361,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",339,, +"PATCSKEL","M-Musculo-skeletal system","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",310.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",95.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",97.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",98.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",103,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",99.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",104,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",115.9,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",125.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",179.7,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",208,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",199.5,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",181.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",100.3,, +"PATCCNSY","N-Nervous system","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",1224.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",253.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",276.3,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",258.9,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",270.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",276.6,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",238.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",242.4,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",250.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",265.2,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",253.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",257.5,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",263,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",90.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",95.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",88.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",91.6,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",89.1,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",77.5,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",79.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",85.9,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",87.7,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",76.4,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",75.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",91.5,, +"PATCACID","A02A-Antacids","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",0.1,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",60,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",70,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",75,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",89,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",90,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",97,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",105,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",114,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",118,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",115,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",115,, +"PATCHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",120.7,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",4837,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",5068,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",5075,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",5183,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",5006,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",5267,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",5803,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",6132,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",6626,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",7650,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",8409,, +"PATCTOTT","Total pharmaceutical sales","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",9877,, +"PATCBLOO","B-Blood and blood forming organs","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",1005,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",89.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",93.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",96.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",80.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",63.2,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",58.1,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",59.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",63.7,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",67.9,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",73.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",70.6,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",76.1,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",1.5,, +"PATCBIOT","J01-Antibacterials for systemic use","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",100.8,, +"PATCACID","A02A-Antacids","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",0.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",84.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",90.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",92,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",93.6,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",92.9,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",95.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",98.2,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",100.4,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",110.7,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",124.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",139.5,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",138.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",284,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",291.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",281.7,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",259.2,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",242.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",218.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",218.3,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",188.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",179.8,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",159.4,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",150.1,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",131.9,, +"PATCTOTT","Total pharmaceutical sales","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",40153.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",66.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",68,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",66,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",60.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",57.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",52,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",52.3,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",45.5,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",43.9,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",39.2,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",37.1,, +"PATCCCBR","C08-Calcium channel blockers","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",33.4,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",88,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",87,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",86,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",84,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",82,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",81,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",82,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",80,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",79,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",76,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",78,, +"PATCDEPR","N06A-Antidepressants","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",80,, +"PATCHYPN","N05C-Hypnotics and sedatives","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",3.2,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",43,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",48,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",51,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",53,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",52,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",49,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",43,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",47,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",53,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",59,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",72,, +"PATCHYPO","C02-Antihypertensives","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",72,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",39.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",40.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",41.4,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",41.6,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",41.2,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",41.3,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",43.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",43.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",43.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",43.8,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",45.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",46.9,, +"PATCCCBR","C08-Calcium channel blockers","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",27.3,, +"PATCOTHR","Products not elsewhere classified","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",2727.7,, +"PATCARIT","C01B-Antiarrhythmics, Class I and III","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",3,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",186,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",194,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",191,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",189,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",185,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",187,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",184,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",183,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",199,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",216,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",237,, +"PATCANAL","N02-Analgesics","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",237,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",5.3,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",975,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",984,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",1005,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",946,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",778,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",782,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",777,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",785,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",792,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",817,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",863,, +"PATCCARV","C-Cardiovascular system","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",880,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",925.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",929.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",880.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",904.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",867.5,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",881.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",1084.9,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",1380.1,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",1374.4,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",1673.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",1700.6,, +"PATCINFC","J-Antiinfectives for systemic use","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",3197,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",215.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",220.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",232.4,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",248.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",267.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",276.7,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",294.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",315,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",345.9,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",382.1,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",397.8,, +"PATCFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",307.7,, +"PATCOBAI","R03-Drugs for obstructive airway diseases","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",60.9,, +"PATCHYPO","C02-Antihypertensives","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",51.1,, +"PATCSKEL","M-Musculo-skeletal system","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",11.3,, +"PATCANAL","N02-Analgesics","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",3.8,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2010","2010",197,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2011","2011",200,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2012","2012",201,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2013","2013",163,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2014","2014",126,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2015","2015",114,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2016","2016",112,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2017","2017",116,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2018","2018",122,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2019","2019",128,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2020","2020",120,, +"PATCPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","MLLNCUMT","Million of national currency units","HRV","Croatia","2021","2021",130,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",2.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",3,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",2.4,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",2.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",3.1,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",2.6,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",2.7,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",2.5,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",2.9,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",2.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",2.8,, +"PATCACID","A02A-Antacids","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",2.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",317.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",333.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",335.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",339.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",340.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",353.9,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",383.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",405.7,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",423.3,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",459.4,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",469.2,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",462.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",42.2,, +"PATCBIOT","J01-Antibacterials for systemic use","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",5.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2010","2010",1244.9,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2011","2011",1385.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2012","2012",1455.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2013","2013",1502.6,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2014","2014",1471.4,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2015","2015",1544.5,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2016","2016",1724.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2017","2017",1810.7,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2018","2018",1877.3,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2019","2019",2083.8,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2020","2020",2122.2,, +"PATCALIM","A-Alimentary tract and metabolism","MTMOPPMT","Million US$, purchasing power parity","HRV","Croatia","2021","2021",2120.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",85.2,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",85.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",85.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",89.1,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",93.8,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",92.7,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",118.3,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",136.6,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",151.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",172.9,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",189.4,, +"PATCBLOO","B-Blood and blood forming organs","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",233.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",126.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",133.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",124.9,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",124.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",119.3,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",97.8,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",94.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",99,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",108,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",103.5,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",107.1,, +"PATCBETA","C07-Beta blocking agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",111.4,, +"PATCBIOT","J01-Antibacterials for systemic use","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",472.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",250.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",267,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",246.2,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",251.8,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",246,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",212,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",225.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",229.7,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",252.3,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",247.6,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",260.1,, +"PATCCNSY","N-Nervous system","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",278.9,, +"PATCDEPR","N06A-Antidepressants","PPPPERMT","/capita, US$ purchasing power parity","ROU","Romania","2022","2022",3.1,, +"PATCGENU","G-Genito urinary system and sex hormones","MTMOPPMT","Million US$, purchasing power parity","ROU","Romania","2022","2022",41.8,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","TCPPERMT","/capita, US$ exchange rate","ROU","Romania","2022","2022",0.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",19.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",22.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",24.6,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",26.3,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",26.1,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",25,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",23,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",25.8,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",29.5,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",34,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",42.4,, +"PATCHYPO","C02-Antihypertensives","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",42.2,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2010","2010",331.6,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2011","2011",352.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2012","2012",318.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2013","2013",295.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2014","2014",194,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2015","2015",182.4,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2016","2016",162.7,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2017","2017",169.5,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2018","2018",186,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2019","2019",179.8,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2020","2020",189.1,, +"PATCCHLS","C10-Lipid modifying agents","MTMOTCMT","Million US$ at exchange rate","HRV","Croatia","2021","2021",204.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2010","2010",441.4,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2011","2011",461.3,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2012","2012",484.1,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2013","2013",468.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2014","2014",390.5,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2015","2015",398.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2016","2016",414.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2017","2017",430.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2018","2018",440.6,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2019","2019",470.8,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2020","2020",507.9,, +"PATCCARV","C-Cardiovascular system","PPPPERMT","/capita, US$ purchasing power parity","HRV","Croatia","2021","2021",515.5,, +"PATCSHMG","G03-Sex hormones and modulators of the genital system","MLLNCUMT","Million of national currency units","ROU","Romania","2022","2022",7.1,, +"PATCBLOO","B-Blood and blood forming organs","MTMOTCMT","Million US$ at exchange rate","ROU","Romania","2022","2022",214.4,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2010","2010",7.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2011","2011",7.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2012","2012",7.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2013","2013",9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2014","2014",9.3,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2015","2015",8.1,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2016","2016",8.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2017","2017",9.6,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2018","2018",10.9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2019","2019",9.8,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2020","2020",9,, +"PATCHYPN","N05C-Hypnotics and sedatives","TCPPERMT","/capita, US$ exchange rate","HRV","Croatia","2021","2021",12.3,, diff --git a/exercicios/para-casa/exercicioCrisPereira/instrucoes_exercicio_casa.md b/exercicios/para-casa/exercicioCrisPereira/instrucoes_exercicio_casa.md new file mode 100644 index 0000000..c6651dc --- /dev/null +++ b/exercicios/para-casa/exercicioCrisPereira/instrucoes_exercicio_casa.md @@ -0,0 +1,14 @@ +# INSTRUÇÕES +## Criar um banco de dados +Realizar operações de: +- leitura +- adição +- edição +- desafio extra: deleção + +# EXERCÍCIO REALIZADO +Tenho interesse em manipular dois bancos de dados, então baixei duas tabelas cvs, uma com os índices de mortalidade materna e outra com a receita de farmacêuticas ao longo do tempo. +Usei python para ler as duas tabelas e criar dois bancos de dados: +1. maternal-mortality +2. health indicators + diff --git a/exercicios/para-casa/exercicioCrisPereira/maternal-mortality-who.csv b/exercicios/para-casa/exercicioCrisPereira/maternal-mortality-who.csv new file mode 100644 index 0000000..e7333d4 --- /dev/null +++ b/exercicios/para-casa/exercicioCrisPereira/maternal-mortality-who.csv @@ -0,0 +1,3421 @@ +Entity,Code,Year,Indicator:Maternal mortality ratio (per 100 000 live births) +Afghanistan,AFG,2000,1450 +Afghanistan,AFG,2001,1390 +Afghanistan,AFG,2002,1300 +Afghanistan,AFG,2003,1240 +Afghanistan,AFG,2004,1180 +Afghanistan,AFG,2005,1140 +Afghanistan,AFG,2006,1120 +Afghanistan,AFG,2007,1090 +Afghanistan,AFG,2008,1030 +Afghanistan,AFG,2009,993 +Afghanistan,AFG,2010,954 +Afghanistan,AFG,2011,905 +Afghanistan,AFG,2012,858 +Afghanistan,AFG,2013,810 +Afghanistan,AFG,2014,786 +Afghanistan,AFG,2015,701 +Afghanistan,AFG,2016,673 +Afghanistan,AFG,2017,638 +Africa,,2000,857 +Africa,,2001,837 +Africa,,2002,822 +Africa,,2003,801 +Africa,,2004,771 +Africa,,2005,735 +Africa,,2006,701 +Africa,,2007,673 +Africa,,2008,653 +Africa,,2009,634 +Africa,,2010,615 +Africa,,2011,599 +Africa,,2012,585 +Africa,,2013,572 +Africa,,2014,562 +Africa,,2015,548 +Africa,,2016,536 +Africa,,2017,525 +Albania,ALB,2000,23 +Albania,ALB,2001,23 +Albania,ALB,2002,21 +Albania,ALB,2003,21 +Albania,ALB,2004,18 +Albania,ALB,2005,22 +Albania,ALB,2006,18 +Albania,ALB,2007,19 +Albania,ALB,2008,20 +Albania,ALB,2009,20 +Albania,ALB,2010,21 +Albania,ALB,2011,22 +Albania,ALB,2012,17 +Albania,ALB,2013,16 +Albania,ALB,2014,16 +Albania,ALB,2015,15 +Albania,ALB,2016,16 +Albania,ALB,2017,15 +Algeria,DZA,2000,161 +Algeria,DZA,2001,155 +Algeria,DZA,2002,148 +Algeria,DZA,2003,145 +Algeria,DZA,2004,134 +Algeria,DZA,2005,127 +Algeria,DZA,2006,122 +Algeria,DZA,2007,119 +Algeria,DZA,2008,117 +Algeria,DZA,2009,117 +Algeria,DZA,2010,115 +Algeria,DZA,2011,116 +Algeria,DZA,2012,116 +Algeria,DZA,2013,115 +Algeria,DZA,2014,114 +Algeria,DZA,2015,114 +Algeria,DZA,2016,113 +Algeria,DZA,2017,112 +Americas,,2000,73 +Americas,,2001,72 +Americas,,2002,71 +Americas,,2003,70 +Americas,,2004,70 +Americas,,2005,68 +Americas,,2006,67 +Americas,,2007,66 +Americas,,2008,65 +Americas,,2009,66 +Americas,,2010,64 +Americas,,2011,62 +Americas,,2012,61 +Americas,,2013,60 +Americas,,2014,60 +Americas,,2015,59 +Americas,,2016,59 +Americas,,2017,57 +Angola,AGO,2000,827 +Angola,AGO,2001,766 +Angola,AGO,2002,690 +Angola,AGO,2003,628 +Angola,AGO,2004,574 +Angola,AGO,2005,519 +Angola,AGO,2006,473 +Angola,AGO,2007,431 +Angola,AGO,2008,395 +Angola,AGO,2009,359 +Angola,AGO,2010,326 +Angola,AGO,2011,300 +Angola,AGO,2012,281 +Angola,AGO,2013,269 +Angola,AGO,2014,258 +Angola,AGO,2015,251 +Angola,AGO,2016,246 +Angola,AGO,2017,241 +Antigua and Barbuda,ATG,2000,44 +Antigua and Barbuda,ATG,2001,44 +Antigua and Barbuda,ATG,2002,43 +Antigua and Barbuda,ATG,2003,44 +Antigua and Barbuda,ATG,2004,41 +Antigua and Barbuda,ATG,2005,40 +Antigua and Barbuda,ATG,2006,46 +Antigua and Barbuda,ATG,2007,48 +Antigua and Barbuda,ATG,2008,50 +Antigua and Barbuda,ATG,2009,45 +Antigua and Barbuda,ATG,2010,44 +Antigua and Barbuda,ATG,2011,43 +Antigua and Barbuda,ATG,2012,44 +Antigua and Barbuda,ATG,2013,43 +Antigua and Barbuda,ATG,2014,42 +Antigua and Barbuda,ATG,2015,43 +Antigua and Barbuda,ATG,2016,43 +Antigua and Barbuda,ATG,2017,42 +Argentina,ARG,2000,66 +Argentina,ARG,2001,67 +Argentina,ARG,2002,65 +Argentina,ARG,2003,65 +Argentina,ARG,2004,61 +Argentina,ARG,2005,59 +Argentina,ARG,2006,57 +Argentina,ARG,2007,56 +Argentina,ARG,2008,53 +Argentina,ARG,2009,56 +Argentina,ARG,2010,51 +Argentina,ARG,2011,48 +Argentina,ARG,2012,47 +Argentina,ARG,2013,44 +Argentina,ARG,2014,42 +Argentina,ARG,2015,41 +Argentina,ARG,2016,40 +Argentina,ARG,2017,39 +Armenia,ARM,2000,43 +Armenia,ARM,2001,42 +Armenia,ARM,2002,39 +Armenia,ARM,2003,38 +Armenia,ARM,2004,36 +Armenia,ARM,2005,35 +Armenia,ARM,2006,36 +Armenia,ARM,2007,32 +Armenia,ARM,2008,36 +Armenia,ARM,2009,32 +Armenia,ARM,2010,32 +Armenia,ARM,2011,30 +Armenia,ARM,2012,30 +Armenia,ARM,2013,26 +Armenia,ARM,2014,27 +Armenia,ARM,2015,28 +Armenia,ARM,2016,26 +Armenia,ARM,2017,26 +Australia,AUS,2000,7 +Australia,AUS,2001,6 +Australia,AUS,2002,6 +Australia,AUS,2003,6 +Australia,AUS,2004,5 +Australia,AUS,2005,5 +Australia,AUS,2006,5 +Australia,AUS,2007,5 +Australia,AUS,2008,5 +Australia,AUS,2009,5 +Australia,AUS,2010,5 +Australia,AUS,2011,6 +Australia,AUS,2012,6 +Australia,AUS,2013,6 +Australia,AUS,2014,6 +Australia,AUS,2015,6 +Australia,AUS,2016,6 +Australia,AUS,2017,6 +Austria,AUT,2000,6 +Austria,AUT,2001,6 +Austria,AUT,2002,6 +Austria,AUT,2003,6 +Austria,AUT,2004,5 +Austria,AUT,2005,6 +Austria,AUT,2006,5 +Austria,AUT,2007,5 +Austria,AUT,2008,5 +Austria,AUT,2009,5 +Austria,AUT,2010,5 +Austria,AUT,2011,5 +Austria,AUT,2012,5 +Austria,AUT,2013,5 +Austria,AUT,2014,5 +Austria,AUT,2015,5 +Austria,AUT,2016,5 +Austria,AUT,2017,5 +Azerbaijan,AZE,2000,47 +Azerbaijan,AZE,2001,44 +Azerbaijan,AZE,2002,43 +Azerbaijan,AZE,2003,44 +Azerbaijan,AZE,2004,39 +Azerbaijan,AZE,2005,42 +Azerbaijan,AZE,2006,35 +Azerbaijan,AZE,2007,34 +Azerbaijan,AZE,2008,32 +Azerbaijan,AZE,2009,32 +Azerbaijan,AZE,2010,31 +Azerbaijan,AZE,2011,30 +Azerbaijan,AZE,2012,29 +Azerbaijan,AZE,2013,28 +Azerbaijan,AZE,2014,28 +Azerbaijan,AZE,2015,27 +Azerbaijan,AZE,2016,26 +Azerbaijan,AZE,2017,26 +Bahamas,BHS,2000,75 +Bahamas,BHS,2001,76 +Bahamas,BHS,2002,78 +Bahamas,BHS,2003,79 +Bahamas,BHS,2004,78 +Bahamas,BHS,2005,77 +Bahamas,BHS,2006,78 +Bahamas,BHS,2007,77 +Bahamas,BHS,2008,77 +Bahamas,BHS,2009,78 +Bahamas,BHS,2010,78 +Bahamas,BHS,2011,78 +Bahamas,BHS,2012,78 +Bahamas,BHS,2013,78 +Bahamas,BHS,2014,77 +Bahamas,BHS,2015,74 +Bahamas,BHS,2016,72 +Bahamas,BHS,2017,70 +Bahrain,BHR,2000,27 +Bahrain,BHR,2001,19 +Bahrain,BHR,2002,25 +Bahrain,BHR,2003,21 +Bahrain,BHR,2004,21 +Bahrain,BHR,2005,19 +Bahrain,BHR,2006,24 +Bahrain,BHR,2007,16 +Bahrain,BHR,2008,18 +Bahrain,BHR,2009,19 +Bahrain,BHR,2010,18 +Bahrain,BHR,2011,15 +Bahrain,BHR,2012,18 +Bahrain,BHR,2013,17 +Bahrain,BHR,2014,15 +Bahrain,BHR,2015,15 +Bahrain,BHR,2016,15 +Bahrain,BHR,2017,14 +Bangladesh,BGD,2000,434 +Bangladesh,BGD,2001,423 +Bangladesh,BGD,2002,410 +Bangladesh,BGD,2003,395 +Bangladesh,BGD,2004,372 +Bangladesh,BGD,2005,343 +Bangladesh,BGD,2006,315 +Bangladesh,BGD,2007,297 +Bangladesh,BGD,2008,280 +Bangladesh,BGD,2009,269 +Bangladesh,BGD,2010,258 +Bangladesh,BGD,2011,248 +Bangladesh,BGD,2012,238 +Bangladesh,BGD,2013,227 +Bangladesh,BGD,2014,214 +Bangladesh,BGD,2015,200 +Bangladesh,BGD,2016,186 +Bangladesh,BGD,2017,173 +Barbados,BRB,2000,50 +Barbados,BRB,2001,48 +Barbados,BRB,2002,47 +Barbados,BRB,2003,45 +Barbados,BRB,2004,43 +Barbados,BRB,2005,42 +Barbados,BRB,2006,41 +Barbados,BRB,2007,40 +Barbados,BRB,2008,39 +Barbados,BRB,2009,38 +Barbados,BRB,2010,36 +Barbados,BRB,2011,35 +Barbados,BRB,2012,34 +Barbados,BRB,2013,32 +Barbados,BRB,2014,31 +Barbados,BRB,2015,31 +Barbados,BRB,2016,30 +Barbados,BRB,2017,27 +Belarus,BLR,2000,22 +Belarus,BLR,2001,19 +Belarus,BLR,2002,18 +Belarus,BLR,2003,15 +Belarus,BLR,2004,13 +Belarus,BLR,2005,11 +Belarus,BLR,2006,9 +Belarus,BLR,2007,7 +Belarus,BLR,2008,6 +Belarus,BLR,2009,6 +Belarus,BLR,2010,5 +Belarus,BLR,2011,5 +Belarus,BLR,2012,4 +Belarus,BLR,2013,3 +Belarus,BLR,2014,3 +Belarus,BLR,2015,3 +Belarus,BLR,2016,3 +Belarus,BLR,2017,2 +Belgium,BEL,2000,8 +Belgium,BEL,2001,8 +Belgium,BEL,2002,7 +Belgium,BEL,2003,7 +Belgium,BEL,2004,7 +Belgium,BEL,2005,7 +Belgium,BEL,2006,7 +Belgium,BEL,2007,7 +Belgium,BEL,2008,7 +Belgium,BEL,2009,6 +Belgium,BEL,2010,6 +Belgium,BEL,2011,6 +Belgium,BEL,2012,6 +Belgium,BEL,2013,6 +Belgium,BEL,2014,6 +Belgium,BEL,2015,5 +Belgium,BEL,2016,5 +Belgium,BEL,2017,5 +Belize,BLZ,2000,89 +Belize,BLZ,2001,88 +Belize,BLZ,2002,82 +Belize,BLZ,2003,80 +Belize,BLZ,2004,75 +Belize,BLZ,2005,70 +Belize,BLZ,2006,65 +Belize,BLZ,2007,61 +Belize,BLZ,2008,59 +Belize,BLZ,2009,57 +Belize,BLZ,2010,54 +Belize,BLZ,2011,52 +Belize,BLZ,2012,50 +Belize,BLZ,2013,48 +Belize,BLZ,2014,46 +Belize,BLZ,2015,43 +Belize,BLZ,2016,39 +Belize,BLZ,2017,36 +Benin,BEN,2000,520 +Benin,BEN,2001,516 +Benin,BEN,2002,511 +Benin,BEN,2003,510 +Benin,BEN,2004,505 +Benin,BEN,2005,500 +Benin,BEN,2006,493 +Benin,BEN,2007,486 +Benin,BEN,2008,480 +Benin,BEN,2009,471 +Benin,BEN,2010,464 +Benin,BEN,2011,458 +Benin,BEN,2012,450 +Benin,BEN,2013,441 +Benin,BEN,2014,432 +Benin,BEN,2015,421 +Benin,BEN,2016,408 +Benin,BEN,2017,397 +Bhutan,BTN,2000,423 +Bhutan,BTN,2001,384 +Bhutan,BTN,2002,365 +Bhutan,BTN,2003,348 +Bhutan,BTN,2004,332 +Bhutan,BTN,2005,310 +Bhutan,BTN,2006,291 +Bhutan,BTN,2007,275 +Bhutan,BTN,2008,264 +Bhutan,BTN,2009,255 +Bhutan,BTN,2010,247 +Bhutan,BTN,2011,239 +Bhutan,BTN,2012,231 +Bhutan,BTN,2013,223 +Bhutan,BTN,2014,214 +Bhutan,BTN,2015,203 +Bhutan,BTN,2016,193 +Bhutan,BTN,2017,183 +Bolivia,BOL,2000,331 +Bolivia,BOL,2001,320 +Bolivia,BOL,2002,309 +Bolivia,BOL,2003,297 +Bolivia,BOL,2004,283 +Bolivia,BOL,2005,271 +Bolivia,BOL,2006,258 +Bolivia,BOL,2007,246 +Bolivia,BOL,2008,234 +Bolivia,BOL,2009,222 +Bolivia,BOL,2010,212 +Bolivia,BOL,2011,202 +Bolivia,BOL,2012,192 +Bolivia,BOL,2013,184 +Bolivia,BOL,2014,175 +Bolivia,BOL,2015,168 +Bolivia,BOL,2016,161 +Bolivia,BOL,2017,155 +Bosnia and Herzegovina,BIH,2000,17 +Bosnia and Herzegovina,BIH,2001,16 +Bosnia and Herzegovina,BIH,2002,14 +Bosnia and Herzegovina,BIH,2003,14 +Bosnia and Herzegovina,BIH,2004,14 +Bosnia and Herzegovina,BIH,2005,13 +Bosnia and Herzegovina,BIH,2006,13 +Bosnia and Herzegovina,BIH,2007,13 +Bosnia and Herzegovina,BIH,2008,11 +Bosnia and Herzegovina,BIH,2009,11 +Bosnia and Herzegovina,BIH,2010,11 +Bosnia and Herzegovina,BIH,2011,10 +Bosnia and Herzegovina,BIH,2012,10 +Bosnia and Herzegovina,BIH,2013,10 +Bosnia and Herzegovina,BIH,2014,10 +Bosnia and Herzegovina,BIH,2015,10 +Bosnia and Herzegovina,BIH,2016,10 +Bosnia and Herzegovina,BIH,2017,10 +Botswana,BWA,2000,262 +Botswana,BWA,2001,271 +Botswana,BWA,2002,278 +Botswana,BWA,2003,278 +Botswana,BWA,2004,264 +Botswana,BWA,2005,239 +Botswana,BWA,2006,221 +Botswana,BWA,2007,209 +Botswana,BWA,2008,203 +Botswana,BWA,2009,189 +Botswana,BWA,2010,179 +Botswana,BWA,2011,176 +Botswana,BWA,2012,170 +Botswana,BWA,2013,164 +Botswana,BWA,2014,160 +Botswana,BWA,2015,156 +Botswana,BWA,2016,151 +Botswana,BWA,2017,144 +Brazil,BRA,2000,69 +Brazil,BRA,2001,68 +Brazil,BRA,2002,69 +Brazil,BRA,2003,70 +Brazil,BRA,2004,71 +Brazil,BRA,2005,71 +Brazil,BRA,2006,72 +Brazil,BRA,2007,71 +Brazil,BRA,2008,70 +Brazil,BRA,2009,69 +Brazil,BRA,2010,65 +Brazil,BRA,2011,61 +Brazil,BRA,2012,60 +Brazil,BRA,2013,61 +Brazil,BRA,2014,62 +Brazil,BRA,2015,63 +Brazil,BRA,2016,62 +Brazil,BRA,2017,60 +Brunei,BRN,2000,28 +Brunei,BRN,2001,28 +Brunei,BRN,2002,29 +Brunei,BRN,2003,30 +Brunei,BRN,2004,30 +Brunei,BRN,2005,29 +Brunei,BRN,2006,28 +Brunei,BRN,2007,27 +Brunei,BRN,2008,27 +Brunei,BRN,2009,27 +Brunei,BRN,2010,28 +Brunei,BRN,2011,28 +Brunei,BRN,2012,29 +Brunei,BRN,2013,28 +Brunei,BRN,2014,29 +Brunei,BRN,2015,30 +Brunei,BRN,2016,31 +Brunei,BRN,2017,31 +Bulgaria,BGR,2000,19 +Bulgaria,BGR,2001,18 +Bulgaria,BGR,2002,17 +Bulgaria,BGR,2003,16 +Bulgaria,BGR,2004,16 +Bulgaria,BGR,2005,15 +Bulgaria,BGR,2006,14 +Bulgaria,BGR,2007,13 +Bulgaria,BGR,2008,13 +Bulgaria,BGR,2009,12 +Bulgaria,BGR,2010,12 +Bulgaria,BGR,2011,12 +Bulgaria,BGR,2012,11 +Bulgaria,BGR,2013,10 +Bulgaria,BGR,2014,11 +Bulgaria,BGR,2015,10 +Bulgaria,BGR,2016,10 +Bulgaria,BGR,2017,10 +Burkina Faso,BFA,2000,516 +Burkina Faso,BFA,2001,501 +Burkina Faso,BFA,2002,486 +Burkina Faso,BFA,2003,471 +Burkina Faso,BFA,2004,454 +Burkina Faso,BFA,2005,437 +Burkina Faso,BFA,2006,422 +Burkina Faso,BFA,2007,410 +Burkina Faso,BFA,2008,401 +Burkina Faso,BFA,2009,393 +Burkina Faso,BFA,2010,385 +Burkina Faso,BFA,2011,377 +Burkina Faso,BFA,2012,369 +Burkina Faso,BFA,2013,362 +Burkina Faso,BFA,2014,353 +Burkina Faso,BFA,2015,343 +Burkina Faso,BFA,2016,331 +Burkina Faso,BFA,2017,320 +Burundi,BDI,2000,1010 +Burundi,BDI,2001,956 +Burundi,BDI,2002,925 +Burundi,BDI,2003,890 +Burundi,BDI,2004,844 +Burundi,BDI,2005,814 +Burundi,BDI,2006,785 +Burundi,BDI,2007,756 +Burundi,BDI,2008,733 +Burundi,BDI,2009,698 +Burundi,BDI,2010,665 +Burundi,BDI,2011,635 +Burundi,BDI,2012,608 +Burundi,BDI,2013,591 +Burundi,BDI,2014,576 +Burundi,BDI,2015,568 +Burundi,BDI,2016,558 +Burundi,BDI,2017,548 +Cambodia,KHM,2000,488 +Cambodia,KHM,2001,456 +Cambodia,KHM,2002,430 +Cambodia,KHM,2003,404 +Cambodia,KHM,2004,378 +Cambodia,KHM,2005,351 +Cambodia,KHM,2006,326 +Cambodia,KHM,2007,303 +Cambodia,KHM,2008,284 +Cambodia,KHM,2009,265 +Cambodia,KHM,2010,248 +Cambodia,KHM,2011,232 +Cambodia,KHM,2012,215 +Cambodia,KHM,2013,202 +Cambodia,KHM,2014,189 +Cambodia,KHM,2015,178 +Cambodia,KHM,2016,168 +Cambodia,KHM,2017,160 +Cameroon,CMR,2000,886 +Cameroon,CMR,2001,844 +Cameroon,CMR,2002,803 +Cameroon,CMR,2003,771 +Cameroon,CMR,2004,732 +Cameroon,CMR,2005,692 +Cameroon,CMR,2006,658 +Cameroon,CMR,2007,635 +Cameroon,CMR,2008,618 +Cameroon,CMR,2009,606 +Cameroon,CMR,2010,597 +Cameroon,CMR,2011,589 +Cameroon,CMR,2012,580 +Cameroon,CMR,2013,567 +Cameroon,CMR,2014,564 +Cameroon,CMR,2015,554 +Cameroon,CMR,2016,538 +Cameroon,CMR,2017,529 +Canada,CAN,2000,9 +Canada,CAN,2001,10 +Canada,CAN,2002,10 +Canada,CAN,2003,10 +Canada,CAN,2004,10 +Canada,CAN,2005,11 +Canada,CAN,2006,11 +Canada,CAN,2007,11 +Canada,CAN,2008,12 +Canada,CAN,2009,12 +Canada,CAN,2010,11 +Canada,CAN,2011,11 +Canada,CAN,2012,11 +Canada,CAN,2013,11 +Canada,CAN,2014,11 +Canada,CAN,2015,11 +Canada,CAN,2016,10 +Canada,CAN,2017,10 +Cape Verde,CPV,2000,118 +Cape Verde,CPV,2001,109 +Cape Verde,CPV,2002,101 +Cape Verde,CPV,2003,96 +Cape Verde,CPV,2004,91 +Cape Verde,CPV,2005,86 +Cape Verde,CPV,2006,82 +Cape Verde,CPV,2007,78 +Cape Verde,CPV,2008,75 +Cape Verde,CPV,2009,72 +Cape Verde,CPV,2010,70 +Cape Verde,CPV,2011,67 +Cape Verde,CPV,2012,65 +Cape Verde,CPV,2013,63 +Cape Verde,CPV,2014,62 +Cape Verde,CPV,2015,61 +Cape Verde,CPV,2016,59 +Cape Verde,CPV,2017,58 +Central African Republic,CAF,2000,1280 +Central African Republic,CAF,2001,1290 +Central African Republic,CAF,2002,1280 +Central African Republic,CAF,2003,1250 +Central African Republic,CAF,2004,1230 +Central African Republic,CAF,2005,1200 +Central African Republic,CAF,2006,1170 +Central African Republic,CAF,2007,1130 +Central African Republic,CAF,2008,1090 +Central African Republic,CAF,2009,1050 +Central African Republic,CAF,2010,1000 +Central African Republic,CAF,2011,981 +Central African Republic,CAF,2012,963 +Central African Republic,CAF,2013,1030 +Central African Republic,CAF,2014,961 +Central African Republic,CAF,2015,912 +Central African Republic,CAF,2016,890 +Central African Republic,CAF,2017,829 +Chad,TCD,2000,1420 +Chad,TCD,2001,1410 +Chad,TCD,2002,1400 +Chad,TCD,2003,1370 +Chad,TCD,2004,1350 +Chad,TCD,2005,1330 +Chad,TCD,2006,1340 +Chad,TCD,2007,1300 +Chad,TCD,2008,1310 +Chad,TCD,2009,1270 +Chad,TCD,2010,1240 +Chad,TCD,2011,1210 +Chad,TCD,2012,1190 +Chad,TCD,2013,1170 +Chad,TCD,2014,1170 +Chad,TCD,2015,1160 +Chad,TCD,2016,1140 +Chad,TCD,2017,1140 +Chile,CHL,2000,31 +Chile,CHL,2001,32 +Chile,CHL,2002,28 +Chile,CHL,2003,27 +Chile,CHL,2004,27 +Chile,CHL,2005,25 +Chile,CHL,2006,25 +Chile,CHL,2007,23 +Chile,CHL,2008,21 +Chile,CHL,2009,21 +Chile,CHL,2010,20 +Chile,CHL,2011,18 +Chile,CHL,2012,17 +Chile,CHL,2013,16 +Chile,CHL,2014,15 +Chile,CHL,2015,14 +Chile,CHL,2016,13 +Chile,CHL,2017,13 +China,CHN,2000,59 +China,CHN,2001,55 +China,CHN,2002,51 +China,CHN,2003,48 +China,CHN,2004,46 +China,CHN,2005,44 +China,CHN,2006,42 +China,CHN,2007,40 +China,CHN,2008,40 +China,CHN,2009,37 +China,CHN,2010,36 +China,CHN,2011,34 +China,CHN,2012,33 +China,CHN,2013,32 +China,CHN,2014,31 +China,CHN,2015,30 +China,CHN,2016,29 +China,CHN,2017,29 +Colombia,COL,2000,94 +Colombia,COL,2001,93 +Colombia,COL,2002,92 +Colombia,COL,2003,88 +Colombia,COL,2004,85 +Colombia,COL,2005,83 +Colombia,COL,2006,82 +Colombia,COL,2007,83 +Colombia,COL,2008,84 +Colombia,COL,2009,87 +Colombia,COL,2010,85 +Colombia,COL,2011,84 +Colombia,COL,2012,85 +Colombia,COL,2013,85 +Colombia,COL,2014,85 +Colombia,COL,2015,85 +Colombia,COL,2016,84 +Colombia,COL,2017,83 +Comoros,COM,2000,444 +Comoros,COM,2001,437 +Comoros,COM,2002,429 +Comoros,COM,2003,423 +Comoros,COM,2004,414 +Comoros,COM,2005,404 +Comoros,COM,2006,393 +Comoros,COM,2007,382 +Comoros,COM,2008,370 +Comoros,COM,2009,356 +Comoros,COM,2010,341 +Comoros,COM,2011,326 +Comoros,COM,2012,313 +Comoros,COM,2013,302 +Comoros,COM,2014,293 +Comoros,COM,2015,285 +Comoros,COM,2016,279 +Comoros,COM,2017,273 +Congo,COG,2000,739 +Congo,COG,2001,752 +Congo,COG,2002,769 +Congo,COG,2003,757 +Congo,COG,2004,724 +Congo,COG,2005,677 +Congo,COG,2006,623 +Congo,COG,2007,580 +Congo,COG,2008,552 +Congo,COG,2009,526 +Congo,COG,2010,506 +Congo,COG,2011,488 +Congo,COG,2012,468 +Congo,COG,2013,449 +Congo,COG,2014,433 +Congo,COG,2015,416 +Congo,COG,2016,397 +Congo,COG,2017,378 +Costa Rica,CRI,2000,40 +Costa Rica,CRI,2001,37 +Costa Rica,CRI,2002,38 +Costa Rica,CRI,2003,37 +Costa Rica,CRI,2004,36 +Costa Rica,CRI,2005,33 +Costa Rica,CRI,2006,35 +Costa Rica,CRI,2007,29 +Costa Rica,CRI,2008,29 +Costa Rica,CRI,2009,29 +Costa Rica,CRI,2010,32 +Costa Rica,CRI,2011,30 +Costa Rica,CRI,2012,29 +Costa Rica,CRI,2013,29 +Costa Rica,CRI,2014,29 +Costa Rica,CRI,2015,28 +Costa Rica,CRI,2016,28 +Costa Rica,CRI,2017,27 +Cote d'Ivoire,CIV,2000,704 +Cote d'Ivoire,CIV,2001,706 +Cote d'Ivoire,CIV,2002,713 +Cote d'Ivoire,CIV,2003,711 +Cote d'Ivoire,CIV,2004,709 +Cote d'Ivoire,CIV,2005,704 +Cote d'Ivoire,CIV,2006,699 +Cote d'Ivoire,CIV,2007,698 +Cote d'Ivoire,CIV,2008,694 +Cote d'Ivoire,CIV,2009,700 +Cote d'Ivoire,CIV,2010,701 +Cote d'Ivoire,CIV,2011,703 +Cote d'Ivoire,CIV,2012,702 +Cote d'Ivoire,CIV,2013,691 +Cote d'Ivoire,CIV,2014,676 +Cote d'Ivoire,CIV,2015,658 +Cote d'Ivoire,CIV,2016,636 +Cote d'Ivoire,CIV,2017,617 +Croatia,HRV,2000,11 +Croatia,HRV,2001,10 +Croatia,HRV,2002,10 +Croatia,HRV,2003,10 +Croatia,HRV,2004,10 +Croatia,HRV,2005,10 +Croatia,HRV,2006,9 +Croatia,HRV,2007,9 +Croatia,HRV,2008,9 +Croatia,HRV,2009,9 +Croatia,HRV,2010,9 +Croatia,HRV,2011,9 +Croatia,HRV,2012,8 +Croatia,HRV,2013,9 +Croatia,HRV,2014,8 +Croatia,HRV,2015,8 +Croatia,HRV,2016,7 +Croatia,HRV,2017,8 +Cuba,CUB,2000,46 +Cuba,CUB,2001,44 +Cuba,CUB,2002,41 +Cuba,CUB,2003,41 +Cuba,CUB,2004,40 +Cuba,CUB,2005,41 +Cuba,CUB,2006,38 +Cuba,CUB,2007,38 +Cuba,CUB,2008,40 +Cuba,CUB,2009,40 +Cuba,CUB,2010,41 +Cuba,CUB,2011,38 +Cuba,CUB,2012,39 +Cuba,CUB,2013,40 +Cuba,CUB,2014,39 +Cuba,CUB,2015,38 +Cuba,CUB,2016,37 +Cuba,CUB,2017,36 +Cyprus,CYP,2000,14 +Cyprus,CYP,2001,9 +Cyprus,CYP,2002,10 +Cyprus,CYP,2003,9 +Cyprus,CYP,2004,9 +Cyprus,CYP,2005,12 +Cyprus,CYP,2006,9 +Cyprus,CYP,2007,8 +Cyprus,CYP,2008,9 +Cyprus,CYP,2009,8 +Cyprus,CYP,2010,8 +Cyprus,CYP,2011,8 +Cyprus,CYP,2012,7 +Cyprus,CYP,2013,6 +Cyprus,CYP,2014,8 +Cyprus,CYP,2015,7 +Cyprus,CYP,2016,6 +Cyprus,CYP,2017,6 +Czechia,CZE,2000,7 +Czechia,CZE,2001,7 +Czechia,CZE,2002,6 +Czechia,CZE,2003,6 +Czechia,CZE,2004,5 +Czechia,CZE,2005,5 +Czechia,CZE,2006,5 +Czechia,CZE,2007,5 +Czechia,CZE,2008,5 +Czechia,CZE,2009,4 +Czechia,CZE,2010,4 +Czechia,CZE,2011,4 +Czechia,CZE,2012,4 +Czechia,CZE,2013,4 +Czechia,CZE,2014,4 +Czechia,CZE,2015,4 +Czechia,CZE,2016,4 +Czechia,CZE,2017,3 +Democratic Republic of Congo,COD,2000,760 +Democratic Republic of Congo,COD,2001,740 +Democratic Republic of Congo,COD,2002,734 +Democratic Republic of Congo,COD,2003,699 +Democratic Republic of Congo,COD,2004,661 +Democratic Republic of Congo,COD,2005,627 +Democratic Republic of Congo,COD,2006,598 +Democratic Republic of Congo,COD,2007,578 +Democratic Republic of Congo,COD,2008,565 +Democratic Republic of Congo,COD,2009,555 +Democratic Republic of Congo,COD,2010,542 +Democratic Republic of Congo,COD,2011,532 +Democratic Republic of Congo,COD,2012,524 +Democratic Republic of Congo,COD,2013,514 +Democratic Republic of Congo,COD,2014,500 +Democratic Republic of Congo,COD,2015,490 +Democratic Republic of Congo,COD,2016,481 +Democratic Republic of Congo,COD,2017,473 +Denmark,DNK,2000,8 +Denmark,DNK,2001,8 +Denmark,DNK,2002,8 +Denmark,DNK,2003,7 +Denmark,DNK,2004,7 +Denmark,DNK,2005,6 +Denmark,DNK,2006,6 +Denmark,DNK,2007,6 +Denmark,DNK,2008,6 +Denmark,DNK,2009,6 +Denmark,DNK,2010,5 +Denmark,DNK,2011,5 +Denmark,DNK,2012,5 +Denmark,DNK,2013,4 +Denmark,DNK,2014,4 +Denmark,DNK,2015,4 +Denmark,DNK,2016,4 +Denmark,DNK,2017,4 +Djibouti,DJI,2000,507 +Djibouti,DJI,2001,490 +Djibouti,DJI,2002,470 +Djibouti,DJI,2003,449 +Djibouti,DJI,2004,426 +Djibouti,DJI,2005,393 +Djibouti,DJI,2006,361 +Djibouti,DJI,2007,335 +Djibouti,DJI,2008,320 +Djibouti,DJI,2009,299 +Djibouti,DJI,2010,283 +Djibouti,DJI,2011,272 +Djibouti,DJI,2012,262 +Djibouti,DJI,2013,256 +Djibouti,DJI,2014,256 +Djibouti,DJI,2015,247 +Djibouti,DJI,2016,246 +Djibouti,DJI,2017,248 +Dominican Republic,DOM,2000,80 +Dominican Republic,DOM,2001,75 +Dominican Republic,DOM,2002,75 +Dominican Republic,DOM,2003,76 +Dominican Republic,DOM,2004,81 +Dominican Republic,DOM,2005,83 +Dominican Republic,DOM,2006,86 +Dominican Republic,DOM,2007,90 +Dominican Republic,DOM,2008,92 +Dominican Republic,DOM,2009,95 +Dominican Republic,DOM,2010,96 +Dominican Republic,DOM,2011,95 +Dominican Republic,DOM,2012,94 +Dominican Republic,DOM,2013,94 +Dominican Republic,DOM,2014,94 +Dominican Republic,DOM,2015,94 +Dominican Republic,DOM,2016,94 +Dominican Republic,DOM,2017,95 +East Timor,TLS,2000,745 +East Timor,TLS,2001,720 +East Timor,TLS,2002,668 +East Timor,TLS,2003,603 +East Timor,TLS,2004,507 +East Timor,TLS,2005,415 +East Timor,TLS,2006,348 +East Timor,TLS,2007,300 +East Timor,TLS,2008,269 +East Timor,TLS,2009,242 +East Timor,TLS,2010,219 +East Timor,TLS,2011,198 +East Timor,TLS,2012,185 +East Timor,TLS,2013,176 +East Timor,TLS,2014,168 +East Timor,TLS,2015,160 +East Timor,TLS,2016,152 +East Timor,TLS,2017,142 +Eastern Mediterranean,,2000,330 +Eastern Mediterranean,,2001,319 +Eastern Mediterranean,,2002,306 +Eastern Mediterranean,,2003,298 +Eastern Mediterranean,,2004,286 +Eastern Mediterranean,,2005,275 +Eastern Mediterranean,,2006,267 +Eastern Mediterranean,,2007,255 +Eastern Mediterranean,,2008,241 +Eastern Mediterranean,,2009,230 +Eastern Mediterranean,,2010,220 +Eastern Mediterranean,,2011,208 +Eastern Mediterranean,,2012,199 +Eastern Mediterranean,,2013,190 +Eastern Mediterranean,,2014,186 +Eastern Mediterranean,,2015,175 +Eastern Mediterranean,,2016,169 +Eastern Mediterranean,,2017,164 +Ecuador,ECU,2000,122 +Ecuador,ECU,2001,117 +Ecuador,ECU,2002,110 +Ecuador,ECU,2003,100 +Ecuador,ECU,2004,94 +Ecuador,ECU,2005,94 +Ecuador,ECU,2006,90 +Ecuador,ECU,2007,85 +Ecuador,ECU,2008,82 +Ecuador,ECU,2009,80 +Ecuador,ECU,2010,78 +Ecuador,ECU,2011,76 +Ecuador,ECU,2012,71 +Ecuador,ECU,2013,67 +Ecuador,ECU,2014,65 +Ecuador,ECU,2015,63 +Ecuador,ECU,2016,61 +Ecuador,ECU,2017,59 +Egypt,EGY,2000,64 +Egypt,EGY,2001,63 +Egypt,EGY,2002,60 +Egypt,EGY,2003,57 +Egypt,EGY,2004,54 +Egypt,EGY,2005,52 +Egypt,EGY,2006,50 +Egypt,EGY,2007,47 +Egypt,EGY,2008,45 +Egypt,EGY,2009,45 +Egypt,EGY,2010,45 +Egypt,EGY,2011,42 +Egypt,EGY,2012,42 +Egypt,EGY,2013,40 +Egypt,EGY,2014,39 +Egypt,EGY,2015,39 +Egypt,EGY,2016,38 +Egypt,EGY,2017,37 +El Salvador,SLV,2000,73 +El Salvador,SLV,2001,75 +El Salvador,SLV,2002,68 +El Salvador,SLV,2003,66 +El Salvador,SLV,2004,64 +El Salvador,SLV,2005,62 +El Salvador,SLV,2006,60 +El Salvador,SLV,2007,58 +El Salvador,SLV,2008,57 +El Salvador,SLV,2009,57 +El Salvador,SLV,2010,54 +El Salvador,SLV,2011,53 +El Salvador,SLV,2012,52 +El Salvador,SLV,2013,50 +El Salvador,SLV,2014,49 +El Salvador,SLV,2015,48 +El Salvador,SLV,2016,47 +El Salvador,SLV,2017,46 +Equatorial Guinea,GNQ,2000,454 +Equatorial Guinea,GNQ,2001,421 +Equatorial Guinea,GNQ,2002,392 +Equatorial Guinea,GNQ,2003,370 +Equatorial Guinea,GNQ,2004,357 +Equatorial Guinea,GNQ,2005,344 +Equatorial Guinea,GNQ,2006,331 +Equatorial Guinea,GNQ,2007,322 +Equatorial Guinea,GNQ,2008,314 +Equatorial Guinea,GNQ,2009,310 +Equatorial Guinea,GNQ,2010,308 +Equatorial Guinea,GNQ,2011,308 +Equatorial Guinea,GNQ,2012,305 +Equatorial Guinea,GNQ,2013,300 +Equatorial Guinea,GNQ,2014,295 +Equatorial Guinea,GNQ,2015,296 +Equatorial Guinea,GNQ,2016,301 +Equatorial Guinea,GNQ,2017,301 +Eritrea,ERI,2000,1280 +Eritrea,ERI,2001,1180 +Eritrea,ERI,2002,1130 +Eritrea,ERI,2003,1060 +Eritrea,ERI,2004,938 +Eritrea,ERI,2005,804 +Eritrea,ERI,2006,705 +Eritrea,ERI,2007,635 +Eritrea,ERI,2008,605 +Eritrea,ERI,2009,583 +Eritrea,ERI,2010,567 +Eritrea,ERI,2011,558 +Eritrea,ERI,2012,549 +Eritrea,ERI,2013,540 +Eritrea,ERI,2014,530 +Eritrea,ERI,2015,518 +Eritrea,ERI,2016,498 +Eritrea,ERI,2017,480 +Estonia,EST,2000,29 +Estonia,EST,2001,27 +Estonia,EST,2002,25 +Estonia,EST,2003,20 +Estonia,EST,2004,18 +Estonia,EST,2005,18 +Estonia,EST,2006,16 +Estonia,EST,2007,17 +Estonia,EST,2008,14 +Estonia,EST,2009,14 +Estonia,EST,2010,11 +Estonia,EST,2011,13 +Estonia,EST,2012,12 +Estonia,EST,2013,10 +Estonia,EST,2014,11 +Estonia,EST,2015,10 +Estonia,EST,2016,11 +Estonia,EST,2017,9 +Eswatini,SWZ,2000,521 +Eswatini,SWZ,2001,528 +Eswatini,SWZ,2002,534 +Eswatini,SWZ,2003,538 +Eswatini,SWZ,2004,539 +Eswatini,SWZ,2005,532 +Eswatini,SWZ,2006,518 +Eswatini,SWZ,2007,496 +Eswatini,SWZ,2008,474 +Eswatini,SWZ,2009,460 +Eswatini,SWZ,2010,450 +Eswatini,SWZ,2011,441 +Eswatini,SWZ,2012,435 +Eswatini,SWZ,2013,432 +Eswatini,SWZ,2014,434 +Eswatini,SWZ,2015,435 +Eswatini,SWZ,2016,436 +Eswatini,SWZ,2017,437 +Ethiopia,ETH,2000,1030 +Ethiopia,ETH,2001,988 +Ethiopia,ETH,2002,985 +Ethiopia,ETH,2003,972 +Ethiopia,ETH,2004,929 +Ethiopia,ETH,2005,865 +Ethiopia,ETH,2006,795 +Ethiopia,ETH,2007,731 +Ethiopia,ETH,2008,681 +Ethiopia,ETH,2009,638 +Ethiopia,ETH,2010,597 +Ethiopia,ETH,2011,558 +Ethiopia,ETH,2012,527 +Ethiopia,ETH,2013,498 +Ethiopia,ETH,2014,472 +Ethiopia,ETH,2015,446 +Ethiopia,ETH,2016,422 +Ethiopia,ETH,2017,401 +Europe,,2000,27 +Europe,,2001,26 +Europe,,2002,25 +Europe,,2003,24 +Europe,,2004,23 +Europe,,2005,22 +Europe,,2006,20 +Europe,,2007,19 +Europe,,2008,18 +Europe,,2009,17 +Europe,,2010,17 +Europe,,2011,16 +Europe,,2012,15 +Europe,,2013,15 +Europe,,2014,14 +Europe,,2015,14 +Europe,,2016,13 +Europe,,2017,13 +Fiji,FJI,2000,51 +Fiji,FJI,2001,49 +Fiji,FJI,2002,48 +Fiji,FJI,2003,48 +Fiji,FJI,2004,47 +Fiji,FJI,2005,46 +Fiji,FJI,2006,44 +Fiji,FJI,2007,43 +Fiji,FJI,2008,42 +Fiji,FJI,2009,40 +Fiji,FJI,2010,39 +Fiji,FJI,2011,38 +Fiji,FJI,2012,38 +Fiji,FJI,2013,37 +Fiji,FJI,2014,36 +Fiji,FJI,2015,35 +Fiji,FJI,2016,34 +Fiji,FJI,2017,34 +Finland,FIN,2000,6 +Finland,FIN,2001,5 +Finland,FIN,2002,5 +Finland,FIN,2003,5 +Finland,FIN,2004,5 +Finland,FIN,2005,5 +Finland,FIN,2006,4 +Finland,FIN,2007,4 +Finland,FIN,2008,4 +Finland,FIN,2009,4 +Finland,FIN,2010,4 +Finland,FIN,2011,4 +Finland,FIN,2012,4 +Finland,FIN,2013,4 +Finland,FIN,2014,3 +Finland,FIN,2015,3 +Finland,FIN,2016,3 +Finland,FIN,2017,3 +France,FRA,2000,10 +France,FRA,2001,10 +France,FRA,2002,10 +France,FRA,2003,9 +France,FRA,2004,9 +France,FRA,2005,9 +France,FRA,2006,9 +France,FRA,2007,9 +France,FRA,2008,9 +France,FRA,2009,9 +France,FRA,2010,9 +France,FRA,2011,9 +France,FRA,2012,9 +France,FRA,2013,9 +France,FRA,2014,8 +France,FRA,2015,8 +France,FRA,2016,8 +France,FRA,2017,8 +Gabon,GAB,2000,380 +Gabon,GAB,2001,370 +Gabon,GAB,2002,361 +Gabon,GAB,2003,356 +Gabon,GAB,2004,354 +Gabon,GAB,2005,348 +Gabon,GAB,2006,340 +Gabon,GAB,2007,336 +Gabon,GAB,2008,332 +Gabon,GAB,2009,324 +Gabon,GAB,2010,314 +Gabon,GAB,2011,304 +Gabon,GAB,2012,292 +Gabon,GAB,2013,277 +Gabon,GAB,2014,267 +Gabon,GAB,2015,261 +Gabon,GAB,2016,256 +Gabon,GAB,2017,252 +Gambia,GMB,2000,932 +Gambia,GMB,2001,905 +Gambia,GMB,2002,876 +Gambia,GMB,2003,843 +Gambia,GMB,2004,802 +Gambia,GMB,2005,756 +Gambia,GMB,2006,716 +Gambia,GMB,2007,690 +Gambia,GMB,2008,675 +Gambia,GMB,2009,668 +Gambia,GMB,2010,661 +Gambia,GMB,2011,656 +Gambia,GMB,2012,650 +Gambia,GMB,2013,644 +Gambia,GMB,2014,637 +Gambia,GMB,2015,625 +Gambia,GMB,2016,611 +Gambia,GMB,2017,597 +Georgia,GEO,2000,31 +Georgia,GEO,2001,33 +Georgia,GEO,2002,42 +Georgia,GEO,2003,37 +Georgia,GEO,2004,38 +Georgia,GEO,2005,39 +Georgia,GEO,2006,33 +Georgia,GEO,2007,36 +Georgia,GEO,2008,39 +Georgia,GEO,2009,43 +Georgia,GEO,2010,32 +Georgia,GEO,2011,32 +Georgia,GEO,2012,30 +Georgia,GEO,2013,30 +Georgia,GEO,2014,29 +Georgia,GEO,2015,27 +Georgia,GEO,2016,26 +Georgia,GEO,2017,25 +Germany,DEU,2000,7 +Germany,DEU,2001,7 +Germany,DEU,2002,7 +Germany,DEU,2003,6 +Germany,DEU,2004,6 +Germany,DEU,2005,6 +Germany,DEU,2006,6 +Germany,DEU,2007,6 +Germany,DEU,2008,6 +Germany,DEU,2009,6 +Germany,DEU,2010,6 +Germany,DEU,2011,6 +Germany,DEU,2012,5 +Germany,DEU,2013,5 +Germany,DEU,2014,5 +Germany,DEU,2015,5 +Germany,DEU,2016,5 +Germany,DEU,2017,7 +Ghana,GHA,2000,484 +Ghana,GHA,2001,445 +Ghana,GHA,2002,415 +Ghana,GHA,2003,398 +Ghana,GHA,2004,384 +Ghana,GHA,2005,371 +Ghana,GHA,2006,359 +Ghana,GHA,2007,349 +Ghana,GHA,2008,342 +Ghana,GHA,2009,339 +Ghana,GHA,2010,339 +Ghana,GHA,2011,339 +Ghana,GHA,2012,336 +Ghana,GHA,2013,331 +Ghana,GHA,2014,325 +Ghana,GHA,2015,320 +Ghana,GHA,2016,314 +Ghana,GHA,2017,308 +Greece,GRC,2000,3 +Greece,GRC,2001,3 +Greece,GRC,2002,3 +Greece,GRC,2003,3 +Greece,GRC,2004,3 +Greece,GRC,2005,3 +Greece,GRC,2006,3 +Greece,GRC,2007,3 +Greece,GRC,2008,3 +Greece,GRC,2009,3 +Greece,GRC,2010,3 +Greece,GRC,2011,3 +Greece,GRC,2012,3 +Greece,GRC,2013,3 +Greece,GRC,2014,3 +Greece,GRC,2015,3 +Greece,GRC,2016,3 +Greece,GRC,2017,3 +Grenada,GRD,2000,38 +Grenada,GRD,2001,36 +Grenada,GRD,2002,34 +Grenada,GRD,2003,34 +Grenada,GRD,2004,38 +Grenada,GRD,2005,33 +Grenada,GRD,2006,31 +Grenada,GRD,2007,31 +Grenada,GRD,2008,30 +Grenada,GRD,2009,30 +Grenada,GRD,2010,29 +Grenada,GRD,2011,28 +Grenada,GRD,2012,28 +Grenada,GRD,2013,27 +Grenada,GRD,2014,26 +Grenada,GRD,2015,25 +Grenada,GRD,2016,25 +Grenada,GRD,2017,25 +Guatemala,GTM,2000,161 +Guatemala,GTM,2001,147 +Guatemala,GTM,2002,145 +Guatemala,GTM,2003,137 +Guatemala,GTM,2004,137 +Guatemala,GTM,2005,142 +Guatemala,GTM,2006,137 +Guatemala,GTM,2007,132 +Guatemala,GTM,2008,125 +Guatemala,GTM,2009,131 +Guatemala,GTM,2010,129 +Guatemala,GTM,2011,122 +Guatemala,GTM,2012,118 +Guatemala,GTM,2013,113 +Guatemala,GTM,2014,107 +Guatemala,GTM,2015,103 +Guatemala,GTM,2016,98 +Guatemala,GTM,2017,95 +Guinea,GIN,2000,1020 +Guinea,GIN,2001,1070 +Guinea,GIN,2002,1090 +Guinea,GIN,2003,1080 +Guinea,GIN,2004,1020 +Guinea,GIN,2005,920 +Guinea,GIN,2006,831 +Guinea,GIN,2007,772 +Guinea,GIN,2008,754 +Guinea,GIN,2009,750 +Guinea,GIN,2010,747 +Guinea,GIN,2011,748 +Guinea,GIN,2012,744 +Guinea,GIN,2013,731 +Guinea,GIN,2014,767 +Guinea,GIN,2015,699 +Guinea,GIN,2016,621 +Guinea,GIN,2017,576 +Guinea-Bissau,GNB,2000,1210 +Guinea-Bissau,GNB,2001,1180 +Guinea-Bissau,GNB,2002,1150 +Guinea-Bissau,GNB,2003,1110 +Guinea-Bissau,GNB,2004,1050 +Guinea-Bissau,GNB,2005,979 +Guinea-Bissau,GNB,2006,912 +Guinea-Bissau,GNB,2007,860 +Guinea-Bissau,GNB,2008,827 +Guinea-Bissau,GNB,2009,800 +Guinea-Bissau,GNB,2010,779 +Guinea-Bissau,GNB,2011,762 +Guinea-Bissau,GNB,2012,744 +Guinea-Bissau,GNB,2013,726 +Guinea-Bissau,GNB,2014,711 +Guinea-Bissau,GNB,2015,694 +Guinea-Bissau,GNB,2016,679 +Guinea-Bissau,GNB,2017,667 +Guyana,GUY,2000,231 +Guyana,GUY,2001,216 +Guyana,GUY,2002,227 +Guyana,GUY,2003,226 +Guyana,GUY,2004,220 +Guyana,GUY,2005,223 +Guyana,GUY,2006,221 +Guyana,GUY,2007,208 +Guyana,GUY,2008,192 +Guyana,GUY,2009,185 +Guyana,GUY,2010,179 +Guyana,GUY,2011,180 +Guyana,GUY,2012,185 +Guyana,GUY,2013,175 +Guyana,GUY,2014,174 +Guyana,GUY,2015,172 +Guyana,GUY,2016,170 +Guyana,GUY,2017,169 +Haiti,HTI,2000,437 +Haiti,HTI,2001,437 +Haiti,HTI,2002,441 +Haiti,HTI,2003,446 +Haiti,HTI,2004,513 +Haiti,HTI,2005,459 +Haiti,HTI,2006,467 +Haiti,HTI,2007,473 +Haiti,HTI,2008,484 +Haiti,HTI,2009,484 +Haiti,HTI,2010,506 +Haiti,HTI,2011,496 +Haiti,HTI,2012,500 +Haiti,HTI,2013,496 +Haiti,HTI,2014,492 +Haiti,HTI,2015,488 +Haiti,HTI,2016,489 +Haiti,HTI,2017,480 +Honduras,HND,2000,85 +Honduras,HND,2001,83 +Honduras,HND,2002,80 +Honduras,HND,2003,78 +Honduras,HND,2004,77 +Honduras,HND,2005,77 +Honduras,HND,2006,77 +Honduras,HND,2007,77 +Honduras,HND,2008,76 +Honduras,HND,2009,75 +Honduras,HND,2010,74 +Honduras,HND,2011,72 +Honduras,HND,2012,70 +Honduras,HND,2013,69 +Honduras,HND,2014,68 +Honduras,HND,2015,67 +Honduras,HND,2016,65 +Honduras,HND,2017,65 +Hungary,HUN,2000,16 +Hungary,HUN,2001,15 +Hungary,HUN,2002,16 +Hungary,HUN,2003,15 +Hungary,HUN,2004,15 +Hungary,HUN,2005,15 +Hungary,HUN,2006,14 +Hungary,HUN,2007,15 +Hungary,HUN,2008,14 +Hungary,HUN,2009,13 +Hungary,HUN,2010,13 +Hungary,HUN,2011,13 +Hungary,HUN,2012,12 +Hungary,HUN,2013,12 +Hungary,HUN,2014,12 +Hungary,HUN,2015,12 +Hungary,HUN,2016,12 +Hungary,HUN,2017,12 +Iceland,ISL,2000,6 +Iceland,ISL,2001,6 +Iceland,ISL,2002,6 +Iceland,ISL,2003,6 +Iceland,ISL,2004,6 +Iceland,ISL,2005,5 +Iceland,ISL,2006,5 +Iceland,ISL,2007,5 +Iceland,ISL,2008,5 +Iceland,ISL,2009,5 +Iceland,ISL,2010,5 +Iceland,ISL,2011,5 +Iceland,ISL,2012,4 +Iceland,ISL,2013,4 +Iceland,ISL,2014,5 +Iceland,ISL,2015,4 +Iceland,ISL,2016,4 +Iceland,ISL,2017,4 +India,IND,2000,370 +India,IND,2001,354 +India,IND,2002,336 +India,IND,2003,319 +India,IND,2004,303 +India,IND,2005,286 +India,IND,2006,270 +India,IND,2007,255 +India,IND,2008,240 +India,IND,2009,225 +India,IND,2010,210 +India,IND,2011,197 +India,IND,2012,185 +India,IND,2013,175 +India,IND,2014,166 +India,IND,2015,158 +India,IND,2016,150 +India,IND,2017,145 +Indonesia,IDN,2000,272 +Indonesia,IDN,2001,269 +Indonesia,IDN,2002,265 +Indonesia,IDN,2003,261 +Indonesia,IDN,2004,264 +Indonesia,IDN,2005,252 +Indonesia,IDN,2006,249 +Indonesia,IDN,2007,243 +Indonesia,IDN,2008,239 +Indonesia,IDN,2009,234 +Indonesia,IDN,2010,228 +Indonesia,IDN,2011,221 +Indonesia,IDN,2012,214 +Indonesia,IDN,2013,207 +Indonesia,IDN,2014,199 +Indonesia,IDN,2015,192 +Indonesia,IDN,2016,184 +Indonesia,IDN,2017,177 +Iran,IRN,2000,48 +Iran,IRN,2001,44 +Iran,IRN,2002,41 +Iran,IRN,2003,39 +Iran,IRN,2004,36 +Iran,IRN,2005,34 +Iran,IRN,2006,32 +Iran,IRN,2007,30 +Iran,IRN,2008,28 +Iran,IRN,2009,25 +Iran,IRN,2010,22 +Iran,IRN,2011,19 +Iran,IRN,2012,18 +Iran,IRN,2013,17 +Iran,IRN,2014,17 +Iran,IRN,2015,17 +Iran,IRN,2016,16 +Iran,IRN,2017,16 +Iraq,IRQ,2000,79 +Iraq,IRQ,2001,76 +Iraq,IRQ,2002,74 +Iraq,IRQ,2003,136 +Iraq,IRQ,2004,122 +Iraq,IRQ,2005,127 +Iraq,IRQ,2006,158 +Iraq,IRQ,2007,138 +Iraq,IRQ,2008,90 +Iraq,IRQ,2009,75 +Iraq,IRQ,2010,70 +Iraq,IRQ,2011,67 +Iraq,IRQ,2012,66 +Iraq,IRQ,2013,75 +Iraq,IRQ,2014,92 +Iraq,IRQ,2015,83 +Iraq,IRQ,2016,78 +Iraq,IRQ,2017,79 +Ireland,IRL,2000,7 +Ireland,IRL,2001,7 +Ireland,IRL,2002,6 +Ireland,IRL,2003,6 +Ireland,IRL,2004,6 +Ireland,IRL,2005,7 +Ireland,IRL,2006,6 +Ireland,IRL,2007,6 +Ireland,IRL,2008,7 +Ireland,IRL,2009,7 +Ireland,IRL,2010,6 +Ireland,IRL,2011,7 +Ireland,IRL,2012,6 +Ireland,IRL,2013,6 +Ireland,IRL,2014,6 +Ireland,IRL,2015,6 +Ireland,IRL,2016,6 +Ireland,IRL,2017,5 +Israel,ISR,2000,7 +Israel,ISR,2001,7 +Israel,ISR,2002,7 +Israel,ISR,2003,6 +Israel,ISR,2004,6 +Israel,ISR,2005,5 +Israel,ISR,2006,5 +Israel,ISR,2007,5 +Israel,ISR,2008,4 +Israel,ISR,2009,4 +Israel,ISR,2010,4 +Israel,ISR,2011,4 +Israel,ISR,2012,4 +Israel,ISR,2013,4 +Israel,ISR,2014,4 +Israel,ISR,2015,3 +Israel,ISR,2016,3 +Israel,ISR,2017,3 +Italy,ITA,2000,4 +Italy,ITA,2001,3 +Italy,ITA,2002,3 +Italy,ITA,2003,3 +Italy,ITA,2004,3 +Italy,ITA,2005,3 +Italy,ITA,2006,2 +Italy,ITA,2007,2 +Italy,ITA,2008,2 +Italy,ITA,2009,2 +Italy,ITA,2010,2 +Italy,ITA,2011,2 +Italy,ITA,2012,2 +Italy,ITA,2013,2 +Italy,ITA,2014,2 +Italy,ITA,2015,2 +Italy,ITA,2016,2 +Italy,ITA,2017,2 +Jamaica,JAM,2000,77 +Jamaica,JAM,2001,79 +Jamaica,JAM,2002,78 +Jamaica,JAM,2003,79 +Jamaica,JAM,2004,80 +Jamaica,JAM,2005,80 +Jamaica,JAM,2006,79 +Jamaica,JAM,2007,79 +Jamaica,JAM,2008,79 +Jamaica,JAM,2009,79 +Jamaica,JAM,2010,79 +Jamaica,JAM,2011,79 +Jamaica,JAM,2012,79 +Jamaica,JAM,2013,79 +Jamaica,JAM,2014,78 +Jamaica,JAM,2015,78 +Jamaica,JAM,2016,80 +Jamaica,JAM,2017,80 +Japan,JPN,2000,9 +Japan,JPN,2001,8 +Japan,JPN,2002,8 +Japan,JPN,2003,7 +Japan,JPN,2004,7 +Japan,JPN,2005,7 +Japan,JPN,2006,7 +Japan,JPN,2007,6 +Japan,JPN,2008,6 +Japan,JPN,2009,6 +Japan,JPN,2010,6 +Japan,JPN,2011,6 +Japan,JPN,2012,5 +Japan,JPN,2013,5 +Japan,JPN,2014,5 +Japan,JPN,2015,5 +Japan,JPN,2016,5 +Japan,JPN,2017,5 +Jordan,JOR,2000,70 +Jordan,JOR,2001,68 +Jordan,JOR,2002,65 +Jordan,JOR,2003,63 +Jordan,JOR,2004,62 +Jordan,JOR,2005,62 +Jordan,JOR,2006,58 +Jordan,JOR,2007,56 +Jordan,JOR,2008,55 +Jordan,JOR,2009,54 +Jordan,JOR,2010,53 +Jordan,JOR,2011,52 +Jordan,JOR,2012,52 +Jordan,JOR,2013,51 +Jordan,JOR,2014,49 +Jordan,JOR,2015,48 +Jordan,JOR,2016,47 +Jordan,JOR,2017,46 +Kazakhstan,KAZ,2000,61 +Kazakhstan,KAZ,2001,57 +Kazakhstan,KAZ,2002,52 +Kazakhstan,KAZ,2003,49 +Kazakhstan,KAZ,2004,46 +Kazakhstan,KAZ,2005,43 +Kazakhstan,KAZ,2006,40 +Kazakhstan,KAZ,2007,36 +Kazakhstan,KAZ,2008,30 +Kazakhstan,KAZ,2009,24 +Kazakhstan,KAZ,2010,22 +Kazakhstan,KAZ,2011,19 +Kazakhstan,KAZ,2012,17 +Kazakhstan,KAZ,2013,14 +Kazakhstan,KAZ,2014,13 +Kazakhstan,KAZ,2015,12 +Kazakhstan,KAZ,2016,10 +Kazakhstan,KAZ,2017,10 +Kenya,KEN,2000,708 +Kenya,KEN,2001,702 +Kenya,KEN,2002,692 +Kenya,KEN,2003,678 +Kenya,KEN,2004,653 +Kenya,KEN,2005,618 +Kenya,KEN,2006,583 +Kenya,KEN,2007,545 +Kenya,KEN,2008,513 +Kenya,KEN,2009,472 +Kenya,KEN,2010,432 +Kenya,KEN,2011,398 +Kenya,KEN,2012,373 +Kenya,KEN,2013,364 +Kenya,KEN,2014,358 +Kenya,KEN,2015,353 +Kenya,KEN,2016,346 +Kenya,KEN,2017,342 +Kiribati,KIR,2000,136 +Kiribati,KIR,2001,131 +Kiribati,KIR,2002,127 +Kiribati,KIR,2003,124 +Kiribati,KIR,2004,121 +Kiribati,KIR,2005,119 +Kiribati,KIR,2006,117 +Kiribati,KIR,2007,115 +Kiribati,KIR,2008,115 +Kiribati,KIR,2009,113 +Kiribati,KIR,2010,112 +Kiribati,KIR,2011,110 +Kiribati,KIR,2012,107 +Kiribati,KIR,2013,104 +Kiribati,KIR,2014,100 +Kiribati,KIR,2015,97 +Kiribati,KIR,2016,94 +Kiribati,KIR,2017,92 +Kuwait,KWT,2000,10 +Kuwait,KWT,2001,10 +Kuwait,KWT,2002,10 +Kuwait,KWT,2003,10 +Kuwait,KWT,2004,10 +Kuwait,KWT,2005,10 +Kuwait,KWT,2006,10 +Kuwait,KWT,2007,10 +Kuwait,KWT,2008,10 +Kuwait,KWT,2009,10 +Kuwait,KWT,2010,10 +Kuwait,KWT,2011,10 +Kuwait,KWT,2012,11 +Kuwait,KWT,2013,11 +Kuwait,KWT,2014,11 +Kuwait,KWT,2015,11 +Kuwait,KWT,2016,12 +Kuwait,KWT,2017,12 +Kyrgyzstan,KGZ,2000,79 +Kyrgyzstan,KGZ,2001,76 +Kyrgyzstan,KGZ,2002,83 +Kyrgyzstan,KGZ,2003,82 +Kyrgyzstan,KGZ,2004,79 +Kyrgyzstan,KGZ,2005,82 +Kyrgyzstan,KGZ,2006,85 +Kyrgyzstan,KGZ,2007,84 +Kyrgyzstan,KGZ,2008,81 +Kyrgyzstan,KGZ,2009,80 +Kyrgyzstan,KGZ,2010,79 +Kyrgyzstan,KGZ,2011,79 +Kyrgyzstan,KGZ,2012,74 +Kyrgyzstan,KGZ,2013,70 +Kyrgyzstan,KGZ,2014,69 +Kyrgyzstan,KGZ,2015,66 +Kyrgyzstan,KGZ,2016,63 +Kyrgyzstan,KGZ,2017,60 +Laos,LAO,2000,544 +Laos,LAO,2001,517 +Laos,LAO,2002,491 +Laos,LAO,2003,465 +Laos,LAO,2004,437 +Laos,LAO,2005,410 +Laos,LAO,2006,385 +Laos,LAO,2007,360 +Laos,LAO,2008,336 +Laos,LAO,2009,314 +Laos,LAO,2010,292 +Laos,LAO,2011,272 +Laos,LAO,2012,254 +Laos,LAO,2013,238 +Laos,LAO,2014,223 +Laos,LAO,2015,209 +Laos,LAO,2016,196 +Laos,LAO,2017,185 +Latvia,LVA,2000,34 +Latvia,LVA,2001,35 +Latvia,LVA,2002,33 +Latvia,LVA,2003,34 +Latvia,LVA,2004,32 +Latvia,LVA,2005,30 +Latvia,LVA,2006,32 +Latvia,LVA,2007,32 +Latvia,LVA,2008,29 +Latvia,LVA,2009,28 +Latvia,LVA,2010,26 +Latvia,LVA,2011,26 +Latvia,LVA,2012,23 +Latvia,LVA,2013,27 +Latvia,LVA,2014,24 +Latvia,LVA,2015,23 +Latvia,LVA,2016,26 +Latvia,LVA,2017,19 +Lebanon,LBN,2000,28 +Lebanon,LBN,2001,27 +Lebanon,LBN,2002,26 +Lebanon,LBN,2003,25 +Lebanon,LBN,2004,24 +Lebanon,LBN,2005,24 +Lebanon,LBN,2006,24 +Lebanon,LBN,2007,23 +Lebanon,LBN,2008,23 +Lebanon,LBN,2009,23 +Lebanon,LBN,2010,23 +Lebanon,LBN,2011,25 +Lebanon,LBN,2012,25 +Lebanon,LBN,2013,27 +Lebanon,LBN,2014,28 +Lebanon,LBN,2015,29 +Lebanon,LBN,2016,29 +Lebanon,LBN,2017,29 +Lesotho,LSO,2000,614 +Lesotho,LSO,2001,633 +Lesotho,LSO,2002,653 +Lesotho,LSO,2003,671 +Lesotho,LSO,2004,680 +Lesotho,LSO,2005,679 +Lesotho,LSO,2006,668 +Lesotho,LSO,2007,652 +Lesotho,LSO,2008,623 +Lesotho,LSO,2009,607 +Lesotho,LSO,2010,594 +Lesotho,LSO,2011,585 +Lesotho,LSO,2012,586 +Lesotho,LSO,2013,583 +Lesotho,LSO,2014,579 +Lesotho,LSO,2015,574 +Lesotho,LSO,2016,559 +Lesotho,LSO,2017,544 +Liberia,LBR,2000,894 +Liberia,LBR,2001,913 +Liberia,LBR,2002,1010 +Liberia,LBR,2003,878 +Liberia,LBR,2004,837 +Liberia,LBR,2005,816 +Liberia,LBR,2006,782 +Liberia,LBR,2007,754 +Liberia,LBR,2008,738 +Liberia,LBR,2009,724 +Liberia,LBR,2010,708 +Liberia,LBR,2011,694 +Liberia,LBR,2012,683 +Liberia,LBR,2013,674 +Liberia,LBR,2014,688 +Liberia,LBR,2015,691 +Liberia,LBR,2016,661 +Liberia,LBR,2017,661 +Libya,LBY,2000,70 +Libya,LBY,2001,68 +Libya,LBY,2002,66 +Libya,LBY,2003,64 +Libya,LBY,2004,61 +Libya,LBY,2005,57 +Libya,LBY,2006,55 +Libya,LBY,2007,53 +Libya,LBY,2008,52 +Libya,LBY,2009,53 +Libya,LBY,2010,53 +Libya,LBY,2011,56 +Libya,LBY,2012,55 +Libya,LBY,2013,58 +Libya,LBY,2014,63 +Libya,LBY,2015,70 +Libya,LBY,2016,73 +Libya,LBY,2017,72 +Lithuania,LTU,2000,17 +Lithuania,LTU,2001,16 +Lithuania,LTU,2002,14 +Lithuania,LTU,2003,14 +Lithuania,LTU,2004,13 +Lithuania,LTU,2005,14 +Lithuania,LTU,2006,14 +Lithuania,LTU,2007,14 +Lithuania,LTU,2008,13 +Lithuania,LTU,2009,11 +Lithuania,LTU,2010,10 +Lithuania,LTU,2011,10 +Lithuania,LTU,2012,10 +Lithuania,LTU,2013,10 +Lithuania,LTU,2014,9 +Lithuania,LTU,2015,9 +Lithuania,LTU,2016,8 +Lithuania,LTU,2017,8 +Luxembourg,LUX,2000,10 +Luxembourg,LUX,2001,10 +Luxembourg,LUX,2002,9 +Luxembourg,LUX,2003,8 +Luxembourg,LUX,2004,8 +Luxembourg,LUX,2005,9 +Luxembourg,LUX,2006,9 +Luxembourg,LUX,2007,8 +Luxembourg,LUX,2008,6 +Luxembourg,LUX,2009,7 +Luxembourg,LUX,2010,8 +Luxembourg,LUX,2011,8 +Luxembourg,LUX,2012,7 +Luxembourg,LUX,2013,6 +Luxembourg,LUX,2014,6 +Luxembourg,LUX,2015,5 +Luxembourg,LUX,2016,5 +Luxembourg,LUX,2017,5 +Madagascar,MDG,2000,559 +Madagascar,MDG,2001,552 +Madagascar,MDG,2002,547 +Madagascar,MDG,2003,543 +Madagascar,MDG,2004,539 +Madagascar,MDG,2005,526 +Madagascar,MDG,2006,513 +Madagascar,MDG,2007,503 +Madagascar,MDG,2008,491 +Madagascar,MDG,2009,474 +Madagascar,MDG,2010,453 +Madagascar,MDG,2011,432 +Madagascar,MDG,2012,413 +Madagascar,MDG,2013,394 +Madagascar,MDG,2014,378 +Madagascar,MDG,2015,363 +Madagascar,MDG,2016,348 +Madagascar,MDG,2017,335 +Malawi,MWI,2000,749 +Malawi,MWI,2001,735 +Malawi,MWI,2002,714 +Malawi,MWI,2003,687 +Malawi,MWI,2004,654 +Malawi,MWI,2005,610 +Malawi,MWI,2006,566 +Malawi,MWI,2007,526 +Malawi,MWI,2008,493 +Malawi,MWI,2009,466 +Malawi,MWI,2010,444 +Malawi,MWI,2011,428 +Malawi,MWI,2012,413 +Malawi,MWI,2013,396 +Malawi,MWI,2014,381 +Malawi,MWI,2015,370 +Malawi,MWI,2016,358 +Malawi,MWI,2017,349 +Malaysia,MYS,2000,38 +Malaysia,MYS,2001,36 +Malaysia,MYS,2002,34 +Malaysia,MYS,2003,33 +Malaysia,MYS,2004,32 +Malaysia,MYS,2005,31 +Malaysia,MYS,2006,30 +Malaysia,MYS,2007,30 +Malaysia,MYS,2008,29 +Malaysia,MYS,2009,29 +Malaysia,MYS,2010,30 +Malaysia,MYS,2011,30 +Malaysia,MYS,2012,30 +Malaysia,MYS,2013,30 +Malaysia,MYS,2014,30 +Malaysia,MYS,2015,30 +Malaysia,MYS,2016,29 +Malaysia,MYS,2017,29 +Maldives,MDV,2000,125 +Maldives,MDV,2001,111 +Maldives,MDV,2002,105 +Maldives,MDV,2003,97 +Maldives,MDV,2004,89 +Maldives,MDV,2005,75 +Maldives,MDV,2006,71 +Maldives,MDV,2007,71 +Maldives,MDV,2008,72 +Maldives,MDV,2009,71 +Maldives,MDV,2010,67 +Maldives,MDV,2011,62 +Maldives,MDV,2012,60 +Maldives,MDV,2013,58 +Maldives,MDV,2014,56 +Maldives,MDV,2015,54 +Maldives,MDV,2016,54 +Maldives,MDV,2017,53 +Mali,MLI,2000,836 +Mali,MLI,2001,797 +Mali,MLI,2002,764 +Mali,MLI,2003,739 +Mali,MLI,2004,715 +Mali,MLI,2005,691 +Mali,MLI,2006,675 +Mali,MLI,2007,663 +Mali,MLI,2008,661 +Mali,MLI,2009,661 +Mali,MLI,2010,660 +Mali,MLI,2011,663 +Mali,MLI,2012,663 +Mali,MLI,2013,663 +Mali,MLI,2014,642 +Mali,MLI,2015,620 +Mali,MLI,2016,590 +Mali,MLI,2017,562 +Malta,MLT,2000,9 +Malta,MLT,2001,10 +Malta,MLT,2002,9 +Malta,MLT,2003,10 +Malta,MLT,2004,9 +Malta,MLT,2005,8 +Malta,MLT,2006,8 +Malta,MLT,2007,8 +Malta,MLT,2008,8 +Malta,MLT,2009,7 +Malta,MLT,2010,8 +Malta,MLT,2011,7 +Malta,MLT,2012,7 +Malta,MLT,2013,7 +Malta,MLT,2014,6 +Malta,MLT,2015,7 +Malta,MLT,2016,6 +Malta,MLT,2017,6 +Mauritania,MRT,2000,834 +Mauritania,MRT,2001,835 +Mauritania,MRT,2002,836 +Mauritania,MRT,2003,836 +Mauritania,MRT,2004,830 +Mauritania,MRT,2005,826 +Mauritania,MRT,2006,821 +Mauritania,MRT,2007,820 +Mauritania,MRT,2008,819 +Mauritania,MRT,2009,822 +Mauritania,MRT,2010,824 +Mauritania,MRT,2011,822 +Mauritania,MRT,2012,812 +Mauritania,MRT,2013,805 +Mauritania,MRT,2014,796 +Mauritania,MRT,2015,785 +Mauritania,MRT,2016,777 +Mauritania,MRT,2017,766 +Mauritius,MUS,2000,59 +Mauritius,MUS,2001,54 +Mauritius,MUS,2002,54 +Mauritius,MUS,2003,57 +Mauritius,MUS,2004,54 +Mauritius,MUS,2005,53 +Mauritius,MUS,2006,55 +Mauritius,MUS,2007,56 +Mauritius,MUS,2008,53 +Mauritius,MUS,2009,59 +Mauritius,MUS,2010,66 +Mauritius,MUS,2011,54 +Mauritius,MUS,2012,63 +Mauritius,MUS,2013,60 +Mauritius,MUS,2014,70 +Mauritius,MUS,2015,73 +Mauritius,MUS,2016,67 +Mauritius,MUS,2017,61 +Mexico,MEX,2000,55 +Mexico,MEX,2001,55 +Mexico,MEX,2002,56 +Mexico,MEX,2003,55 +Mexico,MEX,2004,54 +Mexico,MEX,2005,54 +Mexico,MEX,2006,51 +Mexico,MEX,2007,49 +Mexico,MEX,2008,49 +Mexico,MEX,2009,51 +Mexico,MEX,2010,46 +Mexico,MEX,2011,43 +Mexico,MEX,2012,41 +Mexico,MEX,2013,39 +Mexico,MEX,2014,38 +Mexico,MEX,2015,36 +Mexico,MEX,2016,34 +Mexico,MEX,2017,33 +Micronesia (country),FSM,2000,154 +Micronesia (country),FSM,2001,150 +Micronesia (country),FSM,2002,163 +Micronesia (country),FSM,2003,141 +Micronesia (country),FSM,2004,137 +Micronesia (country),FSM,2005,133 +Micronesia (country),FSM,2006,128 +Micronesia (country),FSM,2007,123 +Micronesia (country),FSM,2008,118 +Micronesia (country),FSM,2009,114 +Micronesia (country),FSM,2010,110 +Micronesia (country),FSM,2011,106 +Micronesia (country),FSM,2012,103 +Micronesia (country),FSM,2013,99 +Micronesia (country),FSM,2014,96 +Micronesia (country),FSM,2015,95 +Micronesia (country),FSM,2016,90 +Micronesia (country),FSM,2017,88 +Moldova,MDA,2000,44 +Moldova,MDA,2001,39 +Moldova,MDA,2002,38 +Moldova,MDA,2003,36 +Moldova,MDA,2004,32 +Moldova,MDA,2005,34 +Moldova,MDA,2006,31 +Moldova,MDA,2007,31 +Moldova,MDA,2008,29 +Moldova,MDA,2009,28 +Moldova,MDA,2010,29 +Moldova,MDA,2011,21 +Moldova,MDA,2012,22 +Moldova,MDA,2013,21 +Moldova,MDA,2014,23 +Moldova,MDA,2015,22 +Moldova,MDA,2016,20 +Moldova,MDA,2017,19 +Mongolia,MNG,2000,155 +Mongolia,MNG,2001,138 +Mongolia,MNG,2002,124 +Mongolia,MNG,2003,114 +Mongolia,MNG,2004,106 +Mongolia,MNG,2005,98 +Mongolia,MNG,2006,91 +Mongolia,MNG,2007,85 +Mongolia,MNG,2008,80 +Mongolia,MNG,2009,73 +Mongolia,MNG,2010,66 +Mongolia,MNG,2011,59 +Mongolia,MNG,2012,54 +Mongolia,MNG,2013,51 +Mongolia,MNG,2014,49 +Mongolia,MNG,2015,47 +Mongolia,MNG,2016,46 +Mongolia,MNG,2017,45 +Montenegro,MNE,2000,12 +Montenegro,MNE,2001,12 +Montenegro,MNE,2002,11 +Montenegro,MNE,2003,11 +Montenegro,MNE,2004,10 +Montenegro,MNE,2005,9 +Montenegro,MNE,2006,9 +Montenegro,MNE,2007,8 +Montenegro,MNE,2008,8 +Montenegro,MNE,2009,8 +Montenegro,MNE,2010,7 +Montenegro,MNE,2011,7 +Montenegro,MNE,2012,7 +Montenegro,MNE,2013,6 +Montenegro,MNE,2014,6 +Montenegro,MNE,2015,6 +Montenegro,MNE,2016,6 +Montenegro,MNE,2017,6 +Morocco,MAR,2000,188 +Morocco,MAR,2001,174 +Morocco,MAR,2002,162 +Morocco,MAR,2003,152 +Morocco,MAR,2004,142 +Morocco,MAR,2005,131 +Morocco,MAR,2006,121 +Morocco,MAR,2007,113 +Morocco,MAR,2008,106 +Morocco,MAR,2009,99 +Morocco,MAR,2010,92 +Morocco,MAR,2011,86 +Morocco,MAR,2012,81 +Morocco,MAR,2013,78 +Morocco,MAR,2014,76 +Morocco,MAR,2015,74 +Morocco,MAR,2016,72 +Morocco,MAR,2017,70 +Mozambique,MOZ,2000,798 +Mozambique,MOZ,2001,745 +Mozambique,MOZ,2002,700 +Mozambique,MOZ,2003,657 +Mozambique,MOZ,2004,615 +Mozambique,MOZ,2005,577 +Mozambique,MOZ,2006,539 +Mozambique,MOZ,2007,505 +Mozambique,MOZ,2008,471 +Mozambique,MOZ,2009,439 +Mozambique,MOZ,2010,412 +Mozambique,MOZ,2011,389 +Mozambique,MOZ,2012,371 +Mozambique,MOZ,2013,356 +Mozambique,MOZ,2014,339 +Mozambique,MOZ,2015,318 +Mozambique,MOZ,2016,301 +Mozambique,MOZ,2017,289 +Myanmar,MMR,2000,340 +Myanmar,MMR,2001,331 +Myanmar,MMR,2002,323 +Myanmar,MMR,2003,314 +Myanmar,MMR,2004,307 +Myanmar,MMR,2005,299 +Myanmar,MMR,2006,293 +Myanmar,MMR,2007,287 +Myanmar,MMR,2008,289 +Myanmar,MMR,2009,274 +Myanmar,MMR,2010,265 +Myanmar,MMR,2011,259 +Myanmar,MMR,2012,254 +Myanmar,MMR,2013,251 +Myanmar,MMR,2014,247 +Myanmar,MMR,2015,246 +Myanmar,MMR,2016,245 +Myanmar,MMR,2017,250 +Namibia,NAM,2000,348 +Namibia,NAM,2001,352 +Namibia,NAM,2002,356 +Namibia,NAM,2003,359 +Namibia,NAM,2004,358 +Namibia,NAM,2005,346 +Namibia,NAM,2006,328 +Namibia,NAM,2007,306 +Namibia,NAM,2008,284 +Namibia,NAM,2009,276 +Namibia,NAM,2010,266 +Namibia,NAM,2011,256 +Namibia,NAM,2012,240 +Namibia,NAM,2013,231 +Namibia,NAM,2014,223 +Namibia,NAM,2015,217 +Namibia,NAM,2016,207 +Namibia,NAM,2017,195 +Nepal,NPL,2000,553 +Nepal,NPL,2001,521 +Nepal,NPL,2002,520 +Nepal,NPL,2003,470 +Nepal,NPL,2004,447 +Nepal,NPL,2005,415 +Nepal,NPL,2006,386 +Nepal,NPL,2007,361 +Nepal,NPL,2008,342 +Nepal,NPL,2009,323 +Nepal,NPL,2010,305 +Nepal,NPL,2011,285 +Nepal,NPL,2012,266 +Nepal,NPL,2013,248 +Nepal,NPL,2014,231 +Nepal,NPL,2015,236 +Nepal,NPL,2016,200 +Nepal,NPL,2017,186 +Netherlands,NLD,2000,13 +Netherlands,NLD,2001,13 +Netherlands,NLD,2002,13 +Netherlands,NLD,2003,12 +Netherlands,NLD,2004,11 +Netherlands,NLD,2005,11 +Netherlands,NLD,2006,9 +Netherlands,NLD,2007,9 +Netherlands,NLD,2008,8 +Netherlands,NLD,2009,8 +Netherlands,NLD,2010,7 +Netherlands,NLD,2011,7 +Netherlands,NLD,2012,7 +Netherlands,NLD,2013,6 +Netherlands,NLD,2014,6 +Netherlands,NLD,2015,6 +Netherlands,NLD,2016,6 +Netherlands,NLD,2017,5 +New Zealand,NZL,2000,12 +New Zealand,NZL,2001,11 +New Zealand,NZL,2002,12 +New Zealand,NZL,2003,12 +New Zealand,NZL,2004,11 +New Zealand,NZL,2005,11 +New Zealand,NZL,2006,11 +New Zealand,NZL,2007,11 +New Zealand,NZL,2008,10 +New Zealand,NZL,2009,11 +New Zealand,NZL,2010,11 +New Zealand,NZL,2011,10 +New Zealand,NZL,2012,10 +New Zealand,NZL,2013,9 +New Zealand,NZL,2014,10 +New Zealand,NZL,2015,10 +New Zealand,NZL,2016,10 +New Zealand,NZL,2017,9 +Nicaragua,NIC,2000,162 +Nicaragua,NIC,2001,157 +Nicaragua,NIC,2002,151 +Nicaragua,NIC,2003,145 +Nicaragua,NIC,2004,138 +Nicaragua,NIC,2005,131 +Nicaragua,NIC,2006,124 +Nicaragua,NIC,2007,121 +Nicaragua,NIC,2008,116 +Nicaragua,NIC,2009,113 +Nicaragua,NIC,2010,112 +Nicaragua,NIC,2011,110 +Nicaragua,NIC,2012,108 +Nicaragua,NIC,2013,105 +Nicaragua,NIC,2014,103 +Nicaragua,NIC,2015,101 +Nicaragua,NIC,2016,100 +Nicaragua,NIC,2017,98 +Niger,NER,2000,813 +Niger,NER,2001,803 +Niger,NER,2002,795 +Niger,NER,2003,782 +Niger,NER,2004,770 +Niger,NER,2005,755 +Niger,NER,2006,739 +Niger,NER,2007,725 +Niger,NER,2008,709 +Niger,NER,2009,688 +Niger,NER,2010,663 +Niger,NER,2011,639 +Niger,NER,2012,616 +Niger,NER,2013,594 +Niger,NER,2014,573 +Niger,NER,2015,555 +Niger,NER,2016,530 +Niger,NER,2017,509 +Nigeria,NGA,2000,1200 +Nigeria,NGA,2001,1200 +Nigeria,NGA,2002,1180 +Nigeria,NGA,2003,1170 +Nigeria,NGA,2004,1130 +Nigeria,NGA,2005,1080 +Nigeria,NGA,2006,1040 +Nigeria,NGA,2007,1010 +Nigeria,NGA,2008,996 +Nigeria,NGA,2009,987 +Nigeria,NGA,2010,978 +Nigeria,NGA,2011,972 +Nigeria,NGA,2012,963 +Nigeria,NGA,2013,951 +Nigeria,NGA,2014,943 +Nigeria,NGA,2015,931 +Nigeria,NGA,2016,925 +Nigeria,NGA,2017,917 +North Korea,PRK,2000,139 +North Korea,PRK,2001,128 +North Korea,PRK,2002,122 +North Korea,PRK,2003,121 +North Korea,PRK,2004,120 +North Korea,PRK,2005,120 +North Korea,PRK,2006,120 +North Korea,PRK,2007,119 +North Korea,PRK,2008,118 +North Korea,PRK,2009,113 +North Korea,PRK,2010,106 +North Korea,PRK,2011,100 +North Korea,PRK,2012,96 +North Korea,PRK,2013,94 +North Korea,PRK,2014,93 +North Korea,PRK,2015,91 +North Korea,PRK,2016,90 +North Korea,PRK,2017,89 +North Macedonia,MKD,2000,13 +North Macedonia,MKD,2001,12 +North Macedonia,MKD,2002,12 +North Macedonia,MKD,2003,10 +North Macedonia,MKD,2004,11 +North Macedonia,MKD,2005,10 +North Macedonia,MKD,2006,10 +North Macedonia,MKD,2007,10 +North Macedonia,MKD,2008,8 +North Macedonia,MKD,2009,8 +North Macedonia,MKD,2010,8 +North Macedonia,MKD,2011,8 +North Macedonia,MKD,2012,8 +North Macedonia,MKD,2013,8 +North Macedonia,MKD,2014,8 +North Macedonia,MKD,2015,8 +North Macedonia,MKD,2016,8 +North Macedonia,MKD,2017,7 +Norway,NOR,2000,6 +Norway,NOR,2001,5 +Norway,NOR,2002,5 +Norway,NOR,2003,5 +Norway,NOR,2004,5 +Norway,NOR,2005,5 +Norway,NOR,2006,4 +Norway,NOR,2007,4 +Norway,NOR,2008,4 +Norway,NOR,2009,4 +Norway,NOR,2010,4 +Norway,NOR,2011,4 +Norway,NOR,2012,3 +Norway,NOR,2013,3 +Norway,NOR,2014,3 +Norway,NOR,2015,3 +Norway,NOR,2016,3 +Norway,NOR,2017,2 +Oman,OMN,2000,20 +Oman,OMN,2001,20 +Oman,OMN,2002,20 +Oman,OMN,2003,20 +Oman,OMN,2004,19 +Oman,OMN,2005,19 +Oman,OMN,2006,18 +Oman,OMN,2007,18 +Oman,OMN,2008,18 +Oman,OMN,2009,18 +Oman,OMN,2010,18 +Oman,OMN,2011,18 +Oman,OMN,2012,18 +Oman,OMN,2013,18 +Oman,OMN,2014,18 +Oman,OMN,2015,19 +Oman,OMN,2016,19 +Oman,OMN,2017,19 +Pakistan,PAK,2000,286 +Pakistan,PAK,2001,275 +Pakistan,PAK,2002,264 +Pakistan,PAK,2003,254 +Pakistan,PAK,2004,243 +Pakistan,PAK,2005,237 +Pakistan,PAK,2006,222 +Pakistan,PAK,2007,214 +Pakistan,PAK,2008,205 +Pakistan,PAK,2009,199 +Pakistan,PAK,2010,191 +Pakistan,PAK,2011,180 +Pakistan,PAK,2012,173 +Pakistan,PAK,2013,166 +Pakistan,PAK,2014,161 +Pakistan,PAK,2015,154 +Pakistan,PAK,2016,143 +Pakistan,PAK,2017,140 +Panama,PAN,2000,91 +Panama,PAN,2001,86 +Panama,PAN,2002,91 +Panama,PAN,2003,93 +Panama,PAN,2004,88 +Panama,PAN,2005,88 +Panama,PAN,2006,88 +Panama,PAN,2007,86 +Panama,PAN,2008,84 +Panama,PAN,2009,82 +Panama,PAN,2010,79 +Panama,PAN,2011,76 +Panama,PAN,2012,74 +Panama,PAN,2013,66 +Panama,PAN,2014,60 +Panama,PAN,2015,58 +Panama,PAN,2016,55 +Panama,PAN,2017,52 +Papua New Guinea,PNG,2000,249 +Papua New Guinea,PNG,2001,242 +Papua New Guinea,PNG,2002,234 +Papua New Guinea,PNG,2003,225 +Papua New Guinea,PNG,2004,213 +Papua New Guinea,PNG,2005,200 +Papua New Guinea,PNG,2006,187 +Papua New Guinea,PNG,2007,179 +Papua New Guinea,PNG,2008,173 +Papua New Guinea,PNG,2009,170 +Papua New Guinea,PNG,2010,168 +Papua New Guinea,PNG,2011,166 +Papua New Guinea,PNG,2012,164 +Papua New Guinea,PNG,2013,160 +Papua New Guinea,PNG,2014,155 +Papua New Guinea,PNG,2015,151 +Papua New Guinea,PNG,2016,148 +Papua New Guinea,PNG,2017,145 +Paraguay,PRY,2000,165 +Paraguay,PRY,2001,160 +Paraguay,PRY,2002,155 +Paraguay,PRY,2003,150 +Paraguay,PRY,2004,144 +Paraguay,PRY,2005,137 +Paraguay,PRY,2006,130 +Paraguay,PRY,2007,124 +Paraguay,PRY,2008,118 +Paraguay,PRY,2009,113 +Paraguay,PRY,2010,108 +Paraguay,PRY,2011,103 +Paraguay,PRY,2012,98 +Paraguay,PRY,2013,94 +Paraguay,PRY,2014,91 +Paraguay,PRY,2015,88 +Paraguay,PRY,2016,86 +Paraguay,PRY,2017,84 +Peru,PER,2000,144 +Peru,PER,2001,138 +Peru,PER,2002,132 +Peru,PER,2003,127 +Peru,PER,2004,122 +Peru,PER,2005,118 +Peru,PER,2006,114 +Peru,PER,2007,112 +Peru,PER,2008,108 +Peru,PER,2009,106 +Peru,PER,2010,104 +Peru,PER,2011,102 +Peru,PER,2012,100 +Peru,PER,2013,98 +Peru,PER,2014,96 +Peru,PER,2015,94 +Peru,PER,2016,91 +Peru,PER,2017,88 +Philippines,PHL,2000,160 +Philippines,PHL,2001,163 +Philippines,PHL,2002,160 +Philippines,PHL,2003,156 +Philippines,PHL,2004,156 +Philippines,PHL,2005,156 +Philippines,PHL,2006,156 +Philippines,PHL,2007,149 +Philippines,PHL,2008,148 +Philippines,PHL,2009,149 +Philippines,PHL,2010,144 +Philippines,PHL,2011,141 +Philippines,PHL,2012,139 +Philippines,PHL,2013,136 +Philippines,PHL,2014,131 +Philippines,PHL,2015,127 +Philippines,PHL,2016,124 +Philippines,PHL,2017,121 +Poland,POL,2000,7 +Poland,POL,2001,6 +Poland,POL,2002,5 +Poland,POL,2003,5 +Poland,POL,2004,5 +Poland,POL,2005,4 +Poland,POL,2006,4 +Poland,POL,2007,4 +Poland,POL,2008,4 +Poland,POL,2009,3 +Poland,POL,2010,3 +Poland,POL,2011,3 +Poland,POL,2012,3 +Poland,POL,2013,3 +Poland,POL,2014,2 +Poland,POL,2015,2 +Poland,POL,2016,2 +Poland,POL,2017,2 +Portugal,PRT,2000,10 +Portugal,PRT,2001,10 +Portugal,PRT,2002,10 +Portugal,PRT,2003,10 +Portugal,PRT,2004,10 +Portugal,PRT,2005,9 +Portugal,PRT,2006,9 +Portugal,PRT,2007,9 +Portugal,PRT,2008,9 +Portugal,PRT,2009,9 +Portugal,PRT,2010,9 +Portugal,PRT,2011,9 +Portugal,PRT,2012,9 +Portugal,PRT,2013,8 +Portugal,PRT,2014,8 +Portugal,PRT,2015,9 +Portugal,PRT,2016,9 +Portugal,PRT,2017,8 +Qatar,QAT,2000,14 +Qatar,QAT,2001,14 +Qatar,QAT,2002,13 +Qatar,QAT,2003,13 +Qatar,QAT,2004,13 +Qatar,QAT,2005,12 +Qatar,QAT,2006,11 +Qatar,QAT,2007,11 +Qatar,QAT,2008,11 +Qatar,QAT,2009,10 +Qatar,QAT,2010,10 +Qatar,QAT,2011,10 +Qatar,QAT,2012,10 +Qatar,QAT,2013,10 +Qatar,QAT,2014,10 +Qatar,QAT,2015,9 +Qatar,QAT,2016,9 +Qatar,QAT,2017,9 +Romania,ROU,2000,54 +Romania,ROU,2001,49 +Romania,ROU,2002,47 +Romania,ROU,2003,43 +Romania,ROU,2004,39 +Romania,ROU,2005,35 +Romania,ROU,2006,32 +Romania,ROU,2007,30 +Romania,ROU,2008,28 +Romania,ROU,2009,28 +Romania,ROU,2010,27 +Romania,ROU,2011,24 +Romania,ROU,2012,23 +Romania,ROU,2013,21 +Romania,ROU,2014,21 +Romania,ROU,2015,21 +Romania,ROU,2016,21 +Romania,ROU,2017,19 +Russia,RUS,2000,56 +Russia,RUS,2001,53 +Russia,RUS,2002,51 +Russia,RUS,2003,49 +Russia,RUS,2004,45 +Russia,RUS,2005,42 +Russia,RUS,2006,36 +Russia,RUS,2007,32 +Russia,RUS,2008,30 +Russia,RUS,2009,27 +Russia,RUS,2010,25 +Russia,RUS,2011,23 +Russia,RUS,2012,22 +Russia,RUS,2013,20 +Russia,RUS,2014,19 +Russia,RUS,2015,18 +Russia,RUS,2016,18 +Russia,RUS,2017,17 +Rwanda,RWA,2000,1160 +Rwanda,RWA,2001,1100 +Rwanda,RWA,2002,961 +Rwanda,RWA,2003,870 +Rwanda,RWA,2004,758 +Rwanda,RWA,2005,643 +Rwanda,RWA,2006,541 +Rwanda,RWA,2007,469 +Rwanda,RWA,2008,427 +Rwanda,RWA,2009,424 +Rwanda,RWA,2010,373 +Rwanda,RWA,2011,349 +Rwanda,RWA,2012,329 +Rwanda,RWA,2013,308 +Rwanda,RWA,2014,291 +Rwanda,RWA,2015,275 +Rwanda,RWA,2016,260 +Rwanda,RWA,2017,248 +Saint Lucia,LCA,2000,86 +Saint Lucia,LCA,2001,86 +Saint Lucia,LCA,2002,90 +Saint Lucia,LCA,2003,92 +Saint Lucia,LCA,2004,89 +Saint Lucia,LCA,2005,83 +Saint Lucia,LCA,2006,82 +Saint Lucia,LCA,2007,87 +Saint Lucia,LCA,2008,93 +Saint Lucia,LCA,2009,100 +Saint Lucia,LCA,2010,109 +Saint Lucia,LCA,2011,116 +Saint Lucia,LCA,2012,116 +Saint Lucia,LCA,2013,108 +Saint Lucia,LCA,2014,104 +Saint Lucia,LCA,2015,115 +Saint Lucia,LCA,2016,117 +Saint Lucia,LCA,2017,117 +Saint Vincent and the Grenadines,VCT,2000,80 +Saint Vincent and the Grenadines,VCT,2001,75 +Saint Vincent and the Grenadines,VCT,2002,72 +Saint Vincent and the Grenadines,VCT,2003,69 +Saint Vincent and the Grenadines,VCT,2004,64 +Saint Vincent and the Grenadines,VCT,2005,59 +Saint Vincent and the Grenadines,VCT,2006,62 +Saint Vincent and the Grenadines,VCT,2007,67 +Saint Vincent and the Grenadines,VCT,2008,70 +Saint Vincent and the Grenadines,VCT,2009,67 +Saint Vincent and the Grenadines,VCT,2010,63 +Saint Vincent and the Grenadines,VCT,2011,64 +Saint Vincent and the Grenadines,VCT,2012,71 +Saint Vincent and the Grenadines,VCT,2013,73 +Saint Vincent and the Grenadines,VCT,2014,69 +Saint Vincent and the Grenadines,VCT,2015,64 +Saint Vincent and the Grenadines,VCT,2016,67 +Saint Vincent and the Grenadines,VCT,2017,68 +Samoa,WSM,2000,88 +Samoa,WSM,2001,85 +Samoa,WSM,2002,84 +Samoa,WSM,2003,80 +Samoa,WSM,2004,74 +Samoa,WSM,2005,72 +Samoa,WSM,2006,66 +Samoa,WSM,2007,62 +Samoa,WSM,2008,60 +Samoa,WSM,2009,58 +Samoa,WSM,2010,58 +Samoa,WSM,2011,54 +Samoa,WSM,2012,52 +Samoa,WSM,2013,48 +Samoa,WSM,2014,47 +Samoa,WSM,2015,45 +Samoa,WSM,2016,44 +Samoa,WSM,2017,43 +Sao Tome and Principe,STP,2000,179 +Sao Tome and Principe,STP,2001,173 +Sao Tome and Principe,STP,2002,169 +Sao Tome and Principe,STP,2003,167 +Sao Tome and Principe,STP,2004,166 +Sao Tome and Principe,STP,2005,163 +Sao Tome and Principe,STP,2006,158 +Sao Tome and Principe,STP,2007,154 +Sao Tome and Principe,STP,2008,150 +Sao Tome and Principe,STP,2009,145 +Sao Tome and Principe,STP,2010,140 +Sao Tome and Principe,STP,2011,137 +Sao Tome and Principe,STP,2012,134 +Sao Tome and Principe,STP,2013,132 +Sao Tome and Principe,STP,2014,131 +Sao Tome and Principe,STP,2015,130 +Sao Tome and Principe,STP,2016,130 +Sao Tome and Principe,STP,2017,130 +Saudi Arabia,SAU,2000,24 +Saudi Arabia,SAU,2001,24 +Saudi Arabia,SAU,2002,23 +Saudi Arabia,SAU,2003,23 +Saudi Arabia,SAU,2004,22 +Saudi Arabia,SAU,2005,22 +Saudi Arabia,SAU,2006,21 +Saudi Arabia,SAU,2007,21 +Saudi Arabia,SAU,2008,20 +Saudi Arabia,SAU,2009,20 +Saudi Arabia,SAU,2010,19 +Saudi Arabia,SAU,2011,18 +Saudi Arabia,SAU,2012,18 +Saudi Arabia,SAU,2013,17 +Saudi Arabia,SAU,2014,17 +Saudi Arabia,SAU,2015,17 +Saudi Arabia,SAU,2016,17 +Saudi Arabia,SAU,2017,17 +Senegal,SEN,2000,553 +Senegal,SEN,2001,545 +Senegal,SEN,2002,537 +Senegal,SEN,2003,532 +Senegal,SEN,2004,526 +Senegal,SEN,2005,519 +Senegal,SEN,2006,514 +Senegal,SEN,2007,504 +Senegal,SEN,2008,492 +Senegal,SEN,2009,472 +Senegal,SEN,2010,447 +Senegal,SEN,2011,423 +Senegal,SEN,2012,400 +Senegal,SEN,2013,381 +Senegal,SEN,2014,364 +Senegal,SEN,2015,346 +Senegal,SEN,2016,330 +Senegal,SEN,2017,315 +Serbia,SRB,2000,13 +Serbia,SRB,2001,13 +Serbia,SRB,2002,13 +Serbia,SRB,2003,13 +Serbia,SRB,2004,13 +Serbia,SRB,2005,12 +Serbia,SRB,2006,12 +Serbia,SRB,2007,12 +Serbia,SRB,2008,12 +Serbia,SRB,2009,12 +Serbia,SRB,2010,12 +Serbia,SRB,2011,12 +Serbia,SRB,2012,12 +Serbia,SRB,2013,12 +Serbia,SRB,2014,12 +Serbia,SRB,2015,13 +Serbia,SRB,2016,12 +Serbia,SRB,2017,12 +Seychelles,SYC,2000,53 +Seychelles,SYC,2001,54 +Seychelles,SYC,2002,54 +Seychelles,SYC,2003,54 +Seychelles,SYC,2004,55 +Seychelles,SYC,2005,55 +Seychelles,SYC,2006,55 +Seychelles,SYC,2007,55 +Seychelles,SYC,2008,55 +Seychelles,SYC,2009,55 +Seychelles,SYC,2010,55 +Seychelles,SYC,2011,55 +Seychelles,SYC,2012,55 +Seychelles,SYC,2013,55 +Seychelles,SYC,2014,55 +Seychelles,SYC,2015,54 +Seychelles,SYC,2016,54 +Seychelles,SYC,2017,53 +Sierra Leone,SLE,2000,2480 +Sierra Leone,SLE,2001,2250 +Sierra Leone,SLE,2002,2080 +Sierra Leone,SLE,2003,1960 +Sierra Leone,SLE,2004,1850 +Sierra Leone,SLE,2005,1760 +Sierra Leone,SLE,2006,1680 +Sierra Leone,SLE,2007,1610 +Sierra Leone,SLE,2008,1530 +Sierra Leone,SLE,2009,1450 +Sierra Leone,SLE,2010,1360 +Sierra Leone,SLE,2011,1270 +Sierra Leone,SLE,2012,1210 +Sierra Leone,SLE,2013,1180 +Sierra Leone,SLE,2014,1190 +Sierra Leone,SLE,2015,1180 +Sierra Leone,SLE,2016,1120 +Sierra Leone,SLE,2017,1120 +Singapore,SGP,2000,13 +Singapore,SGP,2001,13 +Singapore,SGP,2002,14 +Singapore,SGP,2003,13 +Singapore,SGP,2004,14 +Singapore,SGP,2005,13 +Singapore,SGP,2006,13 +Singapore,SGP,2007,12 +Singapore,SGP,2008,11 +Singapore,SGP,2009,10 +Singapore,SGP,2010,10 +Singapore,SGP,2011,10 +Singapore,SGP,2012,10 +Singapore,SGP,2013,9 +Singapore,SGP,2014,8 +Singapore,SGP,2015,9 +Singapore,SGP,2016,8 +Singapore,SGP,2017,8 +Slovakia,SVK,2000,8 +Slovakia,SVK,2001,8 +Slovakia,SVK,2002,7 +Slovakia,SVK,2003,7 +Slovakia,SVK,2004,7 +Slovakia,SVK,2005,7 +Slovakia,SVK,2006,6 +Slovakia,SVK,2007,7 +Slovakia,SVK,2008,6 +Slovakia,SVK,2009,6 +Slovakia,SVK,2010,6 +Slovakia,SVK,2011,6 +Slovakia,SVK,2012,6 +Slovakia,SVK,2013,6 +Slovakia,SVK,2014,5 +Slovakia,SVK,2015,6 +Slovakia,SVK,2016,6 +Slovakia,SVK,2017,5 +Slovenia,SVN,2000,12 +Slovenia,SVN,2001,10 +Slovenia,SVN,2002,11 +Slovenia,SVN,2003,10 +Slovenia,SVN,2004,11 +Slovenia,SVN,2005,10 +Slovenia,SVN,2006,8 +Slovenia,SVN,2007,8 +Slovenia,SVN,2008,8 +Slovenia,SVN,2009,8 +Slovenia,SVN,2010,8 +Slovenia,SVN,2011,8 +Slovenia,SVN,2012,7 +Slovenia,SVN,2013,7 +Slovenia,SVN,2014,7 +Slovenia,SVN,2015,7 +Slovenia,SVN,2016,7 +Slovenia,SVN,2017,7 +Solomon Islands,SLB,2000,245 +Solomon Islands,SLB,2001,233 +Solomon Islands,SLB,2002,222 +Solomon Islands,SLB,2003,210 +Solomon Islands,SLB,2004,199 +Solomon Islands,SLB,2005,188 +Solomon Islands,SLB,2006,177 +Solomon Islands,SLB,2007,172 +Solomon Islands,SLB,2008,159 +Solomon Islands,SLB,2009,152 +Solomon Islands,SLB,2010,141 +Solomon Islands,SLB,2011,134 +Solomon Islands,SLB,2012,127 +Solomon Islands,SLB,2013,122 +Solomon Islands,SLB,2014,120 +Solomon Islands,SLB,2015,112 +Solomon Islands,SLB,2016,108 +Solomon Islands,SLB,2017,104 +Somalia,SOM,2000,1210 +Somalia,SOM,2001,1170 +Somalia,SOM,2002,1140 +Somalia,SOM,2003,1100 +Somalia,SOM,2004,1080 +Somalia,SOM,2005,1040 +Somalia,SOM,2006,1040 +Somalia,SOM,2007,1030 +Somalia,SOM,2008,1010 +Somalia,SOM,2009,994 +Somalia,SOM,2010,985 +Somalia,SOM,2011,955 +Somalia,SOM,2012,943 +Somalia,SOM,2013,893 +Somalia,SOM,2014,878 +Somalia,SOM,2015,855 +Somalia,SOM,2016,865 +Somalia,SOM,2017,829 +South Africa,ZAF,2000,160 +South Africa,ZAF,2001,168 +South Africa,ZAF,2002,177 +South Africa,ZAF,2003,186 +South Africa,ZAF,2004,195 +South Africa,ZAF,2005,201 +South Africa,ZAF,2006,201 +South Africa,ZAF,2007,199 +South Africa,ZAF,2008,191 +South Africa,ZAF,2009,179 +South Africa,ZAF,2010,171 +South Africa,ZAF,2011,161 +South Africa,ZAF,2012,143 +South Africa,ZAF,2013,133 +South Africa,ZAF,2014,128 +South Africa,ZAF,2015,125 +South Africa,ZAF,2016,122 +South Africa,ZAF,2017,119 +South Korea,KOR,2000,17 +South Korea,KOR,2001,15 +South Korea,KOR,2002,15 +South Korea,KOR,2003,16 +South Korea,KOR,2004,15 +South Korea,KOR,2005,15 +South Korea,KOR,2006,14 +South Korea,KOR,2007,15 +South Korea,KOR,2008,15 +South Korea,KOR,2009,16 +South Korea,KOR,2010,15 +South Korea,KOR,2011,14 +South Korea,KOR,2012,13 +South Korea,KOR,2013,13 +South Korea,KOR,2014,12 +South Korea,KOR,2015,12 +South Korea,KOR,2016,11 +South Korea,KOR,2017,11 +South Sudan,SSD,2000,1730 +South Sudan,SSD,2001,1690 +South Sudan,SSD,2002,1660 +South Sudan,SSD,2003,1610 +South Sudan,SSD,2004,1550 +South Sudan,SSD,2005,1480 +South Sudan,SSD,2006,1410 +South Sudan,SSD,2007,1330 +South Sudan,SSD,2008,1250 +South Sudan,SSD,2009,1170 +South Sudan,SSD,2010,1100 +South Sudan,SSD,2011,1070 +South Sudan,SSD,2012,1050 +South Sudan,SSD,2013,1090 +South Sudan,SSD,2014,1140 +South Sudan,SSD,2015,1110 +South Sudan,SSD,2016,1130 +South Sudan,SSD,2017,1150 +South-east Asia,,2000,355 +South-east Asia,,2001,341 +South-east Asia,,2002,326 +South-east Asia,,2003,311 +South-east Asia,,2004,297 +South-east Asia,,2005,280 +South-east Asia,,2006,266 +South-east Asia,,2007,252 +South-east Asia,,2008,239 +South-east Asia,,2009,226 +South-east Asia,,2010,214 +South-east Asia,,2011,202 +South-east Asia,,2012,191 +South-east Asia,,2013,182 +South-east Asia,,2014,173 +South-east Asia,,2015,165 +South-east Asia,,2016,157 +South-east Asia,,2017,152 +Spain,ESP,2000,5 +Spain,ESP,2001,5 +Spain,ESP,2002,5 +Spain,ESP,2003,5 +Spain,ESP,2004,5 +Spain,ESP,2005,5 +Spain,ESP,2006,4 +Spain,ESP,2007,4 +Spain,ESP,2008,4 +Spain,ESP,2009,4 +Spain,ESP,2010,4 +Spain,ESP,2011,4 +Spain,ESP,2012,4 +Spain,ESP,2013,4 +Spain,ESP,2014,4 +Spain,ESP,2015,4 +Spain,ESP,2016,4 +Spain,ESP,2017,4 +Sri Lanka,LKA,2000,56 +Sri Lanka,LKA,2001,53 +Sri Lanka,LKA,2002,50 +Sri Lanka,LKA,2003,50 +Sri Lanka,LKA,2004,48 +Sri Lanka,LKA,2005,45 +Sri Lanka,LKA,2006,47 +Sri Lanka,LKA,2007,43 +Sri Lanka,LKA,2008,42 +Sri Lanka,LKA,2009,41 +Sri Lanka,LKA,2010,38 +Sri Lanka,LKA,2011,38 +Sri Lanka,LKA,2012,37 +Sri Lanka,LKA,2013,37 +Sri Lanka,LKA,2014,36 +Sri Lanka,LKA,2015,36 +Sri Lanka,LKA,2016,36 +Sri Lanka,LKA,2017,36 +Sudan,SDN,2000,667 +Sudan,SDN,2001,645 +Sudan,SDN,2002,614 +Sudan,SDN,2003,598 +Sudan,SDN,2004,580 +Sudan,SDN,2005,529 +Sudan,SDN,2006,508 +Sudan,SDN,2007,479 +Sudan,SDN,2008,454 +Sudan,SDN,2009,433 +Sudan,SDN,2010,408 +Sudan,SDN,2011,390 +Sudan,SDN,2012,368 +Sudan,SDN,2013,349 +Sudan,SDN,2014,333 +Sudan,SDN,2015,320 +Sudan,SDN,2016,308 +Sudan,SDN,2017,295 +Suriname,SUR,2000,221 +Suriname,SUR,2001,218 +Suriname,SUR,2002,207 +Suriname,SUR,2003,189 +Suriname,SUR,2004,176 +Suriname,SUR,2005,164 +Suriname,SUR,2006,165 +Suriname,SUR,2007,167 +Suriname,SUR,2008,169 +Suriname,SUR,2009,159 +Suriname,SUR,2010,148 +Suriname,SUR,2011,139 +Suriname,SUR,2012,134 +Suriname,SUR,2013,129 +Suriname,SUR,2014,124 +Suriname,SUR,2015,122 +Suriname,SUR,2016,121 +Suriname,SUR,2017,120 +Sweden,SWE,2000,5 +Sweden,SWE,2001,5 +Sweden,SWE,2002,5 +Sweden,SWE,2003,5 +Sweden,SWE,2004,5 +Sweden,SWE,2005,5 +Sweden,SWE,2006,5 +Sweden,SWE,2007,5 +Sweden,SWE,2008,5 +Sweden,SWE,2009,5 +Sweden,SWE,2010,4 +Sweden,SWE,2011,5 +Sweden,SWE,2012,5 +Sweden,SWE,2013,5 +Sweden,SWE,2014,5 +Sweden,SWE,2015,4 +Sweden,SWE,2016,4 +Sweden,SWE,2017,4 +Switzerland,CHE,2000,7 +Switzerland,CHE,2001,7 +Switzerland,CHE,2002,7 +Switzerland,CHE,2003,7 +Switzerland,CHE,2004,7 +Switzerland,CHE,2005,7 +Switzerland,CHE,2006,7 +Switzerland,CHE,2007,6 +Switzerland,CHE,2008,6 +Switzerland,CHE,2009,6 +Switzerland,CHE,2010,6 +Switzerland,CHE,2011,6 +Switzerland,CHE,2012,6 +Switzerland,CHE,2013,6 +Switzerland,CHE,2014,5 +Switzerland,CHE,2015,5 +Switzerland,CHE,2016,5 +Switzerland,CHE,2017,5 +Syria,SYR,2000,26 +Syria,SYR,2001,26 +Syria,SYR,2002,26 +Syria,SYR,2003,25 +Syria,SYR,2004,26 +Syria,SYR,2005,25 +Syria,SYR,2006,26 +Syria,SYR,2007,26 +Syria,SYR,2008,26 +Syria,SYR,2009,26 +Syria,SYR,2010,27 +Syria,SYR,2011,28 +Syria,SYR,2012,28 +Syria,SYR,2013,29 +Syria,SYR,2014,30 +Syria,SYR,2015,30 +Syria,SYR,2016,30 +Syria,SYR,2017,31 +Tajikistan,TJK,2000,53 +Tajikistan,TJK,2001,52 +Tajikistan,TJK,2002,43 +Tajikistan,TJK,2003,35 +Tajikistan,TJK,2004,33 +Tajikistan,TJK,2005,32 +Tajikistan,TJK,2006,29 +Tajikistan,TJK,2007,27 +Tajikistan,TJK,2008,26 +Tajikistan,TJK,2009,26 +Tajikistan,TJK,2010,23 +Tajikistan,TJK,2011,22 +Tajikistan,TJK,2012,21 +Tajikistan,TJK,2013,20 +Tajikistan,TJK,2014,19 +Tajikistan,TJK,2015,18 +Tajikistan,TJK,2016,17 +Tajikistan,TJK,2017,17 +Tanzania,TZA,2000,854 +Tanzania,TZA,2001,819 +Tanzania,TZA,2002,788 +Tanzania,TZA,2003,763 +Tanzania,TZA,2004,741 +Tanzania,TZA,2005,721 +Tanzania,TZA,2006,703 +Tanzania,TZA,2007,685 +Tanzania,TZA,2008,666 +Tanzania,TZA,2009,656 +Tanzania,TZA,2010,644 +Tanzania,TZA,2011,628 +Tanzania,TZA,2012,615 +Tanzania,TZA,2013,593 +Tanzania,TZA,2014,574 +Tanzania,TZA,2015,556 +Tanzania,TZA,2016,539 +Tanzania,TZA,2017,524 +Thailand,THA,2000,43 +Thailand,THA,2001,43 +Thailand,THA,2002,44 +Thailand,THA,2003,44 +Thailand,THA,2004,46 +Thailand,THA,2005,43 +Thailand,THA,2006,42 +Thailand,THA,2007,42 +Thailand,THA,2008,43 +Thailand,THA,2009,43 +Thailand,THA,2010,42 +Thailand,THA,2011,41 +Thailand,THA,2012,39 +Thailand,THA,2013,39 +Thailand,THA,2014,38 +Thailand,THA,2015,38 +Thailand,THA,2016,37 +Thailand,THA,2017,37 +Togo,TGO,2000,489 +Togo,TGO,2001,489 +Togo,TGO,2002,489 +Togo,TGO,2003,489 +Togo,TGO,2004,488 +Togo,TGO,2005,492 +Togo,TGO,2006,482 +Togo,TGO,2007,480 +Togo,TGO,2008,473 +Togo,TGO,2009,458 +Togo,TGO,2010,440 +Togo,TGO,2011,422 +Togo,TGO,2012,410 +Togo,TGO,2013,404 +Togo,TGO,2014,401 +Togo,TGO,2015,398 +Togo,TGO,2016,395 +Togo,TGO,2017,396 +Tonga,TON,2000,77 +Tonga,TON,2001,73 +Tonga,TON,2002,71 +Tonga,TON,2003,69 +Tonga,TON,2004,67 +Tonga,TON,2005,66 +Tonga,TON,2006,64 +Tonga,TON,2007,62 +Tonga,TON,2008,60 +Tonga,TON,2009,61 +Tonga,TON,2010,57 +Tonga,TON,2011,56 +Tonga,TON,2012,56 +Tonga,TON,2013,56 +Tonga,TON,2014,55 +Tonga,TON,2015,54 +Tonga,TON,2016,53 +Tonga,TON,2017,52 +Trinidad and Tobago,TTO,2000,81 +Trinidad and Tobago,TTO,2001,78 +Trinidad and Tobago,TTO,2002,74 +Trinidad and Tobago,TTO,2003,75 +Trinidad and Tobago,TTO,2004,76 +Trinidad and Tobago,TTO,2005,76 +Trinidad and Tobago,TTO,2006,73 +Trinidad and Tobago,TTO,2007,65 +Trinidad and Tobago,TTO,2008,72 +Trinidad and Tobago,TTO,2009,74 +Trinidad and Tobago,TTO,2010,71 +Trinidad and Tobago,TTO,2011,72 +Trinidad and Tobago,TTO,2012,71 +Trinidad and Tobago,TTO,2013,70 +Trinidad and Tobago,TTO,2014,69 +Trinidad and Tobago,TTO,2015,68 +Trinidad and Tobago,TTO,2016,68 +Trinidad and Tobago,TTO,2017,67 +Tunisia,TUN,2000,66 +Tunisia,TUN,2001,63 +Tunisia,TUN,2002,60 +Tunisia,TUN,2003,57 +Tunisia,TUN,2004,54 +Tunisia,TUN,2005,51 +Tunisia,TUN,2006,49 +Tunisia,TUN,2007,47 +Tunisia,TUN,2008,47 +Tunisia,TUN,2009,46 +Tunisia,TUN,2010,46 +Tunisia,TUN,2011,46 +Tunisia,TUN,2012,46 +Tunisia,TUN,2013,46 +Tunisia,TUN,2014,46 +Tunisia,TUN,2015,46 +Tunisia,TUN,2016,45 +Tunisia,TUN,2017,43 +Turkey,TUR,2000,42 +Turkey,TUR,2001,41 +Turkey,TUR,2002,39 +Turkey,TUR,2003,38 +Turkey,TUR,2004,35 +Turkey,TUR,2005,33 +Turkey,TUR,2006,30 +Turkey,TUR,2007,28 +Turkey,TUR,2008,27 +Turkey,TUR,2009,25 +Turkey,TUR,2010,24 +Turkey,TUR,2011,23 +Turkey,TUR,2012,22 +Turkey,TUR,2013,20 +Turkey,TUR,2014,19 +Turkey,TUR,2015,19 +Turkey,TUR,2016,18 +Turkey,TUR,2017,17 +Turkmenistan,TKM,2000,29 +Turkmenistan,TKM,2001,27 +Turkmenistan,TKM,2002,25 +Turkmenistan,TKM,2003,21 +Turkmenistan,TKM,2004,20 +Turkmenistan,TKM,2005,18 +Turkmenistan,TKM,2006,18 +Turkmenistan,TKM,2007,15 +Turkmenistan,TKM,2008,13 +Turkmenistan,TKM,2009,12 +Turkmenistan,TKM,2010,10 +Turkmenistan,TKM,2011,10 +Turkmenistan,TKM,2012,9 +Turkmenistan,TKM,2013,9 +Turkmenistan,TKM,2014,8 +Turkmenistan,TKM,2015,8 +Turkmenistan,TKM,2016,8 +Turkmenistan,TKM,2017,7 +Uganda,UGA,2000,578 +Uganda,UGA,2001,550 +Uganda,UGA,2002,537 +Uganda,UGA,2003,520 +Uganda,UGA,2004,512 +Uganda,UGA,2005,491 +Uganda,UGA,2006,473 +Uganda,UGA,2007,465 +Uganda,UGA,2008,455 +Uganda,UGA,2009,442 +Uganda,UGA,2010,430 +Uganda,UGA,2011,419 +Uganda,UGA,2012,412 +Uganda,UGA,2013,401 +Uganda,UGA,2014,394 +Uganda,UGA,2015,387 +Uganda,UGA,2016,381 +Uganda,UGA,2017,375 +Ukraine,UKR,2000,35 +Ukraine,UKR,2001,33 +Ukraine,UKR,2002,33 +Ukraine,UKR,2003,32 +Ukraine,UKR,2004,33 +Ukraine,UKR,2005,33 +Ukraine,UKR,2006,31 +Ukraine,UKR,2007,33 +Ukraine,UKR,2008,33 +Ukraine,UKR,2009,27 +Ukraine,UKR,2010,25 +Ukraine,UKR,2011,23 +Ukraine,UKR,2012,24 +Ukraine,UKR,2013,23 +Ukraine,UKR,2014,24 +Ukraine,UKR,2015,21 +Ukraine,UKR,2016,20 +Ukraine,UKR,2017,19 +United Arab Emirates,ARE,2000,6 +United Arab Emirates,ARE,2001,6 +United Arab Emirates,ARE,2002,5 +United Arab Emirates,ARE,2003,5 +United Arab Emirates,ARE,2004,5 +United Arab Emirates,ARE,2005,5 +United Arab Emirates,ARE,2006,4 +United Arab Emirates,ARE,2007,4 +United Arab Emirates,ARE,2008,4 +United Arab Emirates,ARE,2009,4 +United Arab Emirates,ARE,2010,4 +United Arab Emirates,ARE,2011,4 +United Arab Emirates,ARE,2012,4 +United Arab Emirates,ARE,2013,3 +United Arab Emirates,ARE,2014,3 +United Arab Emirates,ARE,2015,3 +United Arab Emirates,ARE,2016,3 +United Arab Emirates,ARE,2017,3 +United Kingdom,GBR,2000,10 +United Kingdom,GBR,2001,11 +United Kingdom,GBR,2002,11 +United Kingdom,GBR,2003,11 +United Kingdom,GBR,2004,11 +United Kingdom,GBR,2005,11 +United Kingdom,GBR,2006,11 +United Kingdom,GBR,2007,11 +United Kingdom,GBR,2008,11 +United Kingdom,GBR,2009,10 +United Kingdom,GBR,2010,10 +United Kingdom,GBR,2011,9 +United Kingdom,GBR,2012,8 +United Kingdom,GBR,2013,8 +United Kingdom,GBR,2014,8 +United Kingdom,GBR,2015,8 +United Kingdom,GBR,2016,7 +United Kingdom,GBR,2017,7 +United States,USA,2000,12 +United States,USA,2001,13 +United States,USA,2002,13 +United States,USA,2003,13 +United States,USA,2004,13 +United States,USA,2005,13 +United States,USA,2006,14 +United States,USA,2007,14 +United States,USA,2008,14 +United States,USA,2009,15 +United States,USA,2010,15 +United States,USA,2011,15 +United States,USA,2012,16 +United States,USA,2013,16 +United States,USA,2014,16 +United States,USA,2015,18 +United States,USA,2016,19 +United States,USA,2017,19 +Uruguay,URY,2000,26 +Uruguay,URY,2001,25 +Uruguay,URY,2002,25 +Uruguay,URY,2003,23 +Uruguay,URY,2004,23 +Uruguay,URY,2005,22 +Uruguay,URY,2006,20 +Uruguay,URY,2007,20 +Uruguay,URY,2008,19 +Uruguay,URY,2009,19 +Uruguay,URY,2010,17 +Uruguay,URY,2011,17 +Uruguay,URY,2012,17 +Uruguay,URY,2013,18 +Uruguay,URY,2014,17 +Uruguay,URY,2015,18 +Uruguay,URY,2016,18 +Uruguay,URY,2017,17 +Uzbekistan,UZB,2000,41 +Uzbekistan,UZB,2001,41 +Uzbekistan,UZB,2002,41 +Uzbekistan,UZB,2003,39 +Uzbekistan,UZB,2004,37 +Uzbekistan,UZB,2005,38 +Uzbekistan,UZB,2006,37 +Uzbekistan,UZB,2007,35 +Uzbekistan,UZB,2008,34 +Uzbekistan,UZB,2009,32 +Uzbekistan,UZB,2010,31 +Uzbekistan,UZB,2011,32 +Uzbekistan,UZB,2012,32 +Uzbekistan,UZB,2013,31 +Uzbekistan,UZB,2014,30 +Uzbekistan,UZB,2015,30 +Uzbekistan,UZB,2016,29 +Uzbekistan,UZB,2017,29 +Vanuatu,VUT,2000,140 +Vanuatu,VUT,2001,135 +Vanuatu,VUT,2002,128 +Vanuatu,VUT,2003,123 +Vanuatu,VUT,2004,119 +Vanuatu,VUT,2005,113 +Vanuatu,VUT,2006,108 +Vanuatu,VUT,2007,103 +Vanuatu,VUT,2008,99 +Vanuatu,VUT,2009,96 +Vanuatu,VUT,2010,92 +Vanuatu,VUT,2011,88 +Vanuatu,VUT,2012,85 +Vanuatu,VUT,2013,82 +Vanuatu,VUT,2014,80 +Vanuatu,VUT,2015,76 +Vanuatu,VUT,2016,74 +Vanuatu,VUT,2017,72 +Venezuela,VEN,2000,119 +Venezuela,VEN,2001,123 +Venezuela,VEN,2002,135 +Venezuela,VEN,2003,127 +Venezuela,VEN,2004,119 +Venezuela,VEN,2005,113 +Venezuela,VEN,2006,114 +Venezuela,VEN,2007,114 +Venezuela,VEN,2008,116 +Venezuela,VEN,2009,119 +Venezuela,VEN,2010,117 +Venezuela,VEN,2011,116 +Venezuela,VEN,2012,116 +Venezuela,VEN,2013,115 +Venezuela,VEN,2014,113 +Venezuela,VEN,2015,115 +Venezuela,VEN,2016,121 +Venezuela,VEN,2017,125 +Vietnam,VNM,2000,68 +Vietnam,VNM,2001,65 +Vietnam,VNM,2002,62 +Vietnam,VNM,2003,59 +Vietnam,VNM,2004,57 +Vietnam,VNM,2005,54 +Vietnam,VNM,2006,51 +Vietnam,VNM,2007,49 +Vietnam,VNM,2008,49 +Vietnam,VNM,2009,48 +Vietnam,VNM,2010,47 +Vietnam,VNM,2011,47 +Vietnam,VNM,2012,46 +Vietnam,VNM,2013,46 +Vietnam,VNM,2014,45 +Vietnam,VNM,2015,45 +Vietnam,VNM,2016,44 +Vietnam,VNM,2017,43 +Western Pacific,,2000,75 +Western Pacific,,2001,72 +Western Pacific,,2002,69 +Western Pacific,,2003,66 +Western Pacific,,2004,63 +Western Pacific,,2005,61 +Western Pacific,,2006,59 +Western Pacific,,2007,56 +Western Pacific,,2008,55 +Western Pacific,,2009,53 +Western Pacific,,2010,51 +Western Pacific,,2011,49 +Western Pacific,,2012,47 +Western Pacific,,2013,46 +Western Pacific,,2014,44 +Western Pacific,,2015,43 +Western Pacific,,2016,42 +Western Pacific,,2017,41 +World,OWID_WRL,2000,342 +World,OWID_WRL,2001,335 +World,OWID_WRL,2002,328 +World,OWID_WRL,2003,319 +World,OWID_WRL,2004,309 +World,OWID_WRL,2005,296 +World,OWID_WRL,2006,284 +World,OWID_WRL,2007,274 +World,OWID_WRL,2008,265 +World,OWID_WRL,2009,257 +World,OWID_WRL,2010,248 +World,OWID_WRL,2011,241 +World,OWID_WRL,2012,234 +World,OWID_WRL,2013,229 +World,OWID_WRL,2014,224 +World,OWID_WRL,2015,219 +World,OWID_WRL,2016,214 +World,OWID_WRL,2017,211 +Yemen,YEM,2000,301 +Yemen,YEM,2001,290 +Yemen,YEM,2002,278 +Yemen,YEM,2003,266 +Yemen,YEM,2004,254 +Yemen,YEM,2005,242 +Yemen,YEM,2006,230 +Yemen,YEM,2007,219 +Yemen,YEM,2008,208 +Yemen,YEM,2009,200 +Yemen,YEM,2010,192 +Yemen,YEM,2011,187 +Yemen,YEM,2012,184 +Yemen,YEM,2013,175 +Yemen,YEM,2014,174 +Yemen,YEM,2015,169 +Yemen,YEM,2016,165 +Yemen,YEM,2017,164 +Zambia,ZMB,2000,528 +Zambia,ZMB,2001,491 +Zambia,ZMB,2002,465 +Zambia,ZMB,2003,453 +Zambia,ZMB,2004,437 +Zambia,ZMB,2005,421 +Zambia,ZMB,2006,406 +Zambia,ZMB,2007,387 +Zambia,ZMB,2008,356 +Zambia,ZMB,2009,329 +Zambia,ZMB,2010,305 +Zambia,ZMB,2011,283 +Zambia,ZMB,2012,267 +Zambia,ZMB,2013,254 +Zambia,ZMB,2014,242 +Zambia,ZMB,2015,232 +Zambia,ZMB,2016,222 +Zambia,ZMB,2017,213 +Zimbabwe,ZWE,2000,579 +Zimbabwe,ZWE,2001,629 +Zimbabwe,ZWE,2002,666 +Zimbabwe,ZWE,2003,680 +Zimbabwe,ZWE,2004,686 +Zimbabwe,ZWE,2005,685 +Zimbabwe,ZWE,2006,680 +Zimbabwe,ZWE,2007,671 +Zimbabwe,ZWE,2008,657 +Zimbabwe,ZWE,2009,632 +Zimbabwe,ZWE,2010,598 +Zimbabwe,ZWE,2011,557 +Zimbabwe,ZWE,2012,528 +Zimbabwe,ZWE,2013,509 +Zimbabwe,ZWE,2014,494 +Zimbabwe,ZWE,2015,480 +Zimbabwe,ZWE,2016,468 +Zimbabwe,ZWE,2017,458 \ No newline at end of file diff --git a/exercicios/para-casa/exercicioCrisPereira/maternal_mortality.db b/exercicios/para-casa/exercicioCrisPereira/maternal_mortality.db new file mode 100644 index 0000000..c383cb8 Binary files /dev/null and b/exercicios/para-casa/exercicioCrisPereira/maternal_mortality.db differ